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Summary 
The work presented in this thesis deals with the employment of Schiff base ligands used to 
synthesise novel 3d-4f polynuclear coordination clusters (PCCs) and the investigation into their 
potential magnetic, luminescent and catalytic properties. 
Chapter one provides a general introduction to the chemistry described in the thesis. It includes a 
general overview of 3d-4f PCC chemistry and the applications of these materials and previous 
synthetic strategies for the preparation of Schiff base PCCs. A rationale is presented for the 
ligands employed in the thesis and a synthetic strategy is devised for the synthesis of specific 
materials. 
The initial chapters are focused on the synthesis of 3d-4f PCCs with novel core topologies and 
the study of their magnetic properties. Several novel series of 3d-4f PCCs are presented with 
unique core topologies which are previously unobserved in 3d-4f PCC chemistry. In addition, 
some of the presented PCCs display single-molecule magnet (SMM) properties or a significant 
magnetocaloric effect (MCE). 
Chapter five bridges synthetic aspects discussed in the previous chapters, with a synthetic study 
targeting 3d-4f PCCs with a defect dicubane core (2,3M4-1) and introduces the term “isoskeletal” 
to describe PCCs which possess the same topology or related organic structures with the same 
host framework but different guests.  
Chapters seven to nine are focused on the development of a well characterised isoskeletal family 
of 3d-4f PCCs with a defect dicubane core and the investigation of their potential catalytic 
properties in a range of organic reactions including Michael Addition, Friedel-Crafts alkylations 
and multicomponent reactions. Characterisation of the 3d-4f PCCs is emphasised and verifies the 
stability of the 2,3M4-1 core in solution. An attempt at understanding the catalytic system and 
mechanistic aspects is undertaken, which is not explored in previously reported 3d-4f PCC co-
operative catalysis. 
Chapter ten provides an overall conclusion to the work presented in the thesis, whilst highlighting 
the contributions of this work to the reported literature.  
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Synopsis 
The initial chapters of this thesis present the synthesis and characterisation of novel 3d-4f 
Polynuclear Coordination Clusters (PCCs), which exhibit a range of core topologies, some of 
which demonstrate fascinating magnetic properties and luminescent behaviour. In addition, the 
latter half of this work introduces the concept of “isoskeletal” PCCs and offers a different 
perspective, with the first tetranuclear 3d-4f PCCs with the potential to act as catalysts for organic 
transformations described. This series of 3d-4f PCC catalysts are well characterised in solid and 
solution state and mechanistic aspects are probed and analysed using a wide range of techniques.  
Chapter 1 provides a general introduction to the chemistry described in this thesis. It includes a 
general overview of 3d-4f PCC chemistry and the previous applications of these materials. 
Synthetic strategies for the preparation of Schiff base PCCs are also discussed. In addition, a 
rationale is presented for the ligands employed in this thesis along with a synthetic strategy for 
the design of specific materials.  
In chapter 2, twelve heterometallic ZnII-LnIII PCCs (1 - 12) have been synthesised using H2L1-
H3L3 through serendipitous assembly and a systematic variation of reaction conditions. The first 
examples, [ZnII2LnIII2(L1)4(EtOH)6](ClO4)2 (1-3) possess a defect dicubane topology and are the 
second examples of the 2,3M4-1 topology with a ZnII2LnIII2 core supported by H2L1. With the 
omission of perchlorate counter-ions PCCs with the general formula [ZnII5LnIII(OH)(L1)6(H2O)] 
(4 - 6) are formed with a 2,3,4M6-1 core. The incorporation of acetate counter-ions with H2L2 
resulted in the same 2,3,4M6-1 topology, but with a PCCs formulated [ZnII4LnIII2(OH)2(L2)4 
(OAc)2(NO3)2(DMF)3]·DMF (7-9). Compounds 4 - 9 are the first reported examples of the 
2,3,4M6-1 topology in ZnII-LnIII chemistry. Finally, a tetranuclear series with the general formula 
[ZnII2LnIII2(L3)2(NO3)2(CO3)2(CH3OH)2] (10-12) are formed from 
[ZnIILnIII(HL3)(NO3)(MeOH)] moieties bridges by carbonate ions. A Single Molecule Magnet 
(SMM) response was not detected for 1 and 10, however, ac measurements indicate that 7 is a 
Single Ion Magnet (SIM), with an energy barrier (Ueff) of 10.2 K and τ0 = 7.1·10
-6 s. The crystal 
structures of two novel species are also presented including ZnII4DyIII7 (13) (2,4,4,4M11-1) and 
ZnII6DyIII4 (14) (2,2,3M10-1).  
In chapter 3 a series of hexanuclear isoskeletal [CoII4LnIII2(µ3-OH)2(L1)4Cl2(NO3)2(MeOH)4] 
·3(Et2O) PCCs (15-19) with the 2,3,4M6-1 topology were synthesised from H2L1 and H2L5. 
These are the first examples of CoII4LnIII2 PCCs displaying the 2,3,4M6-1 topology and the second 
example of the topology in CoII-LnIII chemistry. Magnetic studies show that DyIII (17) and TbIII 
(18) analogues display ferromagnetic interactions. Compound 17 (DyIII) exhibits an out-of-phase 
signal χ’’ in ac susceptibility measurements with an energy barrier of (Ueff) = 13.4 K and τ0 = 
8.5×10-7 s. 
2 
 
 
In chapter 4, five heptametallic MII3LnIII4 disk-like PCCs are described supported by the 
monoanionic HL4 ligand, with the formulas [CoII3LnIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 (Ln = 
Gd (20), Y (21)) and [NiII3LnIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 (Ln = Dy (22), Gd (23), Y(24) 
which are isoskeletal analogues of the previously reported CoII3LnIII4 cluster.1 Synthetic issues are 
identified and the methodology is adapted for more reliable crystallisation which results in higher 
yields of targeted species. The MII3LnIII4 core is enumerated 3,6M7-1 and the NiII-LnIII series are 
the first examples of NiII-LnIII disks and the third examples of CoII-LnIII PCC disks. Electrospray 
Ionisation Mass Spectrometry (ESI-MS) studies of compounds 20 - 23 display a well-defined 
fragment pattern, all of which are indicative of the [MII3LnIII4(L4)6(OH)6]x+ core. NiII3GdIII4 (23) 
displayed a modest MCE effect of 15.4 J kg-1 K-1 at 5.0 K, the third highest observed for a 3d-4f 
Schiff base supported PCC. 
In chapter 5, the term “isoskeletal” is introduced to describe PCCs that possess cores of the same 
topology and to describe PCCs constructed from organic ligands that provide a similar 
coordination environment. This concept is demonstrated by systematically synthesising 
isoskeletal NiII/CoII-DyIII PCCs with defect dicubane cores (2,3M4-1) from modified derivatives 
of H2L1 (H2LX). The reaction of H2L1 and its derivatives resulted in the synthesis of eighteen 
PCCs (25 - 42) which were characterised by single-crystal XRD studies. Compounds 25 - 42 were 
synthesised by systematically altering conditions, to target isoskeletal 
[MII2LnIII2(LX)4(solv)6](ClO4)2 (2,3M4-1) PCCs, including oxidation (25 and 26), solvent (27 -
31), solvent concentration (32 - 34), ratio of reactants (35 and 36), crystallisation method (37) and 
co-ligand introduction (38 - 42). The resultant PCCs demonstrate that a slight variation in 
synthetic conditions can drastically alter the formula and topology of the desired 
[MII2LnIII2(LX)4(solv)6](ClO4)2 PCCs. The desired PCCs were further studied by ESI-MS and the 
2,3M4-1 core was found to be retained in solution. Further computational studies demonstrate 
how the activity of the PCCs can be tuned and suggests ways of achieving this.  
In chapter 6, two high nuclearity pentadecanuclear PCCs with the general formula 
[ZnII4LnIII11(µ4-OH)2(µ3-OH)8(µ2-OH2)2(µ3-NO3)2(NO3)6Cl4(HL23)2(L23’)4(µ2-MeO)7(µ3-
MeO)2(MeOH)2(H2O)2], where Ln = Dy (43), Gd (44), were synthesised in situ and characterised 
in the solid state. Single-crystal XRD studies elucidate a unique core structure resembling a 
“purse” with subunits forming a [ZnIILnIII2ZnII(HL23)2(µ2-MeO)3Cl2(MeOH)2] “strap” and a 
[ZnIILnIII9(µ4-O)2(µ3-OH)8(µ2-OH2)2(µ3-NO3)6(NO3)2Cl22(L23’)4(µ2-MeO)4(µ2-MeOH)2(H2O)2] 
“body”. This topology is enumerated 1,2,3,4,5,5,5,8M15-1 and has not been previously reported 
in PCC chemistry. It is also the third highest reported nuclearity for a ZnII-LnIII PCC. Magnetic 
studies confirm the SMM behaviour of the DyIII analogue (43) (Ueff = 4.7 K and τ0 = 4.4x10-5 s). 
With the addition of the “hands and feet” or the “strap” providing a tethering unit which can direct 
the spin of the central ion of the diabolo unit it was possible, finally, to disentangle the “devil in 
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the details” directing the spin structure of such diabolo units, which had not previously been 
described.  
In chapter 7, two isoskeletal NiII2DyIII2 (1NiDy-ClO4) and CoII2DyIII2 PCCs (1CoDy-ClO4) were 
synthesised possessing the defect dicubane core topology (2,3M4-1), with the general formula 
[MII2LnIII2(L1)4(EtOH)6](ClO4)2. ESI-MS studies indicate the stability of the [MII2DyIII2(L1)4]2/1+ 
core in solution. The PCCs were then applied to the catalytic formation of trans-4,5-
diaminocyclopent-2-enones from 2-furaldehyde and secondary amines. At room temperature, the 
PCC catalysts perform poorly (41 - 55% conversion, 10 mol% loading) however, under reflux the 
conversion significantly improves (90 - 95% conversion, 2.5 mol% loading). Refluxing 1NiDy-
ClO4 in MeCN leads to the formation of the isoskeletal [NiII2DyIII2(L1)4Cl2(MeCN)2] (1NiDy-Cl) 
and ESI-MS studies confirmed the stability of the [NiII2LnIII2(L1)4]2+ core in solution. When 
1NiDy-Cl was applied to the transformation, conversion drastically improved (quantitative, 1 
mol% loading). LnIII analogues of 1NiDy-Cl were synthesised, 1NiLn-Cl (Ln = Sm, Eu, Gd, Tb 
and Y), to determine how the substitution of the LnIII site affected the catalytic efficacy of the 
PCC. 1NiY-Cl substantially out-performed the other analogues (98% conversion, 1 mol% 
loading). Through the systematic testing of NiII, LnIII salts and H2L1 as catalysts in the catalytic 
reaction, it was determined that only the LnIII ion of the 1NiLn-Cl was catalytically active and 
the bimetallic system was not co-operative. Three isoskeletal analogues of 1NiY-Cl PCCs were 
synthesised (2NiY-Cl, 6NiY-Cl and 14NiY-Cl) with modified organic ligands (H2L2, H2L6 and 
H2L14) to optimise the catalytic behaviour of the catalyst. In a comparative study, 1NiDy-Cl and 
the LNiY-Cl series were all used to test the scope of reaction with a variety of primary and 
secondary amines to determine the structure-activity relationship. Overall, 1NiY-Cl was found to 
be the best catalyst for this reaction. In addition, Density Functional Theory (DFT) studies are 
presented as well as numerous by-products from various synthetic methods.  
In chapter 8, a family of eight novel isoskeletal PCCs with the general formula 
[ZnII2LnIII2(L1)4(NO3)2(DMF)2] (1ZnLn-NO3), where Ln = Sm, Eu, Gd, Tb, Dy, Yb and Y, were 
synthesised. 1ZnLn-NO3 possess the defect dicubane topology (2,3M4-1) and are isoskeletal to 
those reported in chapters five and seven. Various solution-based studies of 1ZnLn-NO3 (ESI-
MS, Electron Paramagnetic Resonance (EPR) spectroscopy, 1H NMR spectroscopy) indicate that 
the defect dicubane topology is retained in solution. The family of 1ZnLn-NO3 compounds were 
applied to numerous organic transformations which were previously promoted by either ZnII or 
LnIII salts or Schiff base complexes. The initial experiments probed the Friedel-Crafts (FC) 
alkylation of indoles and aldehydes to BIMs. All PCCs display some catalytic efficacy, with the 
YIII (1ZnY-NO3) analogue (1 mol% loading, 96% conversion) surpassing the performance of the 
corresponding triflate salt (2.5 mol% loading, 55% conversion) substantially. The scope of the 
reaction was then explored with 1ZnY-NO3 to gain information of the plausible mechanism. 
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Secondly, the Petasis borono-Mannich multicomponent reaction is explored, some conversion is 
observed in an uncatalyzed reaction and with ZnII and LnII triflates (1% loading, 40 - 56%), 
1ZnLn-NO3 PCCs surpass this conversion rate, with the DyIII (1ZnDy-NO3) analogue reaching 
96% conversion at 1 mol% loading. The reaction is optimised for 1ZnDy-NO3 PCCs and the 
scope of reaction explored. Finally, these compounds are applied to the FC alkylation of indole 
with nitroalkenes, where 1ZnDy-NO3 substantially out competes uncatalyzed, metal salt or 
isostructural analogues in the conversion at low yields. For the FC catalytic transformations, 
plausible mechanisms are proposed and several products are characterised by single-crystal XRD 
studies. These results confirm the usefulness of altering the 3d or 4f ions in isoskeletal 3d-4f PCCs 
for catalysis and represent one of the first fully characterised series of 3d-4f PCCs used for 
promoting catalysis in a range of organic transformations.  
In chapter 9, the isoskeletal series of 1ZnLn-NO3 PCCs are applied to the Michael addition 
reaction between 1,3-dimethyl barbituric acid and trans-β-nitrostyrene to confirm co-operative 
action between ZnII and LnIII metal centres. After initial optimisation, 1ZnY-NO3 (1 mol%, 91% 
yield, 15 min) was found to have the greatest efficacy (quantitative, 2.5 mol%) and 1ZnY-NO3 
was chosen to investigate the ligand structure-activity relationship. A library of twenty isoskeletal 
PCCs with the general formula [ZnII2YIII2(LX)4(NO3)2(DMF)2] (LZnY-NO3) were synthesised 
and characterised. The LZnY-NO3 series was applied to the MA reaction and the modified 
ligands had a noticeable effect on the efficacy of the catalytic reaction. 28ZnY-NO3 was found 
to be the most catalytically effective (1 mol%, quantitative, 15 min) and the scope of the reaction 
was expanded to a variety of substituted nitrostyrenes and Michael acceptors in good to excellent 
yields. Unexpectedly, diastereoselectivity for the R*, R* product was observed for catalytic 
reactions employing trans-β-methyl-β-nitrostyrene. Further investigation revealed stereoselective 
behaviour on the substitution of the LnIII ion. In addition, a range of evidence for the co-operative 
action between 3d and 4f metal centres is presented including EPR binding studies, 1H NMR 
substrate titration, UV-Vis binding studies, the poor performance of simple metal salts and 
previously reported isoskeletal NiII2DyIII2, CoII2DyIII2 and novel CuII2DyII2 analogues (29%, 34%, 
84%).2 The co-operative action and substrate binding interactions were supported by DFT studies, 
which also support the observed stereoselectivity of the LZnLn-NO3 series. 
Chapter 10 summarises the work presented in this thesis and relates this work to the previously 
reported literature to highlight the relevance and importance of the work presented herein.   
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Chapter 1: General introduction 
1.1 Polynuclear coordination clusters  
Polynuclear Coordination Clusters (PCCs) incorporate multiple metal ions which are linked by 
bridging ligands (in particular elements such as N, O and S), which bridge two to six metal centres 
into a discrete molecular entity.3 These entities are distinctly different from metal-metal bonded 
complexes referred to as “clusters” by Cotton et al.4 PCCs are sub-divided into two categories 1) 
those formed from inorganic ligands “polyoxometalates” and 2) those supported by organic 
ligands. The metal core of PCCs can be either comprised of a single metal (homometallic) or 
combine two or more different metals (heterometallic). Over the last 30 years, the interest and 
rate of discovery of these molecules has increased exponentially due to advances in single-crystal 
X-ray crystallography, which has allowed the elucidation of molecules which are of an 
exceptional size and complexity. 
 
Figure 1.1. The molecular structure of ZnII6LnIII24.5 Colour code: DyIII, light blue; ZnII, grey; O, 
red; N, pale blue; C, white; S, yellow.5  
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PCCs core nuclearities can range from simple bimetallic species to very high nuclearity species 
such as Fe42,6 DyIII72,7 NdIII104,8 Mn70,9 MnIII18Na6,10 ZnII6LnIII24 5 (Figure 1.1) and FeIII168.11 The 
structure of these PCCs is determined both by the geometrical preferences of the metal ions and 
the steric effects of bridging and terminal ligands that combine to form the PCC. In this way, the 
metal ions and ligands can be considered ‘‘building blocks’’ which generate an overall structure 
whose topology is a consequence of the symmetries and connectivity of the constituent parts, 
however, the targeting of high nuclearity PCCs is much more complicated since various metal 
ions have many possible coordination geometries. This complexity is further increased with the 
wide variety of coordination modes that even simple bridging ligands can adopt, including 
terminal to μ2, μ3, and μ4 bridging modes. PCCs may also be supported by polynucleating ligands 
which have structural attributes that combine separate coordination pockets.  
The ligand–metal combination is one of the most important factors in the overall architecture of 
the PCC formed. However, the structure of the PCC does not only depend upon the metal ions 
and oxidation states present but the number of possible binding modes for the ligands, the steric 
properties of the ligands, the presence of templating units and coordinating solvent, factors such 
as pH, concentrations and redox potentials of the species present and the type of counter-ions. 
Consequently, a combination of ligand and metal is often capable of generating a wide range of 
structures, the favoured structure being the result of a subtle balance of many competing variables.  
Due to the variety of PCC structures which have been reported to date, a topological approach 
has been developed that helps to facilitate the understanding of the growth of the core topology, 
which in the long term may lead to the targeted synthesis of PCCs. 
1.1.1 Topology and notations 
The description of the core structure and nuclearity of PCCs has traditionally relied upon 
representation as a classic Platonic polyhedron. When robust polytopic ligands were employed 
into a directed assembly process and the resultant PCCs isolated, these were described as (n x n) 
square grids.12 High nuclearity PCCs have revealed the limitations of this type of platonic 
description, due to the difficulty of describing these cores based on Platonic polyhedra.  
Topological analysis through the TOPOS program package has successfully described a wide 
variety of high nuclearity PCCs.13–16 With this approach, each metal centre of the PCC is 
designated as a “node” and the bridging monoatomic heteroatoms that bridge these metal ions are 
then termed as “linkers”. The resulting graph (PCC skeleton) consists of only metal atoms and its 
topology is described by a characteristic NDk-m symbol notation. These terms are defined where 
N is the number of connections from a single node to topologically non-equivalent nodes through 
heteroatom linkers, D is the dimensionality, D = M for finite (molecular) clusters, k is the overall 
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number of nodes within the cluster and m enumerates topologically different examples with the 
same NDk-m symbol.  
 
Figure 1.2. A simplified defect dicubane core of a MII2LnIII2 PCC with heteroatom linkers shown 
(left) Graph of the defect dicubane (2,3M4-1) topology with heteroatoms represented as “linkers” 
(right). Colour code: MII nodes, grey; LnIII node, light blue and O linkers, red. 
The NDK-m notation will be frequently employed to describe the core topology of PCCs in this 
work. These notations were first used to describe a database of 439 homometallic MnII/III/IV PCCs 
and separate them into 159 separate topologies.13 This technique has been subsequently employed 
to categorise homometallic NiII and CoII/III PCCs,14,15 high nuclearity 3d-4f PCCs16 and also 
adopted for describing newly reported 3d17,18 and 4f PCCs.19–21  
With this approach, it is possible to identify structural similarities between seemingly unrelated 
core topologies whilst providing a universal notation for ligands with different bridging 
heteroatoms. Similar structural configurations can be identified formed from ligands with specific 
cavities and bridging modes, which may allow for topologies which exhibit preferential properties 
to be targeted. 
1.2 3d-4f PCCs 
The first example of a PCC containing both 3d and 4f elements was reported in 1977 by Lindoy, 
Drew and co-workers and was first observed by 1H NMR spectroscopy from the changes of the 
spectrum of tris-(pentane-2,4-dionato_cobalt(III), (Co(acac)3), in CDCl3 upon the addition of tris 
(1,1,1,2,2,3,3, -heptafluoro-7,7-[2H6] dimethyl[2H3] octane-4,6-dionato) europium, (Eu([2H9] 
fod)3. This species was subsequently characterised by single-crystal X-Ray Diffraction (XRD) 
studies and was formulated [Co(acac)3{Eu([2H9]fod)3}].22 
However, it was not until Gatteschi and co-workers, who eight years later, reported two trinuclear 
CuII2GdIII species, where the observed Gd–Cu coupling was strongly ferromagnetic,23,24 that 
opened new perspectives and interest for 3d-4f PCCs in molecular magnetism. The first high 
nuclearity 3d-4f PCC was reported in 1989, from the reaction of Cu(OH)2, Ln(NO3)3 and 2-(1H)-
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pyridone which afforded a species with an unusual hexanuclear octahedral CuII4LnIII2 core, where 
Ln is Gd or Dy (Figure 1.3).25 
 
Figure 1.3. The molecular structure of CuII4LnIII2. Colour code: DyIII, light blue; CuII, blue; O, 
red; N, pale blue; C, white. 25 
1.2.1 Synthetic approach for 3d-4f PCCs 
Rationally designing and synthesising 3d-4f PCCs has been difficult due to the complexity of the 
reaction system. Specifically, according to the “Hard and Soft Acids and Bases” (HSAB) theory,26 
3d and 4f metal ions have priority to coordinate with different donor atoms (e.g. nitrogen and 
oxygen). Therefore, simply mixing 3d ions, 4f ions and organic ligands preferentially form pure 
3d or 4f PCCs over 3d-4f PCCs.  
Traditionally, the synthesis of 3d-4f PCCs has usually relied upon “serendipitous assembly” 
which allows for the preparation of PCCs which could not have been rationally predicted. Within 
this approach, poly-functional ligands are used and reliance is often placed on creating a 
systematic mismatch between the number or type of coordination sites available on a single metal 
centre and the donor set supplied by the ligand. This method can be employed systematically, to 
determine how reaction conditions such as solvent effects, reactant ratio, temperature, time of 
reaction and crystallisation method affect the nature of the product. While the outcome of the 
reaction cannot be predicted, this method has resulted in many high nuclearity27–30 and otherwise 
interesting complexes.29,31–33  
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While serendipitous assembly has resulted in a significant number of 3d-4f PCCs, by applying 
“rational design”, a ligand with specific coordination sites is used in such a way that the resulting 
product or outcome is predictable. While this approach was initially restricted to mono and 
dinuclear complexes,34–37 through the in situ studies of PCC formation with various analytical 
techniques (Electrospray Ionisation Mass Spectrometry (ESI-MS), Cold Spray Ionisation Mass 
Spectrometry (CSI-MS)), it has been possible to identify common structural units and design high 
nuclearity PCCs based on these,38,39 as well as following stepwise syntheses to increase the 
nuclearity PCCs.40 These techniques have also been used to control the nuclearity and topology 
of PCCs with the variation of reaction conditions.41–45  
3d or 4f metal ions, within 3d-4f PCCs, can be targeted selectively and substituted by either 3d or 
4f ions with similar coordination properties without altering the topology of the core. This has 
been reported in numerous 4f-4f ion and 3d-3d ion substitutions,43,46–51 as well as 3d-4f ion 
substitutions which have resulted in enhanced magnetic properties.52,53 With these synthetic 
advantages and knowledge of previous heterometallic core topologies, synthesis of novel 3d-4f 
PCCs can be targeted for specific applications.54  
With both methods, a wide variety of ligands have been employed for the synthesis of 3d-4f PCCs 
(Figure 1.4), including, Schiff base ligands,1,55–77 oximate-based ligands,78–81 ethanolamines,82–86 
phosphonic acids,87,88 carboxylates89–93 and many other varying groups.94–99
 
Figure 1.4. Representative examples of ligand types used for 3d-4f PCC synthesis. 
1.2.2 Schiff base ligands in 3d-4f chemistry 
Schiff base ligands have afforded a variety of 3d-4f PCCs and the reasons for their wide 
employment are manifold. However, their importance is underlined by the chemistry of Schiff 
bases being very generous in providing ligands (Figure 1.5). Given the variety and number of 
keto and amino precursors available for condensation, the number of possible azomethine 
compounds is extremely vast (Figure 1.5, 1 and 2). Importantly, with the considered selection of 
these two precursors a great deal of control over, the denticity of the resulting ligand, nature of 
donor atoms, the coordination “pockets” and chelating moieties of the resultant ligand is 
granted.100–103 In addition, precursors may be modified with bulky groups or various functional 
groups which may affect the nature and properties of the resulting PCC.  
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Figure 1.5. The two main classes of reactions to form Schiff base ligands (upper). The structures 
of commonly used aldehydes and amines (lower).  
The most commonly reported keto precursors used to synthesise Schiff base ligands which 
support high nuclearity 3d-4f PCCs are either o-vanillin (o-van) or salicylaldehyde (HSal) 
(Figure 1.5). Whereas the choice of amine precursor is varied, with two main broad categories 
(Figure 1.5) which are designed either to bridge between metal ions (amino alcohol, 1-amal) or 
to form a selective pocket (diamine, 2-diam) for 3d or 4f ions.  
Schiff base ligands have been designed to target specific low nuclearity PCCs (2, 3 or 4), with a 
fixed number of metal ions in a specific arrangement (Figure 1.6). When 3d-4f PCCs are desired, 
the ligands compartments must be dissimilar and have a different set of donor ions, specifically 
LnIII metal ions which are hard Lewis acids with a high oxophilicity and 3d metal ions are less 
oxophilic and have a greater preference for N donors, therefore pockets can be designed 
accordingly (Figure 1.6). 
A notable example of a bi-compartmental/ dinucleating ligand used to obtain a specific nuclearity 
is reported by Costes104,105 who synthesised a series of CuIILnIII PCCs to study the magnetic 
interaction between CuII and GdIII ions. In this example, the inner compartment (N2O2) hosts the 
CuII ion, while the outer compartment (O2O2) hosts the LnIII ion. Many bimetallic complexes with 
bi-compartmental Schiff base ligands have been reported including MII-LnIII (M = Ni,106–108 Co,109 
Cu,37 and Zn110–112). PCCs derived from these bi-compartmental ligands have been instrumental 
in understanding magnetostructural correlations and can be used as building blocks to construct 
higher nuclearity PCCs.43,113,114 
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Figure 1.6. Diamine based dinucleating ligands for the synthesis of dinuclear, trinuclear and 
tetranuclear 3d-4f PCCs. Colour code: O2N2 compartment, green; O2O2 compartment, light blue. 
Another approach has applied amino alcohol (amal) (Figure 1.5) based Schiff base ligands which 
have been successful in synthesising high nuclearity 3d-4f PCCs. While these ligands have quite 
predictable coordination behaviour, with compartments for specific metal ion coordination 
(Figure 1.7), the resultant structures cannot be predicted due to extensive bridging modes. The 
alkoxide oxygen atoms, which result from the deprotonation of the alcohol group, act as a terminal 
ligand or bridge between several metal centres and the resultant coordination modes cannot be 
controlled. Due to this the synthesis of 3d-4f PCCs from these ligands usually relies upon 
serendipitous assembly. 
Consequently, this type of Schiff base ligand has generated an array of 3d-4f PCCs which are 
primarily interesting for their Single-Molecule Magnet (SMM) properties, these include 
CoII2LnIII4,115 CoII2LnIII2,2 MnIII2GdIII2,116 NiII2LnIII2,117,118 and CuII9 LnII2119 PCCs.  
 
Figure 1.7. Amino-alcohol based Schiff base ligands with specific compartments for binding 
metal ions. Colour code: NO2 compartment, green; O2 compartment, light blue. 
1.3 Overview of properties displayed by 3d-4f PCCs 
Since the discovery of SMM behaviour in a mixed-valent [MnIV4MnIII8O12(OAc)16(H2O)4] (Mn12-
OAc) PCC (Figure 1.11) and subsequently the observation of the first 3d-4f SMM, CuII2TbIII2 
(Figure 1.8),120 there has been a surge in the development of 3d-4f PCCs. 3d-4f PCCs display 
many interesting magnetic properties which have several applications including ultrahigh-density 
magnetic data storage devices,121,122 magnetic refrigeration123–125 and quantum computation.126,127 
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SMMs can also be used to understand and model several complex quantum phenomena such as 
quantum tunnelling,128–130 spin parity130 and quantum superposition.131,132  
 
Figure 1.8. The molecular structure of CuII2TbII2 reported by Osa.120,133 Colour code: DyIII, light 
blue; CuII, blue; O, red; N, pale blue; C, white; F, green. 
Though many magnetic applications have been studied, 3d-4f PCCs have been successfully 
applied in various applications. These include fluoro-immunoassays,134–136 Organic Light-
Emitting Diodes (OLED),137–139 Water Oxidation Catalysts (WOCs)140–142 and catalysts for 
organic asymmetric transformations.143–147  
1.3.1 Overview of magnetic properties 
Before discussing the SMM and the Magnetocaloric Effect (MCE) properties of PCCs, it is 
essential to discuss the fundamental theory behind magnetic interactions. At the atomic level, the 
angular momentum of unpaired electrons, which is comprised of the spin and orbital angular 
momenta, creates a magnetic moment.  
For both 3d and 4f atoms, the Coulomb interaction between electrons is stronger than the spin-
orbit interaction between their individual angular momenta. The electron-electron interaction is 
typically of the order of 1 eV, whereas spin-orbit interaction is of the order 0.1 eV for 4f 
lanthanides and 10 – 102 meV for 3d transition metal atoms.148,149 In these cases, the interaction 
between spin and orbital angular momenta can be described by LS or Russell-Saunders 
coupling.150 
In this coupling scheme, the Coulomb interaction couples individual orbital momenta into the 
total orbital momentum L and exchange interaction couples the individual spin and orbital angular 
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momenta into the total spin momentum S. Finally, the spin-orbit interaction couples the resulting 
L and S into the total angular momentum of an atom, J. 
The quantum numbers of total angular momentum J assume the following values: |L − S| ≤ J ≤ L 
+ S. Further, each J consists of (2J +1) Jz energy levels which are degenerate in the case of free 
atoms, and their degeneracy can be lifted by imposing an anisotropy to an atom. The ground state 
J multiplet can be determined by the three Hund’s rules.151,152 
These rules determine the filling of the electronic orbitals that minimizes the Coulomb interaction 
between the electrons. The filling of the orbitals is further restricted by Pauli exclusion principle, 
from which follows that two electrons in the same orbital must have their spins anti-aligned.  
According to the first two Hund’s rules, the ground state configuration is the one with the 
maximum S and L values. The third Hund’s rule determines the J value for which the energy due 
to the spin-orbit interaction, 
𝐻𝑆𝑂𝐶 =  ζ 𝐋 · 𝐒 
is the lowest; ζ is the constant of the spin-orbit coupling. In the case of more than half-filled 
orbitals, the spin and orbital angular momentum are parallel to each other and the ground state is 
J = L +S. Less than half-filled orbitals have their angular momenta anti-parallel and their ground 
state is given by J = |L −S|. Finally, half-filled shells have L = 0 and J = S. The total magnetic 
moment of an atom is given in Equation 1.1. 
𝒎 =  −μ𝐵(𝑔𝐿𝑳 + 𝑔𝑆𝑺) =  −μ𝐵𝑔𝐽𝑱 
Equation 1.1. where μB is the Bohr magneton, gL, gS and gJ are g -factors of electron orbital, spin, 
and total angular momentum, respectively. The gJ or Landé factor of the total angular momentum 
is given by Equation 1.2. 
𝑔𝐽 =  
3
2
+
𝑆(𝑆 + 1) − 𝐿(𝐿 + 1)
2𝐽(𝐽 + 1)
 
Equation 1.2. where the two g factors are gL = 1 and gS ≈ 2. 
In a free atom, the magnetic moment does not have a preferential axis and its orientation fluctuates 
in space. This results in zero net magnetization of a free atom. Placing an atom in a crystal field 
or applying a magnetic field creates an anisotropy that stabilizes the magnetic moment in a 
preferential orientation. Spin-orbit coupling in both 3d and 4f ions leads to a splitting of the spin 
state levels, known as Zero-Field Splitting (ZFS), which causes magnetic anisotropy and has a 
profound effect on the magnetic properties.  
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ZFS in transition metals contains an axial (D) and rhombic (E) component. For odd electron ions, 
the spin microstates are split by the D component to form Kramer’s doublets, the E component is 
manifested by shifting the energies of the various Kramer’s doublets without further splitting. In 
even-electron systems, the D component also removes the microstate degeneracy by forming non-
Kramer’s doublets without further splitting. In even-electron systems, the D component also 
removes the microstate degeneracy by forming non-Kramer’s doublets, however, in this case, the 
E component further splits the +ms and –ms components of the doublet. 
In transition metals, the spin-orbit coupling may be first or second order depending on the 
symmetry of the ground state. For 3d ions with orbital T states, a stronger first-order spin order 
coupling is operative, whereas those with E ground states are split by second-order spin-orbit 
coupling.153 Isotropic ions with A ground states have negligible spin-orbit coupling and ZFS. The 
effect of the D parameter on ZFS is shown in Figure 1.9. When D = 0, the ms sublevels of the 
ground spin state are degenerate in energy. When D < 0, the largest ms state is lowest and energy; 
the opposite is true when D > 0. 
 
Figure 1.9. The depiction of the ms sublevels of the ground spin state of an S = 2 with D = 0. 
The magnetism of 4f lanthanide atoms originates from electrons in their well shielded 4f orbitals. 
In this case, the spin-orbit interaction between electrons is much larger than their interaction with 
the crystal field, with the latter being of the order of 10 meV. Hence, the crystal field interaction 
can be viewed as a perturbation to the overall energy of an atom and J remains a good quantum 
number for describing the system. The cumulative effect of spin-orbit coupling and crystal-field 
splitting for a DyIII is shown in Figure 1.10. 
1.3.1.1 Magnetic coupling 
In PCCs, there is a magnetic interaction between neighbouring metal ions known as magnetic 
coupling, which is described as the parameter, J. The magnitude of J is usually in the order of 0-
100 cm-1. The coupling between two metal ions may be ferromagnetic (J > 0), where the electron 
spins are aligned, or antiferromagnetic (J < 0), where the spins are orientated antiparallel. The 
sign and strength of the J coupling parameter is governed by Goodenough-Kanamori rule of 
superexchange,154,155 which is dependent on the overlap of the magnetic orbitals.156 However, in 
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the case of lanthanides, which have contracted 4f orbitals,157 magnetic coupling is very weak (<1 
cm-1), these weak interactions are important for the properties displayed in SMM and MCE 
materials.  
 
Figure 1.10. Low energy electronic structure of the DyIII ion with sequential perturbations of 
electron-electron repulsions, spin-orbit coupling and the crystal field.158 
1.3.1.2 The Zeeman effect 
The Zeeman effect describes the removal of the degeneracy of the energies of electrons in an 
applied field.159 For an S = ½ metal ion in an applied magnetic field, the energy of the ms = -1/2 
state is stabilised and the energy of the ms = +1/2 is destabilised. The energy difference between 
the two states is shown in Equation 1.3.160  
∆𝐸 = 𝑔𝛽𝑆𝐻 
Equation 1.3. where g is the Lande factor, β is the Bohr magneton, S is the spin state and H is the 
magnetic field. 
In magnetic susceptibility measurements, the applied field, H is small and thus Zeeman splitting 
will be weak (< 1cm-1). Whereas, in magnetisation experiments, H is large and Zeeman splitting 
will have a pronounced effect on the magnetic properties. 
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1.3.1.3 Magnetic measurements and data analysis 
The Superconducting Quantum Interference Device (SQUID) is the current state-of-the-art in 
magnetometry. With this instrument, the magnetic moment of a powdered sample can be 
measured down to 2 K. Magnetisation experiments are the isothermal application of an external 
field. The molar magnetisation is the Boltzmann average of the magnetic moments (Equation 
1.4).160 
𝑀 =  𝑁𝐴 
∑ (−
𝜕𝐸𝑛
𝜕𝐻 )𝑒
−𝐸𝑛/𝑘𝐵𝑇
𝑛
∑ 𝑒−𝐸𝑛/𝑘𝐵𝑇𝑛
 
Equation 1.4. where M is the magnetization, NA is Avogadro’s number, kB is the Boltzmann 
constant, En is the energy of the quantum state ׀n>, H is the magnetic field.  
Equation 1.4 is considered the fundamental equation of molecular magnetism, as it does not rely 
on any approximations.161 The use of this expression only requires knowledge of how En varies 
with an applied magnetic field, H for all thermally populated states. To simplify the use of this 
equation, many of the equations described below are derived from Equation 1.2 based on various 
assumptions and approximations.161 
For single spin, paramagnetic compounds with no ZFS, Equation 1.5 can be approximated as the 
Brillouin function.161 
𝑀 =  𝑁𝐴𝑔𝛽𝑆𝐵𝑠(𝑥) 
𝐵𝑠(𝑥) =  
2𝑆 + 1
2𝑆
𝑐𝑜𝑡ℎ (
2𝑆 + 1
2𝑆
𝑥) − 
1
2𝑆
𝑐𝑜𝑡ℎ (
𝑥
2
) 
Equation 1.5. where g is the Landé factor, β is the Bohr magneton, S is the spin state and Bs(x) is 
the Brillouin function where 𝑥 =  
𝑔𝛽𝑆𝐻
𝑘𝐵𝑇
. 
Simple paramagnetic compounds can be fit with Equation 1.5 to determine the ground S state. 
However, for molecules with complex and non-negligible coupling, these expressions can’t be 
used. Though at high magnetic fields and low temperatures, the magnetisation can be expressed 
in Equation 1.6 
𝑀 = 𝑁𝐴𝛽𝑆 
Equation 1.6. 
This equation corresponds to the magnetic saturation. This equation can be used for magnetisation 
experiments at low temperature and high fields and can be used to determine the ground S state 
for molecular complexes.  
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In direct current (dc) susceptibility measurements, a small magnetic field is applied (usually 1000 
or 200 Oe) and the temperature varied. At low magnetic field and high temperatures, the magnetic 
properties can be described by the simplified van Vleck equation (Equation 1.7).162 
𝜒𝑚 =  
𝑁𝐴 𝑔
2𝛽2
3𝑘𝐵𝑇
 𝑆(𝑆 + 1) 
Equation 1.7.  
Equation 1.7 can be used to describe the dc susceptibility data for well isolated single-spin 
paramagnets of for PCCs at high temperature. Through perturbation theory, van Vleck was able 
to derive a more precise approximation for the molar magnetic susceptibility (Equation 1.8).162 
𝜒𝑚 =  
𝑁𝐴 𝑔
2𝛽2
3𝑘𝐵𝑇
 
∑ 𝑆(𝑆 + 1)(2𝑆 + 1)𝑒−𝐸𝑆/𝑘𝐵𝑇𝑆
∑ 𝑆(2𝑆+1)𝑒
−𝐸𝑆/𝑘𝐵𝑇
 
Equation 1.8. where ES is the energy of spin state, S.  
It is important to note that the susceptibility is usually plotted as χmT vs T, as it can visually give 
more information about magnetic interactions.160  
1.3.2 Overview of single-molecule magnetism  
3d-4f PCCs have the potential to display SMM behaviour and this is one of the main motivations 
behind their development. SMMs have many advantages over traditional magnets, these include 
solubility in organic solvents, uniform size and structure and air stability.  
The characteristic property of an SMM is the retention of magnetization (spin orientation) after 
the removal of the external magnetic field. SMMs display a slow relaxation of the magnetization 
which is of a molecular origin. Magnetic analysis has previously revealed that there are two 
important criteria necessary for a molecule to display SMM behaviour, a large ground state spin 
(S) and a negative uni-axial magnetic anisotropy (D).163  
𝑈𝑒𝑓𝑓 = 𝑆
2|𝐷| (integer spin) 
𝑈𝑒𝑓𝑓 = (𝑆
2 − 1/4)|𝐷| (half-integer spin) 
Equation 1.9. 
The magnetic anisotropy is influenced by the ZFS of the ground state configuration. In a 
polynuclear molecular system, the ZFS depends on three major factors, the spin-orbit coupling, 
structural distortions and spin-spin interactions. The combined effect of S and D create an energy 
barrier, Ueff which needs to be overcome to achieve relaxation of magnetization (Equation 1.9). 
For SMM behaviour, D must be negative in order for the largest Ms sublevel to be the lowest 
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energy. It is clear from Equation 1.9 that S and D must be large in order to achieve a large barrier 
height.  
 
Figure 1.11. The molecular structure of Mn12-OAc (left). Colour code: MnIII/IV, purple; O, red; 
C, white; hydrogen ions omitted for clarity.  
The dodecanuclear mixed valence Mn12-OAc PCC was synthesised in an attempt to oxidise MnII 
ions by using permanganate in acetic acid solution.164 Mn12-OAc has eight outer MnIII ions and 
four central MnIV ions. Dynamic magnetic susceptibility measurements on this complex resulted 
in the discovery of the slow relaxation of its magnetisation165 and a hysteresis166 pattern also 
revealed steps at below 2 K.  
Polynuclear SMMs generally consist of paramagnetic 3d, 4d, 3d-4f or 4f metal ions and a variety 
of homonuclear 3d and 4f PCCs have been reported with improved SMM properties since.167–173 
An unprecedented example is the recently reported dysprosium metallocene 
[(Cp)2DyIII][(B(C6F5)4] (Cp = 1,2,4-tri(tert-butyl)cyclopentadienide), with a record anisotropy 
barrier of 1837 K at zero field and a record magnetic blocking temperature of 60 K, which both 
far exceed any previously reported SMMs.174 However, as this thesis is concentrated with 3d-4f 
PCCs only these will be discussed further. 
1.3.2.1 SMM characterisation techniques 
There are two commonly used techniques for the characterisation of the SMM properties of a 
molecule: 
1) Alternating current (ac) magnetic susceptibility measurements. 
2) Magnetisation vs field hysteresis measurements.  
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The first of these techniques is used extensively for the characterisation of materials in this thesis, 
whereas hysteresis loops were not employed. Only ac susceptibility experiments will be described 
herein.  
To identify SMM properties, the PCC is subjected to an ac field and susceptibility is measured 
over a range of temperatures at different frequencies. In this experiment, a small (~3 Oe) 
oscillating magnetic field is applied to the sample. The susceptibility, χ, is related to the in-phase 
ac susceptibility, χ’ and the out-of-phase ac susceptibility χ’’ by Equation 1.10.175 
𝜒 =  𝜒′ + 𝑖𝜒′′ 
Equation 1.10. 
For paramagnetic materials, the magnetic moment of the sample will follow the oscillating 
magnetic field. However, in superparamagnetic materials which include SMMs, at low enough 
temperatures and high enough frequencies, the magnetic moment of the sample will lag behind 
the ac field, which is measured as the phase shift, φ. The in-phase and out-of-phase susceptibilities 
are related to the phase shift by Equation 1.11.175 
 𝜒′ =  𝜒𝑐𝑜𝑠φ 
𝜒′′ =  𝜒𝑠𝑖𝑛φ 
Equation 1.11. 
The presence of an out-of-phase, χ’’ signal is a strong indicator of superparamagnetic behaviour. 
At a given oscillation frequency, ν, the χ’’ peak maximum, Tmax, is the temperature at which the 
thermal magnetisation relaxation is given by 1/τ = 2π υ. The energy barrier, Ueff, of an SMM 
follows an Arrhenius relationship (Equation 1.12). 
𝜏 =  𝜏0𝑒
(
𝑈𝑒𝑓𝑓
𝑘𝐵𝑇
)
 
Equation 1.12. where τ is the relaxation time and τ0 is a pre-exponential factor. 
Therefore, a plot of ln vs 1/T should be linear and fitting the slope and intercept would give values 
of Ueff and τ0, (Figure 1.12), where the relaxation process follows the thermal activation pathway 
(Orbach process).176 
The experimentally determined energy barriers may not reach their theoretical limit due to 
Quantum Tunnelling of Magnetisation (QTM). This phenomenon is a common occurrence in 
SMMs and is due to the superposition of the two Ms states that are of degenerate energy.128,177 
QTM is prevalent at low temperatures, therefore the barrier is often extracted from the high-
temperature regime. QTM may also be reduced upon application of a magnetic field, which 
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removes the degeneracy of spin sublevels. Other common strategies to reduce QTM include 
limiting rhombic anisotropy and increasing the strength of magnetic coupling.178–180 
  
Figure 1.12. Graph of temperature dependent out-of-phase ac susceptibility at different 
frequencies (left) and an Arrhenius plot for CoII2DyIII2 (right).2 
Cole and Cole described a relaxation model for dielectrics.181 This was followed by Mydosh and 
co-workers who applied this theory to the relaxation of magnetic complexes.182 The in-phase and 
out-of-phase ac susceptibility can be fit simultaneously with a generalised Debye model in 
Equation 1.13. 
 𝜒’(𝜐𝑎𝑐) =  𝜒𝑠 +
(𝜒𝑇−  𝜒𝑆)[1 + (2𝜋𝜐𝑎𝑐𝜏)
1−𝛼sin (
𝛼𝜋
2 )
1 + 2(2𝜋𝜐𝑎𝑐𝜏)1−𝛼sin (
𝛼𝜋
2 ) + (2𝜋𝜐𝑎𝑐𝜏)
2(1−𝛼)
 
𝜒’′(𝜐𝑎𝑐) =
(𝜒𝑇−  𝜒𝑆)[1 + (2𝜋𝜐𝑎𝑐𝜏)
1−𝛼cos (
𝛼𝜋
2 )
1 + 2(2𝜋𝜐𝑎𝑐𝜏)1−𝛼sin (
𝛼𝜋
2 ) + (2𝜋𝜐𝑎𝑐𝜏)
2(1−𝛼)
 
Equation 1.13. where χs is the adiabatic susceptibility, χT is the isothermal susceptibility, υac is 
the ac frequency, τ is the magnetisation relaxation time and α is a value between 1 and 0 which is 
a measure of the distribution of relaxation processes.  
When α is zero, then there is a single relaxation process (Debye process).183 when α is larger there 
are multiple relaxation processes. A plot of χ’’ vs χ’ is known as a Cole-Cole plot and forms a 
semi-circular shape. When there is a distribution of single-relaxation processes (α > 0), the 
semicircle becomes flattened. With complex systems, with more than one relaxation process and 
largely different relaxation times (τ), multiple semi-circles may be present in the Cole-Cole plot.  
1.3.2.2 3d-4f PCC SMMs 
3d-4f PCCs merge 3d and 4f ions into a single material which can result in the following 
advantageous SMM properties including: 
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1) A large magnetic moment which can be achieved by the intrinsic characteristic of 4f ions. 
2) The uniaxial anisotropy can be satisfied more easily from the single ion anisotropy of 4f ions, 
rather than molecular anisotropy in homometallic 3d complexes.  
3) The intermediate magnetic exchange between 3d-4f ions may suppress zero-field QTM and 
improve the energy barrier for spin reversal.  
With the aim of synthesising MII-LnIII PCC SMMs with high core nuclearities, a brief description 
of previously reported 3d-4f SMMs will be described corresponding to the incorporated 3d ion 
(CuII, ZnII, CoII, NiII). 
CuII ions serve as a paramagnetic centre with a strong Jahn-Teller effect, which makes it 
magnetically anisotropic. The first 3d-4f magnetic system (CuII-LnIII) was magnetically 
characterised in 1985, with isotropic CuII and GdIII ions.23 The GdIII ions were exchanged with 
LnIII ions (Ln = DyIII, TbIII) and resulted in a CuII-LnIII series which displayed SMM behaviour. 
The first heterometallic 3d-4f SMM was a CuII2TbIII2 complex reported by Osa and co-workers in 
2004.120 Notably, larger CuII-LnIII PCCs display characteristic SMM behaviour including 
CuII9DyIII2,119,184 CuII4DyIII4,103 CuII4DyIII,19 CuII6DyIII3,19 and CuII36DyIII24.185A recently reported 
CuII6DyIII12186 “windmill” displays one of the highest energy barriers of Ueff = 17 K for CuII-LnIII 
PCCs, with the highest belonging to a CuII4DyIII4 PCC with a Ueff  = 32.2 K.187 
NiII ions have a 3d8 electron configuration and display paramagnetism in an octahedral field (high-
spin) and diamagnetism in a planar square field (low spin). NiII-LnIII PCCs of various nuclearities 
have been reported so far, the first of which was a trinuclear NiIIDyIII2 complex reported by Sessoli 
and co-workers in 2007.188 Higher nuclearity NiII-LnIII PCCs (Ln = Dy, Tb) have exhibited a slow 
relaxation characteristic of SMM behaviour including NiII2LnIII2,50 NiII6DyIII3,189 NiII6DyIII4,190 
NiII2LnIII,191 and NiII8LnIII8,48. Many notable examples of NiII-LnIII PCCs have been reported by 
Chandrasekhar including NiII3LnIII3,49 NiII4LnIII4,192 and the pentanuclear NiII2LnIII3 which displays 
the highest reported effective energy barrier for NiII-LnIII PCCs with a Ueff of 88 K and a blocking 
temperature of 3 K. 
The orbital angular momentum of 3d7 high spin CoII ions is not quenched in octahedral fields, 
which makes it a good spin carrier for magnetic materials. Chandrasekhar et al. reported the first 
CoII-LnIII SMM, a trinuclear CoII2Gd complex,193 which shows slow magnetic relaxation below 8 
K in ac susceptibility measurements and reveals an energy barrier of Ueff = 27 K and τ0 = 1.7x10-
7 s. A number of other trinuclear CoII2LnIII PCCs displaying SMM behaviour have been reported 
with a variety of ligands.194–197 Since then the synthesis and magnetic properties of CoII-LnIII PCCs 
has recently received tremendous attention and a plethora of CoII-LnIII PCCs with a variety of 
nuclearities including CoII2LnIII2,2,67,68,198–203 CoIIDyIII3,68 CoII2DyIII4,204 CoII3DyIII4,1 CoII2DyIII5,68 
22 
 
 
CoII4LnIII4,68,123 CoII6LnIII,205 CoII2CoIII4LnIII4,206 CoII8LnIII2,207 CoII2DyIII10,64 CoII6LnIII8,207 
CoII8LnIII8,207,208 CoII11DyIII6,123 CoII9CoIIILnIII42,209 and CoII16LnIII24 75 have all been reported.  
ZnII has a stable diamagnetic d10 electron configuration. ZnII-LnIII PCCs are usually isolated as 
analogues to help the study of MII-LnIII PCCs as the diamagnetic centres provide an effective 
approach to control magnetic interactions between the transition metal and lanthanide ions and 
study the magnetic contribution of the spin carriers.188,210,211A number of dinuclear ZnII-LnIII 
complexes with compartmental ligands that display SMM behaviour have been reported.212–214 
Interestingly, ZnII ions have also been shown to enhance the Ueff of ZnIIDyIII and ZnII2DyIII2 
SMMs.215,216 Further work supports the enhancement of the Ueff by investigating the effect of 
ligand substitution around the DyIII centre.213 Several larger ZnII-LnIII PCCs display characteristic 
SMM behaviour including ZnII12DyIII18,28 ZnII6LnIII6217 and a giant ZnII6DyIII245 metallic-ring 
(Figure 1.1). 
As one of the objectives of this thesis concentrates on the synthesis of high nuclearity 3d-4f PCCs 
which display SMM behaviour, previously reported examples of MII-LnIII PCCs (NiII, CoII, CuII, 
ZnII) supported by Schiff base ligands (Appendix A, Figure S1.1) are presented in Appendix A 
(Table S1.1), along with the topology of the core and other characteristics. 
1.3.3 Overview of MCE  
Sub-Kelvin refrigeration is critical in many technologically advanced applications such as the 
condensing of hydrogen, methane and propane and the obtaining of sub-Kelvin ultra-low 
temperatures. Currently, 3He - 4He dilution refrigeration is the most popular method of continuous 
refrigeration below 0.3K,218 however, the cost of isotopic helium is a drawback of this technique. 
Other refrigeration methods include adiabatic nuclear diamagnetization218 and adiabatic 
demagnetisation of a paramagnetic salt.218 The latter is based on the MCE. 
The MCE phenomenon relies on the field-temperature and entropy change of a paramagnetic 
material. According to Equation 1.14, in a magnetorefrigerant, the total entropy of the system is 
the sum of the field and temperature-dependent magnetic entropy, SM, and the temperature-
dependent lattice entropy, Slatt: 
STotal(T,H) = SM(T,H) + SLatt(T,H) 
Equation 1.14. 
In the magnetic refrigeration process, the MCE material is brought to the starting temperature, T, 
through a precooling bath. A magnetic field, H, is applied to isothermally magnetize the material; 
the heat of magnetisation (Q = TΔS) is absorbed by the precooling bath. With this first step, the 
magnetic entropy during isothermal magnetisation is lowered due to the ordering of the electronic 
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spin. Since in an isothermal process ΔSlatt = 0, then according to Equation 1.14, ΔSM = ΔSTotal < 
0. Conversely, during isothermal demagnetisation ΔSM > 0. 
In the second step of the cycle, the material is isolated from the precooling bath and adiabatically 
demagnetized (ΔStotal = 0). Here, the spins become disordered and ΔSM > 0. To compensate, there 
must be a decrease in lattice entropy (ΔSLatt < 0) which comes with a commensurate decrease in 
the temperature of the material (ΔTad < 0). Finally, the refrigerant will warm up along the entropy 
curve of the final magnetic field, absorbing heat until it reaches the initial T and STotal, hence, the 
cooling power of the material is related to the entropy change during isothermal magnetization, 
ΔSM. 
Experimentally, the two most important parameters for MCE materials are the temperature during 
adiabatic magnetization, ΔTad, and magnetic entropy change during isothermal magnetization, 
ΔSM. ΔTad, which is related to the total entropy, STotal (Equation 1.14), must be measured by direct 
methods219 or more commonly, indirectly through heat capacity measurements through the 
thermodynamic expression in Equation 1.15. 
∆Tad(T, ∆H) = - ∫ (
T
C (T,H)
Hf
Hi
)
H
 (
∂M(T,H)
∂T
)
H
 dH 
Equation 1.15. H = magnetic field (f = final, I = initial) and C = heat capacity. 
The magnetic entropy change, ΔSM, can also be determined through heat capacity measurements 
through the application of Equation 1.16. 
∆SM(T,H) = ∫
CM(T, H) - CM(T,0)
T
T
0
dT 
Equation 1.16. CM(T,H) and CM(T,0) are heat capacities in a field H and in zero field, 
respectively. 
Furthermore, ΔSM may be evaluated through magnetization experiments using the Maxell 
equation for magnetic entropy: 
∆SM(T,∆H) = ∫ (
∂M(T, H)
∂T
Hf
Hi
)
H
 dH 
Equation 1.17. M = Magnetisation. 
The total available magnetic entropy in a material is associated with the total magnetic degrees of 
freedom at T = ∞ and is equal to Equation 1.18. 
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SM = Rln(2S+1) 
Equation 1.18. R = the gas constant (8.3144621 J K-1 mol-1) and S = spin. 
1.3.3.1 3d-4f magnetic coolers 
Unlike SMMs, PCCs which display a significant MCE require isotropic metal ions with minimal 
ZFS, as the presence of magnetic anisotropy reduces the total available magnetic entropy 
regardless of the sign of D. Therefore, isotropic metal ions such as FeIII, MnIII and GdIII are best 
suited to synthesise 3d-4f PCCs which display a significant MCE effect. 
Consequently, for a PCC to be useful for practical magnetic cooling applications, it must display 
a large magnetic entropy change per unit weight (J kg-1 K-1) at low magnetic fields.220 Therefore 
it is important to maximise the ligand weight ratio. In addition to these factors, magnetic coupling 
may lower the total available magnetic entropy, this makes 3d-4f PCCs ideal for promoting MCE 
behaviour as the insertion of 3d ions between 4f ions usually results in weak magnetic 
interactions.163  
The first reported 3d-4f PCC used for magnetic cooling was a MnIII4GdIII4 PCC which displayed 
a larger MCE than any of the previous homometallic PCC.221 So far, 3d-4f PCCs have been most 
widely studied molecular coolers.222 As previously stated only MII-LnIII PCCs (CuII, ZnII, CoII, 
and NiII) are being targeted, therefore only a brief description of the reported examples with a 
significant MCE in relation to the 3d ion will be described.  
The magnetic coupling between CuII and LnIII ions is usually weak. Several high nuclearity CuII-
LnIII PCCs which display a significant MCE effect have been reported including CuII6GdIII12 (33.7 
J kg-1 K-1),186 CuII6GdIII2 (11.9 J kg-1 K-1),223 CuII5GdIII4 (31 J kg-1 K-1),124 CuII6GdIII6224 and 
CuII2GdIII7 (34.6 J kg-1 K-1).223  
NiII ions were shown to enhance the MCE in a series of MII8GdIII4 complexes by switching the 
CuII-GdIII antiferromagnetic interactions (14.6 J kg-1 K-1) to NiII-GdIII ferromagnetic interactions 
(22 J kg-1 K-1).225,226 The NiII-LnIII PCC displaying the highest MCE effect is a NiII12GdIII36 cage, 
where due to the low molecular weight of the ligands a large MCE effect of 36.3 J kg-1 K-1 is 
observed.227  
In contrast to NiII ions, the use of magnetically highly anisotropic CoII ions is a counter-intuitive 
route to synthesising 3d-4f molecular coolers, however a variety of these have been reported 
including a large family of Co-Ln PCCs reported by Zheng et.al,208 which can be divided into 
“grids”; CoII8LnIII4, CoII4LnIII6, CoII4LnIII2, CoII8LnIII8 and “cages”; CoII6LnIII8, CoII8LnIII2. The 
highest entropy changes were observed in the GdIII cages (23.6 J kg-1 K-1 – 28.6 J kg-1 K-1). The 
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highest value entropy change (41.3 J kg-1 K-1) among 3d-4f coolers is exhibited by a CoII10GdIII42 
“bowl” like PCC.209 
Very high nuclearity 3d-4f PCCs have proven to display a significant and enhanced MCE, which 
include the previously mentioned CoII10GdIII42 and NiII12GdIII36 PCCs as well as NiII10LnIII42,209 
CoII16GdIII24 (26 J kg-1K-1),75 CuII36GdIII42 (21 J kg-1 K-1)228 and ZnII6GdIII24 (30.0 J kg-1 K-1) species.5  
1.3.4 Luminescence 
Near Infrared (NIR) luminescent LnIII (Nd, Yb or Er) complexes229–233 with long-lived and 
characteristic line-like emission bands have potential applications in fluoro-immunoassays134–136 
and OLEDs,137–139,234 though due to forbidden f-f transitions, the absorption coefficient of the LnIII 
ions is usually very low. The introduction of ligands with chromophoric moieties, with fully 
allowed π- π* transitions sensitise the NIR luminescence, in an antenna-like effect.234 Introducing 
other metal ions such as CrIII, RuII, IrIII, ZnII and CdII as sensitizers into lanthanide complexes is 
also a common strategy to enhance lanthanide luminescence and has led to an increased interest 
in the development of bimetallic PCCs.235–237 Due to the low cost and high abundance of Zn, many 
ZnII-LnIII PCCs which enhance lanthanide luminescence have been reported.  
A distinct type of ZnII-LnIII PCCs, which are supported by compartmental Schiff base ligands 
(Figure 1.13), have been reported to enhance the luminescent properties of LnIII ions. These PCCs 
are usually low in nuclearity and include ZnII2LnIII,238,239 ZnIILnIII2,240 ZnIILnIII,237,239,241–246 
ZnII2LnIII3247 and ZnII2LnIII2,243,248,249 PCCs (Ln = Nd, Er, Yb, Eu, Tb).  
Compartmental Schiff base ligands are chosen due to the chromophores and tuneable coordination 
geometry which they can provide. Most of the reported 3d-4f PCCs supported by Salen-type 
Schiff base ligands have an inner N2O2 pocket for binding 3d (ZnII) ions and an outer O2O2 pocket 
which can bind both LnIII and 3d ions (Figure 1.13). With the coordination of both 3d and 4f ions 
to the ligand, luminescent quenching, which would arise from OH-, CH- or NH- oscillators of a 
solvate, is prevented. 
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Figure 1.13. The general structure of dinuclear and trinuclear luminescent 3d-4f PCCs (upper). 
Representative examples of dinucleating ligands for the construction of luminescent 3d-4f PCCs 
(lower). 
Extension of the flexible carbon backbone (Figure 1.13 lower), which is indicative of the Salen-
type ligands, has led to the formation of larger ZnII8LnIII4 “drum” complexes114 (Ln = Nd, Yb), 
which both demonstrate some of the best quantum yields for 3d-4f NIR luminescence. 
Particularly striking examples of 3d-4f NIR luminescent complexes are ZnII16LnIII PCCs (Figure 
1.14) which have long luminescent lifetimes and the highest reported overall quantum yields for 
NdIII and ErIII (Φ = 1.13% and 3.6 x 10-2 % respectively) NIR-emitting lanthanide complexes with 
C-H bonds.250 The well-known metallo-crown motif organises several organic sensitizers at a 
well-controlled distance from the LnIII ion which substantially limits C-H quenching.  
 
Figure 1.14. The molecular structure of ZnII16LnIII. Colour code: LnIII, light blue; ZnII, grey; O, 
red; C, white. Hydrogen ions omitted for clarity.250 
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1.3.5 Co-operative catalysis 
Synergistic, co-operative activation through multiple metal centres can often be found in enzyme 
biocatalysts such as tyrosinase,251 superoxide dismutase,252 urease253 and phosphohydrolase.254 
With the unrivalled efficacy of these enzymes in their respective transformations, there has been 
significant interest in developing PCCs which mimic or surpass the behaviour of their natural 
counterparts.  
Two important areas are WOCs based on the Mn4Ca core of Oxygen-Evolving Complex (OEC) 
in photosynthesis,140,255–261 the dinuclear cores of urease (NiII2) and class II aldolase in 
enantioselective C-C bond formation (ZnII2) for asymmetric transformations. 
1.3.5.1 PCC co-operative catalysis 
Bimetallic PCCs, with multiple metal centres and different coordination environments, have been 
employed as catalysts in a variety of asymmetric organic transformations. This arrangement can 
promote co-operative catalysis between the two metal centres. Bimetallic co-operative catalysis 
usually functions as Lewis acid-Brønsted base catalysis (Figure 1.15), where one metal centre 
(Brønsted base) generates a nucleophile and an electrophile is activated by a second metal (Lewis 
acid). The substrates are brought into proximity (3.5 - 6 Å) and a favourable orientation through 
this interaction and promote efficient catalysis.  
 
Figure 1.15. Bimetallic catalysis mechanism. 
This behaviour is observed in naturally occurring dinuclear metalloenzymes such as urease for 
urea hydrolysis (NiII2, Equation 1.19) and class II aldolase in enantioselective C-C bond formation 
(ZnII2).  
With the first respective example, two NiII cations are held in proximity linked by a ligand frame 
within the active site. One NiII ion is coordinated to urea (Lewis acid) and the other acts as a 
Brønsted base with the aid of a histidine chain, which produces the Ni hydroxide. Through 
synergistic action between the centres, the hydrolysis is significantly accelerated. 
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Equation 1.19. Mechanism of hydrolysis of urea by urease. 
Bimetallic PCCs modelled after these systems have employed an array of metals such as 
lanthanides, transitions metals and alkali metals. Structurally, co-operative bimetallic catalysts 
can be classified into several types, however, this thesis will only concentrate on those that metal 
ions are held within a single ligand frame. 
The careful design of the ligand frame for co-operative asymmetric catalysis is important so that 
the chiral environment for the targeted reactions is efficient for the dual activation of nucleophiles 
and electrophiles through co-operation of the metal centres.  
Many of the previously reported organic transformations postulate the active species is expected 
to form in situ, which requires specific cavities for the coordination of metal ions. So far there 
have been three distinct types of single ligand frames reported for the development of PCCs which 
promote bimetallic catalysis, these include 1,1 binapthol (BINOL) based ligands, amino acids and 
Schiff base ligands. A brief overview will be given for BINOL and amino acid-based systems and 
a more detailed account of the co-operative catalysis displayed by Schiff base derived systems.  
1.3.5.2 BINOL and amino acid derived co-operative PCC catalysts  
The first group of reported PCC catalysts were heterobimetallic with MIIIMII3 (1, 3M4-1) cores, 
supported by BINOL and various derivatives as chiral bidentate ligands (Figure 1.16). This series 
promoted a wide range of asymmetric transformations including nitroaldol reactions,262 aza-henry 
reactions,263 conjugate addition of malonates,264 conjugate addition of malonates to cyclic-
enones,265 epoxide ring opening with thiols,266 1,4-addition of Horner-Wadsworth-Emmons 
reagents267 and direct asymmetric aldol reactions.268 When two BINOL units are fused and treated 
with Et2Zn a trinuclear ZnII complex forms in situ (Figure 1.17), which preferentially affords the 
syn adducts up to 96% ee in the formation of α,β-dihydroxyketones from 2-hydroxyacetophenone 
and aldehydes.269–271  
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Figure 1.16. The general structure of BINOL supported MI3MIII PCC catalysts. 
An alternate ligand scaffold, based on abundant homochiral amino-acids has also been employed 
for the construction of bimetallic co-operative catalysts. Trost et al. reported a dinuclear ZnII2 PCC 
(Figure 1.17, ZnProPhenol) which is supported by a prophenol based ligand derived from 
proline,272 wherein one zinc metal acts as a Lewis acid and the other delivers the nucleophile. 
 
Figure 1.17. The general structure of ZnProPhenol. 
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ZnProPhenol was successfully applied to a variety of direct asymmetric aldol reactions using 
various aldol donors including methyl ketones,272 acetone,273 a-hydroxyl,274 acetylenic ketones275 
and vinyl ketones.276 It was subsequently reported that ZnProPhenol efficiently catalysed both 
Mannich277 and conjugate additions.278,279 
1.3.5.3 Schiff base derived co-operative PCC catalysts  
Shibasaki and Matsunaga et al. reported a series of homo and heterobimetallic dinuclear PCCs 
which are postulated to form in situ and promote a variety of asymmetric transformations 
reactions. These dinuclear PCCs are based on a chiral dinucleating ligand reported by Kozlowski 
et al., in which NiII and TiIV-GaIII mononuclear complexes promote the asymmetric conjugate 
addition of dibenzyl malonate to cyclic enones280–282 and asymmetric ring opening of meso 
epoxides with thiols and selenols, respectively.283,284 
These Schiff base ligands share a common ligand structure (Scheme 1.1) and contain two specific 
cavities for coordination of metal ions. The first is the N2O2 cavity which preferentially 
coordinates transition metal ions. The second is the O2O2 cavity which can selectively coordinate 
oxophilic lanthanide ions. This specificity is important as in all the reported protocols the 
formation of the active species is during the reaction and the PCC catalyst is not characterised 
independently. The geometry of the common ligand frame brings the two metal ions into 
proximity (3.5 – 6 Å) which is essential for the promotion of co-operative catalysis.143,285 
Various transition metal homometallic dinuclear PCCs supported by these ligands have been 
reported to form in situ and they promote a variety of asymmetric catalytic transformations 
(Scheme 1.1). A bimetallic NiII2 catalyst, bearing a 1,1 binaphthyl diamine as a chiral diamine 
(H2LB), was particularly versatile and promoted Mannich reactions,147,286,287 conjugate 
additions,286,288,289 amination,290 desymmetization291 and aldol-type reactions.292,293 By 
substituting NiII ions and the chiral diamine linker, it was possible to tune the catalytic efficacy of 
this system to specific reactions with CoII and MnIII analogues which promote 1,4 addition 
reactions.146,294,295  
The first example of a heterometallic PCC catalyst of this type was a CuIISmII PCC which 
promoted a syn-selective asymmetric nitroaldol reaction,296 substituting the metal ions with PdII 
and LaIII permitted the use of aldehydes as electrophiles and catalysed an anti-syn selective 
nitroaldol reaction.297 Further examples of heterometallic 3d-4f PCC catalysed reactions will be 
discussed in the next section.  
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Scheme 1.1. Ligands reported in in situ asymmetric transformations with 3d and 4f salts.
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1.3.5.4 3d-4f PCCs as co-operative catalysts 
Though there are few reported 3d-4f PCCs used for catalysis, the most common are dinuclear 
PCCs (1M2-1), which have been employed for asymmetric transformations. The ligands which 
have been reported in these systems are shown in Figure 1.18. 
 
Figure 1.18. Schiff base and Schiff base-derived ligands used to form catalytically active 3d-4f 
dinuclear PCCs. 
The first example of a 3d-4f PCC acting as a co-operative catalyst was reported by Shibasaki for 
an asymmetric transformation. A bimetallic Lewis acid/Brønsted base CuII-SmIII (1M2-1) PCC 
which was postulated to form in situ, with an achiral phenol additive, catalysed nitro-Mannich 
reactions with a high syn diastereoselectivity (>20:1 - 13:1) and enantioselectivity (66 - 99% ee) 
(Equation 1.20).297+296 It is suggested that the dinucleating Schiff base ligand, H2CL1, supports 
the PCC with a CuII ion coordinated to the N2O2 cavity and a SmIII ion in the O2O2 pocket to give 
a dinuclear CuII-SmIII species. 
 
Equation 1.20. A CuII/SmIII catalysed nitro-Mannich reaction.297+296 
Interestingly, the substitution of H2CL1 with H2CL2 or H2CL3, under identical conditions, 
showed no conversion to product. In addition, with the replacement of the CuII(OAc)2 with 
ZnII(OAc)2 or NiII(OAc)2 no conversion to product was observed, whereas the replacement of the 
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SmIII salt by other LnIII salts (LaIII, PrIII, NdIII, EuIII, GdIII, DyIII, ErIII, YbIII) resulted in lower yields 
(63 - 96%) with reduced stereoselectivity (3:1 > 20:1) and enantioselectivity (5 – 80 ee).  
The co-operative activation of the Sm-OAr moiety as a Brønsted base and the CuII ion as a Lewis 
acid is thought to be the key to the efficacy of these transformations. Though ESI-MS and optical 
purity studies indicated a trimer of CuII-SmIII dinuclear PCCs with an achiral phenol additive was 
the active species in the promotion of this selectivity, many other oligomers including Cu3Sm3, 
Cu6Sm6, Cu7Sm7, Cu8Sm8 and Cu9Sm9 were detected by ESI-MS. The proposed monomeric and 
trimeric CuII-SmIII species was never isolated or characterised.  
Subsequently, Zhou et al. reported a dinuclear CuII-SmIII PCC supported by H3CL5 which 
catalysed an in situ anti-selective asymmetric Henry reaction (Equation 1.21).298 Anti-β-nitro-
alcohols are obtained in up to 99% conversion, > 30:1 dr and 98% ee. The use of other MII and 
LnIII ions was not investigated. Furthermore, the reaction with only H3CL5 and Sm(OiPr)3 lead 
to a reduction in yield to 90% with an ee of 91%. ESI-MS studies indicated the presence of a 
[CuIISmIIICL5]+ dimer, which was postulated to be the active species, however, a [CuII2CL5]+ 
species is also observed with no further explanation. Although the in situ catalysis with H3CL5 
and Sm(OiPr)3 gave a higher yield than H3CL5 and Cu(OAc)2, the species in the more active 
reaction is not studied via ESI-MS.  
 
Equation 1.21. A CuII/SmIII catalysed anti-selective asymmetric Henry reaction.298 
These studies were followed by a proposed NiII-LaIII PCC, supported by H2CL4, which catalysed 
the enantioselective decarboxylation -1,4-addition of malonic acid half thioester to nitroalkenes 
(Equation 1.22).299 The NiII-LaIII PCC gave products in a 40 - 99% yield with 66 - 94% ee. No 
further identification or characterisation of the active species was presented. 
Equation 1.22. A NiII-LaIII asymmetric decarboxylative 1,4-addition of Malonic acid half 
thioester.299 
More recently, a dinuclear PCC with the general formula [ZnIIYbIII(CL6)(μ1-OAc)2(μ2-
OAc)(H2O)] (Figure 1.19) has been reported for the solvent-free copolymerization of cyclohexane 
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oxide and maleic anhydride (Scheme 1.2).300 The presence of TPP or DMAP as a co-catalyst leads 
to the formation of polyester and poly (ester-coether) respectively. The ZnII-YbIII PCC can 
effectively catalyse the co-polymerisation alone, unlike similar salen-based MIII complexes, 
which may indicate that [OAc]- initiators are working co-operatively with the active ZnII and YbIII 
centres.301 The ZnII-YbIII structure was elucidated by single-crystal XRD studies and has a similar 
structure to the 3d-4f PCC catalysts which were proposed in Shikasaki’s work. ESI-MS confirms 
the [ZnIIYbIII(CL6)]+ core configuration and Thermogravimetric Analysis (TGA) shows an 
indicative weight loss with the hetero-bimetallic framework stable up to 200 oC.
Scheme 1.2. Solvent-free co-polymerisation of cyclohexane oxide and maleic anhydride by ZnII-
YbII.300 
 
Figure 1.19. The molecular structure of ZnII-YbIII. Colour code: YbIII, light blue; ZnII, grey; O, 
red; C, white; N, blue. Hydrogen ions and counter-ions are omitted for clarity.300 
Though all in situ 3d-4f catalytic systems promote enantioselective and diastereoselective 
transformations, the characterisation of the proposed dinuclear 3d-4f PCCs, which are postulated 
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to promote the transformations, have been overlooked with only ESI-MS studies and the nature 
of the dinucleating ligands used as evidence to propose their formation. The characterisation of 
the active species and understanding of the catalytic mechanism are considered vital aspects for 
the development of 3d-4f PCC catalysis and will be addressed rigorously throughout the rest of 
this work. 
Higher nuclearity 3d-4f PCCs have been reported as catalysts, however, these are limited to 
oxidation catalysts and WOCs. Further, these examples report the prior synthesis and 
characterisation of the PCC and attempt to understand the catalytic mechanism.  
A heptanuclear MnIV6CeIV (3M7-1) PCC with TEMPO, was reported to catalyse the oxidation of 
benzyl alcohol to benzaldehyde with quantitative yields (Equation 1.23).302 The MnIV6CeIV PCC 
was well characterised in the solid state, which includes single-crystal XRD studies (Figure 1.20). 
The conversion to the product does not decrease with time and Fourier Transform Infrared 
Spectroscopy (FT-IR) data of the recovered product is consistent with the starting material, 
suggesting the PCC remains stable during the reaction. It was highlighted that the high efficiency 
of transformation could only be achieved when both high oxidation CeIV and MnIV ions were 
present in the same cluster. In contrast to previous dinuclear examples, the MnIV6CeIV cluster was 
well characterised and it was suggested that the catalyst remains stable under the reaction 
conditions.  
 
Equation 1.23. The MnIV6CeIV catalysed oxidation of benzyl alcohol to benzaldehyde.302 
More recently, a family of CoII3LnIII cubanes (Figure 1.20) (3M4-1) with the general formula 
[CoII3LnIII(hmp)4(OAc)]·5H2O (Ln = Ho, Er, Tm, Yb, hmp = 2-(hydroxymethyl)pyridine) were 
reported as the first 3d-4f WOCs.141,303 Initially synthesised by Wang et al.,303 the series of 
CoII3LnIII WOC activity is highest in a pH 8 borate/HCl buffer solution with yields of O2 between 
90 - 97% and TON vales of 42 - 99. The embedment of the LnIII centres into the cubane was 
shown to be essential for tunability and performance enhancement, with ErIII and HoIII analogues 
among leading CoII containing molecular WOCs to date.255,304–306 
The stability of the CoII3LnIII cores during the reaction was established with three distinct stages 
including spectroscopic solution tests and exclusion of nanoparticles, trace metal tests with CoII 
chelators or ICP-MS analysis and post-catalytic structural integrity checks which encompassed 
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HPLC analyses as well as XANES/EXAFS spectroscopy. In addition, Density Functional Theory 
(DFT) studies provides proof that LnIII centres are active catalytic promoters with flexible ligand 
binding modes. Overall, this contribution has opened up 3d-4f PCCs for photocatalytic 
applications.  
In the wake of the CoII3LnIII cubanes WOC activity, a dinuclear FeIII-CeIV PCC (Figure 1.20) with 
the general formula [FeIIICeIV(N4Py)(OH2)(NO3)4]+ was reported as a catalyst for water oxidation, 
which was demonstrated to be a facile and reversible process.307 The position of this equilibrium 
depends on the number of nitrate ligands on the Ce centre as controlled by the MeCN/H2O ratio 
in the solvent, which tunes the CeIV/III potential. A variety of characterisation techniques (single-
crystal XRD studies, ESI-MS, XAS and TGA) were used to confirm the identity of the FeIIICeIV 
PCC. Cyclic Voltammetry (CV) confirms the reversible nature of the process and it represents 
the first example of a reversible inner-sphere electron transfer between CeIII and FeIV= O PCCs. 
 
Figure 1.20. The molecular structure of MnIV6CeIV (upper). The molecular structure of FeIII-CeIV 
(lower left). The molecular structure of CoII3LnIII (lower right). Colour code: LnIII/IV, light blue; 
MnIV, purple; FeIII, brown; CoII, pink; O, red; C, white. Hydrogen ions and lattice molecules 
omitted for clarity.  
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1.4 Ligand selection and synthetic strategy for novel topologies and 
magnetic properties 
An objective of this research is to synthesise heterometallic 3d-4f PCCs with novel topologies 
and to study their enhanced magnetic and/or optical properties. The Schiff-base ligands selected 
to fulfil this objective were all synthesised from the keto precursor o-vanillin and amal (Figure 
1.5), which form ligands with a wide range of coordination modes. In this work several diprotic, 
tripotic and monoprotic Schiff base ligands; (E)-2-(2-hydroxy-3- methoxybenzylideneamino)-
phenol (H2L1), (E)-2-(2-hydroxy-3- methoxybenzylideneamino)-naphthol (H2L2), 6,6'-
((1E,1'E)-((2-hydroxypropane-1,3-diyl)bis(azanylylidene))bis(methanylylidene))bis(2-
methoxyphenol) (H3L3) and (E)-4-(2-hydroxy-3-methoxybenzylideneamino)-2,3-dimethyl-1-
phenyl-1,2-dihydropyrazol-5-one (HL4) have been selected (Figure 1.21). 
H2L1 has been previously reported for the synthesis of a small number of 3d-4f PCCs. These 
include isostructural MII/III2LnIII2 (M = Mn,116 Ni,50 Zn,46 Co,2,46) PCCs with a 2,3M4-1 core which 
all display SMM behaviour, with the CoII analogues displaying some of the highest reported 
blocking temperatures for 3d-4f PCC SMMs. A dodecanuclear NiII8LnIII4 PCC is also reported. 
H2L2 has not been previously reported for the synthesis of 3d-4f PCCs, however, it has identical 
co-ordination modes to H2L1. 
The coordination properties of H3L3 have been investigated extensively.308 This work was 
extended to synthesise dinuclear PCCs, including CoIIDyIII,309 CuII DyIII 309 and CuIISmIII 308 all of 
which display a typical SMM response. The highest nuclearity 3d-4f PCCs synthesised with H3L3 
were a family of isostructural heptanuclear CuII5LnIII2 PCCs reported by Chandrasekhar et al. in 
2013,113 where DyIII and HoIII analogues display SMM behaviour with energy barriers below 5 K.  
HL4 has only been employed for the synthesis of CoII-DyIII PCCs. The first 3d-4f PCC supported 
by HL4 was a heptanuclear CoII3DyIII4 disk.1 In addition, a family of nine CoII-DyIII PCCs 
including CoII2DyIII2, CoIIDyIII3, CoII4DyIII4 and CoII2DyIII5 were reported, many possessing 
previously unobserved topologies in 3d-4f chemistry.68 
The synthesis of novel 3d-4f PCCs with these ligands will rely on serendipitous assembly through 
a systematic variation of the reaction conditions (metal salts, temperature, reaction time, reactant 
ratio, solvent, and crystallisation method). In this pursuit, 3d-4f PCCs of new topologies and with 
magnetically interesting species should be isolated.  
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Figure 1.21. Schiff base ligands for targeting novel topologies and enhanced magnetic properties 
in 3d-4f PCCs. 
1.5 Ligand selection and synthetic strategy for catalytic properties 
Another main objective of this research is to construct well characterised 3d-4f PCCs which retain 
a stable core topology in solution and can be applied as catalysts in a variety of organic 
transformations.  
One of the most studied core topologies in 3d-4f PCC chemistry is the defect dicubane structure 
(2,3M4-1) and it is an ideal topology to study for catalytic activity. In this topology, the four metal 
ions are linked together by two µ3-O and further bridged by four µ2-O, forming an MII2LnIII2O6 
core. The two 3d ions and two 4f ions can be co-planar, and the six oxygen atoms are located 
above and below the plane with a centrosymmetric feature.  
In 3d-4f chemistry, this topology has been formed from a variety of ligands (Figure 1.22) and 
they display some of the most outstanding SMM properties hitherto reported.50,215 Notable 
examples include a MnIII2LnIII2 PCC formed from 1,1,1-trihydroxymethyl propane,310 a FeIII2DyIII2 
PCC supported by triethanolamine and carboxylic acids and two CoIII2LnIII2 PCCs were obtained 
with an analogous structure to the previous FeIII2DyIII2 PCC.311,312 
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Figure 1.22. Representative examples of ligands used for the synthesis of 3d-4f defect dicubane 
PCCs.  
Additionally, two isostructural NiII2LnIII2 and CoII2DyIII2 (Figure 1.23) defect dicubane PCCs, 
supported by L1, were reported by Powell.2,50 These PCCs presented an ideal starting point for 
targeting of catalytically active 3d-4f PCCs. The two crystallographically equivalent MII and two 
DyIII ions are linked via two u3-O phenol bridges from two separate L1 ligands to construct the 
M2Ln2O2 core. The two ligands provide µ2-O-phenol along the four outer edges of the MII2DyIII2 
rhombus with chelating [NO3]- and oxygen from a solvent molecule to complete the respective 
LnIII and MII coordination spheres. As the core is formed without the support of additional 
bridging ligands or co-ligands, the [MII2LnIII2(L1)4]2+ core may be stable in solution or in a 
potential catalytic reaction.  
The 3d ions coordination sphere also contains solvent molecules (THF/ DMF), which may allow 
interaction with possible substrate molecules, however, the LnIII node is capped by a nitrate 
counter-ion (Figure 1.24, 1CoDy-NO3).  
As the [MII2LnIII2(L1)4]2+ core is only supported by L1, it may be possible to synthesise 
isostructural analogues without coordinated counter-ions ([NO3]-, [Cl]-), instead replacing these 
with lattice counter-ions ([ClO4]-, [OTf3]-, [BF4]-), so that potential substrates are free to interact 
with the metal centres (Figure 1.24, 1CoDy-Solvent). The previously reported examples by 
Powell have already demonstrated that metal centres can be exchanged, 3d ions (NiII and CoII) 
and 4f ions (DyIII, TbIII), without affecting the defect dicubane core topology which grants scope 
for ZnII and CuII analogues to be synthesised.  
The advantages of using H2L1 to synthesise defect dicubane isostructural analogues of 
MII2LnIII22,50 over the previously described examples (Figure 1.22), is the simplicity of H2L1 
synthesis and the myriad of o-vanillin and modified aminophenol derivatives available. With the 
possible combinations of substrates to form modified H2L1 ligands (Table 1.1, H2LX), it would 
allow the synthesis of a library of 3d-4f PCCs with the same defect dicubane framework, with 
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modified ligands (Table 1.1, H2LX), similar coordination environments (Figure 1.24 right) and 
different guest ions with similar coordination properties. 
 
Figure 1.23. The molecular structure of CoII2LnII2 (1CoDy-NO3). NiII2LnII2 (1NiDy-NO3) is 
isostructural with CoII ions substituted with NiII ions. Colour code: LnIII, light blue; CoII, pink; O, 
red; C, white; N, blue; Hydrogen ions omitted for clarity.2,50 
Figure 1.24. Coordination spheres of CoII and LnIII observed in 1CoDy-NO3 (left). Hypothesised 
coordination spheres of CoII and LnIII in an isoskeletal analogue with uncoordinated lattice 
counter-ions (1CoDy-Solvent) (right). Ligand coordination, red; solvent, blue. 
With this library, the “isoskeletal” PCCs could be applied to a catalytic organic transformation to 
determine how the second sphere effects of the PCC such as the ligand modification, coordinated 
counter-ions and coordinated solvent may affect the catalytic efficacy of the PCC. These 
modifications may also impart other properties such as immobilisation for heterogeneous 
catalysis, Ultra Violet (UV) activated catalysis or act to promote asymmetric transformations with 
the correct selection of organic ligand. 
The term “isoskeletal” is based on the isoreticular concept introduced by O’Keeffe and Yaghi and 
it will be used to describe a PCC which possesses the same topology but with a modified organic 
periphery. This term will be further discussed, with an investigation into targeting the 2,3M4-1 
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topology, by varying the reaction conditions (solvent, environment, reactant ratio, temperature, 
crystallisation method, concentration and reaction time) with each H2LX ligand and determining 
how this affects the nature of the final product. 
 
Figure 1.25. Schiff base ligands for targeting catalytically active 3d-4f PCCs. 
Table 1.1. Key for modified ligands (H2LX) of H2L1. 
  H2L-H H2L-
NO2 
H2L-
Cl-NO2 
H2L-
NAP 
H2L-PP H2L-Py H2L-
tButyl 
R1 = H H2L1 H2L8 H2L12 H2L2 H2L19 H2L24 H2L27 
 
H2L6 H2L9 H2L13 H2L16 H2L20 H2L25 H2L28 
NO2 H2L7 H2L10 H2L14 H2L17 H2L21 N/S N/S 
Br H2L5 H2L11 H2L15 H2L18 H2L22 H2L26 H2L29 
N/S – Not synthesised. Synthetic protocol (chapter eleven) and characterisation (1H NMR and 13C 
NMR, Appendix B, S1.1-S1.26).  
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Chapter 2: Four new families of ZnII-LnIII PCCs. Synthetic, 
topological, magnetic and luminescent aspects. 
Abstract: The employment of three structurally related Schiff bases H2L1, H2L2, and H3L3 with 
zinc (II) and lanthanide (III) salts under various reaction conditions, gave four families of 
compounds formulated as [ZnII2LnIII2(L1)4(EtOH)6](ClO4)2 (1-3), [ZnII5LnIII(OH)(L1)6(H2O)] (4-
6), [ZnII4LnIII2(OH)2(L2)4(OAc)2(NO3)2(DMF)3]·DMF(7-9) and 
[ZnII2LnIII2(L3)2(NO3)2(CO3)2(CH3OH)2] (10-12). A comprehensive topological analysis of all 
reported ZnII-LnIII polynuclear coordination clusters with a core nuclearity of four and above is 
presented and identifies that families (4 - 9) are the first examples of the 2,3,4M6-1 motif in ZnII-
LnIII chemistry. Magnetic studies are presented for the DyIII analogues (1, 7 and 10), compound 7 
demonstrates a field-induced slow relaxation of the magnetization. Fluorescence studies are also 
discussed. 
2.1 Introduction 
This chapter presents the synthesis, topological analysis and magnetic properties of ZnII-LnIII 
Schiff base PCCs. Previously, ZnII-LnIII PCCs have displayed a number of interesting properties 
and topologies, with the first example of a heteronuclear ZnII – EuIII/SmIII PCCs reported in 1995 
by Brennan et al.313,314 Many dinuclear ZnII-LnIII examples followed.315–317 However, the most 
pivotal example of a ZnII-LnIII PCC was a pentanuclear ZnII2DyIII3 PCC which exhibited SMM 
and fluorescent properties and was reported by Murugesu et al.318 Since then, the synthesis of 
ZnII-LnIII PCCs has gained a remarkable amount of attention due to their unique characteristics 
including: 
a) A magnetic behaviour which can be explained due to the diamagnetic character of the ZnII ion 
and which has been shown to enhance the energy barrier in ZnII-DyIII SMMs.216 
b) EuIII and TbIII ions are attractive luminescent centres, due to their long-lived 5D0 and 5D4 excited 
states and the accompanying large Stokes’ Shifts. In addition, the combination with ZnII ions may 
produce species with enhanced luminescent properties via 3d-4f energy transfer.319  
 
A plethora of such mixed metal species have been reported and the magnetic and luminescent 
properties of such compounds have been very well investigated.72,114,210,212,225,237,239,320–335 H2L1 
and its structurally related pro-ligands, H2L2 and H3L3 (Figure 2.1), have not been reported for 
the synthesis of ZnII-LnIII PCCs. Due to these multifunctional properties and the wide range of 
previously synthesised core topologies in ZnII-LnIII PCC chemistry, it was thought that this 
combination would provide an ideal starting point for the discovery of novel 3d-4f Schiff base 
supported PCCs. 
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Figure 2.1. Schiff base ligands used in this chapter. 
A systematic synthetic study using H2L1, H2L2 and H3L3, a variety of solvents, metal salts and 
crystallisation techniques is presented in an effort to discover novel ZnII-LnIII PCCs. Herein, 
twelve new PCCs formulated as [ZnII2LnIII2(L1)4(EtOH)6](ClO4)2 where Ln is DyIII (1), TbIII (2) 
or EuIII (3), [ZnII5Ln(OH)(L1)6(H2O)], where Ln is DyIII (4), TbIII (5) or EuIII (6), 
[ZnII4LnIII2(OH)2(L2)4(OAc)2(NO3)2(DMF)3]·DMF, where Ln is DyIII (7), TbIII (8) or EuIII (9), 
[ZnII2LnIII2(L3)2(CO3)2(NO3)2(CH3OH)2] where Ln is DyIII (10), TbIII (11) and EuIII (12) are 
described. Magnetic studies of the DyIII analogues are presented, as well as luminescent properties 
in solution.  
2.2 Results and discussion 
2.2.1 Synthetic strategy  
It is well-known that the stoichiometric ratio, metal salt, temperature, atmosphere, solvent and 
time of reaction, can all affect the nature of the final product. The semi-rigid H2L1 ligand has two 
pockets-I (ONO) and –II (ONO) (Figure 2.3) which are suitable for binding both 3d and 4f metal 
ions.  
The reaction between, Dy(OTf)3, Zn(ClO4)2·6H2O and H2L1 in the presence of Et3N, in EtOH, in 
the molar ratio 1:2:2:4.5, afforded yellow needle like crystals of 1 in a moderate yield (57%) after 
1 week (Table 2.1, entry 1). The reaction with similar ratios but different counter anions and 
solvent yielded the recently reported isoskeletal PCCs formulated as [Zn2Ln2(L1)4(NO3)2(DMF)2] 
(Table 2.1, entry 2).336 
With the aim of synthesising the isoskeletal ZnII analogue of [Ni2Ln2(L1)4Cl2(CH3CN)2],337 a 
reaction with similar ratios of MeCN, DyCl3 and ZnCl2, was performed, which yielded crystals 
of 4 after 2 weeks (Table 2.1, entry 3). The resultant PCCs displayed a topology previously 
unobserved in the literature for ZnII-LnIII PCCs.  
A modified form of this ligand, H2L2 (Figure 2.1 middle), that offers identical pockets to H2L1 
has been employed to act as a sensitizer to enhance luminescence of the resulting complexes. A 
reaction was performed with same molar reactant ratios in DMF, with Dy(NO3)3·5H2O and 
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Zn(OAc)2·4H2O and after 1 week of Vapour Diffusion (VD) with Et2O, large yellow plate-like 
crystals of 7 formed in 70% yield (Table 2.1, entry 4).  
With the retention of the o-vanillin unit and replacement of the aminophenol by 1,3-diamino-2-
propanol the ligand, H3L3 (Figure 2.1, right), which offers similar pockets to that in H2L1 and 
H2L2 and one extra pocket was obtained. The use of H3L3 for the first time in ZnII-LnIII chemistry, 
gave the tetranuclear compounds 10 – 12 (Table 2.1, entry 5). A summary of these synthetic 
procedures is shown in Table 2.1 and Scheme 2.1. 
 
Scheme 2.1. Synthetic scheme for the preparation of (1-12). 
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Table 2.1. Synthetic strategies for the preparation of ZnII-LnIII PCCs. 
Entry Ligand LnIII salt ZnII salt Crystallisation method/ 
time (days) 
Solvent Compound 
1 H2L1 Ln(OTf)3 Zn(ClO4)2·6H2O SE / 7 EtOH ZnII2LnIII2  
(1, 2, 3) 
2 H2L1 Ln(NO3)3·5H2O Zn(NO3)2·6H2O VD Et2O / 9 DMF ZnII2LnIII2336 
(chapter nine) 
3 H2L1 LnCl3·xH2O ZnCl2 SE / 3 MeCN ZnII5LnIII 
 (4, 5, 6) 
4 H2L2 Ln(NO3)3·5H2O Zn(CH3CO2)2·4H2O VD Et2O / 7 DMF ZnII4LnIII2 
(7, 8, 9) 
5 H3L3 Ln(NO3)3·xH2O Zn(NO3)2·6H2O SE / 5 MeOH ZnII2LnIII2 
(10, 11, 12) 
a Ratio of all reactants 1:2:2:4.5 = A: B: C: D. A = DyIII salt, B = ZnII salt, C = HxLX, D = Et3N. Slow Evaporation (SE). Vapour Diffusion (VD).
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2.2.2 Molecular structure and crystal structure descriptions of 1 - 12  
In addition to single-crystal XRD studies, compounds 1 - 12 were characterised by FT-IR 
spectroscopy (Appendix B, S2.1-S2.12), TGA (Appendix B, S2.13-S2.20), ESI-MS (Appendix 
B, S2.24-S2.26) and Elemental Analysis (EA) (chapter eleven), which all support the following 
descriptions. 
2.2.2.1 Molecular structure of 1 - 3 
Compounds 1 – 3 crystallize in the monoclinic P21/n space group and are isostructural, thus only 
1 will be described (Figure 2.2). The asymmetric unit of 1 contains one ZnII ion, one DyIII ion, 
two doubly deprotonated organic ligands (L1), three coordinated ethanol molecules (one to the 
ZnII and the other two to the DyIII ion), one perchlorate and one ethanol molecule. The main core 
of 1 can be described as a defect dicubane338 and is isoskeletal to the previously reported 
NiII2LnIII250,337 and CoII2LnIII22,337 cores. 
The organic ligands exhibit two different coordination modes (Figure 2.3). In the first mode 
(Figure 2.3, mode I), the two phenoxide oxygen atoms and the imine nitrogen atom are chelated 
to the ZnII centre and the two phenoxide atoms are further bonded to two DyIII ions (Dy (1) and 
its symmetry-related counterpart) and the methoxide oxygen atoms are bound to Dy (1). In the 
second mode (Figure 2.3, mode II), the two phenoxide oxygen atoms and the imine nitrogen atom 
are chelated to the DyIII centre, while the phenoxide oxygen atom (from the 2-aminophenol unit), 
is further bound to two ZnII centres. One ethanol molecule is bound one to the ZnII ion and two 
others are bound to the DyIII ion.  
Each ZnII centre coordinates to six atoms (O5N) and displays an octahedral coordination, while 
each DyIII centre coordinates to eight atoms (O7N). Using SHAPE software,339 the geometry of 
Dy(1) can be best described as biaugmented trigonal prismatic, with an S(P) value 1.415. There 
are two ZnII···DyIII distances at 3.5513(5) Å and 3.5329(5) Å and one ZnII···ZnII distance at 
3.172(5) Å. Two coordinating ethanol molecules, one to ZnII and one to DyIII ion, form an H-bond 
(O8 – H8···O9) while the third coordinating ethanol molecule forms an H-bond with the lattice 
EtOH (O7 – H7···O10), which in turn is H-bonded to the uncoordinated methoxide oxygen atom 
(O10 – H10A··· O1).  
No other intramolecular interactions (e.g. H-bonds or stacking) can be found between 
neighbouring entities. According to the NDk-m topological representation,13,340 the main core of 
compound 1 can be enumerated as 2,3M4-1.13 According to a literature survey341 this topology 
can be found in ZnII2EuIII2313 and ZnII2YbIII2249 PCCs and other recently reported examples.336 
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Figure 2.2. The molecular structure of compound 1 (upper) and its core (lower). C, H atoms and 
lattice molecules are omitted for clarity. Colour code: ZnII, grey; DyIII, light blue; O, red; N, blue; 
Cl, purple. 
 
Figure 2.3. The coordination modes found in 1 and 3.  
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2.2.2.2 Molecular structure of 4 - 6 
Compounds 4 – 6 crystallize in the triclinic P-1 space group and are isostructural, thus only 4 will 
be further described (Figure 2.4). The asymmetric unit of 4 contains five ZnII ions, one DyIII ion, 
six doubly deprotonated organic ligands (L1), one triply bridging hydroxyl group, one 
coordinated water molecule and two lattice molecules (one water and one acetonitrile). The main 
core of 4 can be considered as four fused triangles forming a distorted ‘‘chair’’ shaped core. 
The five ZnII ions are situated in a plane, while the DyIII is situated 1.998 Å above this plane. Each 
of the six organic ligands is chelated to one metal centre and further bridges other metal centres 
with the phenoxide and methoxide oxygen atoms. Three different coordination modes can be 
found for the six organic ligands (Figure 2.3, modes I, II and III).  
The hydroxyl group bridges Zn2, Zn3 and Dy1 and is situated (0.311 Å) above their plane. The 
coordination sphere of Zn3 is completed by one water molecule. Zn1 and Zn5 are five coordinated 
(O4N) with trigonality index τ = 0.79 and 0.88, respectively, indicating that they adopt distorted 
trigonal bipyramidal coordination. Zn2 and Zn3 are five coordinated (O4N) with trigonality index 
τ = 0.46 and 0.43, respectively, indicating that the coordination is between square pyramidal and 
trigonal bipyramidal.342 Zn4 is six-coordinated (O5N). From SHAPE software,339 the geometry of 
Zn4 can be best described as trigonal prismatic, with S(P) value 5.126. 
The DyIII centre coordinates to nine atoms (O8N). From SHAPE software,339 the coordination of 
Dy(1) can be best described as between a spherical tricapped trigonal prism and a spherical capped 
square antiprism [S(P) 1.606 and 1.656, respectively].  
There are two ZnII···DyIII distances of 3.4317(3) Å and 3.4452(3) Å and four ZnII···ZnII distances 
at 3.0942(3) Å, 3.1296(3) Å, 3.527(3) Å and 3.626(3) Å. The coordinating water molecule forms 
two strong H-bonds, one with the methoxido oxygen atom (O7···O1AA) and the other with lattice 
water (O7···O3A). No other supramolecular interactions (H-bonds or stacking) can be found 
between neighbouring entities.  
According to the NDk-m topological representation,13,340 the main core of compound 4 can be 
enumerated as 2,3,4M6-113 and represents the first example of this configuration in ZnII-DyIII 
chemistry. 
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Figure 2.4. The molecular structure of compound 4 (upper) and its core (middle). C, H atoms and 
lattice molecules are omitted for clarity. The decorated 2,3,4M6-1 motif (lower). Colour code: 
ZnII, grey; DyIII, light blue; O, red; N, blue. 
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2.2.2.3 Molecular structure of 7 - 9 
Compounds 7 – 9 crystallize in the monoclinic P21/c space group and are isostructural, thus only 
7 will be further described (Figure 2.5). The asymmetric unit of 7 contains four ZnII ions, two 
DyIII ions, four doubly deprotonated organic ligands (L2), two triply bridging hydroxyl groups, 
two acetates, three coordinating and one lattice DMF molecule(s). One of the coordination sites 
of DyIII is disordered with water and a nitrate is present.  
 
The core of 7 can be considered as four fused triangles. Dy2, Zn1, Zn2 and Zn3 are strictly 
coplanar, while Dy1, Zn4, Zn3 and Zn2 are nearly so. The distorted angle between the two mean 
planes is 62.39 °. Each organic ligand is chelated to one ZnII ion, forming four neutral 
metalloligands (ZnL2) which are further bridged to neighbouring ZnII and two DyIII ions.  
 
In total each L2 coordinates to three metal centres; two ZnII and one DyIII, exhibiting a 
coordination mode analogous to mode I (Figure 2.3). Each hydroxyl group bridges three metal 
centres, O1 bridges Dy1, Zn2 and Zn4, and O2 bridges Dy2, Zn1 and Zn3, and O1 and O2 are 
0.895 and 0.911 Å, respectively above the plane. Each acetate group bridges two metal centres, 
Dy1 – Zn4 and Dy2, Zn1. Two DMF molecules coordinate to Dy1 and one DMF and one nitrate 
complete the coordination geometry of Dy2. 
 
Each ZnII ion has a coordination number of six (O5N) albeit with a distorted octahedral 
coordination geometry. Each DyIII ion coordinates to eight oxygen atoms. From SHAPE 
software,339 the geometry of Dy(1) and Dy(2) can be best described as between biaugmented 
trigonal prismatic and triangular dodecahedral [S(P) values 1.763 and 1.868, respectively] and 
biaugmented trigonal prism [S(P) value 1.626], respectively. There are four ZnII···DyIII distances 
between 3.3598(10) Å - 3.5333(10) Å and four ZnII··· ZnII distances 3.1216(12) Å - 3.354(12) Å. 
The lattice DMF molecule forms strong H-bonds with the two hydroxyl groups. 
 
No other supramolecular interactions (H-bonds or stacking) can be found between neighbouring 
entities. According to the NDk-m topological representation,13,340 the core of compound 7 can be 
enumerated as 2,3,4M6-1.13 A literature survey reveals that the same motif with the same MII/LnIII 
ratio can be seen in NiII-LnIII 343 and CoII-LnIII 344 chemistry.  
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Figure 2.5. The molecular structure of compound 7 (upper) and its core (middle). C, H atoms and 
lattice molecules are omitted for clarity. The decorated 2,3,4M6-1 motif (lower). Colour code: 
ZnII, grey; DyIII, light blue; O, red; N, blue.  
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2.2.2.4 Molecular structure of 10 - 12 
Compounds 10 – 12 crystallize in the monoclinic P21/n space group and are isostructural, thus 
only 10 is further described (Figure 2.6). The asymmetric unit contains one ZnII ion, one DyIII ion, 
one doubly deprotonated organic ligand (HL3), one carbonate, one nitrate and one methanol 
molecule.  
 
The main core of 10 can be considered as two Zn-Dy pairs bridged by two carbonate groups. The 
four metal centres are situated in a plane (torsion angle Zn1 – Dy1 – Dy1 – Zn1 is 0 ˚). Each 
organic ligand is chelated to the ZnII ion via the two imino N atoms and the two phenoxide O 
atoms and to the DyIII ion via the two methoxido and two phenoxide O atoms (Figure 2.3). The 
carbonate group bridges the two DyIII ions via oxygen O3 and coordinates to Zn1 and the nitrate 
group is chelated to the DyIII ion.  
 
The distorted octahedral geometry (O4N2) of the ZnII ion is completed by the oxygen atom of a 
methanol molecule. The coordination number of the DyIII ion is completed by one chelated nitrate. 
From SHAPE software,339 the geometry of Dy(1) can be best described as spherical capped square 
antiprism [S(P) 2.489]. There is one ZnII···DyIII distance at 3.446(2) Å and one DyIII···DyIII 
distance at 4.007(2) Å. The central OH group of the organic ligand remains protonated and forms 
a strong H-bond with an oxygen atom of a carbonate group of a neighbouring ZnII2DyIII2 entity 
forming a two-dimensional (2D) H-bonded framework, which extends perpendicular to the xy 
plane.  
 
According to the NDk-m topological representation,13,340 the main core of compound 10 can be 
enumerated as 1,2M4-113 and it is the fifth example of the motif in ZnII-DyIII chemistry.72,325,330,332 
A comparison between the H3L3 ligand, which was used for the synthesis of 10 and the Schiff 
base ligands used for the synthesis of the previously reported compounds, the same 1,2M4-1 motif 
indicates that despite the existence of the central OH group, this type of ligand favours the 
formation of Zn-Ln dimers which combine via the carbonate unit to the tetranuclear motif.237  
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Figure 2.6. The molecular structure of compound 10 (upper) and its core (middle). C, H atoms 
and lattice molecules are omitted for clarity. The 2D H-bonded framework seen in the crystal 
structure of 10 (lower). Colour code: ZnII, grey; DyIII, light blue; O, red; N, blue.  
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2.2.3 Magnetic properties.  
Magnetic measurements were made on selected powdered samples of compounds 1, 7 and 10 to 
detect any SMM response. In preliminary ac measurements at zero field and two frequencies (10 
and 1000 Hz) the three compounds showed a similar response, which was only observable by the 
tail of their ac signals (Appendix A, Figure S2.1). A series of new measurements under fields up 
to 3000 G showed a shift of the signals to a higher temperature but ac peaks were not observable 
for 1 and 10. In contrast, with the magnetic field Hdc = 0, ac measurement clearly shows the 
presence of an out-of-phase signal, well-defined peaks were obtained for 7 for frequencies larger 
than 80 Hz and under a field of 3000 G (Appendix A, Figure S2.2). These measurements are 
evidence of strong QTM.  
 
 
Figure 2.7. MT product vs. temperature for complex 7 (upper). ac susceptibility measurements 
for 7 at frequencies comprised between 23 and 1500 Hz (lower). 
55 
 
 
Complementary susceptibility measurements were made for 7. The MT product at room 
temperature is 27.2 cm3 mol-1 K, slightly lower than the expected value of 28.3 cm3 mol-1 K for 
two DyIII cations, (Figure 2.7, upper). On cooling the MT value decreases monotonically down 
to a final value of 20.7 cm3 mol-1 K at 2 K. Magnetization experiments show a fast increase of the 
magnetization and a roughly linear dependence with the applied field in the 2 - 5 T field range. 
The final value of 9.4 N (for the two DyIII cations) under the maximum explored field of 5 T is 
lower than the expected suggesting a moderately high anisotropy, as magnetisation does not 
saturate. 
The ac susceptibility measurement in the 80-1500 Hz frequency range show well defined 
frequency-dependent peaks. An Arrhenius fit of the maxima of the peaks for compound 7 gives 
an energy barrier of 10.2 cm-1 and o = 7.1·10-6 s, (Figure 2.7, lower). In the light of the structural 
data it shows that the two DyIII cations do not interact and are well isolated by the Zn4 butterfly, 
compound 7 should be assumed as a Single-Ion Magnet (SIM) with a low barrier for the reversal 
of magnetization.  
The magnitude of the barrier for systems of this kind is sensitive to multiple factors, but the 
importance of the ligand field and the position of the charged or neutral donors around the 
lanthanide cation determines whether the spatial arrangement of electronic density fits the ideal 
oblate-prolate model for the lanthanide cation.158,345,346  
For the case of DyIII, its oblate electron density will generate larger barriers when negatively 
charged donors are above and below the radial plane of the cation. For 7 it is far from this situation 
because the O-phenoxo and O-carboxylate donors (with the shorter Dy···O distances) are placed 
on the same side of the coordination sphere, whereas the other side is occupied by solvent 
molecules with two Dy···O distances larger than 2.5 Å.  
Calculation of the direction of the easy axis for the DyIII cations, in low symmetry environments, 
such as that of 7 (DyIII), which is assumed to be in the mj = ± 15/2 ground state, can be performed 
with the MAGELLAN program.347 The directions are similar, as can be expected from the similar 
(but not identical) coordination spheres around Dy1 and Dy2. The axes are directed towards the 
O-phenoxo donors and are inclined at 54.1 º which are not parallel. Both factors in non-ideal 
arrangements of the charged O-donors around the DyIII cations and the angle between the easy 
axes contribute to the low energy barrier of the system. 
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Figure 2.8. The relative position of the easy axis of the two DyIII cations on the core of 7 (upper) 
and in their DyO8 coordination spheres (lower). Colour code: red O-atoms corresponds to the O-
phenoxo and O-carboxylate donors. 
2.2.4 Photoluminescence.  
Solution luminescence measurements were made for nine of the ZnII-LnIII PCCs (4 - 12) in DMF 
and each of the three ligands. The spectra of the DyIII containing species (Figure 2.9) show broad 
ligand-based emissions with some metal contribution (resulting in red-shift of the profile) which 
dominates for each of the three compounds. Though each of these species has distinctly different 
absorption spectra, all three emit near 560 nm (4: λem = 560 nm, 7: λem = 567 nm, and 10: λem = 
555 nm) correlating with the 4F9/2 - 6H13/2 transition that accompanies DyIII emission. The broad 
nature of these signals indicates a significant ligand contribution to these emitters.  
 
Compounds 4 - 9 which contain L1 and L2 exhibited similar behaviour (Appendix B, S2.21). 
However, TbIII and EuIII-containing complexes supported by L3 (Appendix B, S2.21-S2.23) 
displayed more typical emission spectra for lanthanide species with multiple narrow emission 
bands correlating to specific transitions within a broad ligand emission peak. In particular, 11 
exhibits an emission spectrum centred at 550 nm, comparable to that described by Murugesu et 
al. in 2009 with discrete 5D4 – 7F6, 5D4 - 7F5, 5D4 – 7F4, 5D4 – 7F3 transitions.318 Emission in the 
NIR region was not observed below 1100 nm for any of the nine compounds tested. 
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Figure 2.9. Normalised absorption (dashed line) and emission spectra (solid line) of compounds 
4 (blue; λex = 440), 7 (red; λex = 400), and 10 (yellow; λex = 355) recorded in DMF (1 x 10-5 mol 
dm-3, 298 K). 
2.2.5 Topological aspects.  
Many ZnII-LnIII PCCs have been reported in the literature, but a significant number of these are 
di or tri-nuclear species. There are fewer reported examples with a core nuclearity above four, 
these higher nuclearity examples are shown in Appendix A (Table S2.1) with their core topology 
(Figure 2.11) and ligand (Figure 2.10). Recently, two ZnII-LnIII PCC with a core nuclearity of 30 
were reported, showcasing the current interest in ZnII-LnIII chemistry.5,28 The most common core 
nuclearity reported for ZnII-LnIII PCCs is four, with several topological motifs which are 
dependent on the structure of the ligand used for their synthesis.  
The 1,2M4-1 topology is the most common for ZnII-LnIII PCCs and the supporting ligands share 
a common structure (Figure 2.10). 1,2M4-1 PCCs are formed in alcoholic solvents (MeOH, 
EtOH) (Table 2.2, entries 1, 4, 9 and 31), the ZnII ions are co-ordinated between the 
imine/secondary amine and deprotonated hydroxyl groups, while LnIII ions are bound to the 
deprotonated hydroxyl and methoxy groups, which form a [ZnIILnIII(LX)]3+ unit. In these 
examples, counter-ions such as [Cl]- or [CO3]2- (from atmospheric CO2) bridge between two 
[ZnIILnIII(LX)]3+ units to form the 1,2M4-1 core as a dimer. The coordination sphere is completed 
by counter-ions such as [NO3]- or [OAc]- for charge balance and solvent molecules.  
Of the Schiff base ligands employed in ZnII-LnIII PCC synthesis, few display a core nuclearity 
above five and tetranuclear Schiff base PCCs are the most frequently reported. This may be due 
to the many co-ordinating groups usually present and the rigid structural fragments. The 2,3M4-
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1 motif is a very common motif in ZnII-4f chemistry and in this thesis two variations of this 
topology are reported.  
The second most widespread motif in hexanuclear 3d-4f chemistry is 2,3,4M6-1. According to a 
survey in Cambridge Structural Database (CSD),341 33 crystal structures55,82,100,115,116,343,348–352 
possess this motif. The first reported 3d-4f PCCs with this topology can be found in a family of 
Mn4IIILn2III compounds, where Ln is Gd, Tb, Y, reported in 2008 by Oshi et al.348 Other examples 
were reported in Mn-4f, 116,349,350 Ni-4f,55,343 Co-4f,115,344,351,352 and Fe-4f 82 chemistry. Although 
this topology is very common in 3d-4f PCC chemistry, compounds 4 - 9 are the first examples of 
the 2,3,4M6-1 motif in ZnII-LnIII PCC chemistry. 
In the present study, despite using organic ligands that offer similar pockets, a range of topologies 
were obtained and the unexpected involvement of the fixed carbonate group does not allow for a 
complete systematic study.  
2.3 Conclusion 
Reactions of zinc (II) and lanthanide (III) salts with various Schiff bases (H2L1 - H3L3) and a 
variety of reaction conditions yield four families of ZnII-LnIII PCCs with robust and previously 
unobserved topologies. The most notable of the PCCs reported are the first examples of ZnII-LnIII 
PCCs with the 2,3,4M6-1 core topology (4 - 9). Magnetic studies reveal the SIM behaviour of 
compound 7 and luminescence studies indicate a significant ligand contribution to the emitters.  
 
Despite incorporating organic ligands that offer similar coordination pockets in similar synthetic 
ratios, products with a range of nuclearities and motifs are obtained, suggesting that more 
systematic studies are required to fully understand the growth of such crystalline species and to 
target specific products. When the reaction that yielded compound 4 was repeated under reflux, 
instead of room temperature, two different type of crystals were obtained with the general 
formulas [ZnII4DyIII7(OH)4(O2)2(L1)8Cl4(H2O)4]Cl5 (13) and 
[ZnII6DyIII4(OH)2(L1)10(MeOH)2(H2O)4]Cl2 (14) which core topologies are enumerated 
2,2,3,3M10-1 and 2,4,4,4M11-1 respectively (Appendix A, Figures S2.3 and S2.4). However, 
these PCCs could not be isolated independently which highlights the limitations of the applied 
synthetic strategy. 
 
Future studies should be focused in the following directions:  
a) To extend the synthetic study to different 3d metals, ligands, co-ligands and ratios to obtain 
higher nuclearity 3d-LnIII PCCs. 
b) To test the ligand pockets and coordination environment selection in the topological approach 
to synthetic strategy.13,353  
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Figure 2.10. The organic ligands used for the synthesis of previously reported ZnII-LnIII PCCs. 
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Figure 2.11. The topological representations of all known ZnII-LnIII PCCs with nuclearities of 
four or higher.  
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Chapter 3: Synthesis, characterization, magnetic properties 
and topological aspects of isoskeletal hexanuclear CoII4LnIII2 
PCCs possessing a 2,3,4M6-1 topology 
Abstract: The employment of H2L1 with Co(NO3)2·6H2O and LnCl3·x(H2O) afforded a family 
of hexanuclear heterometallic polynuclear coordination clusters formulated [CoII4LnIII2(µ3-
OH)2(L1)4Cl2(NO3)2(MeOH)4]·3(Et2O) where Ln is Y (15), Gd (16), Dy (17) and Tb (18). All the 
compounds are stable in solution as confirmed by electrospray ionization mass spectrometry 
studies. The topology of these compounds can be enumerated 2,3,4M6-1. The use of H2L5 with 
Co(NO3)2·6H2O and DyCl3·x(H2O) afforded a CoII4LnIII2 PCC which is isoskeletal to compounds 
15 – 18 and is formulated [CoII4DyIII2(µ3-OH)2(L5)4Cl2(NO3)2(MeOH)4] (19). Magnetic studies 
performed in the temperature range 1.8 – 300 K show that compound 17 shows a slow magnetic 
relaxation. 
3.1 Introduction 
Lanthanides, especially dysprosium (III),354,355 and cobalt (II)15,356 based PCCs have been widely 
used to gain access to PCCs behaving as SMMs. The first example of a CoII-LnIII SMM supported 
by a Schiff base ligand was a trinuclear CoII2GdIII complex, with a Ueff of 27 K and τ0 of 1.7x10-7 
s, which was reported by Chandrasekhar.193 The combination of CoII and LnIII ions with Schiff 
base ligands has resulted in a variety of low nuclearity species (including CoIILnIII,357 
CoII2LnIII,195,358 and CoII2LnIII22,77,359) which display SMM behaviour.  
There has been few Schiff base supported CoII-LnIII PCCs, with a nuclearity above five, that show 
SMM behaviour and all of the reported examples of SMM behaviour have been exclusive to the 
DyIII analogues. The synthesis of these PCCs has traditionally relied upon serendipitous assembly, 
with Schiff base ligand mixed with CoII and LnIII salts in alcohol or acetonitrile solution and 
subsequently crystallised.  
These examples include a “chair-like” CoII2DyIII4 PCC (2,3,4M6-1) which displays a Ueff of 41.9 
K and a τ0 of 1.21 x 10-7 s. Another “chair-like” CoII2DyIII4 (2,3,4M6-1) PCC synthesised from a 
structurally similar ligand (H2CL2.1 and H2CL2.2 respectively) and pivalic acid, displays a 
slightly lower Ueff value of 32.4 K and a τ0 of 4.2 x 10-7 s.  
The remaining examples of CoII-DyIII Schiff base PCCs, which display SMM behaviour, are 
formed from ligands that do not share similar compartments and whose core topologies are 
unrelated. A dodecanuclear CoII2DyIII10 ring (2M12-1) PCC supported by H2CL2.3 displays two 
relaxation pathways, one with a longer relaxation time of τ0 = 1.13 x10-4 s and a lower energy 
barrier Ueff = 4.3 K and the other a higher energy barrier of Ueff  = 25 K and a shorter relaxation 
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time of τ0 of 1.13 x10-4 s. The final example, a CoII3DyIII4 PCC disk (3,6M7-1) formed from HL4, 
displays out-of-phase signals below 4 K.  
 
Figure 3.1. Schiff base ligands used for the synthesis of high nuclearity CoII-DyIII PCCs. 
Though H2L1 has been used for the synthesis of a variety of 3d,360,361 4f 362 and 3d-4f 
PCCs,2,50,116,343,363–365 the only previous example of H2L1 being combined with CoII and DyIII ions 
resulted in the formation of a defect-dicubane CoII2DyIII2 which displays SMM behaviour with a 
blocking temperature of 22 K.2 With the intention of synthesising high nuclearity CoII-LnIII PCCs 
which display SMM behaviour, H2L1 was employed with Co(NO3)2·6H2O and LnCl3·x(H2O). 
This combination resulted in a family of hexanuclear heterometallic PCCs formulated as 
[CoII4LnIII2(µ3-OH)2(L1)4Cl2(NO3)2(MeOH)4]·3(Et2O), where Ln is Y (15), Gd (16), Dy (17) and 
Tb (18), in very good yields. For structural purposes, the employment of H2L5 (Figure 3.1),366 
under similar reaction conditions afforded an isoskeletal compound formulated as [CoII4DyIII2(µ3-
OH)2(L5)4Cl2(NO3)2(MeOH)4] (19). Topological aspects and magnetic properties of these 
compounds are discussed.  
3.2 Results and discussion 
3.2.1 Molecular structures of 15 - 18 
Single-crystal XRD studies show three Et2O molecules367,368 could be successfully refined in the 
lattice of 16 and 17. However, these samples are air sensitive and over time lose their crystallinity. 
Compounds 15-18 were further characterised by EA (chapter eleven), TGA (Appendix B, S3.5) 
and ESI-MS (Appendix B, S3.1-3.4). 
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Compounds 15 - 18 crystallize in the monoclinic space group P21/c and are isostructural, thus 
only compound 16 is discussed further. Four CoII and two GdIII cations form a twisted “boat-like” 
core with CoII ions occupying the four central body positions and the two GdIII ions occupying 
positions in the “bow” and “aft” (Figure 3.2), this configuration will be assigned the notation 
(1Ln: 4Co: 1Ln). 
The hexanuclear core is supported by two μ3-OH groups between the GdIII ion and the two nearest 
CoII ions. Each of the four organic ligands adopts the same coordination mode (Figure 3.3) and 
each is bonded to one GdIII and two CoII ions. Each ligand is chelated to a CoII centre through one 
imino and two phenoxido oxygen atoms, forming a “metalloligand” which is further chelated to 
a GdIII through a phenoxido and methoxido oxygen atom and another CoII via the phenoxido 
oxygen atom of the aminophenol moiety. Each hydroxyl group bridges two CoII and one GdIII 
centres and the angles are within the range 102.16(12) ° - 106.05(13) °.  
The coordination environment of Co2 and Co4 is fulfilled by a [Cl]- ion. All Co centres adopt an 
essentially distorted octahedral geometry, where the Bond Valence Sum (BVS) analysis is 
indicative of oxidation state II (2.082, 1.900, 2.040 and 1.913 for Co1, Co2, Co3 and Co4, 
respectively). 
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Figure 3.2. The molecular structure of compound 16 (upper). The core of compound 16 (middle) 
Co1 - Co4 shown in the body positions. Gd1 shown occupying the “bow” and Gd2 the “aft”. 
Representation of 2,3,4M6-1 core of compound 16 (lower). Colour code: GdIII, light blue; CoII, 
pink; C, yellow; N, pale blue; O, red; Cl, green Hydrogens omitted for clarity 
 
Figure 3.3. The coordination mode of H2L1 found in 15 - 18. 
The coordination number of each GdIII ion is nine. Using SHAPE software339 the geometry of 
both GdIII ions can be described as capped square antiprism with an S(P) agreement factor of 
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1.349. There are four GdIII···CoII distances within the range 3.4745(7) - 3.5837(7) Å and four 
CoII···CoII distances in the range 3.148 (7) -3.366(7) Å. The distance from the “bow” and “aft” 
between GdIII ions is 7.680 Å. There is no hydrogen bonding between adjacent entities, with the 
spacing being well defined. 
3.2.2 Topological aspects 
According to this NDK-m nomenclature, the core of 15 - 19 can be enumerated as 2,3,4M6-1 
(Figure 3.3). A literature survey indicates that the first example of this topology was found in a 
heterometallic Co2Na4 compound.369 The first 3d-4f PCCs of this topology were a family of 
MnIII4LnIII 2 PCCs (2Mn : 2Ln :2Mn) supported by H3RL3.1, which were reported in 2008 by 
Oshi et al.348 Since then, few organic ligands (Figure 3.4) have been used for the synthesis of a 
several of 3d-LnIII PCCs with this topology.  
Ligands H3RL3.2, H3RL3.3 and H3RL3.4 gave access to MnII2LnIII4 (1Mn: 4Ln: 1Mn)116 and 
MnIII2MnII2LnIII2 (1Ln: 1MnIII: 2MnII: 1MnIII: 1Ln).350 In 2009, N-butyl-diethanolamine 
(H2RL3.5) was used to isolate a MnIV2CeIV4 (1Mn: 4Ce: 1Mn)349 PCC, while recently its use has 
resulted in the formation of a FeIII4DyIII2 (2Fe : 2Dy : 2Fe) PCC.82 Ligands H3RL3.8 and H2L1 
afforded NiII4LnIII2 (1Ln : 4Ni : 1Ln)343 and (2Ni : 2Dy : 2Ni)55 PCCs respectively.  
More recently, four series of CoII/III-LnIII PCCs that possess the 2,3,4M6-1 topology have been 
described. The first example is a CoIII2DyIII4 PCC based on the (E)-2-((3-
hydroxypropylimino)methyl)phenol ligand (H2RL3.7, Figure 3.4) which displays a slow 
magnetization relaxation.351  
The second example is a family of eight CoIII2Ln4III PCCs constructed from HRL3.8 (Figure 3.4). 
The DyIII analogue exhibits slow relaxation of magnetization with a Ueff  = 3.8 K and τ0 = 4.8 x 
10-6 s.352 The third example is a series of four CoII2LnIII4 PCCs constructed from ligands H2RL3.9 
and HRL3.10 (Figure 3.4) reported by Du et al. in 2014,115 this example demonstrates the 
importance of Ln – O – Ln bond angles on the magnetic coupling between the centres. The fourth 
example is a family of CoII2LnIII4 PCCs derived from 6,6′-{(2-(dimethylamino)ethyl 
azanediyl)bis(methylene)}bis(2-methoxy-4-methylphenol) (H2RL3.11, Figure 3.4), which 
exhibits a slow magnetic relaxation behaviour for the DyIII analogue.204  
In all four reported families the CoII-LnIII ratio is 2/4 and all four LnIII are close together, unlike 
the compounds reported in this work (15 – 19), (1Ln: 4Co: 1Ln)), where the “bow” and “aft” 
positions are filled by CoII cations (1Co: 4Ln: 1Co). Compounds 15 – 19 are therefore the first 
examples of the CoII4LnIII2 core configuration.  
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Figure 3.4. The protonated form of the organic ligands used to for the synthesis of 3d-4f PCCs 
possessing 2,3,4M6-1 topology. 
It is worth noting that despite H2L1 offering a similar coordination environment to H2R3.9, its 
employment in CoII-LnIII chemistry resulted in a hexanuclear PCC with 2/4 Co/Ln ratio. This 
difference may be attributed to the in situ synthesis of ligand H2RL3.9.115  
To further confirm the structural stability of the CoII4LnIII2 PCCs reported herein, the organic 
ligand H2L5 366 was applied under similar reaction conditions towards the synthesis of a CoII-DyIII 
PCC. Ligand H2L5 offers similar coordination environment to H2L1. The reaction resulted in 
compound 19 (Figure 3.5) which is isoskeletal to 15 – 18.  
3.2.3 ESI-MS studies 
To confirm the identity of the reported compounds in solution, they were identified by ESI-MS. 
For 16, four peaks in the MS (positive-ion mode) were observed at m/z 553.6409, 810.9421, 
819.4479 and at m/z 828.8667 which correspond to the fragments, [CoII4LnIII2(µ3-
OH)2(L1)4(NO3)2(MeOH)2]3+, [CoII2GdIII2(µ3-OH)2(L1)4Cl2+2H]2+, [CoII2GdIII2(µ3-
OH)2(L1)4Cl2+2H+H2O]2+ and [CoII2GdIII2(µ3-OH)2(L1)4Cl2+2H+2H2O]2+, respectively 
(Appendix B, S3.1-S3.4).  
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Figure 3.5. The molecular structure of compound 19. Colour code: GdIII, light blue; CoII, pink; 
C, white; N, pale blue; O, red; Cl, green; Br, brown. Hydrogen atoms omitted for clarity.  
3.2.4 TGA  
TGAs of compounds 16 and 18 (Appendix B, S3.5) confirm their solvent sensitivity (Et2O and 
MeOH) and degradation of the core begins at 300 oC and 260 oC, respectively. The final residue 
at 1000 oC perfectly corresponds to a mixture of metal CoO/Gd2O3 (34.10% expected - 34.22% 
found) and CoO/Tb4O7 (33.31% expected - 33.22% found) oxides. 
3.2.5 Magnetic studies 
Variable-temperature dc magnetic susceptibility data was collected for compounds 15 - 18 in the 
temperature range 1.8 – 300 K in an applied field of 0.1 T. The data is shown as χMT vs. T plots 
in Figure 3.6. The χMT product of compound CoII4YIII2 (15) has a room temperature value of 11.13 
cm3 mol-1 K which is typical for four uncoupled high spin CoII ions, but larger than that for four 
free S = 3/2 spins (χT = 7.50cm3 K mol-1 and g = 2.0) as a result of the presence of a significant 
spin-orbital contribution in the susceptibility of octahedral high-spin CoII.15,356,370–373 Upon 
lowering the temperature the value of χMT gradually decreases and reaches a value of 2.17 cm3 K 
mol-1 at 1.8 K (Figure 3.6). 
 
In the case of PCCs containing octahedral CoII ions, the decrease of the χMT at low temperature 
can be attributed to the important spin-orbital contribution and dominant antiferromagnetic 
interaction between the four paramagnetic centres. The value of χMT at low temperature is low 
for four non-coupling CoII paramagnetic centres and suggests the presence of antiferromagnetic 
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interaction between the four paramagnetic centres. The antiferromagnetic interaction is further 
confirmed by magnetization measurements at 2 - 5 K where the magnetization does not saturate 
at the high-field limit (5 T) and the experimental value of the magnetization at 2.0 K and 5 T, is 
6.12 Nβ, which is low for four non coupled CoII ions (Appendix A, S3.1 and S3.2).372  
 
The room temperature χMT value for 16 is 27.94 cm3 K mol−1 which is slightly higher than the 
expected value for two non-interacting GdIII (free ion; S = 7/2; g = 2)373 and four CoII centres as 
in compound 16. The difference between the χMT value of 16 and 15 at 300 K is 17.51 cm3 K 
mol−1 which is higher of the theoretical expected for two GdIII ions (15.75 cm3 K mol−1). This can 
be justified by the presence of ferromagnetic interaction (in conjunction with antiferromagnetic 
coupling in CoII4 core) as well as the small variation of g factor for octahedral CoII. By decreasing 
the temperature, the χMT product decreases steadily up to a value of 27.15 cm3 mol-1 K at 30 K. 
Upon lowering to 30 K, a rapid increase of the χMT value is observed indicating the presence of 
ferromagnetic interaction in 16.  
The temperature dependence difference between the χMT value of 16 and χMT value of 15 (see 
black stars in Figure 3.6) suggest that the ferromagnetic interaction is operated between the Gd 
ions and Co4 core. The field dependence of magnetization of compound 16 confirms the presence 
of important (non-zero) spin state with a significant component of anisotropy. 
The room temperature χMT values for 17 (Co4Dy2) and 18 (Co4Tb2) (39.62 and 36.46 cm3 K mol−1, 
respectively) are slightly higher than the expected values for two non-interacting DyIII (6H15/2 free 
ion; S = 5/2; L = 5; J = 15/2; gJ = 4/3), Tb (7F6 free ion; S = 3; L = 3; J = 6; gJ = 3/2) and four CoII 
centres.149,163 Similar to the Gd analogue, the temperature dependence of χMT values have a 
minimum at 25 K and 7 K for 17 and 18, respectively. Upon a further decrease in temperature, 
the χMT products increase to reach the values of 44.07 and 33.61 cm3 K mol−1 for 17 and 18, 
respectively. This behaviour suggests the presence of some ferromagnetic interaction between 
CoII4 core and lanthanides ions in 17 and 18.  
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Figure 3.6. Temperature dependence of the χMT product at Hdc = 0.1 T for compounds 15 – 18. 
The dynamic properties of 15 - 18 have been investigated using ac susceptibility measurements 
as a function of temperature at varying frequencies and at different temperatures as a function of 
frequency at 4.0 Oe oscillating field between 1 and 1500 Hz.  
Compounds 15, 16 and 18 do not show an out-of-phase signal at zero dc magnetic field. No 
modifications in out-of-phase susceptibility after applying the dc magnetic field (0 - 3.0 T) are 
detected for 15, 16 and 18. In the case of compound 17, at Hdc = 0, the magnetic field ac 
measurement clearly shows the presence of an out-of-phase signal χ’’ in ac susceptibility with 
strong temperature and frequency dependence (Figure 3.7).  
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Figure 3.7. Temperature dependence of the in-phase (’) (upper) and out-of-phase (”) (lower) 
ac susceptibility for 17 at indicated frequencies at zero applied dc field. 
 
Figure 3.8. Arrhenius plot Ueff (17) = 13.4 K (τ0 = 8.5×10-7 s) at zero applied dc field. 
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The effective barrier of slow magnetic relaxation, Ueff ,is obtained according to the Arrhenius law 
from temperature (Figure 3.8) measurements (Ueff (17) = 13.4 K τ0 = 8.5×10-7 s).The ac 
susceptibility follows the generalized Debye model.153,181 Simultaneous fitting of χ'(ν), χ''(ν) and 
Cole-Cole plot are shown in the Appendix A (Figure S3.3). The relatively large value of α (0.015 
- 0.388) indicates that more than one relaxation process generated by QTM might be operational 
at this condition. 
3.3 Conclusion 
The synthetic strategy of using the dianionic ligand H2L1 in CoII-LnIII chemistry resulted in a 
family of hexametallic CoII4LnII2 (15 – 18) PCCs possessing a 2,3,4M6-1 topology. After an 
extensive review, compounds 15 – 18 were determined to be the first CoII4LnIII2 examples of this 
topology. Magnetic studies of 15 – 18 reveal the presence of ferromagnetic and antiferromagnetic 
interactions and interestingly, compound 17 shows SMM behaviour.  
The use of H2L5, which provides the same coordination pockets as H2L1, with a similar synthetic 
strategy that afforded 15 – 18, results in the formation of compound 19 which is isoskeletal to 
CoII4LnIII2 series. In contrast when H2RL3.9, which provides similar coordination modes similar 
to those of H2L1, was employed in CoII-LnIII chemistry a PCC with the 2,3,4M6-1 topology but 
with a different core configuration is observed.  
Future studies will be focused in two directions:  
a) To perform further systematic synthetic studies which employ organic ligands with similar 
coordination pockets to H2L1, H2L5 and H2RL3.4 in CoII-LnIII chemistry, to afford hexanuclear 
PCCs bearing 2,3,4M6-1 topology and determine how ligand structure determines the core 
configuration.  
 b) To further develop the topological approach353 by including valuable information for the 
synthesis of a specific topology.   
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Chapter 4: Heptanuclear disk-like MII3LnIII4 PCCs: synthesis, 
structures and MCE properties 
Abstract: The synthesis, characterization, crystal structures and magnetic properties of 
isoskeletal heptanuclear disk-like MII3LnIII4 polynuclear coordination clusters with the general 
formula [CoII3LnIII4(µ3-OH)6(L4)6(CF3SO3)](CF3SO3)5, where Ln = Gd (20), Y (21) and 
[NiII3LnIII4(µ3-OH)6(L4)6(CF3SO3)](CF3SO3)5, where Ln = Dy (22), Gd (23), Y (24), are 
presented. All the compounds are stable in solution which is confirmed by electrospray ionization 
mass spectrometry studies. Magnetic studies indicate ferromagnetic coupling for all compounds. 
The magnetocaloric effect properties of 23 are characterized by ΔSm = 15.4 J kg-1 K-1 at T = 5.0 
K and Tad = 5.9 K at T = 2.3 K, for 0ΔH = 7 T. 
4.1 Introduction 
Chapter three and previously reported examples2 demonstrate that the combination of H2L1 with 
CoII and DyIII is a plausible route to SMM behaviour and novel topological motifs. With the idea 
of exploring other potential magnetic applications of 3d-4f Schiff base supported PCCs, it was 
noted that H2L1 is structurally related to the monoanionic HL4 ligand and has similar 
coordination pockets (Figure 4.1).  
 
Figure 4.1. Structures of H2L1 (left) and HL4 (right). Colour code: OO coordination pocket, 
green; ONO coordination pocket, light blue. 
Recently, HL4 was reported for the synthesis of a CoII3DyIII4 disk PCC which displayed behaviour 
indicative of an SMM below 4K.1 The CoII3DyIII4 disk displays a 3,6M7-1 core topology, where 
the heptanuclear pentacationic core has alternating CoII and DyIII ions around a central DyIII ion 
which are bridged by six µ3-OH groups. The alternating fashion of CoII-DyIII ions is similar to 
many previously reported 3d-4f PCC magnetic coolers, where coupling of 3d metal ions with 
GdIII ions leads to weak magnetic interactions23 which are ideal for achieving the maximum 
entropy per mole and an enhanced MCE effect.  
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Notable examples of 3d-4f PCC coolers include MnIII4GdIII4,221 CuII5GdIII4 124 and ZnII8GdIII4.225 Of 
particular interest, alternating CoII-LnIII PCCs were reported by Winpenny,208 which were divided 
into grids (CoII8GdIII4, CoII4GdIII6, CoII8GdIII8) and cages (CoII6GdIII8, CoII8GdIII2) and displayed 
prominent MCE effects (11.8 – 28.6 J kg-1 K-1). Due to the counter-intuitive route of using 
anisotropic CoII ions for synthesising magnetic coolers, an attempt was made to substitute them 
with NiII ions, which resulted in two NiII-GdIII PCCs with enhanced entropy changes. These 
examples include a 48-member metallocycle NiII12GdIII36 (36.3 J kg-1 K-1)227 and a NiII6GdIII6 cage 
(37.4 J kg-1 K-1).374 
Though 3d-4f PCCs are the most common examples of molecular magnetic coolers studied,222 
there are few reported examples of 3d-4f Schiff base PCCs which display a significant MCE 
effect. The best performing examples of Schiff base supported magnetic cooler include CoII2GdIII4 
(24 J kg-1 K-1)115 and CuII6GdII6 (23.5 J kg-1 K-1) PCCs.224 Other higher nuclearity examples include 
NiII2GdIII,375 NiII4GdIII4,376 NiII2GdIII4,377 and CuII6GdIII6 223 all of which display an MCE above 11.9 
J kg-1 K-1. 
Upon exchanging the CoII ions of the CoII3DyIII4 disk with NiII ions to maximise the MCE effect 
and retain SMM behaviour, this resulted in a series of five isostructural MII3LnIII4 disks (where M 
= Ni, Co and Ln = Dy, Gd, Y). The reported examples are isoskeletal to the previously reported 
CoII3DyIII4 disk and are formulated [CoII3GdIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 (20), 
[CoII3YIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 (21), [NiII3DyIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 
(22), [NiII3GdIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 (23) and [NiII3YIII4(μ3-
OH)6(L4)6(CF3SO3)](CF3SO3)5 (24). Synthetic insights, topological analysis and magnetic 
properties of compounds 20 - 24 are discussed. 
4.2 Results and discussion  
4.2.1 Synthetic issues 
The previously reported CoII3DyIII4 PCC (CoDy-MeCN) was prepared from the room temperature 
reaction of Dy(OTf)3 and Co(ClO4)2·6H2O with HL4 in a molar ratio of 2:1:2.5:2.5 (Dy: Co: 
HL4: Et3N) using MeOH as solvent and resulted in crystals forming, after 3 weeks, in a moderate 
yield (30 - 35%).1 When a similar reaction was performed in EtOH, under reflux, an isoskeletal 
compound formulated [CoII3DyIII4(µ3-OH)6(L4)6(CF3SO3)](ClO4)3(CF3SO3)2 (CoDy-EtOH) was 
isolated in only 3 days with moderate yield (Table 4.1).1 The latter indicates that the temperature 
and the solvent of the reaction had a profound effect on the crystallization time and yield of the 
product. 
When these two methods were applied to synthesise the CoII3LnIII4 (Ln = Gd, Y) analogues the 
yield greatly decreased and when applied to the synthesis of NiII3LnIII4 analogues the expected 
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products were formed in very low yields (Table 4.1, entry 6) or hexagonal shaped crystals were 
obtained after almost 6 weeks (Table 4.1, entry 7). 
However, an adaption of the synthetic procedure leads to the formation of the expected disk-like 
PCCs with all MII 3LnIII 4 combinations in very good yields (63 - 85%) and shorter crystallization 
times (Table 4.1, entries 3, 4, 5, 8 and 9).  
Compounds 20 - 24 were prepared from the refluxed reaction of Dy(OTf)3 and M(NO3)2·6H2O 
with HL4 in a molar ratio of 2:1:2.5:12 (Dy: M: HL4: Et3N) with EtOH as a solvent and 
crystallisation times ranged between 2 - 7 days. The change in synthetic protocol resulted in the 
replacement of the [ClO4]- counter-ions molecules with [CF3SO3]- and did not alter the central 
[MII3LnIII 4(µ3-OH)6(L4)6(CF3SO3)]5+ cation. 
4.2.2 Molecular structure and crystal structure descriptions 
Unit cell determinations (chapter twelve), FT-IR spectra (Appendix B, S4.1-S4.6), EA (chapter 
eleven), ESI-MS (Appendix B, S4.7-S4.10) and TGA (Appendix B, S4.11-S4.15) show that 
compounds 20 - 24 are isoskeletal. Therefore, only a detailed crystallographic description of 22 
will be described herein and the molecular structure is shown in Figure 4.2. 
 
Crystallographic studies show that 20 - 24 crystallize in the orthorhombic space group Pbca. 
Three NiII and three DyIII cations form a heterometallic wheel, in an alternating fashion and lay 
within the same plane, whereas the central DyIII lies 0.671 Å out of the plane. The heptanuclear 
pentacationic core is supported by six µ3-OH groups, alternating above and below the NiII3DyIII4 
plane, while a triflate group caps the central Dy centre ion.  
 
The coordination number of the three peripheral and one central DyIII ions is eight and seven, 
respectively. The geometry of the central DyIII cation can be described as a capped octahedron 
whereas the DyIII ions lying within the wheel is that of a bicapped trigonal prism. The NiII centres 
adopt what can be best described as a distorted octahedral geometry.  
The HL4 ligands display the same coordination mode (Figure 4.3) and are each bonded to two 
DyIII and one NiII ion. Each ligand is chelated to a NiII ion, through the phenoxido oxygen and the 
imino nitrogen atoms; to a DyIII ion, through the phenoxido and methoxido oxygen atoms and 
bonded to another DyIII ion through a carbonyl oxygen atom. The angles of the µ3-OH bridges are 
within the range 97.2(3) – 106.7(3) °. 
There are three Dy···Dy distances, 3.6470(9) Å, 3.6561(9) Å and 3.6619(12) Å; and nine Ni···Dy 
distances within the range 3.3715(19) - 3.4806(16) Å. The diameter of the disk is 18.799 Å. 
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Table 4.1. Synthetic conditions for the reported disk-like PCCs.  
Entry PCC Synthetic 
ratio[a] 
Formula Solvent Yield/ %[a] Crystallisation time/ 
days 
1 CoDy-EtOH 2:1:2.5:2.5 [CoII3DyIII4(μ3-OH)6(L4)6(CF3SO3)](ClO4)5 EtOH 45 3 
2 CoDy-MeCN 2:1:2.5:2.5 [CoII3DyIII4(μ3-OH)6(L4)6(CF3SO3)](ClO4)5 MeCN 22 21 
3 20 2:1:2.5:12 [CoII3GdIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 EtOH 81 2 
4 21 2:1:2.5:12 [CoII3YIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 EtOH 77 5 
5 22 2:1:2.5:12 [NiII3DyIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 EtOH 69 3 
6 22’ 2:1:2.5:2.5 [NiII3DyIII4(μ3-OH)6(L4)6(H2O)](ClO4)6 EtOH 5 25 
7 22’’ 2:1:2.5:2.5 [NiII3DyIII4(μ3-OH)6(L4)6(H2O)](ClO4)6 MeOH 12 38 
8 23 2:1:2.5:12 [NiII3GdIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 EtOH 71 2 
9 24 2:1:2.5:12 [NiII3YIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 EtOH 68 7 
[a] (Ln: M: HL4: Et3N). [b ] Yield % based on LnIII. 
76 
 
 
 
Figure 4.2. The molecular structure of 22. Colour code: NiII, green; DyIII, light blue; C, white; N, 
blue; O, red; S, yellow; F, light green. 
 
Figure 4.3. Observed co-ordination mode of HL4 in compounds 20 - 24. 
4.2.3 ESI-MS Studies 
To further confirm the identity of the reported compounds a broad ESI-MS for 20 - 23 was 
performed (Appendix B, S4.7-S4.10). Three main regions were identified for the analogues 
showing three distinct fragments in each region. These perfectly correspond to the tetracationic, 
tricationic and dianionic fragments respectively: [M3Ln4(OH)6(C19H18N3O3)6(CF3SO3)]4+, 
[M3Ln4(OH)6(C19H18N3O3)6(CF3SO3)3]3+ and [M3Ln4(OH)6(C19H18N3O3)6(CF3SO3)4]2+. Only the 
24 analogue displays the [Ni3Y4(OH)6(C19H18N3O3)6(CF3SO3)4]2+ fragment (Appendix B, S4.10). 
Values assigned to these fragments and the corresponding PCC are shown in Table 4.2. Each of 
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these fragments corresponds to the [M3Ln4(OH)6(L46)] core with additional trifluorosulphonate 
counter-ions.  
Table 4.2. m/z fragment vales for reported MII3LnIII4 PCC. 
PCC [M3Ln4(OH)6(C19H18N3
O3)6(CF3SO3)4]2+ /m/z 
[M3Ln4(OH)6(C19H18N3O3)6
(CF3SO3)3]3+ /m/z 
[M3Ln4(OH)6(C19H18N3O3)6
(CF3SO3)]4+ /m/z 
20 1762.06 1125.39 807.06 
21 1624.03 1038.02 761.19 
22 1771.14 1132.07 774.82 
23 1760.61 1124.41 768.09 
24 1624.09 N/A N/A 
4.2.4 TGA. 
TGA measurements were performed to examine the thermal stability of selected compounds. In 
the cases of 20 and 24 (Appendix B, S4.11 – S4.15), the first mass loss corresponds to the loss of 
the counter-anions. The stability of the remaining core is then retained up to the region of ~300 
°C, where gradual decomposition takes place. The final residue fits well to the analogous oxide 
Co3Gd4O9 for 20 calculated (24.86%) found (24.14%) and Ni3Y4O9 for 24 calculated (19.05%) 
found (19.43%). 
4.2.5 Topological aspects 
There are a limited number of examples of 3d-4f disk-like PCCs, the first reported examples 
demonstrating the 3,6M7-1 topology were the MnIV6CeIV disks reported by Christou et al.378,379 
These were followed by CuII6PrIII,380 MnII3LnIII4,381 CuII5LnIII2,113 CoII3DyIII41 and CoII2DyIII568 
examples.  
The seven previously reported examples of 3d-4f PCCs which are enumerated 3,6M7-1 are shown 
in Table 4.3. Compounds 22 - 24 are the first reported NiII-LnIII PCCs of this topology. Whereas 
20 and 21 are the first examples of CoII-YIII and CoII-GdIII disks respectively, whilst both are also 
the fourth and fifth examples of CoII-LnIII disks.  
There are three configurations for the 3d and 4f nodes within the disk, which are dependent on 
the 3d and 4f ratio. The first (Figure 4.5, 3/4 (A)) incorporates an Ln node in the centre of the 
disk, with Ln and M nodes alternating around the central node. This configuration is found in all 
MII3LnIII4 PCCs (Table 4.3, entries 1, 6, 7 and 8) and all form [MnII3LnIII4(µ3-O)6] cores. The next 
(Figure 4.5, 5/2 or 2/5 (B)) configuration is observed in CuII5LnII2 and CoII2DyIII5 (Table 4.3, 
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entries 2 and 7). The Ln or the M nodes can be found in the periphery sandwiched between two 
3d nodes each side, with a central M or Dy node, respectively. The last (Figure 4.6, 6/1 (C)) 
configuration is seen in MnIV6CeIV and CuII6Pr PCCs; the 3d ions form the periphery and the 4f 
ion only occupies the central node.  
The Schiff base ligands (HL4 and H3RL4.2) have now been the most successful in synthesizing 
3d-4f PCCs which display the 3,6M7-1 core topology, however, these are limited to the MII-LnIII 
valences. Ligands containing carboxylic acid groups have been used to form unique MnIV-LnIV 
disk PCCs as well as the MII-LnIII PCCs. Though it is evident there are distinct types of 3,6M7-1 
PCCs, it is difficult to relate the configuration of the core to the types of ligand with the limited 
number of examples. 
None of the previously reported examples have been investigated for the magnitude of their MCE, 
whereas CoII 3DyIII 4, CuII5DyIII 2 and CuII5HoIII 2 PCCs were found to display SMM properties with 
low energy barriers. 
Figure 4.4. Ligands used for the synthesis of 3d-4f PCCs with a 3,6M7-1 core topology. 
 
Figure 4.5. Configurations of 3d and 4f nodes in the 3,6M7-1 topology. A (left), B (middle) and 
C (right). Colour code: Ln node, light blue; M node, grey. 
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Table 4.3. Reported 3d-4f PCCs with a 3, 6M7-1 topology. 
Entry Formula Core nuclearity Ligand Reference 
1 [MnII3LnIII4(Piv)12(RL4.1)2(H2O)3]·H2O 
Ln = La, Pr, Nd, Gd 
MnII3LnIII4 H3RL4.1 381 
2 [CuII5LnIII2(RL4.2)2(μ3-OH)4(μ-OH2)2(μ- OAc)2(OAc)2(OH2)2](NO3)2·2H2O 
Ln = Y, Lu, Dy, Ho, Er, Yb 
CuII5LnIII2 H3RL4.2 113 
3 [MnIV6CeIVO9(RL4.3)9(H2O)2(MeOH)](ClO4) MnIV6CeIV H3RL4.3 378 
4 [MnIV6CeIVO9(RL4.3/RL4.4)9(X)(H2O)2]  MnIV6CeIV H3RL4.3, H3RL4.4 379 
5 [CuII6PrIII(RL4.5)][PrIII(H2O)10]·14H2O CuII6PrIII H3RL4.5 380 
6 [CoII3DyIII4(μ 3-OH)6(L4)6(CF3SO3)](ClO4)5 CoII3DyIII4 HL4 1 
7 [CoII2DyIII5(μ 3-OH)6(L4)2(Piv)8(NO3)4]·4CH3CN CoII2DyIII5 HL4 68 
8 [CoII3LnIII4(μ 3-OH)6(L4)6(CF3SO3)](CF3SO3)5 
Ln = Gd, Y 
CoII3LnIII4 HL4 This work 
9 [NiII3LnIII4(μ 3-OH)6(L4)6(CF3SO3)](CF3SO3)5 
Ln = Dy, Gd, Y 
NiII3LnIII4 HL4 This work 
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4.2.6 Magnetic properties 
Susceptibility measurements were performed for 20, 22 and 23 and for the NiII-YIII complex 24 
to check the degree of interaction between the d cations (Figure 4.6).  
The χMT value for 20 at room temperature is 42.87 cm3 mol-1 K, larger than the corresponding 
spin-only value for three CoII and four GdIII non-interacting cations of 37.125 cm3 mol-1 K. On 
cooling the χMT value decreases very slightly in the 300 - 40 K region and below this temperature 
χMT increases continuously up to 60.23 cm3 mol-1 K at 2 K.  
22 shows a room temperature χMT value of 61.43 cm3 mol-1 K that decreases to a minimum value 
of 57.21 cm3 mol-1 K at 15 K, increasing at lower temperatures up to 98.5 cm3 mol-1 K at 2 K. The 
initial decrease should be attributed to the depopulation of the Stark levels of the DyIII cation.  
23 shows a χMT value of 36.09 cm3 mol-1 K at 300 K, somewhat larger than the 34.50 cm3 mol-1 K 
value expected for three NiII and four GdIII non-interacting cations per molecule, suggesting that 
correlations are sizeable at room temperature. On cooling, the χMT product increases slightly in 
the 300-50 K range and fast below 50 K, reaching the maximum value of 76.2 cm3 mol-1 K at 2.6 
K, below which it decays to 75.0 cm3 mol-1 K at 2 K, likely because of weak antiferromagnetic 
interactions or crystal-field effects. The shape and low-temperature χMT values clearly indicate 
that the dominant interactions are ferromagnetic for the three complexes.  
Magnetization experiments (Figure 4.6) show a fast increase at low fields and a further slow 
increase of the magnetization, reaching quasi-saturated values of 28.1 NµB for 22, 35.7 NµB for 20 
and 34.9 NµB for 23, coherent with the maximum ferromagnetic S ground states for 20 and 23 (S 
= 18.5 and 17 respectively). The fit of the experimental data was not possible for the anisotropic 
CoII3GdIII4 and NiII3DyIII4 complexes 20 and 22, but a spin-only attempt was performed for the 
NiII3GdIII4 (23). The response of the Ni3Y4 (24) was also measured and shows a constant χMT value 
of 3.5 cm3 mol-1 K between 300 - 6 K and a decay below this temperature down to a final value 
of 2.80 cm3 ·mol-1 K at 2 K. This measure indicates that there is no interaction between the NiII 
cations and that 24 magnetically behaves as three isolated NiII cations with a g value of 2.16.  
Next, simultaneous fits of χMT and M (H, T) data (Figure 4.7) were carried out for 23 by using the 
PHI program, if only the Ni-Gd and the Gd-Gd pathways are operative and that g(Ni) = 2.16. The 
best fit, solid lines in Figures 4.6 and 4.7, gives: J1(Gd-Gd) = -0.17 cm-1 and J2(Ni-Gd) = 0.62 cm-
1. It is worth noting that similar fitting curves of χMT and M (H, T) can also be obtained by 
constraining J1(Gd-Gd) and J2(NiGd) to be both ferromagnetic and by adding a weak 
antiferromagnetic effective Jz interaction to consider intermolecular couplings. However, this 
second set of parameters can be safely disregarded because contrary to the first one, it cannot be 
used to reproduce satisfactorily the heat capacity results that are reported herein. 
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Figure 4.6. χMT product for complexes 20 (black), 22 (blue) and 23 (red), for applied field 0.1 T 
(left). The solid line shows the fit of the experimental data for 23. Magnetization plots for 20 
(black), 22 (blue) and 23 (red) (right). Solid lines are eye-guide. 
 
Figure 4.7. Isothermal magnetization curves for T = 2 − 10 K, step 1 K. Solid lines are the best-
fit curves obtained by using spin-only model and by fixing gNi = 2.16; the coupling constant found 
from the fitting are J1(Gd-Gd) = 0.17 cm-1 and J2(Ni-Gd) = 0.62 cm-1. 
Figure 4.8 shows the experimental molar heat capacity C for 23, collected for the temperature 
range 0.35  30 K and for several applied magnetic fields. The heat capacity is best understood 
by comparing the experimental data with the calculated curves (solid lines) on the basis of the 
spin-only model and parameters J1(Gd-Gd) = 0.17 cm-1 and J2(Ni-Gd) = 0.62 cm-1 obtained from 
fitting the susceptibility and magnetization data. Overall, the agreement is good, with the main 
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discrepancy gradually taking place on increasing T above 10 - 15 K. This discrepancy is due to a 
non-magnetic contribution that is ascribed to lattice vibrations and can be described by the Debye 
model (dotted line), which simplifies to a C/R = αT3 dependence at the lowest temperatures, where 
α = 2.3 10-2 K-3. The magnetic contribution to the heat capacity is strongly dependent on the 
applied field, especially for fields larger than 1 T. At the lowest temperatures, the calculated 
curves deviate from the experimental ones for zero field and less so for 0H  1 T. This is very 
likely due to weak, though sizeable, magnetic interactions acting between the molecules, probably 
of dipolar origin, which are not included in the calculations. 
 
Figure 4.8. Temperature-dependence of the molar heat capacity, normalized to the gas constant 
R, for 23, collected for the labelled applied fields. Solid lines are the calculated magnetic 
contributions for J1(Gd-Gd) = 0.17 cm-1 and J2(Ni-Gd) = 0.62 cm-1, while dashed line is the non-
magnetic lattice contribution. 
Finally, the MCE for Ni3Gd4 (23) was evaluated, namely the magnetic entropy change was 
determined, ΔSm, and adiabatic temperature change Tad for selected values of the applied field 
change ΔH = H 0. The results are shown in Figure 4.9, where one can notice that the two sets 
of data for ΔSm that were obtained from C(T, H) and M(T, H) are consistent to each other, thus 
confirming that the procedures used are correct. For 0ΔH = 7 T, −ΔSm reaches 7.3 R = 15.4 J kg-
1 K-1 at T = 5.0 K, while Tad = 5.9 K at T = 2.3 K. Magnetic correlations inhibit the system to 
reach the whole available magnetic entropy that for four GdIII and three NiII ions per molecule 
amounts to 4Rln(2SGd + 1) + 3Rln(2SNi + 1) = 11.62 R, where SGd = 7/2 and SNi = 1. The values of 
ΔSm for 23, when expressed per molar R, are like the corresponding ones reported for other NiII-
GdIII compounds,376,382 whereas they compare less favourably when expressed per unit mass 
because the metal/non-metal ratio is relatively modest in 23. 
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Figure 4.9. Magnetic entropy change vs T, for several values of the applied field change ΔH, as 
labelled (upper). Vertical axis reports units in J kg−1 K−1 (left) and molar R (right). Adiabatic 
temperature change vs T for the labelled applied field change, as obtained from heat capacity data 
(lower). 
4.3 Conclusion 
By altering the synthetic procedure of the previously reported heptanuclear disk-like PCC (CoDy-
EtOH), a family of isoskeletal compounds formulated [MII3LnIII4(µ3-
OH)6(L4)6(CF3SO3)](CF3SO3)5 is obtained in higher yields and shorter crystallization times. 
Compounds 22 – 24 represent the first examples of NiII-LnIII PCCs derived from the HL4 ligand 
and the first to bear the disk-like topology (3,6M7-1). Moreover, 20 and 21 are respectively, the 
first disk-like examples in CoII/ GdIII and CoII/YIII cluster chemistry. All reported compounds are 
solution stable and demonstrate three characteristic regions of peaks when analysed with ESI-
MS. The study of their magnetic properties revealed a dominant ferromagnetic coupling, while 
compound 23 displays MCE properties at liquid-helium temperatures. The present work 
illustrates the effectiveness of the proposed synthetic strategy to synthesize PCCs with fascinating 
magnetic properties.   
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Chapter 5: Isoskeletal Schiff base PCCs: synthetic and 
theoretical aspects 
Abstract: This work addresses and explores the synthetic aspects derived from the effort to 
systematically construct isoskeletal polynuclear coordination clusters with the general formula 
[MII2LnIII2(LX)4(solv)6](ClO4)2 which possess the specific defect dicubane core topology. A 
variety of substituted Schiff base organic ligands (H2LX) and NiII-CoII and Dy(OTf)3 salts are 
employed. Nineteen novel Schiff base ligands are synthesised (H2L2, H2L6-H2L22), as well as a 
series of isoskeletal NiII2DyII2 (27 – 34, 36 – 43) PCCs and by-products are also discussed. The 
[NiII2LnII2(LX)4]2+ core is found to be stable in solution. This work is further supported by density 
functional theory studies. 
5.1 Introduction 
3d-4f PCC catalysed organic transformations have only been studied in situ and the active species 
in these transformations are either unidentified or a mixture of different species.296–299 To develop 
tetranuclear PCCs with the general formula [MII2LnIII2(LX)4(solv)6](ClO4)2 and study their 
behaviour in catalytic reactions, knowledge of the exact structure and purity of these species is of 
the utmost importance to differentiate this work from previous studies.  
Previously, the blending of H2L1 with MII (M = Ni, Co) salts and LnIII nitrate salts, resulted in 
tetranuclear PCCs2,50 with the general formula [MII2LnIII2(L1)4(NO3)2(solv)2], (solv = THF, 
MeOH) which possess a defect dicubane, “butterfly”338 (Figure 5.1, middle) or 2,3M4-1 (Figure 
5.1 , right) core topology.13,340,362 The main goal of this study is to alter the “second sphere” of 
these PCCs and to replace the coordinated [NO3] - ions with solvent molecules and uncoordinated 
[ClO4]2- ions, which are more suitable for catalytic transformations. These second sphere effects 
include ligand modification, coordinating solvent and the types of counter-ion. Additionally, the 
influence of a variety of reaction conditions on the final structure of the product is evaluated.  
 
Figure 5.1. The defect dicubane motif (left). The H2L1 ligand (middle) and the 2,3M4-1 topology 
(right). 
Ligand modification has successfully enhanced the properties of PCCs, such as when Murugesu 
et al.65 reported a seven-fold enhancement of the energy barrier, Ueff, of a DyIII2 complex that 
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behaves as an SMM, by introducing electron-withdrawing terminal ligands. Additionally, in 
previously reported catalytic transformations, modification of the ligand frame of the active 
complex was shown to improve efficacy.383–386 In this chapter, a variety of modified Schiff base 
ligands, with the same coordination modes as H2L1, were synthesised to study the influence of 
the modified groups for the formation of the defect dicubane core topology (termed H2LX).  
Adopting the isoreticular concept, which was defined by O'Keeffe and Yaghi in Metal-Organic 
Framework (MOF) chemistry,387 the term “isoskeletal” is introduced. This term is used to describe 
PCCs that possess the same topology388,389 or related organic structures with the same host 
framework but different guests.390,391 This term will be used to describe the targeted PCCs 
constructed from the modified organic ligands with a similar coordination environment and the 
same underlying 2,3M4-1 topology. Herein, the synthesis of nineteen Schiff base ligands are 
described and they are used to systematically construct isoskeletal PCCs with the general formula 
[MII2LnIII2(LX)4(solv)6](ClO4)2. A variety of reaction conditions are explored and a series of 
isoskeletal defect dicubane MII2LnIII2 PCCs are isolated (27 – 34, 36 – 43). ESI-MS studies are 
presented to confirm the solution stability of the defect dicubane motif. 
5.2 Results and discussion  
5.2.1 Synthesis of modified H2L1 analogues (H2L2 - H2L22) 
A typical synthesis of a Schiff base ligand takes place in an alcoholic solution sometimes in the 
presence of acidic or basic catalysts, although other synthetic methods such as microwave-
mediated392 or solvent-free mechanochemical synthesis393,394 can be employed.  
 
Figure 5.2. The modified organic ligands used in this work (left). R1 = H, allyl, NO2; R2 = H, Cl, 
C6H5; R3 = H, NO2; R2-R3 = C4H4. The substituted monocarboxylates used in this work; M1 (R4 
= R5 = NO2, R5 = H); M2 (R4 = NO2, R5 = R6 = H).  
The attempts to synthesize Schiff base ligands which bear electron withdrawing groups (Figure 
5.2, left) (Table 5.1, entries 2 - 20) via a typical synthesis, viz. reflux in an alcoholic solution of 
equivalent amounts of the corresponding aldehyde and amine, resulted in the desired products, 
but in very low yields. Microwave-assisted organic synthesis enables the rapid synthesis of 
organic molecules, often with excellent yields and selectivity. Interestingly, by applying 
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microwave-assisted synthesis395,396 for the synthesis of the corresponding Schiff base ligands, the 
yield increases drastically.  
In total, nineteen new Schiff Base ligands (Table 5.1, entries 2 - 19) were synthesised and two 
examples, H2L12 and H2L22, were characterized via single-crystal XRD studies (Figure 5.3). 
Single-crystal XRD studies at 173 K reveal that both H2L12 and H2L22 are a mixture of keto-
enol tautomer. In H2L12, where two molecules can be found in the asymmetric unit, the enol form 
of the ligand is indicative of the existence of protons H3 and H8A that could be freely refined 
with chemical occupancy 22 and 23%, respectively.  
However, to obtain a suitable structure solution, both protons were restrained to have 25% 
occupancy and their O – H bond distance to be at 0.88 Å. The C – O bond distances are 1.282(3) 
and 1.282(3) Å which are slightly higher than a typical C = O double bond. Similarly, for ligand 
H2L22, protons H1 and H2 (Figure 5.3) could be free refined and have 79% and 21% occupancies, 
indicating a 79/21 existence of ketonic/enolic form, while the C – O bond distance is 1.285(2) Å. 
These findings are consistent with previously reported compounds.393 Solution studies (1H and 
13C NMR spectroscopy) of the synthesized compounds, revealed the existence of both keto and 
enol forms.  
 
 
Figure. 5.3. A schematic representation of H2L12 (upper) and H2L22 (lower) ligands. Colour 
code; O, red; N, pale blue; C, black; Cl, green; Br, blue. 
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Table 5.1. A list of all substituted Schiff bases synthesized for this study. R1, R2 and R3 correspond 
to the substituted groups seen in Figure 5.2. 
Entry 
Ligand 
(H2LX)  
R1 R2 R3 Yield/ % 
1 H2L1 H H H 95 
2 H2L2 H C4H4  88 
3 H2L6 allyl H H 70 [98]a 
4 H2L7 NO2 H H 93 
5 H2L8 H H NO2 66 [96]a 
6 H2L9 allyl H NO2 72 
7 H2L10 NO2 H NO2 94 
8 H2L11 Br H NO2 79 
9 H2L12 H Cl NO2 76 [95]a 
10 H2L13 allyl Cl NO2 70 
11 H2L14 NO2 Cl NO2 80 
12 H2L15 Br Cl NO2 35 [85]a 
13 H2L16 allyl C4H4  61 [95]a 
14 H2L17 NO2 C4H4  74 
15 H2L18 Br C4H4  79 
16 H2L19 H C6H5 H 91 
17 H2L20 allyl C6H5 H 69 
18 H2L21 NO2 C6H5 H 92 
19 H2L22 Br C6H5 H 83 
[a] MW technique         
5.2.2 Synthetic protocols for targeting [MII2LnIII2(LX)4(solv)6](ClO4)2 PCCs  
Based on the previously reported synthetic protocols that resulted in the isolation of tetranuclear 
PCCs, with the general formula [MII2LnIII2(LX)4(solv)6](ClO4)2,337 and considering that a subtle 
change in the synthetic procedure may affect the shape, dimensionality and nuclearity of the final 
product, several molecular ratios to isolate the corresponding-targeted isoskeletal PCCs were 
screened. It is worth mentioning that to avoid complicating the synthetic procedures only 
Dy(OTf)3 as the lanthanide source was employed. During this screening procedure, several 
interesting and unexpected results were obtained, which are grouped and presented below. 
5.2.2.1 Oxidation  
Reaction of H2L8 with Co(ClO4)2·6H2O, Dy(OTf)3 and Et3N in the molar ratio 2:1:1:5 in MeOH 
resulted after 3 days, in approximately 82% yield, in dark-red crystals formulated as 
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(Et3NH)[CoIII(L8)2]·3MeOH (25·3MeOH) (Figure 5.4 left). Similarly, the reaction of H2L18 with 
Co(ClO4)·6H2O, Dy(OTf)3 and Et3N in the molar ratio 1:1:1:3 in MeOH resulted after 6 days, in 
approximately 82% yield, dark red crystals formulated as (Et3NH)[CoIII(L18)2]·2MeOH 
(26·2MeOH). (Figure 5.4, right). 
 
In the cases of 25 and 26, during crystallization at room temperature, CoII is oxidized to CoIII.  
To target for the isoskeletal 2,3M4-1 CoII2DyIII2 analogues, it is important to perform the synthesis 
and crystallization under an inert atmosphere to prevent oxidation of CoII to CoIII. 
 
Figure 5.4. The crystal structure of compound 25 (left). The crystal structure of compound 26 
(right). Colour code: CoIII, pink; N, light blue; O, red; C, white; Br, blue. Hydrogen atoms and 
solvent molecules are omitted for clarity. 
5.2.2.2 Solvent influence 
As anticipated, modification of the organic periphery of the parent organic ligand (H2L1) 
drastically affects its solubility. However, when targeting for the corresponding isoskeletal 
tetranuclear species, the use of a mixture of solvents enhanced solubility, resulting in the 
formation of undesired compounds.  
 
For example, the reaction of ligand H2L14 with Ni(ClO4)2.6H2O, Dy(OTf)3 and Et3N in the molar 
ratio 2:1:1:5 in a mixture of EtOH/CH2Cl2 results in the formation of a tetranuclear compound, 
formulated as [NiII2DyIII2(L20)4(allyl-o-vanillin)2(EtOH)2]·3CH2Cl2 (27·3CH2Cl2) (Figure 5.5). 
The two allyl-o-vanillin moieties derive from the disassembling of H2L20 during the reaction. 
Interestingly, performing a similar reaction, in solely DMF results in the formation of the desired 
[NiII2DyIII2(L20)4(DMF)6](ClO4)2·4DMF (28·4DMF) (Figure 5.5).  
 
This observation was additionally proven by performing a reaction of ligand H2L22 with 
Ni(ClO4)2·6H2O, Dy(OTf)3 and Et3N in the molar ratio 2:1:1:5 in a mixture of EtOH/CH2Cl2 
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which resulted in the isolation of compound [NiII2DyIII2(L22)4(bromo-o-vanillin)2(EtOH)2] 
·6EtOH (29·6EtOH) (Figure 5.5). Moreover, using a blend of EtOH/THF in the following 
reaction with Ni(ClO4)2·6H2O, Dy(OTf)3 and Et3N in the molar ratio 2:1:1:5 results in 
[NiII2DyIII2(L16)4(allyl-o-vanillin)2(EtOH)2]·2THF·2EtOH (30·2THF·2EtOH) (Figure 5.5). 
However, performing a similar reaction in DMF results in the formation of the desired compound 
formulated [NiII2DyIII2(L16)4(DMF)2](ClO4)2 (31) (Figure 5.5).  
 
These examples indicate that the use of a second solvent increases the chance of by-product 
formation and thus the mixture of solvents may not be an ideal synthetic protocol when targeting 
high purity compounds. 
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Figure 5.5. The crystal structures of compounds 27 - 31. The substituted o-vanillin moiety is 
indicated with blue colouring. Colour code: NiII, green; DyIII, light blue; N, blue; O, red; C, white; 
Br, brown. Hydrogen atoms and solvent molecules omitted for clarity. 
5.2.2.3 Solvent concentration influence 
When reactions were performed with less solvent (10 mL instead of 20 mL) or the reactant ratio 
was tripled, a different product was obtained, formulated as 
[NiII2DyIII2(L1)4(EtOH)4(H2O)2](ClO4)2 (32) (Figure 5.6). Two water molecules coordinate to NiII 
centres in 32. Moreover, performing a similarly scaled-up reaction in a different solvent such as 
DMF another compound is formed formulated as [NiII2DyIII2(L1)4(DMF)6](OTf)2·2DMF 
(33·2DMF) (Figure 5.6), instead of the expected perchlorate derivative. In addition, performing 
a concentrated reaction of Ni(ClO4)·6H2O, Dy(OTf)3, Et3N and H2L18 in the molar ratio 1:1:2:8 
resulted in a PCC with the formula [NiII2DyIII2(L18)4(DMF)6] 
[NiII2DyIII2(L18)4(DMF)4(H2O)2](ClO4)4·5DMF (34·5DMF). (Figure 5.6). 
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Figure 5.6. The crystal structures of 32 - 34. Colour code: NiII, green; DyIII, light blue; N blue; 
O, red; C, white; Br, blue; F, green; S, yellow. Hydrogen atoms omitted for clarity. 
5.2.2.4 Molar ratio  
The reaction of Ni(ClO4)2·6(H2O), Dy(OTf)3 and H2L2 with Et3N in MeOH, in the molar ratio 
1:1:2:5, resulted in the isolation of a tetranuclear cubane formulated as [NiII4(L2)4(MeOH)4] 
·6MeOH (35·6MeOH) which is isoskeletal to a cubic Ni4 PCC reported recently.361 However, 
performing the same reaction in EtOH, results in the isolation of the targeted isoskeletal 
tetranuclear [NiII2DyIII2(L2)4(EtOH)6](ClO4)2·4EtOH (36·4EtOH) (Figure 5.7).  
 
Figure. 5.7. The crystal structures of compounds 35 (left) and 36 (right). Colour code: NiII, green; 
DyIII, light blue; N, blue; O, red; C, white. Hydrogen atoms omitted for clarity. 
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5.2.2.5 Solvent diffusion crystallization 
In the effort to obtain the targeted tetranuclear NiII2DyIII2 analogues with H2L19 as a ligand via 
the diffusion crystallization technique, a compound formulated as [NiII2DyIII2(L19)4(DMF)6] 
(ClO4)2·2Et2O (37·2Et2O) (Figure 5.8, left) which contains two ether molecules as lattice solvent, 
was isolated.367,368,397,398 Upon standing at room temperature, compound 37 immediately loses its 
crystallinity.  
 
Figure. 5.8. The crystal structures of compound 37 (left) and 38 (right). Colour code: NiII, green; 
DyIII, light blue; N, blue; O, red; C, white; Cl, light green. Hydrogen atoms omitted for clarity. 
5.2.2.6 Co-ligand introduction 
To identify the possibility of whether a monocarboxylate co-ligand could bridge between NiII and 
DyIII centres, a pilot reaction with H2L1, Ni(OAc)2·4(H2O), Dy(OTf)3 and Et3N in the molar ratio 
2:1:1:2 in MeOH was performed and resulted in the isolation of a compound formulated as 
[NiII2DyIII2(L1)4(OAc)2(MeOH)2]·2MeOH (38·2MeOH) (Figure 5.8, right). Each acetate group 
bridges the NiII and DyIII centres, which contrasts with the NO3 analogues that prefer to chelate to 
the LnIII centres.2,50  
 
Employment of the bulky co-ligands M1 and M2 along with ligand H2L9, Co(ClO4)2·6H2O and 
Dy(OTf)3 in the molar ratio of 2:1:1:5 and in DMF as solvent results in the isolation of two 
compounds formulated as [CoII2DyIII2(L9)4(M1)2(DMF)2] (39) and 
[CoII2DyIII2(L9)4(M2)2(DMF)2]·2DMF (40·2DMF), respectively (Figure 5.9).  
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Figure. 5.9. The crystal structures of compounds 39 (upper) and 40 (lower). Colour code: CoII, 
pink; DyIII, light blue; N, blue; O, red; C, white. Hydrogen atoms omitted for clarity. 
 
The effort to obtain the isoskeletal M1 CoII2DyIII2 compound with H2L8 instead of H2L9, by 
performing a similar reaction, resulted in red plate crystals formulated as [DyIII(M1)3(DMF)2] 
(41) (Figure 5.10). Compound 41 is a one dimensional (1D) coordination polymer and can be 
considered as a polymorph to a recently reported compound.399 
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Figure. 5.10. The crystal structure of compound 41. Colour code: DyIII, light blue; N, blue; O, 
red; C, orange. Hydrogen atoms omitted for clarity. 
 
Finally, the diffusion of Et2O to a concentrated reaction of ligand H2L5 along with 
Ni(ClO4)·6H2O, Dy(OTf)3, M1 and Et3N in DMF resulted in the formation of a compound 
formulated as [NiII2DyIII2(OH)(L2)3(M1)3(DMF)2]·1.5DMF·Et2O (42·1.5DMF·Et2O) which 
possesses the 2,3M4-1 topology. Surprisingly, only three organic ligands are involved in the 
aggregation in contrast to four ligands used in other 2,3M4-1 PCCs supported by H2LX. The 
skeleton of 42 is further supported by the presence of a hydroxyl µ3-OH group and one Et2O 
molecule is trapped in the lattice. 
 
Figure. 5.11. The crystal structure of compound 42. Colour code: Ni, green; Dy, light blue; N, 
blue; O, red; C, white. Hydrogen atoms omitted for clarity. 
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5.2.2.7 ESI-MS studies 
To confirm the identity of compounds 28, 31 and 37 in solution, ESI-MS studies were performed. 
(Table 5.2). For compound 28, three peaks in the MS (positive-ion mode) which correspond 
perfectly to three dicationic fragments were observed (Appendix B, S5.18). For compounds 31 
and 37, four peaks in the MS (positive-ion mode) which correspond to a cationic fragment and 
three dicationic fragments were observed (Appendix B, S5.19 and S5.20)  
Table 5.2. Observed peaks for 28, 31 and 37 in ESI-MS with corresponding peak assignments. 
Observed fragments and corresponding peaks / m/z 
 [Ni
II
2DyIII2(LX)4(MeOH)]+ [NiII2DyIII2(LX)4]2+ 
28 n/a 936.1485 
X = 20  +(DMF) 972.1730 
  +2(DMF) 1009.2113 
31 1742.2549 803.067 
X = 16  +(DMF) 840.0702 
  +2(DMF) 876.6074 
37 1847.228 855.5781 
X = 19  +(DMF) 892.1121 
  +2(DMF) 929.1356 
All the efforts to obtain similar ESI-MS spectra for compounds 39 and 40, which contain a co-
ligand, were unsuccessful. 
5.2.2.8 Theoretical studies 
To gain further insight into the tuning and modulation of, inter alia, the catalytic activities of the 
tetranuclear 2,3M4-1 PCCs, computational studies were performed. Specifically, the influence of 
the Schiff base ligands on the electronic properties of the metals was studied, in effect, the 
'activity' of the ligands themselves can be, in turn, modified by employing diverse functional 
groups at specific sites/positions.  
Quantitative and qualitative metrics of the functional group effects were established and in 
parallel, several congeners of the ligands were examined (Tables 5.3 and 5.4). Several model 
systems of the PCCs were used. Figure 5.12 shows the visualization of the mapped Molecular 
Electrostatic Potential (MEP) in ligands L1m to L12m, as with the usual MEP rendering, with 
blue zones depicting 'positively' charged zones while red zones the 'negatively charged zones'.  
One way to assess the effect of the electron withdrawing groups on the Schiff base is to 
qualitatively render the MEP mapped onto the van der Waals surface. The nature of the R groups 
has a profound effect on the surface charge of the base on its 'inner cove' – that is, the O-O-N-O 
core pattern directly interacting with the metals. Figure 5.12 and Table 5.6 qualitatively illustrate 
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this idea. Unsurprisingly, results show charge distribution along the cove can be modulated upon 
modification of the groups.  
Table 5.3. Recapitulative table of the model ligands used. 
LX R1 R2 R3 
L1m H H H 
L2m OMe H H 
L3m N(CH2CH3)2 H H 
L4m F H H 
L5m H H NO2 
L6m CH2CH=CH2 H NO2 
L7m NO2 H H 
L8m NO2 H H 
L9m H Cl NO2 
L10m Br H NO2 
L11m NO2 H NO2 
L12m NO2 Cl NO2 
L7m: An additional NO2 is substituted at the ortho position adjacent to R2. 
 
Table 5.4. Recapitulative table of the co-ligands used. 
coL R4 R5 R6 
coL1m H H H 
coL2m H F H 
coL3m NO2 H NO2 
 
In the gas phase, in their most stable geometrical configuration, the ‘simplest’ functionalization, 
i.e. having R1 = R2 = R3 = H turns out to confer the most of negative charge accumulation on the 
ligand 'anchor' points, the least being with R1 = NO2, R2 = Cl, R3 = NO2. Interestingly, for a given 
R1, changing R3 has a profound effect on the charge distribution which is illustrated by 
considering L1m and L5m. On the other hand, for a given R3, changing R1 does not have a 
noticeable altering effect, as shown for example by L5m versus L10m and L1m versus L2m. More 
crucially, the conformation of the ligand ultimately determines the extent, nature and motifs of 
interaction between the metal-interacting side of the ligands and the metals (Figure 5.13). 
 
Single point (sp) calculations on L6m in its ligand-bound geometry exhibits a different charge 
distribution signature with respect to that of its gas-phase optimized structure (gp). The 
geometries differ by having the nitrogen-bound aryl group (ring 2) rotated clockwise (gp) or 
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counter-clockwise (sp) around the N-C(aryl) bond. This observation can be rationalized when one 
considers the Frontier Molecular Orbitals (FMO)s. 
 
Figure. 5.12. The rendition of the MEP of the model ligands. 
 
Figure. 5.13. The rendition of the MEP of L6m in its ligand-bound (left) and in its free 
conformation (right). 
Inspection of the LUMO – HOMO-2 of the L6m (sp), indicates that the Molecular Orbitals (MO) 
consist mainly of a π network running throughout the whole of the molecule. Even more 
remarkable is the low mixing of atomic p orbitals perpendicular to the molecular plane, defined 
by ring 1 (the aryl-containing R1) and the N-centred p orbital that is parallel to this plane (Figure 
5.14). This very orientation of the p orbital should also be responsible for the dependence of the 
cove charge distribution on the orientation of the hydrogens over the OH functions on both rings 
(data not shown).  
L1m L2m 
L3m L4m 
L5m L6m 
L7m L8m 
L9m L10m 
L11m L12m 
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In terms of partial atomic charge within the Mulliken partitioning scheme, it can be noted that 
there are variations in values on the metals on the two oxygen and the nitrogen atoms (see Table 
5.6) depending on the makeup of the ligand. Close examination suggests that, in terms of partial 
charges, both M2 and O1 (OH on ring 1) are spectator elements, i.e. the value of their partial 
charge does not depend on that of the other atoms whereas there is a correlation between the 
partial charge on N, O2 (OH on ring 2) and M1, there exist an interdependence of the values of 
partial charge on these centres. The largest of such variations occur for metal M1 and is observed 
between model m2 11a and model m3 12. These results perfectly correspond with that of the 
charge distribution being dependent on the orientation of ring 2.  
Table 5.5. Recapitulative table of the models used. 
Model M1 M2 LX coL S 
m1 11 Zn Y L1m coL2m (CH3)2NCOH 
m2 11a Ni Y L1m coL2m (CH3)2NCOH 
m3 12  Zn Y L5m MeOH NO3 
m4 12a Ni Y L5m MeOH NO3 
m5 13 Zn Y L1m EtOH - 
m6 14 Zn Y L6m coL3m S1m 
m7 14b Zn Y L1m coL3m S1m 
 
Table 5.6. Mulliken charges. 
model q(M1) q(M2) q(O1) q(N) q(O2) 
m1 11 0.79 1.49 -0.64 -0.20 -0.61 
m2 11a 0.53 1.49 -0.61 -0.16 -0.59 
m3 12 0.93 1.34 -0.55 -0.26 -0.73 
m4 12a 0.69 1.36 -0.62 -0.17 -0.58 
m5 13 0.86 1.32 -0.56 -0.30 -0.73 
m6 14 0.85 1.56 -0.55 -0.27 -0.70 
m7 14b 0.85 1.55 -0.56 -0.27 -0.71 
The above results clearly show the richness of the chemistry of the presented PCCs. The nature 
of metal ions and the identity of the R groups in the ligands play preponderant roles in both the 
tuning and control of the behaviour of the clusters. With the trends and rationale hereby 
demonstrated, it should be possible in future work to better modulate the activity of the clusters 
through tuning of the electronic structure and control of structural constraints. 
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Figure 5.14. FMOs of L6m (sp). 
5.3 Conclusion 
In this work, the synthesis of nineteen new modified Schiff base organic ligands (H2L2 - H2L22) 
and eighteen new PCCs is presented. The term “isoskeletal” is introduced, which ideally describes 
structural and topological similarities found in compounds 30 – 37, 39 – 43 and 45.  
 
Microwave synthesis has proven to be very effective for the synthesis of the substituted Schiff 
base ligands.400 To target defect dicubane isoskeletal species, it is shown that several parameters 
must be taken into account. It is shown here that a slight change in the synthetic procedure 
drastically affects the formula of the desired PCC. However, the usage of different lanthanide 
sources and the lanthanide contraction are two parameters that have not been considered in this 
study and are anticipated to have a major impact in the shape, nuclearity and formula of the final 
product.  
 
The possibility of producing isoskeletal species and exchanging the 3d and/or the 4f element with 
diamagnetic elements such as ZnII or YIII, presents the opportunity to further study the targeted 
molecules in the solid and/or solution state, with additional spectroscopic techniques such as 
NMR (1H, 13C, 89Y) or Electron Paramagnetic Resonance (EPR) studies for the GdIII analogue.  
ESI-MS studies of compounds 31, 34 and 40 are indicative that the targeted species retain intact 
in solution. However, upon introduction of co-ligands, the targeted PCCs do not remain intact in 
solution. Computational studies demonstrate how the likely activity of the PCCs can be tuned and 
modulated and suggesting ways of achieving this, hence demonstrating the richness of the 
chemistry of the hereby reported constructs.   
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Chapter 6: Two unprecedented purse-shaped 
pentadecanuclear ZnII4LnIII11 (Ln = Gd, Dy) PCCs 
Abstract: The in situ reaction of o-vanillin and trans-2-amino-cyclohexanol with 
Zn(NO3)2·6H2O, LnCl3·5H2O afforded a family of pentadecanuclear heterometallic polynuclear 
coordination clusters formulated [ZnII4LnIII11(µ4-OH)2(µ3-OH)8(µ2-OH2)2(µ3-
NO3)2(NO3)6Cl4(HL23)2(L23’)4(µ2-MeO)7(µ3-MeO)2(MeOH)2(H2O)2] where Ln = Dy (43), Gd = 
(44). These compounds display a unique topology and are enumerated as 1,2,3,4,5,5,5,8M15-1. 
The core displays many unique features including a LnIII diabolo motif (4,8M9-1) and a 
previously unseen ligand transformation. Magnetic studies demonstrate the importance of the 
central spin orientation in the spin structure of the ambiguous Ln9-diabolo motif. The single-
molecule magnet properties of the DyIII analogue (43) are elucidated through disentangling the 
magnetic properties of the isostructural GdIII analogue (44). 
6.1 Introduction  
A few 3d-4f, crystallographically characterised141,302 or formed in situ,296–298 bimetallic catalysts 
have been reported. Previously the catalytic efficiency of a series of tetranuclear ZnII2LnIII2 PCCs, 
built from H2L1 (Figure 6.1, left) towards Friedel-Crafts (FC) alkylation344 and Petasis-
Mannich401 reactions were reported. Aiming to develop a class of bimetallic co-operative catalysts 
for enantioselective purposes, it was envisioned that ligand H2L23 (Figure 6.1), that offers similar 
coordination pockets to H2L1, was an excellent candidate to harvest the corresponding isoskeletal 
defect dicubane tetranuclear PCCs.366 The coordination chemistry of H2L23 has received less 
attention and has never been used in 3d, 4f or 3d-4f chemistry.402 
 
Figure 6.1. The protonated form of H2L1 (left). The protonated form of H2L23 (middle). The 
protonated form of the transformed ligand (H2L23’) (right). 
In a reaction aimed at yielding such a chiral ZnII2LnIII2 defect cicubanes, the in situ reaction of o-
vanillin and trans-2-amino-cyclohexanol in methanolic solvent with LnCl3·xH2O, 
Zn(NO3)2·6H2O and Et3N was performed which resulted instead in an unprecedented 
transformation of some of the H2L23 ligand to the achiral H2L23’ ligand (Figure 6.1, right) 
accompanied by the stabilization of one of the largest ZnII-4f PCCs so far reported with the general 
101 
 
 
formula [ZnII4LnIII11(µ4-OH)2(µ3-OH)8(µ2-OH2)2(µ3-NO3)2(NO3)6Cl4(HL23)2(L23’)4(µ2-
MeO)7(µ3-MeO)2(MeOH)2(H2O)2] where Ln = Dy (43), Gd = (44). The resulting structure forms 
around the well known LnIII9 “diabolo” motif encapsulated within units of ZnII2LnII2 and ZnII2, 
which provide a C2 symmetry and thereby confer the system with a chirality which aids in 
understanding the spin structure of the central Ln9 diabolo unit. The molecular structure, 
topological representations and magnetic studies are discussed. 
6.2 Results and discussion  
6.2.1 Molecular structure of compounds 43 and 44 
Single-crystal XRD studies reveal the formation of a pentadecanuclear PCC with the general 
formula [ZnII4LnIII11(µ4-OH)2(µ3-OH)8(µ2-OH2)2(µ3-NO3)2(NO3)6Cl4(HL23)2(L23’)4(µ2-
MeO)7(µ3-MeO)2(MeOH)2(H2O)2] where Ln is Gd (43) and Dy (44) (Figure 6.3). Compounds 43 
and 44 are isostructural and isomorphous, as identified by single-crystal XRD studies (chapter 
twelve), EA (chapter eleven), FT-IR (Appendix B) and TGA (Appendix B, S6.1).  
Compounds 43 and 44 crystallize in the monoclinic space group C2/c with Z = 4. The 
pentadecanuclear core consists of two units, a trianionic undecanuclear [ZnII2LnIII9(µ4-O)2(µ3-
OH)8(µ2-OH)2(NO3)8Cl2(L23’)4(µ2-MeO)4(µ3-MeO)2(H2O)2]3- “body” unit (Figure 6.2) and a 
tetranuclear [ZnIILnIII2ZnII(HL23)2(µ2MeO)3Cl2(MeOH)2]3+ “handlebar” unit (Figure 6.2).  
Within the ZnII2LnIII9 part, the nonanuclear lanthanide unit is held together by two μ4- O (O29), 
eight μ3-OH (O25, O26, O27, O28 and their symmetry-related counterparts), two μ2-OH 
molecules (O30) and four in situ formed o-vanillin derivatives (L23’) (Figure 6.1). This 
nonanuclear motif is often referred to as “diabolo” shaped and has been identified in several 
compounds.403–405 
The diabolo description derives from the similarity to the topology of a double spinning top which 
a player performs tricks with using a two-handled rope. In the compound that is described here, 
the hands and rope are provided by the “handlebar unit”, corresponding to Zn2 and Ln6 and their 
symmetry equivalents, respectively, the diabolo is provided by the Ln9 core, where Ln2, Ln3, Ln4 
and Ln5 (and their symmetry-related counterparts) form two square planes arranged as a square 
antiprism with Ln1 in the middle. The “feet” of the player corresponding to the lower two Zn2 
and Zn2’ ions (Figure 6.2).  
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Figure. 6.2. The undecanuclear [ZnII2LnIII9(µ4-O)2(µ3-OH)8(µ2-
OH)2(NO3)8Cl2(L23’)4(µ2MeO)4(µ3-MeO)2(H2O)2]3- “body” unit (upper) and tetranuclear 
[ZnIILnIII2ZnII(HL23)2(µ2MeO)3Cl2(MeOH)2]3+ “handlebar” unit (lower). Colour code: LnIII, light 
blue; ZnII, grey; C, black; N, blue; O, red; C, green; H atoms omitted for clarity. 
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Figure 6.3. The molecular structure of 44. Colour code: GdIII, light blue; ZnII, grey; C, black; N, 
blue; O, red; C, green; H atoms omitted for clarity. 
The nonanuclear Ln9 core is connected by two triply bridging methoxido units (O3) bridging Gd3, 
Gd4 to Zn1 and the symmetry equivalents, thereby forming the undecanuclear core. The 
attachment of Zn1 to the Gd9 unit is further supported by two doubly bridging methoxido moieties 
(O2 and O4). Gd2, Gd3 and Gd4 are chelated by a nitrate moiety, whereas Gd5, Gd 6 and Gd6’ 
are linked by another tridentate nitrate group thereby providing attachment to the main core and 
the tetranuclear unit. Gd6 and Gd6’ are bridged by a methoxido moiety (O32), whereas Gd6 is 
linked to Zn2 by doubly bridging methoxido (O33) and phenoxido (O35) units. Both Zn metal 
centres are five coordinate. Zn1 has a coordination geometry between square based pyramidal and 
trigonal bipyramidal with a trigonality index (τ) = 0.46, whereas Zn2 possesses an almost idea 
square pyramidal geometry (trigonality index (τ) = 0.06).  
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Gd1 and Gd6 are eight-coordinate and Gd2, Gd3, Gd4 and Gd5 are nine-coordinate. An analysis 
(S) using the SHAPE program (Appendix B, S6.3 and S6.4) shows that that the central Ln1 ion 
has an almost perfectly square antiprismatic geometry (0.33% deviation from SAPR-8) whilst the 
nine-coordinate LnIII ions are close to a spherical capped square antiprismatic (CSAPR-9). These 
were determined as follows, Ln3 to Ln5 have a nitrate anion to fulfil their coordination sphere, 
where the Ln-N bond is within the range of 2.90 - 2.96 Å and are therefore not considered. In the 
case of Ln2 and Ln6 which are linked together via two nitrate groups, the Ln-N bond is shortened 
to 2.84 Å, but with the electron density coming most from the oxygens, these Ln-N are not 
considered either. Ln2 to Ln5 and Ln2’ to Ln5’ which are generated by symmetry operation 
respectively, are surrounded by nine oxygens, while Ln1, which is the metal ion located in the 
centre of the “sandglass”, and the two Ln6 metal ions, which are part of the tetranuclear handle 
bar, are only eight-coordinated.  
It appears here that, from the SHAPE analysis, Gd3/Dy4 and Gd4/Dy3 resemble each other. A 
similar behaviour occurs for Gd2/ Dy5, and Dy2/ Gd5 respectively. This is a consequence of 
having refined 44 anticlockwise in comparison to 43. The nine-coordinate LnIII ions are close to 
a spherical capped square antiprism (CSAPR-9, Appendix B, Table S6.3), with a deviation 
between 1.41-1.87% from the perfect geometry, although in case of Gd3, the surrounding atoms 
are closer to a “muffin” topology with a deviation of 1.34%. Gd6 is more distorted in the 
coordination environment and the smallest deviation was found to be biaugmented trigonal 
prismatic (BTPR-8, Appendix B, Table S6.4) with a deviation of 3.86%. 
The o-vanillin derivative (H2L23, Figure 6.1) and the in situ formed Schiff base ligand (HL23’, 
Figure 6.1) both bridge two metal centres respectively (Figure 6.4). Notably, the transformation 
of the o-vanillin moiety has never been observed before and moreover, the chiral framework of 
the ligand retains its stereochemistry. 
 
Figure 6.4. Observed coordination modes for H2L23 and HL23’. 
TGA of compounds 43 and 44 (Appendix B, S6.2) show that they are stable up to 250 oC, with 
only a 4.82% loss in mass before this temperature, which corresponds to a loss of methanolic 
solvent. Decomposition starts at 300 oC and has a significant mass loss between 300 oC - 320 oC 
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(~40 - 42%). The mass slowly decreases until 500 oC, where the final residue corresponds to the 
Zn4Ln11O20.5 oxide 51.62% for Gd (44) and 52.36% for Dy (43).  
6.2.2 Topological descriptions 
The ZnII4LnIII11 core of compounds 43 and 44 can be enumerated as 1,2,3,4,5,5,5,8M15-1 (Figure 
6.5) and has never been observed in PCC chemistry before. The pentadecanuclear compound is 
the third highest nuclearity example in ZnII-LnIII chemistry.5,28,250  
From the automatic graph-based search of TOPOS, a comparison of the topology of the present 
compounds with previously reported compounds containing the diabolo motif (4,8M9-1 graph, 
Figure 6.6) provides very interesting structural data which has not been identified previously in 
any structural description (Table 6.1).  
 
  
Figure 6.5. The 1,2,3,4,5,5,5,8M15-1 purse topology (upper), the 2,4,5,8M11-1 “body” topology 
(lower left) and the 1,2M4-1 “strap” topology (lower right). Colour code: LnIII node, light blue; 
ZnII node, grey. 
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In both 44 and 43, the two Ln4 planes of the diabolo are not parallel to each other. For 44 they are 
tilted at an angle of 0.888 ° and for 43 at 1.157 ° These values lie between those reported for 
previous examples, which range from 0.290 ° – 0.535 ° for the nearly co-parallel examples to the 
significantly tilted Dy9 example reported by Tang et al. where the angle is 1.809 °. The two μ4-
O2- bridge are placed 0.382 Å (in 44) and 0.393 Å (in 43) above the Ln4 plane; these values are 
significantly higher than those previously reported ranging from 0.147 Å to 0.325 Å. The 
nonanuclear core in 44 and 43 is tetra-anionic, while all previously reported compounds are singly 
positively or negatively charged. The observed structural features for the compounds reported 
here are probably directed by the attachment of the ZnIILnIII2ZnII handlebar unit to the nonanuclear 
core providing the twist to the structure. 
 
Figure 6.6. Diabolo topology (4,8M9-1). Colour code: LnIII node, light blue. 
6.2.3 Magnetic properties of compounds 43 and 44 
The magnetic properties of both 43 and 44 complexes were recorded. The magnetic susceptibility 
of both compounds was measured between 1.9 and 300 K under an applied field of 1000 Oe 
(Figure 6.7). 
The χMT value of 60.6 cm3 K mol-1 at 300 K for Zn4Gd11 (44) is smaller than the expected value 
of 86.7 cm3 K mol-1 for eleven non-interacting GdIII ions (S = 7/2, 8S7/2, g = 2, C = 7.88 cm3 K mol-
1). On lowering the temperature, the χMT product stays almost constant until 100 K, below which 
it steadily decreases until it reaches a minimum value of 58.9 cm3 K mol-1 at 13.8 K. Below 4.7 
K further cooling results in the χMT value increasing sharply to reach a value of 61.5 cm3 K mol-1 
at 1.8 K, indicating an onset of dominant ferromagnetic interactions among the lanthanide centres 
within the complex.  
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Table 6.1. Structural characteristic of reported compounds containing the diabolo (4,8M9-1) motif. 
Compound 
core 
Reference LnIII ion Ln9 Charge Ln4 
plane 
CN 
Ln 
central 
CN 
Ln4 planes 
angle 
Ln4 planes 
distance / Å 
Nuclearity O distance 
from Ln4 
plane/ Å 
Space 
Group 
Gd17 406 Gd neutral 9 8 0 5.499 17 0.319 P4212 
Dy17 406 Dy neutral 9 8 0 5.482 17 0.325 P4212 
Dy9 403 Dy 1+ 8 8 1.809 5.772 9 0.147 C2/c 
Dy9 404 Dy 1+ 9 8 0.535 5.672 9 0.300 C2/c 
Dy9 405 Dy 1+ 9 8 0 5.759 9 0.248 P4/n 
Gd9 405 Gd 1+ 9 8 0 5.759 9 0.248 P4/n 
Gd9 407 Gd 1+ 8 8 0 5.427 9 0.266 Pn-3n 
Dy9 407 Dy 1+ 8 8 0 5.372 9 0.270 Pn-3n 
Gd9 408 Gd 1- 8 8 0.541 5.319 9 0.236 C2/c 
Gd9 409 Gd 1+ 8 8 0.326 5.329 9 0.271 Pbcn 
Dy9 408 Dy 1+ 8 8 0.29 5.328 9 0.236 C2/c 
Zn4Gd 11 (44) This work Gd 4- 9 8 0.888 5.559 15 0.382 C2/c 
Zn4Dy11 (43) This work Dy 4- 9 8 1.157 5.599 15 0.393 C2/c 
Coordination Number (CN)
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In the case of Zn4Dy11 (43) the χMT value at 300 K of 105.9 cm3 K mol-1 is also smaller than the 
expected value of 155.8 cm3 K mol-1 for eleven non-interacting DyIII ions (S = 5/2, 6H15/2, g = 4/3, 
C = 14.17 cm3 K mol-1). On lowering the temperature, the χMT value steadily decreases until it 
reaches a minimum value of 85.6 cm3 K mol-1 at 12.0 K and then steeply increases upon further 
cooling to reach a value of 116.0 cm3 K mol-1 at 1.9 K, which again suggests the presence of 
intramolecular ferromagnetic interactions. This contrasts with other “diabolo” or “hourglass” 
shaped Gd9 or Dy9 cores reported in the literature, which are found to be antiferromagnetically 
coupled. It is believed this is the result of the presence of the tetranuclear 
[ZnIILnIII2ZnII(HL23)2(µ2-MeO)3Cl2(MeOH)2]3+ “handlebar” unit (Figure 6.1), containing a 
dimeric triply-oxygen bridged LnIII motif and the chiral HL23 ligand, with the C2 axis lying 
between the two-lanthanide metal centres. 
 
Figure 6.7. Temperature dependence of the χMT product at 1000 Oe for ZnII4GdIII11 (44) (light 
grey points) and ZnII4DyIII11 (43) (grey triangles). 
 
The field dependence of the magnetization (Figure 6.8 and Figure 6.9) was measured between 2.0 
to 5.0 K. For ZnII4DyIII11 (43) the lack of saturation in the magnetization values indicates the 
presence of magnetic anisotropy and/or low-lying excited states.  
 
The magnetization curve for compound 43 shows no saturation up to 7.0 T and the values of the 
isotherms rapidly increase at small fields before following a more gradual linear increase above 
1.0 T without saturation. The reduced magnetization plot shown as M vs. H/T in Figure 6.9, shows 
the magnetization isotherms which clearly do not superpose onto a single master curve, which 
indicates the presence of anisotropy within the system. 
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Figure 6.8. Field dependence of the magnetization plot of ZnII4GdIII11 (44) measured between 0 
and 7 T at different temperatures; inset: the reduced magnetization. 
Figure 6.9. Field dependence of the magnetization plot of ZnII4DyIII11 (43) (left) measured 
between 0 and 7 T at different 2 K (blue), 4 K (red) and 5 K (green) reduced magnetization (right). 
 
On the other hand, for ZnII4GdIII11 (44), which contains the isotropic GdIII ions, the magnetization 
shows a rapid increase at small magnetic fields, which also follows a more gradual slope after 1.0 
T, and reaches a clear saturation above 4.0 T. The reduced magnetization (Figure 6.8) shows a 
superposition of the three isotherms onto one master curve, as expected for an isotropic system. 
The saturation value of 52.2 µB at 7.0 T and 2.0 K is lower than the expected value of 77.0 µB for 
eleven GdIII ions, which are uncoupled or completely ferromagnetically coupled, suggesting that 
not all metal centres have the same spin orientation. 
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ac magnetic susceptibility measurements were performed on ZnII4DyIII11 (43) to explore the 
presence of any slow relaxation of the magnetization compatible with SMM behaviour. The 
frequency dependent ac susceptibility was measured using various applied fields in attempts to 
suppress any QTM. 
The optimum dc field, where the QTM is smallest, was found to be at 1000 Oe (Figure 6.10). The 
data obtained (Figure 6.11) between 1.8 and 4.0 K show temperature-dependent signals with 
shifting maxima clearly visible. The relaxation time as a function of the temperature (Figure 6.12) 
was analysed in terms of an ln(τ) versus 1/T points and fitted to an Arrhenius law to give Ueff = 
4.7 K and τ0 = 4.4.10-5 s (R = 0.99) (Figure 6.12). 
 
Figure 6.10. In-phase (left) and out-of-phase susceptibility (right) of ZnII4DyIII11 (43) at the 
varying field at 1.8 K. 
 
Figure 6.11. Frequency dependence of the in-phase χM’ (left) and out-of phase χM’’ (right) 
susceptibility for ZnII4DyIII11 (43) at different temperatures under an applied field of 1000 Oe. 
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Figure 6.12. Arrhenius fit for ZnII4DyIII11 (43), leading to Ueff = 4.7 K and τ0 = 4.4.10-5 s (R = 
0.99). 
On its own, the Ln9 diabolo spin structure is ambiguous as discussed here for the Gd9 spin 
structure. The spins on the squares forming the “sandwich” motifs providing the square 
antiprismatic coordination environment of the central LnIII ion lead to two limiting cases.  
The known Ln9 diabolo structures tend towards the first case where the overall contribution of the 
two sandwich slices is effectively a zero-giant spin as a result of antiparallel arrangements of the 
eight S = 7/2 spins. In this case, the central spin is frustrated and possibly takes an overall average 
position essentially at right angles to the antiprismatic sandwiching squares. This leads to an 
observable but small S = 7/2 spin.  
In the second limiting case, all the spins would be aligned parallel, which for nine x GdIII would 
mean an expected spin ground state of S = 63/2. Neither limiting case has ever been identified. 
The compounds that are described in this chapter may provide the answer. 
For case one, it is assumed eight antiparallel aligned spins are supplied by the sandwiching parts 
and thus a contribution of S = 0. The central spin number nine is essentially frustrated. In case 
two, where the spins on the “sandwich” part are all parallel, the contribution is S = eight x 7/2 = 
56/2 and one might expect the central spin to be parallel, to these (S = 63/2). Case two is tended 
towards here in the central diabolo.  
However, a key feature of the structure is that the introduction of the zinc “feet and hands” along 
with the tethering rope provided by the connecting Ln ions emphasizes the importance of the C2 
symmetry for the diabolo motif. The tethering rope provides a means for directing the spin on the 
central Ln of the diabolo unit and neatly explains why the spin structure for such units has always 
seemed ambiguous. Simply put, the central spin does not know which way to turn and is therefore 
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frustrated in the absence of any external influence. Here it can be seen that through the twisting 
action provided by the C2 axis and emphasized by the handlebar motif, the resolution of the 
inherent chirality into “left or right” explains the induced spin ambiguity of the central Ln of the 
diabolo. 
The electrostatically based modelling of Magellan fitting procedure was used to estimate the 
orientations of the magnetic anisotropy of the lanthanide ions. Layfield et al. showed for a dimeric 
DyIII complex, that using the Magellan approach provided results similar to those obtained from 
ab initio calculations. This analysis provides insights into the interplay of the additional ZnII2DyIII2 
handle-bar with the Dy9 diabolo motif. The results of the analysis are shown in Figure 6.13 and 
indicate that the magnetic moments are oriented toroidally within the squares of the hourglass 
motif, pointing each towards their coordinating nitrate anion on the outside and the µ4-O2- link in 
the middle of the metal plane. The axes lie at an angle of 37 ° to the plane defined by the four 
DyIII ions (Dy2 to Dy5 and symmetry equivalents). 
 
Figure 6.13. The orientation of the magnetic moments of the ground doublet according to an 
electrostatic model using the Magellan program, shown as dark blue lines for complex 43. In this 
orientation, the uppermost pairs of ZnII/LnIII ions can be pictured as the hands (Zn) and handles 
to the (imaginary) rope which will twist the central Ln9 diabolo in a left or right-handed sense 
whilst the bottom pair of Zn ions can be imagined as the feet of the diabolo artist. 
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If the alternative description is considered of the central hourglass as a diabolo, it is a useful 
description for the role of the outer Dy and Zn (Dy6 and Zn2 and symmetry equivalent) ions. 
When playing with a diabolo a two-handled rope, the ZnLn2Zn unit, provides a spin direction 
through the centre of the diabolo (here Dy (1)) and the performance of the diabolo depends on the 
applied spin direction induced on the central ion by either a slightly stronger left-hand or right-
hand pull on the rope. This inherent induced chirality is clarified by examining the fine details of 
the molecular structure. Just as in the case of chiral bisphenoid and analogous structures, the 
scissor angle is crucial in deciding the degree to which the natural chirality of two homochiral 
scissor blades allows or blocks a cutting action. In the case here, it is concluded that the distorted 
orientation of the magnetic anisotropy axes can explain the ambiguity in the orientation of the 
spin of the central “bottleneck” Dy (1) centre of the hourglass motif. 
 
In this case, the Magellan analysis suggests that the constriction at the centre of the hourglass 
corresponding to Dy1, has an orientation where its magnetic anisotropy axis points towards the a 
axis of the crystal system and is thus displaced from the central position of the axially elongated 
square antiprism sandwiching this central Dy1 ion. The magnetic anisotropy axes of the Dy6 and 
Dy6’ ions are perpendicular to this and thus point towards the b axis of the crystal system. This 
distorted orientation of the magnetic anisotropy axes provides an explanation as to why the 
magnetization values at 7.0 T and 2.0 K are ca 1/3 smaller than the value expected for eleven LnIII 
ions, which are either uncoupled or ferromagnetically coupled.  
 
6.3 Conclusion 
In conclusion, the first examples of 3d-4f PCCs containing the nonanuclear “diabolo” motif and 
the first example of a PCC with the 1,2,3,4,5,5,5,8M15-1 topology are presented. By extending 
the diabolo unit with “hands and feet” and by providing a tethering unit, which can direct the spin 
of the central ion of the diabolo unit, it has been possible to disentangle the “devil in the details” 
directing the spin structure of such diabolo units. In addition, the o-vanillin moiety gives an 
unseen chemical transformation yielding the organic ligand HL23’. Moreover, the isolation and 
characterization of these species showcase the importance of structural determination of potential 
catalysts and avoid their in situ formation. Future work will focus to develop other congeners of 
this system as well as new ZnII-LnIII PCCs with unusual topologies and interesting catalytic 
properties.  
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Chapter 7: Heteronuclear 3d/LnIII PCCs as catalysts for the 
efficient synthesis of trans-4,5-diaminocyclopent-2-enones 
from 2-furaldehyde and primary or secondary amines 
Abstract: Two isoskeletal defect dicubane polynuclear coordination clusters (PCCs) formulated 
[MII2DyIII2(L1)4(EtOH)6](ClO4)2·2EtOH (M = Ni (1NiDy-ClO4), Co (1CoDy-ClO4) were 
synthesized and applied to the domino ring-opening electrocyclization synthesis of trans-4,5-
diaminocyclopentanones from 2-furaldehyde and primary or secondary amines. Under reflux, an 
improved catalytic efficacy was observed and two isoskeletal PCCs were isolated, with the 
general formulas [MII2DyIII2(L1)4(Cl)2(MeCN)2]·2MeCN (M = Ni (1NiDy-Cl), Co (1CoDy-Cl).  
Isoskeletal analogues of 1NiDy-Cl were synthesized to investigate the influence of the LnIII ion 
towards catalytic efficacy, with the general formula [NiII2LnIII2(L1)4(Cl)2(MeCN)2]·2MeCN 
(1NiLn-Cl where Ln = Sm, Eu, Gd, Tb, Y). 1NiY-Cl demonstrated a significantly improved 
catalytic efficacy over the other LnIII analogues with half the catalytic loading. Optimized 
isoskeletal analogues (LNiY-Cl) with a modified organic periphery were synthesized, however, 
1NiY-Cl remained the catalyst of choice for the transformation. Density functional theory studies 
are presented to support catalytic data. 
7.1 Introduction 
This chapter represents the first attempt at developing well-characterised tetranuclear 3d-4f PCC 
catalysts, which are subsequently applied to an organic transformation. The isoskeletal MII2LnIII2 
frameworks investigated in chapter five will be the basis for the PCC catalysts developed in this 
chapter. 
Chapter five targeted 3d-DyIII PCCs possessing a defect dicubane topology derived from H2L1 
with 3d and 4f ions and were synthesised in high yields.410 This topology bears two divalent 3d 
ions (centre) and two trivalent 4f ions (wings) (Figure 7.1), in the absence of any additional 
bridging atom,2,50 with five out of six and six out of seven or eight coordination sites occupied by 
H2L1 for the 3d and the DyIII centres, respectively (Figure 7.1). The key point in developing these 
catalytic species, from H2L1, is the absence of any additional bridging atoms as the four metal 
centres assemble into the desired topology and the PCC can, therefore, remain intact in the 
solution.337  
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Figure 7.1. The defect dicubane motif (left). A representation of the coordination environment of 
the 3d and 4f ions in this motif (right). 
The choice of the 4f ion, in the MII2LnIII2 framework, that could demonstrate catalytic efficacy in 
a corresponding transformation was paramount. Previously, dysprosium salts, due to their mild 
nature, have proven to be excellent catalysts for reactions where both nitrogen and oxygen 
functionalities are present.411 Of particular interest is its ability to retain catalytic activity in the 
presence of Lewis-basic nitrogen groups, allowing for its use in transformations involving 
unprotected amines.412–414  
With these factors in mind a potential reaction in which the efficacy of 3d-DyIII PCCs could be 
tested was sought. Batey and co-workers reported on the use of Dy(OTf)3 as a Lewis acid catalyst 
for the domino condensation/ring-opening/electrocyclization of secondary amines and 2-
furaldehyde, leading to the synthesis of exclusively trans-4,5-diaminocyclopent-2-enones.412 This 
is a remarkably atom-efficient reaction with only one equivalent of water generated as a side 
product. The authors postulated that the reaction proceeds through a deprotonated Stenhouse salt 
intermediate, although they showed that the lanthanide is not involved in the cyclization step. 
Primary amines required the use of the more expensive Sc(OTf)3 to produce the corresponding 
products, albeit with considerably lower yields. The synthesis of MII2LnIII2 defect dicubane PCCs, 
as well as, catalytic and theoretical aspects are discussed for the development of this reaction 
system.  
7.2 Results and discussion  
7.2.1 Initial efforts 
7.2.1.1 Synthetic strategy 
With the initial objective of developing 3d-DyIII PCCs which were catalytically active towards 
the domino condensation/ring-opening/electrocyclization of secondary amines and 2-
furaldehyde, the synthetic insights discussed in chapter five were followed. The targeted 
compounds have no coordinated counter-ions, with vacant positions only coordinated to by 
solvent molecules (Figure 7.1, middle), for the possible binding or interaction with substrates. 
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The reaction, under aerobic conditions of M(ClO4)2·6H2O (M = Ni, Co), Dy(OTf)3, H2L1 and in 
the presence of Et3N in a 1:1:2:5 ratio, in EtOH, followed by Slow Evaporation (SE) led to the 
formation of block shape crystals after 6 - 9 days. These crystals were determined to be the 
targeted , air stable, tetranuclear defect dicubane PCCs (Figure 7.1) by single-crystal-XRD studies 
(chapter twelve), with the general formula [MII2DyIII2(L1)4(EtOH)6](ClO4)2·2(EtOH) (1MDy-
ClO4) where M is Co (1CoDy-ClO4) and Ni (1NiDy-ClO4). The two compounds were further 
characterized by FT-IR spectra (Appendix B), ESI-MS (Appendix B, S7.1-S7.4) and EA (chapter 
eleven).  
 
Equation 7.1. Pictorial representation of the synthesis of 1MDy-ClO4.  
7.2.1.2 Molecular structure of 1MDy-ClO4 PCCs 
1NiDy-ClO4 and 1CoDy-ClO4 are isoskeletal to the previously described ZnII PCC (1) described 
in chapter two. As 1NiDy-ClO4 and 1CoDyClO4 are analogues, only the full structure of 1NiDy-
ClO4 will be described (Figure 7.2). 
1NiDy-ClO4 crystallizes in the monoclinic P21/n space group. The asymmetric unit of 1NiDy-
ClO4 contains one NiII ion, one DyIII ion, two doubly deprotonated organic ligands (L1), three 
coordinated ethanol molecules, one to NiII and the other two to the DyIII ion and one lattice 
perchlorate counter-ion.  
The main core of 1NiDy-ClO4 can be described as a defect dicubane (2,3M4-1). Each 3d metal 
ion has an octahedral geometry and each DyIII centre has a square-antiprismatic geometry. The 
H2L1 ligand exhibits two different coordination modes (Figure 7.3, modes I and II). In the first 
mode (Figure 7.3, mode I), the two phenoxide oxygen atoms and the imine nitrogen atom are 
chelated to the NiII centre, and the two phenoxide atoms are further bonded to two DyIII ions (Dy 
(1) and its symmetry-related counterpart) and the methoxide oxygen atoms are bound to Dy (1).  
In the second mode (Figure 7.3, mode II), the two phenoxide oxygen atoms and the imine nitrogen 
atom are chelated to the DyIII centre, while the phenoxide oxygen atom (from the 2-aminophenol 
unit), is further bound to two NiII centres, occupying five and six vertices for the 3d and the DyIII 
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centres, respectively. The remaining vertices are occupied by one (NiII) and two (DyIII) ethanol 
molecules. 
 
Figure 7.2. The molecular structure of 1NiDy-ClO4. Colour code: NiII, green; DyIII, light blue; 
O, red; N, blue; C, white; Cl, purple. Hydrogen atoms omitted for clarity. 
 
Figure 7.3. Coordination modes of H2L1 in 1NiDy -ClO4. 
7.2.1.3 ESI-MS studies of 1MDy -ClO4  
A broad ESI-MS study was performed for 1MDy-ClO4 PCCs.  
For 1CoDy-ClO4, two prominent peaks in the MS (positive ion mode) were observed at 
1506.9719 m/z and at 736.0393 m/z which perfectly correspond to two fragments, 
[CoII2DyIII2(L1)4(ClO4)-H]+ and [CoII2DyIII2(L1)4(MeOH)2-H]2+, respectively (Appendix B, S7.1-
S7.2).  
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Similarly, for 1NiDy-ClO4, peaks at 1520.0169 and 744.55 correspond to 
{[NiII2DyIII2(L1)4(MeOH)2(EtOH)]+2H}+ and {[NiII2DyIII2(L1)4(MeOH)(EtOH)]+2H}2+ 
fragments respectively (Appendix B, S7.3-S7.4). This data indicates that the [MII2DyIII2(L1)4]2/1+ 
core remains intact in solution.  
7.2.1.4 Benchmarking studies  
Initial experiments were performed to determine the catalytic efficacy of the 1MDy-ClO4 PCCs 
for a domino condensation ring-opening electrocyclization process toward the formation of 
(4S,5R)-dimorpholinocyclopent-2-enone (C7a) from 2-furaldehyde (C7S1) and morpholine 
(C7S2) in acetonitrile solution (Scheme 7.1).412  
 
Scheme 7.1. The previously proposed mechanism for the DyIII catalysed synthesis of trans-4,5-
diaminocyclopent-2-enones.412 
Previously, the reactions were carried out in acetonitrile solution under a nitrogen atmosphere, at 
room temperature and using a catalyst (Dy(OTf)3) loading of 10 mol%. Under these conditions, 
the reaction between 2-furaldehyde (C7S1) and morpholine (C7S2) led to a quantitative amount 
of (4S,5R)-dimorpholinocyclopent-2-enone (C7a) (Table 7.1, entry 1) with Dy(OTf)3 as a 
catalyst.412 
To make the protocol more user-friendly, the reactions were conducted without an inert 
atmosphere and all the reactions were set up in the open air. Under these conditions, both 
complexes (1NiDy-ClO4 and 1CoDy-ClO4) only afforded moderate yields of the desired product 
after 16 h (Table 7.1, entries 2 and 3). Upon increasing the temperature (refluxing), both 
complexes allowed the reaction to take place with excellent yields and a reduced time (2 h) (Table 
7.1, entries 4 and 5). At this temperature and in both cases, the catalyst loading could be decreased 
to 2.5 mol% with only a slight decrease in the yields (Table 7.1, entries 6 - 11). Interestingly, the 
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use of Dy(OTf)3 under these conditions led to a considerable decrease in the yield when compared 
with the reaction at room temperature (Table 7.1, entry 12). As expected, neither 
Co(ClO4)2·6(H2O) nor Ni(ClO4)2·6(H2O), showed catalytic behaviour (Table 7.1, entries 13 - 14). 
Table 7.1. Comparison of catalytic activity for compounds 1NiDy-ClO4, 1CoDy-ClO4 and 
1NiDy-Cl. 
 
Entry PCC T Loading / mol%[a] Time / h Yield / %[b] 
1 Dy(OTf)3[c] r.t 10 16 quantitative 
2 1CoDy-ClO4 r.t 10 16 55 
3 1NiDy-ClO4 r.t 10 16 41 
4 1CoDy-ClO4 reflux 10 2 93 
5 1NiDy-ClO4 reflux 10 2 95 
6 1CoDy-ClO4 reflux 5 2 92[d] 
7 1CoDy-ClO4 reflux 2.5 2 90[d] 
8 1CoDy-ClO4 reflux 1 2 79[d] 
9 1NiDy-ClO4 reflux 5 2 94[d] 
10 1NiDy-ClO4 reflux 2.5 2 94[d] 
11 1NiDy-ClO4 reflux 1 2 80[d] 
12 Dy(OTf)3 reflux 10 2 63 
13 Co(ClO4)2·6H2O reflux 10 2 0 
14 Ni(ClO4)2·6H2O reflux 10 2 0 
15 1NiDy-Cl r.t 1 16 quantitative 
16 1CoDy-Cl r.t 1 16 98 
[a] Catalyst loading calculated per equivalent of DyIII; [b] Reaction conditions: amine, 1 mmol; 2-
furaldehyde, 0.5 mmol; 4 Å MS, 100 mg; catalyst; anhydrous MeCN, 4 mL; room temperature. 
[c] Batey. [d] Product not isolated, yield determined by 1H NMR spectroscopy. 
With promising results at high temperature and at low catalyst loadings, it was considered that 
1NiDy-ClO4 and 1CoDy-ClO4 could be under-going structural changes under these reaction 
conditions. To test this hypothesis, 1NiDy-ClO4, which had a slightly higher efficacy was 
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refluxed in acetonitrile for 2 h. This reaction provided the air-stable 
[NiII2DyIII2(L1)4Cl2(CH3CN)2]·2(CH3CN) (1NiDy-Cl) (Scheme 7.2, A)415 upon SE.  
 
Scheme 7.2. Pictorial representation of the synthesis of 1NiDy-Cl. 
The use of 1 mol% of 1NiDy-Cl at room temperature in the benchmarking reaction led to the 
quantitative formation of C7a (Table 7.1, entry 13). This is a decrease of catalyst loading of one 
order of magnitude when compared to the state-of-the-art for this Multicomponent Reaction 
(MCR), as well as a more user-friendly protocol that does not require the use of an inert 
atmosphere.  
Realising the convenience of circumventing the need to synthesize 1NiDy-ClO4 to obtain 1NiDy-
Cl, the original procedure was modified by substituting ethanol with acetonitrile and refluxing 
for 1 h (Figure 7.3, B). After SE for 7 days, small green crystals were afforded with the general 
formula [NiII2DyIII2(L1)4Cl2(CH3CN)2]·2(CH3CN) (1NiDy-Cl) in 68% yield. Following this 
adapted procedure (Scheme 7.2, B) but substituting Ni(ClO4)2·6H2O for Co(ClO4)2·6H2O, in the 
same ratio, led to the formation of small needle-like pink crystals with the general formula 
[CoII2DyIII2(L1)4Cl2(CH3CN)2]·2(CH3CN) (1CoDy-Cl) in a 61% yield.  
Though 1CoDy-Cl demonstrated an improved catalytic efficacy, at room temperature, over 
1CoDy-ClO4 (Table 7.1, entries 16 and 2 respectively) the efficacy was slightly lower than the 
NiII analogue (Table 7.1, entry 17). These transformed PCCs will be abbreviated, in the collective, 
as 1MDy-Cl. Compounds 1MDy-Cl were characterized in full by single-crystal XRD studies 
(chapter twelve), FT-IR spectra (Appendix B), ESI-MS (Figure 7.5) and EA (chapter eleven). 
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7.2.1.5 Molecular structure of 1MDy-Cl 
1NiDy-Cl and 1CoDy-Cl are isostructural and crystallise in the same triclinic P1 space group 
with the same unit cell parameters, therefore only the structure of 1NiDy-Cl will be described. 
The molecular structure of 1NiDy-Cl is shown in Figure 7.4. A similar coordination behaviour to 
1NiDy-ClO4 and 1CoDy-ClO4 is observed for the L1 ligands in 1MDy-Cl, but a perchlorate to 
chlorine transformation is observed.416  
The asymmetric unit of 1NiDy-Cl contains one NiII ion, one DyIII ion, two doubly deprotonated 
organic ligands (L1), one coordinated chloride ion, one coordinated MeCN molecule and two 
lattice MeCN molecules.  
The main core of 1NiDy-Cl is a defect dicubane (2,3M4-1). The H2L1 ligands exhibit the two-
previously described coordinated modes (Figure 7.3). One MeCN molecule is bound to the NiII 
ion and a chloride anion is coordinated to the DyIII ion. The NiII atom coordinates to six atoms 
(O5N) and displays an octahedral geometry with one vertex occupied by a CH3CN molecule, 
while DyIII is coordinated to seven atoms (O5NCl) and has an almost ideal pentagonal bipyramidal 
geometry with one phenolic oxygen and the chlorine atoms occupying the axial positions. There 
are two NiII···DyIII distances at 3.464 (5) Å and 3.428 (5) Å and one NiII···NiII distance at 3.521(4) 
Å. No intramolecular interactions (e.g. H-bonds or stacking) can be found between neighbouring 
entities. 
 
Figure 7.4. The molecular structure of 1NiDy-Cl. Colour code: NiII, green; DyIII, light blue; O, 
red; N, blue; C, white; Cl, purple. Hydrogen atoms are omitted for clarity. 
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7.2.1.6 ESI-MS studies of 1NiDy-Cl 
ESI-MS studies for 1NiDy-Cl show that it retains its topology in solution. Two main peaks were 
observed at 1556.1150 m/z and 703.5109 m/z corresponding to 
{[NiII2DyIII2(L1)4Cl2(CH3CN)(CH3OH)]+4H}+ and {[NiII2DyIII2(L1)4]-H}2+ fragments, 
respectively (Figure 7.5).  
 
Figure 7.5. Experimental and theoretical ESI-MS patterns of 1NiDy-Cl corresponding to 
{[NiII2DyIII2(L1)4Cl2(CH3CN)(CH3OH)]+4H}+ (upper) and {[NiII2DyIII2(L1)4]-H}2+ (lower) 
fragments. 
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7.2.1.7 Scope of reaction 
The scope of the reaction was then investigated with 1NiDy-Cl due to its slightly higher efficacy 
and a variety of secondary amines as substrates were employed (Table 7.2). In all cases, the 
reactions proceeded smoothly, and it was possible to isolate the corresponding products (C7a -
C7e) in excellent yields. Interestingly, when the same conditions were applied to primary amines, 
1NiDy-Cl catalysed the formation of the corresponding deprotonated Stenhouse salts (C7f - C7e). 
The combination of C7f or C7g with very dilute HCl or silica gel promoted the ring-closing 
leading to the corresponding trans-4,5-diaminocyclopent-2-enones in very high yields (Scheme 
7.3, 95% and 56% overall yield, for C7j and C7k, respectively). The latter transformations are 
consistent with Batey’s proposition that DyIII is not involved in the cyclization step.412 
Interestingly, the same treatment when applied to C7h and C7i did not afford the cyclized 
products to any extent, the substrates remaining unaltered. 
Table 7.2. 1NiDy-Cl catalysed condensation/ring-opening/cyclization of secondary amines with 
2-furaldehyde and condensation/ring-opening of primary amines with 2-furaldehyde. 
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Scheme 7.3. The ring closing of C7f or C7g is promoted by very dilute HCl or silica gel leading 
to the corresponding trans-4,5-diaminocyclopent-2-enones C7j and C7k, respectively. 
7.2.2 Optimization of the NiII2LnIII2 catalysts 
Considering the effectiveness of 1NiDy-Cl at catalysing the condensation/ring-
opening/cyclization of secondary amines with 2-furaldehyde (C7S1) and condensation/ring-
opening of primary amines with 2-furaldehyde, it was reasoned that substitution of the DyIII ion 
with lanthanides of lower cost would allow the evaluation of the relationship between cost and 
effectiveness. Therefore, an attempt was made to isolate and characterize isoskeletal analogues 
of compound 1NiDy-Cl with YIII, SmIII, EuIII, GdIII, and TbIII. 
7.2.2.1 Synthetic insights and characterization of 1NiLn-Cl  
Reproducing both reaction procedures that had produced 1NiDy-Cl (Scheme 7.3, A and B), 
attempts to synthesize and isolate LnIII analogues of 1NiDy-Cl were not successful. 
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In an adapted procedure, where the mixture of LnCl3·xH2O (Ln = Y, Sm, Eu, Gd and Tb), 
NiCl2·6H2O and H2L1 in the presence of Et3N (in a molecular ratio of 1/1/2/5) in CH3CN was 
reﬂuxed for 1 h, resulted in all samples producing a large amount of green precipitate. The 
precipitate was filtered and dried overnight for all reactions (Equation 7.2). A range of techniques 
including ESI-MS (Table 7.3, Appendix B, S7.6-S7.14), EA (chapter eleven), FT-IR spectroscopy 
(Appendix B, S7.15-S7.23), and TGA (Appendix B, S7.24-S7.29) confirmed that the ﬁltrates 
were identical to 1NiDy-Cl and have the general formula [NiII2LnIII2(L1)4(Cl)2(MeCN)2]·2MeCN 
(1NiLn-Cl) (Ln = Sm (1NiSm-Cl), Eu (1NiEu-Cl), Gd (1NiGd-Cl), Tb (1NiTb-Cl), Y (1NiY-
Cl)] (Equation 7.2). 
 
Equation 7.2. Pictorial representation of the synthesis of 1NiLn-Cl. 
The TGA data (Appendix B, S7.24-S7.29) for all solid compounds indicated the loss of four 
CH3CN molecules (lattice and coordinated) up to 290 °C and decomposition at higher 
temperatures.  
ESI-MS spectra of all 1NiLn-Cl species were similar, with two main peaks in the positive ion 
mode corresponding to the {[NiII2LnIII2(L1)4Cl(CH3CN)(CH3OH)]+4H}+ 
and{[NiII2LnIII2(L1)4]}2+ fragments (Appendix B, S7.6-S7.14 with Table 7.3 for peak 
assignments).  
Table 7.3. Observed peaks for 1NiLn-Cl PCCs in ESI-MS with corresponding peak assignments. 
Observed peaks and corresponding fragments in ESI-MS /m/z 
PCC [Ni2Ln2(L1)4(CH3CN)]1+ [Ni2Ln2(L1)4]2+ 
1NiY-Cl 1302.9743 628.9899 
1NiSm-Cl 1428.9876 692.0004 
1NiEu-Cl 1430.9948 693.0042 
1NiTb-Cl 1443.0186 699.0098 
1NiGd-Cl 1441.0109 698.0069 
1NiDy-Cl 1556 / + MeOH 703.5109 
Finally, EA are consistent with the calculated values without lattice CH3CN molecules (chapter 
eleven). 
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In the attempt to characterize the species via single-crystal XRD studies, several unexpected 
products were structurally characterized, indicating that the synthesis of these species is not a 
simple task.  
For example, the eﬀort to obtain crystals of 1NiSm-Cl resulted in the structural characterization 
of three diﬀerent compounds, formulated as [NiII5SmIII2(CO3)(L1)7(L1′)(H2O)3] (1NiSm-Cl-A), 
[NiII2SmIII2(L1)4(o-van)2(H2O)2]·4CH3CN (1NiSm-Cl-B), and 
[SmIII4(OH)2(L1)4(HL1)2]·2CH3CN (1NiSm-Cl-C), where L1′ is 2-aminophenol and o-van is o-
vanillin (Appendix B, S7.33-S7.35). In the attempt to obtain crystals of 1NiEu-Cl, a compound 
formulated as [NiII8EuIII4(L1)8(CO3)4Cl4(H2O)14] (1NiEu-Cl-A) was obtained (Appendix B, 
S7.33-7.35). The latter molecule is isoskeletal to compounds recently reported by Ke et al.417 
7.2.2.2 Comparison of catalytic activity of 1NiLn-Cl (LnIII) analogues 
To ascertain whether the catalytic activity of these species is driven solely by the 4f ions or co-
operative action between 4f and 3d ions, various blank tests were performed (Table 7.4).  
Firstly, three NiII salts each with three diﬀerent loadings (Table 7.4, entries 2 - 10) were used in 
the prototype reaction. NiCl2·6H2O was found to catalyse the reaction with very high loadings 
and very low yields after 24 h (Table 7.4, entry 2) reﬂecting that its contribution is negligible for 
the shorter time. An in situ mixture of NiII salt and H2L1 (Table 7.4, entries 11 - 13) gave none of 
the anticipated product after 24 h.  
In Batey’s protocol, since Dy(OTf)3 was found to be an excellent catalyst using a loading of 10 
mol%, the catalytic efficacy of other lanthanide salts (Table 7.4, entries 14 - 20) along with 
yttrium salts were tested. YIII has a size and Lewis acidity like HoIII and its use allows a catalytic 
reaction to be possibly monitored with NMR spectroscopy (1H, 13C, 15N, or 89Y), because of its 
diamagnetic character. Y(OTf)3 showed similar excellent catalytic performance (Table 7.4, entry 
14) to Dy(OTf)3, and the lanthanide chlorides showed the poorest performance (Table 7.4, entries 
15 - 20).  
To further understand the nature of the system, a mixture of NiII and LnIII salts (Table 7.4, entries 
21 - 26), reveal that the presence of the NiII salt had negligible inﬂuence on the catalytic 
performance. Finally, the use of Ni(ClO4)2·6H2O  and Dy(OTf)3 or Y(OTf)3 (Table 7.4, entries 27 
and 28) exhibited an insigniﬁcant inﬂuence of the NiII source on the catalytic performance. The 
YIII salt had a higher efficacy the DyIII salt. All these experiments confirmed the superior catalytic 
behaviour of 1NiDy-Cl (1 mol%; Table 7.4, entry 1) over the simple metal salts as catalysts and 
the insigniﬁcant role of NiII in the catalysis. 
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Table 7.4. Comparison of NiII, LnIII, a combination of NiII/LnIII and NiII/H2L1 sources catalytic 
activity. 
 
Entry Catalyst T Loading / mol%[b] Time / h Yield / %[c] 
1 None r.t N/A 24 0.1 
2 NiCl2 r.t 30 24 6.5 
3 NiCl2 r.t 20 24 2.0 
4 NiCl2 r.t 10 24 0.2 
5 Ni(NO3)2·6H2O r.t 30 24 2.9 
6 Ni(NO3)2.6H2O r.t 20 24 1.0 
7 Ni(NO3)2·6H2O r.t 10 24 0.0 
8 Ni(ClO4)2·6H2O r.t 30 24 0.3 
9 Ni(ClO4)2·6H2O r.t 20 24 0.0 
10 Ni(ClO4)2·6H2O r.t 10 24 0.0 
11 Ni(NO3)2/H2L1 r.t 10/10 24 0.0 
12 Ni(ClO4)2/H2L1 r.t 10/10 24 0.0 
13 NiCl2/H2L1 r.t 10/10 24 0.0 
14 Y(OTf)3 r.t 10 24 99 
15 SmCl3 r.t 10 24 37 
16 EuCl3 r.t 10 24 22 
17 GdCl3 r.t 10 24 41 
18 TbCl3 r.t 10 24 43 
19 DyCl3 r.t 10 24 72 
20 YCl3 r.t 10 24 73 
21 NiCl2/SmCl3 r.t 10/10 24 31 
22 NiCl2/EuCl3 r.t 10/10 24 21 
23 NiCl2/GdCl3 r.t 10/10 24 41 
24 NiCl2/TbCl3 r.t 10/10 24 39 
25 NiCl2/DyCl3 r.t 10/10 24 72 
26 NiCl2/YCl3 r.t 10/10 24 71 
27 Ni(ClO4)2/Dy(OTf)3 r.t 10/10 24 95 
28 Ni(ClO4)2/Y(OTf)3 r.t 10/10 24 98 
[a]Reaction conditions: amine, 1 mmol; 2-furaldehyde, 0.5 mmol; 4 Å MS, 100 mg; catalyst; 
anhydrous MeCN, 4 mL; r.t; [b] Catalyst loading calculated per equivalent of M; [c] determined by 
1H NMR spectroscopy.  
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1NiLn-Cl PCCs (Table 7.5, entries 2 - 5) catalyse the formation of C7a in moderate to good 
yields in comparison to 1NiDy-Cl but display higher yields than simple salts. When 1NiY-Cl 
(Table 7.5, entry 6) was employed, a catalytic performance similar to 1NiDy-Cl was observed. A 
further decrease of the catalytic amount of 1NiY-Cl to 0.5 mol% loading results in excellent 
conversion (Table 7.5, entry 7). The higher eﬃcacy of YIII than LnIII in Lewis acid catalysis has 
been previously reported,418,419 but no rationale has been proposed. All attempts to recover the 
1NiLn-Cl catalyst, to reuse it, were unsuccessful. 
 Table 7.5. Comparison of 1NiLn-Cl PCC catalytic activity. 
 
Entry Catalyst T Loading /mol%[b] Time /h Yield / %[c] 
1 1NiDy-Cl r.t 1 2 quantitative 
2 1NiSm-Cl r.t 1 2 (24) 55 (75) 
3 1NiEu-Cl r.t 1 2 (24) 60 (99) 
4 1NiGd-Cl r.t 1 2 (24) 63 (99) 
5 1NiTb-Cl r.t 1 2 (24) 63 (86) 
6 1NiY-Cl r.t 1 2 quantitative 
7 1NiY-Cl r.t 0.5 2 (24) 98 (100) 
[a] Reaction conditions: amine, 1 mmol; 2-furaldehyde, 0.5 mmol; 4 Å MS, 100 mg; catalyst; 
anhydrous MeCN, 4 mL; r.t; [b] Catalyst loading calculated per equivalent of Ln; [c] determined 
by 1H NMR spectroscopy.  
7.2.3 Tuning the organic periphery 
7.2.3.1 Synthetic strategy 
1NiY-Cl shows similar or better catalytic behaviour than 1NiDy-Cl (Table 7.5). Given the 
excellent results that were obtained using even lower catalyst loadings (0.5 mol% for 1NiY-Cl, 
instead of 1.0 mol% for 1NiDy-Cl), along with the less-expensive lanthanide source, it was 
considered that 1NiY-Cl could be structurally modiﬁed to achieve immobilization or to 
demonstrate photosensitivity.  
From the nineteen Schiff base ligands synthesised in chapter five, the three organic ligands shown 
in Figure 7.6 were selected for the synthesis of the corresponding tetranuclear defect dicubane 
PCCs. These were chosen with the following considerations (i) to increase the solubility, as well 
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to oﬀer the possibility for deposition of these species on surfaces by the introduction of an allyl 
group (H2L6); (ii) to create “photosensitive” catalysts by inclusion of a naphtho group (H2L2); 
and (iii) to combine both features (H2L16).  
 
Figure 7.6. The three modified organic ligands used for the synthesis of LNiY-Cl PCCs. 
From a generalized reaction procedure, using initial steps identical to the previously discussed 
protocols for 1NiLn-Cl (Scheme 7.2), H2L2, H2L6 and H2L16 were blended with NiCl2·6H2O, 
and YCl3·xH2O, in the presence of Et3N in a 1:1:2:5 ratio in MeCN and refluxed for 2 h. All three 
samples resulted in a green precipitate, which was subsequently recrystallized from DMF and 
Et2O by VD (Scheme 7.4). Each sample resulted in needle-like green crystals which will be 
described.  
 
Scheme 7.4. Pictorial representation of the synthesis of LNiY-Cl. 
From ligand H2L6 (Figure 7.6, left), in a slightly diﬀerent synthetic ratio to 1NiY-Cl, a compound 
formulated as [NiII2YIII2(L6)4Cl2(DMF)2] (6NiY-Cl) (Figure 7.7, upper) was obtained. Also, the 
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ligands H2L2 and H2L16 (Figure 7.6), with slightly diﬀerent synthetic ratios, gave 
[NiII2YIII2(L2)4Cl2(DMF)2]·2DMF·2Et2O (2NiY-Cl·2DMF·2Et2O) (Figure 7.7, middle) and 
[NiII2YIII2(L14)4Cl2(DMF)2] (14NiY-Cl) (Figure 7.7, lower), respectively.  
These compounds were characterized by single-crystal XRD studies (Figure 7.7), FT-IR spectra 
(Appendix B, S7.21-S7.23), ESI-MS (Appendix B, S7.12-7.14), EA (chapter eleven) and TGA 
(Appendix B, S7.20-S7.22). Single-crystal XRD studies indicate that compounds 2NiY-Cl, 
6NiY-Cl, and 14NiY-Cl are isoskeletal to 1NiDy -Cl. These PCCs will be collectively referred 
to as LNiY-Cl. 
7.2.3.2 Molecular structures of LNiY-Cl 
LNiY-Cl are isoskeletal to the previously described defect dicubane 1NiLn-Cl PCCs. The ligands 
display the same coordination modes as previously described (Figure 7.3). The coordination 
environments around each metal centre are the same as 1NiDy-Cl. Each NiII centre coordinates 
to six atoms (O5N environment) possessing an octahedral geometry and each YIII centre 
coordinates to seven atoms (O5NCl environment) possessing a pentagonal bipyramidal geometry. 
No intermolecular interactions are observed and selected bond lengths can be found in Appendix 
B. 
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Figure 7.7. Molecular structures of 6NiY-Cl (upper), 2NiY-Cl (middle) and 14NiY-Cl (lower). 
Colour code: NiII, green; DyIII, light blue; O, red; N, blue; C, white; Cl, purple. Hydrogen atoms 
and disordered solvent molecules are omitted for clarity. 
7.2.3.3 ESI-MS studies 
Broad ESI-MS data from 2NiY-Cl, 6NiY-Cl and 14NiY-Cl indicate that all three compounds 
retain their core structures in solution, shown by two prominent peaks in the MS (positive ion 
mode). These two peaks were observed for 6NiY-Cl and 2NiY-Cl and perfectly correspond to 
the {[NiII2YII2(L6)4Cl2]}+ and {[NiII2YIII2(L6)4]}2+ or {[Ni2Ln2(L2)4(CH3OH)Cl]}2+ fragments 
respectively (Table 7.6). However, for 14NiY-Cl only a peak corresponding to the 
{[Ni2Ln2(L1)4(CH3CN)]}1+ is observed. This data, as with other isoskeletal MII2NiII2 PCCs in this 
chapter, indicates that the [MII2DyIII2(LX)4] core remains intact in solution. 
Table 7.6. Observed Peaks and corresponding fragments of 1NiY-Cl in ESI-MS. 
Observed Peaks 
 [Ni2Ln2(L6)4(CH3CN)]
1+ [Ln2Ni2(L6)4]2+ 
6NiY-Cl 1465.1169 710.488 
  [Ni2Ln2(L2)4(CH3OH) Cl]1+ [Ni2Ln2(L2)4(CH3OH) Cl]2+ 
2NiY-Cl 1430.9948 762.0541 
  [Ni2Ln2(L14)4(CH3CN)]1+ n/a 
14NiY-Cl 1663.2231 n/a 
7.2.3.4 Scope of reaction for optimized NiII2LnII2 PCCs 
The catalytic activity of 6NiY-Cl, 2NiY-Cl, and 14NiY-Cl toward the prototype reaction is shown 
in Table 7.7. Compounds 14NiY-Cl and 6NiY-Cl are not as eﬃcient, relative to 1NiY-Cl (1.0 
mol% loading, instead of 0.5 mol% loading, and slightly lower yields), but these results can be 
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attributed to the decreased solubility in MeCN. When 2NiY-Cl was employed as a catalyst (Table 
7.7), yields similar to those with 1NiY-Cl were obtained.  
7.2.3.5 Immobilization of NiII2LnII2 PCCs 
To explore the potential of these catalysts for immobilization and therefore heterogeneous 
catalysis, attempts were made to synthesize the organic ligands H4L30 and H4L31 shown in 
Figure 7.8. 
Ligand H4L30 offers a similar coordination environment to H2L1 and thus it was anticipated to 
form coordination polymers upon complexation with the NiII and YIII salts. However, H4L30 is 
slightly soluble in the polar solvents DMF or DMSO. To overcome the solubility issue, the 
organic ligand H4L31 was synthesized, this provides two t-butyl groups, but, similarly to H4L30, 
it is slightly soluble in polar solvents. All efforts to synthesize the corresponding coordination 
polymers were unsuccessful. 
 
Figure 7.8. The modified organic ligands H4L30 (R = H) and H4L31 [R = C(CH3)3]. 
7.3 Theoretical studies 
To further identify the formation of the previously discussed deprotonated Stenhouse salt 
intermediate a computational study was undertaken. Energy minimization calculations within the 
Kohn–Sham DFT at the B3LYP/6-311G** level employing the Polarizable Continuum Media 
(PCM) formalism were carried out on model compounds C7f, C7j, C7II and C7I (Figure 7.9).  
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Table 7.7. Comparison of catalytic activity of LNiY-Cl (where L = 1, 2, 6 and 14) and 1NiDy-Cl with secondary and primary substrates. 
 Compound 1NiDy-Cl 1NiY-Cl 6NiY-Cl 2NiY-Cl 14NiY-Cl 
 Loading /mol%[b] 1 0.5 1 0.5 1 
 Time/ h 16 8 12 8 12 
Entry Product Yield / %[c] Yield / %[c] Yield / %[c] Yield / %[c] Yield / %[c] 
1 C7a quantitative quantitative 91 quantitative 85 
2 C7b 99 96 85 95 80 
3 C7c 95 99 70 94 64 
4 C7d 61 53 58 51 52 
5 C7e 63 71 69 69 62 
6 C7f 96 99 96 99 94 
7 C7g 62 91 91 93 91 
8 C7h 70 95 94 94 92 
9 C7i 26 90 81 86 81 
[a] Reaction conditions: amine, 1 mmol; 2-furaldehyde, 0.5 mmol; 4 Å MS, 100 mg; catalyst; anhydrous MeCN, 4 mL; r.t; [b] Catalyst loading calculated per 
equivalent of Dy; [c] Determined by 1H NMR spectroscopy. 
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Figure 7.9. Energy profile of the reaction with aniline of the ring-opening (C7f) and closure (C7j) 
products. 
The overall energy profile together with the calculated NMR data (Appendix B, Table S7.1) 
suggests: 
a) The pathway from intermediate C7II – C7f towards the final product is highly favourable, 
which confirms that the catalysis takes place prior to this step. 
b) The intermediate C7II – C7f likely resembles a configuration somewhere between C7II (in 
which the nitrogen bears a hydrogen) and C7f (in which the hydrogen migrates to the 
neighbouring oxygen. 
c) That one factor that highly affects the total electronic energy of C7i concerns a pyramidal-to-
planar evolution of the beta-nitrogen, a key feature that is likely involved in the catalytic process. 
Computational studies also show that it was possible to modify ligand sterics without 
compromising the electrostatic properties that are key to the activities of the complexes.  
Renditions of the MEP for H2L2, H2L6, and H2L16 are shown in Figure 7.10. The results also 
suggest that the charge distribution within the O−O−N−O core pattern directly interacting with 
the metals is a function of the conformation of the ligands.  
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Figure 7.10. The rendition of the MEP of H2L6 (upper), H2L2 (middle), and H2L16 (lower) 
organic ligands: Bound (left) and free conformation (right). 
7.4 Conclusion 
This chapter presents and demonstrates a simple and high yielding isoskeletal series of MII2LnIII2 
(M = Ni, Co) PCCs, supported by structurally homologous Schiff base ligands, which show 
remarkable catalytic activity towards the synthesis of trans-4,5-diaminocyclopent-2-enones from 
2-furaldehyde and primary or secondary amines.  
From two poorly performing 3d-DyIII, defect dicubane PCCs (1MDy-ClO4) under mild 
conditions, it was possible to synthesize an optimized isoskeletal analogue with an altered 
coordination environment (1NiDy-Cl) and generate an analogous family (1NiLn-Cl) with the 
substitution of the 4f ion. It was then possible to determine the relationship between efficacy and 
4f ion node. 
In addition, considering the catalyst loadings and the reaction times, the NiII contribution appears 
negligible and it is, therefore, safe to conclude that the domino reaction is driven solely by the 4f 
ion. Remarkably, the employment of YIII (1NiY-Cl) instead of DyIII (1NiDy-Cl) results in a lower 
loading and reduced cost catalyst.  
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With further optimization, it was demonstrated that the functionalization of the organic skeleton 
is feasible (2NiY-Cl, 6NiY-Cl and 14NiY-Cl), without deterioration of the catalytic activity. 
Moreover, the modified species 6NiY-Cl and 14NiY-Cl, that bear allyl groups, can be 
immobilized by deposition on surfaces, but this is the goal of a following study. The results 
presented herein show the richness of this chemistry and pave the way for the future employment 
of 3d-4f PCCs in catalysis.  
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Chapter 8: Tetranuclear Zn/4f PCCs as highly efficient 
catalysts for Friedel-Crafts alkylations and for the Petasis 
borono-Mannich multicomponent reaction 
Abstract: A series of novel, high yielding, isoskeletal tetranuclear polynuclear coordination 
clusters formulated [ZnII2LnIII2(L1)4(NO3)2(DMF)2] (1ZnLn-NO3) which display a defect 
dicubane (2,3M4-1) core topology were synthesised and characterised. Synthetic insights are 
discussed. The ability to substitute the 4f centres in these catalysts without altering the core 
topology was studied and allows further confirmation of their solution stability via electrospray 
ionization mass spectrometry, electron paramagnetic resonance and NMR studies. 1ZnLn-NO3 
are shown to be high-efficiency catalysts with low catalytic loadings in two types of Friedel-
Crafts (FC) alkylations and in a Petasis Borono-Mannich (PBR) transformation. The 1ZnY-NO3 
analogue demonstrates the highest efficacy in the FC alkylation of indoles by aldehydes, whereas 
1ZnDy-NO3 surpasses the rest of the series for the FC alkylation of indoles by nitrostyrenes and 
the PBR reaction. Insights into plausible reaction mechanisms are presented which are supported 
by ultra violet visible spectroscopy substrate binding studies.  
8.1 Introduction 
Chapter seven established the catalytic activity of a series of tetranuclear NiII/CoII-LnIII PCCs 
(1MLn-ClO4 and LMLn-Cl) for the domino ring-opening electrocyclization reaction between 
furaldehyde and a wide range of secondary and primary amine substrates. Furthermore, the 
organic periphery of the catalysts could be modified without a substantial impact on the efficacy 
of the catalytic transformation. A noticeable limitation of this study was that only the LnIII ion of 
the NiII/CoII-LnIII PCCs was catalytically active and there was no evidence of a co-operative action 
between the 3d and 4f metal centres. Considering that Ln(OTf)3420 and Zn(ClO)4/Schiff base421 
compounds have been employed as catalysts in the reactions of indole derivatives with aldehydes 
and ketones, it was envisioned that ZnII2LnIII2 PCCs isoskeletal to those in chapter seven could be 
applied to these types of reactions and have a significant co-operative catalytic effect.  
Catalysts based on zinc or lanthanide elements have been extensively employed in FC reactions 
and sizeable development has taken place.411,422 FC reactions are an important carbon-carbon 
bond forming reaction in organic and medicinal chemistry.423 In particular, the indole ring system 
represents one of the most abundant and important heterocycles in nature exhibiting wide-ranging 
biological activity.424  
The nucleophilic addition of aldehydes or ketones to indoles, in the presence of a Lewis acid, is 
a facile route towards the synthesis of bis indolyl-methane (BIM) derivatives with only one 
equivalent of water generated as a side product. BIMs have recently been shown to be useful in 
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the treatment of fibromyalgia,425 as antibacterial agents426 and even in the prevention of cancer.426 
Various catalytic systems and metal salts have been reported for the synthesis of BIMS, however, 
these methods suffer from a number of disadvantages such as expense, the toxicity of reagents, 
high temperatures, high catalytic loading and photosensitivity.427–430  
Another important FC reaction is the reaction between indole and β-nitrostyrene which gives 
access to indole-based alkaloids such as melatonin analogues, 1,2,3,4-tetrahydro-β-carbolines 
(THBCs) and “triptans”. Nitroalkenes have received considerable attention as active Michael 
acceptors431 because the nitro derivatives can be transformed into amino compounds with a 
variety of different functionalities.432–436 In streamlining the reaction between indole and β-
nitrostyrene various catalytic systems have been proposed. These include hydrogen-bond-based 
compounds437–442 such as thiourea,437,440,441,443–446 phosphoric acid,442 silanediols,447,448 sulfamic 
acid,449 2,6-bis(amido)benzoic acid,450 metal based compounds451–467 such as AlIII,451,465 CuII, 452–
456,467 ZnII,422,457–461,466 FeIII,462 PdII,463 RhII 468,469 and SmI3464 and heterogeneous systems including 
MOFs,470,471 nano n-propylsulfonated γ-Fe2O3 (NPS-γ-Fe2O3) 472 and zeolite HY.473 However 
efficient metal-based catalytic systems for this transformation are very rare. Du developed an 
efficient catalyst containing bisoxazolines, bisimidazolines and Zn(OTf)2.452,474–477 Wang reported 
the involvement of a dimeric CuII PCC and piperidine as a catalyst for reactions between aromatic 
nitroalkenes and ortho-substituted indoles.467 However, some of the reported protocols have 
drawbacks such as high catalyst loading, long reaction time, multi-step designed ligands, the need 
for additives and the reaction at low temperature (0 to -20 oC) which limits their practical 
applications. 
MCRs have dominated synthetic chemistry for the following reasons, they yield products from 
simple starting materials, in fewer steps and in a shorter time when the reactions are carried out 
in a combinatorial way.478–489 Among these transformations, the Mannich-type condensation that 
involves amines, aldehydes and boronic acids, developed by Petasis,490 known as Petasis Borono-
Mannich Reaction (PBR) has received considerable attention because it produces skeletons that 
can easily convert to amino acids, heterocycles and alkylaminophenols.491 More specifically, the 
reaction between aryl boronic acids, amines and salicylaldehydes yield, in a single step, novel 
aminophenol derivatives492 which are suitable for the preparation of dihydro-1,3-oxazines,493,494 
triarylmethanes495 and polycyclic N, O-acetals.30 It is worth noting that aldehydes lacking an OH 
group in position 2 failed to deliver the desired product, highlighting the importance of the 
hydroxyl group in the aldehyde to activate the boronic acid.491 The first report for the specific 
transformation included a reaction at 90 oC, in dioxane as a solvent, in 16 hours and in absence of 
catalyst in very good yields.496 In 2004, Tye et al developed a rapid, microwave-assisted protocol 
for carrying this reaction that required a 10 min reaction time.497 In 2009, Gois et al., reported the 
synthesis of several alkylaminophenols in moderate to good yields, in water, at 80 oC, in absence 
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of a catalyst.498 Recently, an effective and rapid synthesis was carried out using protonated 
trititanate (H2Ti3O7) nanotubes as a heterogeneous solid–acid catalyst.499 However, these methods 
all suffer from a number of disadvantages such as high temperatures, high catalyst loadings (10 
mol%) and long-time reactions. 
Herein a series of isoskeletal defect dicubane PCCs with the general formula 
[ZnII2LnIII2(L1)4(NO3)2(DMF)2] (1ZnLn-NO3) where Ln is Y, Sm, Eu, Gd, Tb and Yb were 
synthesised and characterised. For the first time, they were applied towards the aforementioned 
FC reactions. In addition, bearing in mind that the Zn-Y/Ln metals are very close (~ 3.3 Å) in this 
specific topology and observing a chelation preference of aldehydes to Y-Ln metals,336 it was 
anticipated that these catalysts would be an ideal synergistic template for the PBR reaction. 
8.2 Results and discussion 
8.2.1 Synthetic strategy  
To develop ZnII2LnII2 defect dicubane PCC catalysts, isoskeletal to those NiII2LnII2 discussed in 
chapter five, several synthetic procedures were employed. As discussed in chapter two, ZnII2LnII2 
defect dicubane PCCs (1-3) were synthesized, though these display the targeted defect dicubane 
topology supported by H2L1, the presence of perchlorate counter-ions previously had an adverse 
effect on the catalytic efficacy with the isoskeletal 1MDy-ClO4 PCCs described in chapter seven. 
For this reason, (1-3) were not considered for promoting FC or MCR reactions.  
Attempts were made to synthesize ZnII analogues of the previously described 1MLn-Cl PCCs, 
however, these efforts failed. Following an adapted method, a series of isoskeletal defect dicubane 
ZnII2LnII2 PCCs supported by H2L1 with nitrate counter-ions were synthesized with the following 
procedure. 
The stirred reaction of Dy(NO3)3·6H2O, Zn(NO3)2·6H2O, EtOH and H2L1 in the presence of Et3N 
in a 1:2:2:4.5 ratio under aerobic conditions afforded a yellow precipitate. The precipitate was 
subsequently crystallized by VD of Et2O in DMF solution which afforded block shape crystals of 
air-stable tetranuclear defect dicubane compound formulated [ZnII2DyIII2(L1)4(NO3)2(DMF)2] 
(1ZnDy-NO3) after 1 week (Scheme 8.1) in very good yields (78%). 
When the same reaction was performed with other lanthanide salts, isoskeletal analogues with the 
general formula [ZnII2LnIII2(L1)4(NO3)2(DMF)2] (1ZnLn-NO3) where Ln is Y (1ZnY-NO3), Sm 
(1ZnSm-NO3), Eu (1ZnEu-NO3) Gd (1ZnGd-NO3), Tb (1ZnTb-NO3) and Yb (1ZnYb-NO3) 
were isolated. These compounds were characterized in full by single-crystal XRD studies (Figure 
8.1), FT-IR spectra (Appendix B, S8.1-S8.7), ESI-MS (Appendix B, S8.8-S8.25), TGA 
(Appendix B, S8.26-S8.32) and EA (chapter eleven). 
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Scheme 8.1. Pictorial representation of the synthesis of 1ZnLn-NO3. 
8.2.2 Crystal structures of 1ZnLn-NO3 
As 1ZnLn-NO3 PCCs are isostructural, which is confirmed by single-crystal XRD studies 
(chapter twelve) and the aforementioned characterisation, only the crystal structure of 1ZnGd-
NO3 is described herein.  
1ZnGd-NO3 crystallises in the monoclinic space group P21/c. The asymmetric unit cell contains 
one ZnII ion, one GdIII ion, two doubly deprotonated (L1) ligands, one coordinated nitrate anion 
and one coordinated DMF molecule (Figure 8.1). The main core of 1ZnGd-NO3 can be described 
as a defect dicubane (2,3M4-1). 
L1 exhibits two different coordination modes (Figure 8.2). In the first mode (Figure 8.2, mode I), 
the two phenoxide oxygen atoms and the imine nitrogen atom are chelated to the ZnII centre and 
the two phenoxide atoms are further bonded to two GdIII ions Gd (1) (and its symmetry-related 
counterpart) and the methoxide oxygen atom is bound to Gd (1).  
In the second mode (Figure 8.2, mode II), the two phenoxide oxygen atoms and the imine nitrogen 
atom are chelated to the GdIII centre, while the phenoxide oxygen atom (from the 2-aminophenol 
unit), is further bound to two ZnII centres. The DMF molecule is bound to the ZnII ion and the 
[NO3]- anion is bound to the GdIII. The ZnII ion adopts a slightly distorted octahedral geometry 
with an O5N donor set, while the Ln ion has a very distorted square antiprismatic geometry, due 
to the chelating nitrate anion with an O7N donor set. Gd··· Zn distances are 3.505 - 3.564 Å and 
the Zn···Zn distance 3.291 Å. No intramolecular interactions (e.g. H-bonds or stacking) can be 
found between neighbouring entities. 
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Figure 8.1. Molecular Structure of 1ZnGd-NO3. Colour code: ZnII, grey; GdIII, light blue; O, 
red; N, blue; C, white. Hydrogen atoms have been omitted for clarity.  
 
 
Figure 8.2. Observed coordination modes of L1 in 1ZnLn -NO3. 
8.2.3 Solution studies of 1ZnLn-NO3 
To verify that the [ZnII2LnIII2(L1)4]2+ core is stable in solution and that it is the active species 
towards the catalytic efficacy in the following investigated reactions, several solution-based 
studies were conducted (ESI-MS, EPR, 1H NMR spectroscopy). These verify core stability and 
determine that other by-product species are not present. 
8.2.3.1 ESI-MS studies of 1ZnLn-NO3 
The identity of 1ZnLn-NO3 was confirmed by ESI-MS studies. In all cases, two peaks (positive-
ion mode) in the MS were observed at an m/z which correspond respectively to the monocationic 
[ZnII2LnIII2(L1)4(NO3)] + and the dicationic [ZnII2LnIII2(L1)4(MeOH)]2+ fragments perfectly (Table 
8.1, Appendix B, S8.8-S8.25.). The identification of these fragments indicates that the defect 
dicubane core is retained in solution. 
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Table 8.1. ESI-MS peak assignments 
Observed Peaks 
PCC [Zn2Ln2(L1)4(NO3)]1+ [Zn2Ln2 (L1)4(MeOH)]2+ 
1ZnY-NO3 1335.9672 652.9971 
1ZnSm-NO3 1457.0803 717.0056 
1ZnEu-NO3 1460.0661 718.9654 
1ZnTb-NO3 1476.0757 720.1311 
1ZnGd-NO3 1471.9936 722.0254 
1ZnDy-NO3 1482.0975 726.0345 
1ZnYb-NO3 1504.9225 737.9388 
8.2.3.2 EPR studies of 1ZnGd-NO3 
To further confirm the solution stability of the 1ZnLn-NO3 PCCs, Q-band EPR studies of 
1ZnGd-NO3 in both solid and solution (80% DMF, 20% Et2O) phase were performed, (Figure 
8.3). Simulations with PHI500 confirm that the spectra are owed to S = 7/2 GdIII ions with ZFS 
(Figure 8.3). The highly sensitive, finger-print-like ZFS of the S = 7/2 state directly indicates that 
the coordination environment of the GdIII ion is unchanged in solution. 
 
Figure 8.3. Experimental EPR spectra at the Q-band (34.0865 GHz) of 1ZnGd-NO3, recorded at 
7 K in the solid (green line) and solution phase (red line). 
8.2.3.3 1H NMR studies of 1ZnY-NO3 
Despite the diamagnetic nature of 1ZnY-NO3, characterizing it in the solution state by 1H NMR 
spectroscopy proved difficult due to its asymmetry, dynamic behaviour and its relatively low 
143 
 
 
solubility. However, the peak areas for the imine, aromatic, and methoxy protons were all 
consistent with the structure as determined by single-crystal XRD studies (Figure 8.1). Gradually 
warming to 75 °C in 10 °C steps caused gradual broadening of the peaks, which then recoalesced 
on cooling back to room temperature, without any apparent decomposition of the complex. 
8.2.4 1ZnLn-NO3 as catalysts for organic transformations 
With the series of 1ZnLn-NO3 PCCs characterised in both solid and solution state, this series of 
PCCs was applied as potential catalysts to the FC alkylation reaction of indoles with aldehydes, 
FC alkylation reaction of indoles with nitrostyrenes and the PBR reaction between 
salicylaldehydes, secondary amines and boronic acids. Initial steps involved identifying the best 
reaction conditions and PCC for the respective catalytic reaction, followed by an exploration of 
the scope of reaction. In addition, mechanistic insights are proposed and supported by UV-Vis 
substrate binding studies. 
8.2.4.1 1ZnLn-NO3 catalysed FC alkylation of indoles and aldehydes  
To determine whether 1ZnLn-NO3 had a catalytic effect for the synthesis of BIMs, indole (C8S1) 
and benzaldehyde (C8S2) were selected as reactants for the benchmarking studies for the catalytic 
synthesis of the BIM adduct, C8aa. In initial studies, 1ZnDy-NO3 was used as the catalyst at 10 
mol% loading, based on a previously reported catalytic procedure with Dy(OTf)3.420  
8.2.4.1.1 Benchmarking and optimisation  
To determine the optimised catalytic system, several reaction parameters were investigated, 
including the solvent medium (Table 8.2 and 8.3), different catalysts (Table 8.4) and catalyst 
loading (Table 8.4). 
The first set of reactions were performed to identify the ideal solvent system. After screening 
several solvents (Table 8.2), the ethanol/water (2: 1) solvent system (Table 8.2, entry 7) was 
identified to give the best catalytic yield. The use of DMF, acetonitrile or EtOH as solvent (Table 
8.2, entries 4 - 6) resulted in the same product but with lower yields, indicating that the presence 
of H2O is crucial to obtain high yields. No conversion to product was observed in low polarity 
solvents in which 1ZnDy-NO3 is insoluble (Table 8.2, entries 1 - 3), suggesting that the catalytic 
action is homogeneous. 
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Table 8.2. Comparison of catalytic activity of 1ZnDy-NO3 with multiple solvent systems. 
 
Entry[a] Solvent Loading/ mol%[b] Time/ h Yield/ %[c] 
1 Toluene 10 12 0 
2 CHCl3 10 12 0 
3 DME 10 12 0 
4 DMF 10 12 16 
5 MeCN 10 12 30 
6 EtOH 10 12 95 
7 EtOH/H2O 10 12 Quantitative 
8 MeCN/H2O 10 12 42 
9 MeOH/ H2O 10 12 92 
10 iPrOH/H2O 10 12 70 
[a] Reactions conditions: C8S1, 1 mmol; C8S2, 0.5 mmol; solvent 10 mL; r.t. [b] Catalyst loading 
calculated per equivalent of LnIII. [c] Determined by 1H NMR spectroscopy. 
Table 8.3. Comparison of catalytic activity of 1ZnDy-NO3 with a range of EtOH and H2O 
ratios. 
 
Entry [a] %EtOH Loading/ mol% [b] Time / h Yield / % [c] 
1 100 2.5 12 89 
2 90 2.5 12 92 
3 80 2.5 12 95 
4 70 2.5 12 97 
5 60 2.5 12 Quantitative 
6 50 2.5 12 Quantitative 
 
[a] Reaction conditions: C8S1, 1 mmol; C8S2, 0.5 mmol; solvent 10 mL; r.t. [b]Catalyst loading 
calculated per equivalent of LnIII. [c] Determined by 1H NMR spectroscopy 
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Subsequently, a series of reactions was performed at 2.5 mol% catalyst loading with a varied H2O/ 
EtOH ratio (Table 8.3). Quantitative yields (Table 8.3, entries 5 - 6) were obtained in the 3: 2 and 
1: 1 EtOH/H2O ratio.  
After selecting the optimum solvent system, reactions were sought in the absence of any potential 
catalyst (Table 8.4, entry 1) and no product was obtained. Next, due to the heteronuclear 
(ZnII/LnIII) character of 1ZnLn-NO3, lanthanide and zinc triflates were used at 10 mol% loading 
(Table 8.4, entries 2 - 5) to identify their influence on the conversion to C8aa. Yttrium triflate 
(Table 8.4, entry 3) was found to give quantitative yields whilst dysprosium triflate (Table 8.4, 
entry 2) produced only slightly lower yields, zinc triflate (Table 8.4, entry 5), however, exhibited 
poor catalytic performance. Compound 1ZnDy-NO3 aﬀorded almost quantitative yields of the 
desired product after 2 h at 10 mol% loading. With the use of 1ZnLn-NO3 PCCs, comparable 
performance to 1ZnDy-NO3 was observed, however, the use of 1ZnY-NO3 at 2.5 mol% loading 
aﬀorded the desired material in quantitative yield (Table 8.4, entry 10).  
Table 8.4 Comparison of catalytic activity for compounds 1ZnLn-NO3. 
Entry Catalyst T Loading / mol%[b] Time / h Yield / %[c] 
1 None r.t N/A 12 0 
2 Dy(OTf)3 r.t 10 12 95 
3 Y(OTf)3 r.t 10 12 quantitative 
4 Y(OTf)3 r.t 5 12 55 
5 Zn(OTf)3 r.t 10 12 18 
6 1ZnDy-NO3 r.t 10 12 quantitative 
7 1ZnDy-NO3 r.t 5 12 96 
8 1ZnDy-NO3 r.t 2.5 12 92 
9 1ZnDy-NO3 r.t 1 12 87 
10 1ZnY-NO3 r.t 2.5 12 quantitative 
11 1ZnY-NO3 r.t 1 12 96 
12 1ZnSm-NO3 r.t 2.5 12 87 
13 1ZnEu-NO3 r.t 2.5 12 53 
14 1ZnTb-NO3 r.t 2.5 12 80 
15 1ZnGd-NO3 r.t 2.5 12 75 
16 1ZnYb-NO3 r.t 2.5 12 94 
[a] Reaction conditions: C8S1, 1 mmol; C8S2, 0.5 mmol; catalyst; 10 mL EtOH/H2O (2:1); r.t. [b] 
Catalyst loading calculated per equivalent of LnIII. [c] Determined by 1H NMR spectroscopy. 
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Promisingly, the catalyst loading for 1ZnY-NO3 could be decreased to 1 mol% with only a slight 
decrease in the yields (Table 8.4, entry 11), a catalyst loading which is lower than other reported 
systems. Importantly, reducing the catalyst loading for yttrium triflate to 2.5 mol% (Table 8.4, 
entry 4) results in a severe decrease in yield, compared to the ability of 1ZnDy-NO3 and 1ZnY-
NO3 to maintain high yields at only a few mol%. 
8.2.4.1.2 Scope of reaction  
The scope of the reaction was then explored by employing a variety of aldehydes and substituted 
indoles with 1ZnY-NO3 (Table 8.5). The reactions proceed smoothly with very good to excellent 
yields. Products C8aa, C8am and C8au were characterized via single-crystal XRD studies 
(Figure 8.4).  
The next step was to involve ketones in place of aldehydes. Long reaction times, even with a 
slight increase of the temperature (50 °C) did not yield any product with either aliphatic (acetone, 
cyclohexanone) or aromatic ketones (acetophenone) and no unexpected side products were 
observed. This opposite behaviour recalls the selective reduction of ketones in presence of 
aldehydes (Luche reaction).501 In this reaction, aldehydes bond to Ln centres via hemiketal form, 
whilst ketone remains unprotected and is thus reduced by NaBH4. Eﬀorts to monitor the formation 
of the hemiketal form by 1H NMR spectroscopy were not successful. 
Table 8.5. 1ZnY-NO3 catalysed FC alkylation of indoles and aldehydes.[a] 
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[a] Reaction conditions: C8S1, 1 mmol; C8S2, 0.5 mmol; catalyst; 10 mL EtOH/H2O (2:1); r.t. [b] 
Catalyst loading calculated per equivalent of YIII. [c] Determined by 1H NMR spectroscopy. 
 
 
Figure 8.4. Crystal structures of C8aa (upper left), C8al (upper right) and C8ao (lower). Colour 
code: C, gold; H, pink; N, pale blue; O, red. 
8.2.4.1.3 Mechanistic insights  
To gain information regarding the reaction mechanism and whether substrates were indeed 
binding or interacting with the ZnII2LnII2 core, UV-Vis binding studies of 2-naphthaldehyde with 
Zn(OTf)2, Dy(OTf)3 and 1ZnDy-NO3 were performed (Appendix B, S8.34-S8.36).  
A 0.1 mM water/ethanol solution of 2-naphthaldehyde exhibited a strong absorption at 290 nm. 
1ZnDy-NO3 was added to the solution and the absorption was recorded over 3 h with 5 min 
intervals between measurements. It was observed that the intensities of the peak at 290 nm 
gradually decreased with time (Appendix B, S8.36). The quenching of this band may be attributed 
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to the bonding of 2-naphthaldehyde with 1ZnDy-NO3 through weak Van der Waals interactions. 
Similar quenching was observed with the indole substrate (Appendix B, S8.41), indicating the 
binding behaviour of both substrates to 1ZnDy-NO3. Thus, both substrates can be activated after 
coordination with the two metal centres in 1ZnDy-NO3 which favours the conjugate addition of 
the nucleophiles.  
Similar studies were conducted with Zn(OTf)2 and Dy(OTf)3 to determine the preference of each 
substrate for the LnIII or ZnII metal centres (Appendix B, S8.37 - S8.38 and S8.40 - S.41). 2-
naphthaldehyde shows almost double the rate quenching with Dy(OTf)3 when compared to 
Zn(OTf)2. This may suggest that 2-naphthaldehyde preferentially binds to the DyIII centre. The 
1ZnDy-NO3 catalyst displays a greater rate of quenching for both substrates, than either Zn(OTf)2 
or Dy(OTf)3, perhaps indicating a stronger interaction with the metal centres in tandem. 
With the insights gathered from the UV-Vis binding study, the following set of reactions were 
performed to determine further mechanistic information.  
Firstly, aliphatic aldehyde (cyclohexanecarbaldehyde) was employed instead of an aromatic 
aldehyde in reaction with indole, this gave very low yields of the expected product (C8as) (Table 
8.6) after 72 hours.  
Secondly, substituted indoles such as 2-methyl-indole, 2-(trifluoromethyl)-indole, 3-methyl 
indole, indole-3-acetic acid and N-methyl indole were examined in a reaction with benzaldehyde. 
The use of 2-methyl-indole gave the expected product (C8at) (Table 8.6) in quantitative yield in 
only 2 hours, indicating that substitution in position 2 promotes the reaction. Compound C8at 
was characterized via single-crystal XRD studies (Figure 8.5).  
 
 
Figure 8.5. The molecular structure of C8at. Colour code: C, gold; H, pink; N, pale blue. 
However, the use of the electron withdrawing group -CF3 in place of -CH3 [reaction with 2-
(trifluoromethyl)-indole] gave a yield of only 16% of product C8au, indicating a substantial 
influence on the catalytic activity. The use of indole-3-acetic acid did not yield any product. A 
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logical explanation for the deterioration of catalytic activity is that indole-3-acetic acid is in 
competition with the benzaldehyde to coordinate to the LnIII centre, leading to a poisoning of the 
catalyst.  
In addition, the use of 3-methyl-indole also did not result in the formation of the corresponding 
BIM. The latter indicates that if the most active site (C-3) of the indole group is blocked the 
reaction does not proceed. Finally, the reaction of N-methyl-indole with benzaldehyde did not 
yield any product, revealing that coordination of the nitrogen atom to ZnII is crucial.  
Table 8.6. Reactions for mechanistic insights.[a] 
 
[a] Reaction conditions: indole, 1 mmol; benzaldehyde (C8S2), 0.5 mmol; catalyst; 10 mL 
EtOH/H2O (2:1); r.t. Yields determined by 1H NMR spectroscopy. 
Given the knowledge of the structure of the catalyst and the insights derived from above, the 
following mechanism for the FC reaction is proposed (Scheme 8.2). The first step of the reaction 
involves the coordination of the Nindole atom to the ZnII and the Ocarbonyl atom of the aldehyde to 
the Ln part of the catalyst (Step 1). Then, deprotonation of the coordinated indole leads to the 
formation of negative centre at C-3 of the indole moiety (Step 2). The two organic moieties are 
very close [Y⋯Zn distances are 3.34882(7) and 3.5272(8) Å] which favours the formation of 
benzaldehyde-indole hemiaminal, as suggested by the 1H NMR studies. This is followed (Steps 
3-4) by alkylation of one more indole moiety (Step 5). Finally, the catalytic cycle ends by a proton 
exchange with an additional indole moiety (Step 6) and release of the bis-adduct product and 
water to reform the active catalyst species (Step 7). 
8.2.4.2 1ZnLn-NO3 catalysed FC alkylation of indoles and nitrostyrenes  
With the promising results of the 1ZnY-NO3 PCCs towards the catalysing of the FC alkylation 
of indoles with aldehydes to form BIM adducts, 1ZnLn-NO3 were applied to the FC alkylation 
of indoles with nitrostyrenes to further confirm their efficacy as FC alkylation catalysts. 
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Scheme 8.2. Proposed mechanism for the catalytic reaction of indoles and aldehydes by 1ZnY-NO3.
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The reaction between indole (C8S1) and trans-β-nitrostyrene (C8S3), in EtOH, at room 
temperature and a catalyst loading of 1.0 mol% (Table 8.7, entries 1 - 9) was chosen to optimise 
the reaction conditions. 
8.2.4.2.1 Benchmarking and optimisation  
To determine an optimised catalytic system several reaction parameters were investigated, 
including the solvent (Table 8.7, entries 10 - 13), catalysts (Table 8.7, entries 2 - 9) catalyst 
loading (Table 8.7, entries 18 - 20) and temperature of reaction (Table 8.7, entries 15 - 17). 
Firstly, to determine the efficacy of the reaction without a catalyst, a blank experiment was 
performed and showed no conversion (Table 8.7, entry 1). In addition, very low conversions to 
product (C8ba) were obtained in the presence of DyIII or ZnII salts (Table 8.7, entries 2 - 3). In 
contrast, the first reactions with 1ZnDy-NO3 and 1ZnY-NO3 after 24 h show very high yields, 
99% and 94%, respectively (Table 8.7, entries 4 - 5). Other catalysts such as 1ZnLn-NO3, where 
Ln = Eu, Gd, Sm and Tb, displayed lower yields (Table 8.7, entries 1 - 6). 1ZnDy-NO3 was 
determined to be the best choice for this FC reaction.  
The influence of the solvent on the catalytic performance was then investigated. 1ZnDy-NO3 
showed a high activity in ethanol with 99% yield for the desired product C8ba (Table 8.7, entry 
4). Solvents such as THF, water, acetonitrile and DMF had a negative influence on the catalytic 
activity, therefore ethanol was deemed the best choice for further studies. At room temperature, 
the yield of C8ba was 99%, but only 5% at 0 °C. Lower yields were obtained at 60 °C (Table 8.7, 
entry 18), so the following reactions were made at room temperature. 
As shown in Table 8.7, it was sufficient to use a catalyst loading of 1.0 mol% to obtain a yield up 
to 99% (Table 8.7, entry 4). An increase of the catalyst loading from 1.0 mol% to 5 mol% led to 
a remarkable decrease in the product yield (Table 8.7, entries 19 - 20). This finding can be 
explained due to the low solubility of the catalyst. 
Further, a decrease in the catalyst loading to 0.5 mol% also displayed a lower yield of C8ba 
(Table 8.7, entry 18). Therefore, 1.0 mol% 1ZnDy-NO3 in ethanol at room temperature for further 
experiments was subsequently used. 
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Table 8.7. Optimization of the FC alkylation of C8S1 with C8S3 catalysed by 1ZnLn-
NO3.[a] 
 
Entry Catalyst[n] Yield/ %[b] 
1 none 0 
2 Dy(OTf)3 8 
3 Zn(OTf)2 20 
4 1ZnDy-NO3 99 
5 1ZnY-NO3 94 
6 1ZnEu-NO3 55 
7 1ZnGd-NO3 30 
8 1ZnSm-NO3 12 
9 1ZnTb-NO3 24 
10 1ZnDy-NO3 (Toluene) 30 
11 1ZnDy-NO3 (Water) 0 
12 1ZnDy-NO3 (THF) 0 
13 1ZnDy-NO3 (Acetonitrile) 0 
14 1ZnDy-NO3 (DMF) 5 
15 1ZnDy-NO3 (-30 oC) 0 
16 1ZnDy-NO3 (0 oC) 5 
17 1ZnDy-NO3 (60 oC) 30 
18 1ZnDy-NO3 (0.5 mol%) 26 
19 1ZnDy-NO3 (2.5 mol%) 62 
20 1ZnDy-NO3 (5.0 mol%) 17 
[a] Reaction conditions: C8S1 (0.50 mmol), C8S3 (0.50 mmol) in 3 mL of EtOH under 1.0 mol% 
1ZnLn-NO3 complexes, 24 h, in air, stirred. [b] Isolated yield by column chromatography. 
8.2.4.2.2 Scope of reaction  
To explore the scope of the reaction, various nitroalkenes were treated with indole (Table 8.8). In 
the first of these experiments R2 was aromatic (Table 8.8, C8ba - C8bh). Several catalytic systems 
gave slightly lower yields due to the electronic effect of para substitution of the phenyl group of 
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aromatic nitroalkenes. In all these cases, very good yields were obtained, ranging from the 4-
fluoro substrate (C8bd) to 98% for the tolyl substituted compound (C8bb). A slight improvement 
of the yield up to 99% was observed with the use of a heteroaromatic nitroalkene bearing a furan 
substituent (C8bf). The effect of substitution of the indole is also shown in Table 8.8 (C8bg -
C8bo). The substituent at position at 5 of the indole had little effect on the yield except for the 
electron-drawing group (C8bj) (Table 8.8). 
Table 8.8. The scope of the FC alkylation of indoles with various nitrostyrenes catalysed by 
1ZnDy-NO3.[a] 
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[a] Reaction conditions: indoles (0.5 mmol) with nitroalkene (0.5 mmol) in 3 mL of EtOH, 1.0 
mol% of 1ZnDy-NO3. [b] isolated yield by column chromatography. 
The scope of the reaction was further investigated with N-alkylated and 2-methyl indole with 
various nitrostyrenes. The products were isolated in good to excellent yields (Table 8.9). A change 
of the substituent at the nitrogen atom in position 5, and at the 2-position of indole did not show 
any profound effect on the yield of the desired product (99%, Table 8.9). C8bw was characterized 
via single-crystal XRD studies (Figure 8.6). 
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Table 8.9. FC alkylation of N-alkylated and 2-methyl indoles and various nitrostyrenes.[a] 
 
[a] Reaction conditions: indoles (0.3 mmol), nitrostyrenes (0.3 mmol), 3 mL of EtOH, 1.0 mol% 
1ZnDy -NO3 complex. [b] Isolated yield by column chromatography. 
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Figure 8.6. Crystal structure of C8bw. Colour code: C, gold; H, pink; N, pale blue; O, red; Br, 
brown. 
8.2.4.2.3 Mechanistic insights and UV studies  
UV-Vis binding studies were performed to determine whether there was any interaction between 
C8S3 and 1ZnDy-NO3.  
A 0.1 mM water/ethanol solution of C8S3 exhibited a strong absorption at 320 nm. 1ZnDy-NO3 
was added to the solution and the absorption was recorded over 3 h with 5 min intervals between 
measurements. It was observed (Appendix B, Figure S8.38) that the intensities of the peak at 320 
nm gradually decreased. The quenching of the band may be attributed to Van der Waals 
interactions between nitrostyrene and 1ZnDy-NO3. Similar quenching was observed with the 
C8S1 substrate as discussed previously, indicating the binding behaviour of both substrates to 
1ZnDy-NO3. Thus, both substrates can be activated after coordination with the two metal centres 
in 1ZnDy-NO3 which favours the conjugate addition of the nucleophiles.  
Repeat studies were conducted with Zn(OTf)2 and Dy(OTf)3 to determine the preference of each 
substrate for the LnIII or ZnII metal centres. C8S3 shows a greater rate of quenching with Dy(OTf)3 
than Zn(OTf)2, whereas with 1ZnDy-NO3 the rates are similar. This may suggest that C8S3 
preferentially binds to the DyIII centre. The 1ZnDy-NO3 catalyst for both substrates demonstrates 
a greater rate of quenching than either Zn(OTf)2 or Dy(OTf)3, perhaps indicating a stronger 
interaction with the metal centres in tandem.  
Based on the previously discussed results and the crystal structure of 1ZnDy-NO3,336 in which a 
nitrate group chelates to DyIII (C8S3 can be considered as an alternative of nitrate), then a 
plausible mechanism and transition state can be proposed, as shown in Scheme 8.3. It is 
envisioned that the nitroalkenes are activated by chelation to DyIII and π-π stacking between the 
phenyl group of the coordinating ligand L1 and the phenyl group of nitroalkenes.469 In addition, 
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the indole substrate will bond to the ZnII ion through the nitrogen atom and bring the two organic 
moieties efficiently close to favour the formation of the alkylated product.  
 
 
Scheme 8.3. A plausible mechanism for the FC alkylation. 
8.2.4.3 A 1ZnLn-NO3 catalysed PBR reaction  
With the success of the 1ZnLn-NO3 PCC series in the previous two FC alkylation reactions, they 
were applied to a PBR. The reaction between salicylaldehyde (C8S4), indoline (C8S5) and 
boronic acid (C8S6) at room temperature and a catalyst loading of 1.0 mol% was chosen to 
optimise the reaction conditions. 
8.2.4.3.1 Benchmarking and optimisation  
Several reaction parameters, such as the use of solvents (Table 8.10), different catalysts (Table 
8.11), temperature (Table 8.12) and catalyst loading (Table 8.13) were studied. 1ZnY-NO3 and 
1ZnDy-NO3 showed a similar catalytic efficacy at room temperature, therefore solvent screening 
reactions were performed with 1ZnDy-NO3. 
 
DME appears to be the most suitable solvent where almost full conversion is achieved (Table 
8.10, entry 5). The use of THF, toluene or ethanol, provided the anticipated product in 
substantially lower yields (Table 8.10, entries 1 - 4), demonstrating an inhibitory influence on the 
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reaction. Interestingly, the use of DMSO or DMF yielded very low conversions (Table 8.10, 
entries 6 - 7).  
Table 8.10. Influence of the solvent.[a] 
 
Entry Solvent Yield / %[b] 
1 Toluene 34 
2 Water 28 
3 THF 40 
4 Ethanol 80 
5 DME 96 
6 DMSO 12 
7 DMF 14 
[a] Reaction conditions: C8S4 (0.50 mmol), C8S5 (0.50 mmol), C8S6 (0.50 mmol), 5 mL solvent, 
1.0 mol% 1ZnDy-NO3 catalyst, r.t. [b] Isolated yield by column chromatography. 
With the optimised solvent established, the remainder of the ZnII2LnIII2 series (1ZnLn-NO3) were 
tested for their catalytic efficacy. The results are summarized in Table 8.11. C8ca was obtained 
in moderate to excellent yields. A control experiment in the absence of the 3d-4f PCCs catalyst 
showed 40% conversion (Table 8.11, entry 1). Moderate conversions were obtained in the 
presence of DyIII or ZnII salts (Table 8.11, entries 2 - 3).  
Both 1ZnDy-NO3 and 1ZnY-NO3 show higher activity than 1ZnLn-NO3, where Ln = Gd, Eu, 
Yb and Tb (Table 8.11, entries 4 - 9). Therefore, 1ZnDy-NO3 was selected for subsequent 
experiments. Efforts to recover the catalyst after the MCR completion were not successful. 
The influence of the temperature on the catalytic performance was then studied. The reactions 
were carried out at various temperatures ranging from room temperature to 120 °C (Table 8.12, 
entries 1 - 6). At room temperature (Table 8.12) the yield of C8ca was 96%, however, no 
conversion was observed at 0 °C. Lower yields were obtained at 60 °C, 80 °C, 100 °C and 120 
°C (Table 8.12, entries 3 - 6), therefore subsequent reactions were performed at room temperature. 
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Table 8.11. MCR of C8S4, C8S5 and C8S6 catalyzed by 1ZnLn-NO3 complexes.[a] 
 
Entry Catalyst Yield / % 
1 none 40 
2 Zn(OTf)2 56 
3 Dy(OTf)3 36 
4 1ZnY-NO3 74 
5 1ZnEu-NO3 55 
6 1ZnGd-NO3 54 
7 1ZnDy-NO3 96 
8 1ZnTb-NO3 66 
9 1ZnYb-NO3 57 
a] Reaction conditions: C8S4 (0.50 mmol), C8S5 (0.50 mmol), C8S6 (0.50 mmol), 5 mL solvent, 
1.0 mol% 1ZnDy-NO3 catalyst, r.t. [b] Isolated yield by column chromatography. 
Table 8.12. Influence of the temperature.[a] 
 
Entry Temperature/ oC Yield/ % 
1 0 0 
2 r.t 96 
3 60 76 
4 80 72 
5 100 65 
6 120 62 
[a] Reaction conditions: C8S4 (0.50 mmol), C8S5 (0.50 mmol), C8S6 (0.50 mmol), 5 mL solvent, 
1.0 mol% 1ZnDy-NO3 catalyst, r.t. [b] Isolated yield by column chromatography. 
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After optimisation of the reaction conditions, the loadings of catalyst 1ZnDy-NO3 were varied 
(Table 8.13). It was sufficient to use a catalyst loading of 1.0 mol% to obtain a yield up to 96% 
(Table 8.13, entry 3). An increase of the catalyst loading from 1.0 mol% to 5 mol% led to a 
remarkable decrease in the yield of C8ca (Table 8.13, entries 3 - 6). Further, a decrease in the 
catalyst loading to 0.5 mol% lowered the yield of C8ca (Table 8.13, entry 2). In absence of 
catalyst, a 40% conversion is observed (Table 8.13, entry 1). Finally, it was determined that the 
use of 1.0 mol% 1ZnDy-NO3, in DME and at room temperature, were the optimal conditions to 
further explore the scope of the MCR. 
Table 8.13. Influence of catalyst (1ZnDy-NO3) loading.[a] 
 
Entry Catalyst loading / mol% Yield / % 
1 - 40 
2 0.5 57 
3 1.0 96 
4 1.5 70 
5 2.0 40 
6 5.0 24 
[a] Reaction conditions: C8S4 (0.50 mmol), C8S5 (0.50 mmol), C8S6 (0.50 mmol), 5 mL solvent, 
1.0 mol% 1ZnDy-NO3 catalyst, r.t. [b] Isolated yield by column chromatography. 
8.2.4.3.2 Scope of reaction and mechanistic insights  
To demonstrate the applicability of the optimised reaction conditions, different secondary amines, 
aldehydes and boronic acids were employed in this MCR, using 1ZnDy-NO3 as catalyst (Table 
8.14). The reaction proceeds in very good to excellent yields (84 - 98%, C8ca - C8cq) at room 
temperature with a catalyst loading of 1.0 mol%. Compound C8cb was characterized via single-
crystal XRD studies (Figure 8.7).  
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Figure 8.7. Crystal structure of C8cb. Colour code: C, gold; O, red; N, blue; H, pink. 
Very good yields were obtained for the reaction involving indoline as a secondary amine (Table 
8.14), but the reaction with N-methylaniline and N-benzylmethylamine, also gave very good 
yields, 94 and 93%, respectively (Table 8.14). The presence of an electron donating group in the 
para position of boronic acid gives the multicomponent product in very good yields, whereas the 
nature of secondary amine influences the total yield (Table 8.14). Compounds C8cj, C8ck, C8cl 
and C8cm (allyl functional group) were isolated only in moderate yields. Moreover, the MCRs 
between a salicylic aldehyde or o-vanillin, secondary amines and benzene 1, 4-diboronic acid 
afforded products C8cn, C8co, C8cp and C8cq in very good yields (Table 8.14).  
After an extensive literature review, it is believed that this is the first time that benzene 1, 4-
diboronic acid has successfully been involved in the titled reaction. It is worth mentioning that 
the reaction does not progress with the use of primary amines or benzaldehyde indicating the 
importance of the hydroxyl group in the aldehyde to activate the boronic acid.31  
Table 8.14. 1ZnDy-NO3 catalysed MCR of aldehydes, amines and boronic acids. [a+b] 
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[a] Reaction conditions: aldehyde (0.50 mmol), secondary amine (0.50 mmol), boronic acid 
(0.50 mmol), 5 mL solvent, 1.0 mol% 1ZnDy-NO3 catalyst, r.t. [b] Isolated yield by column 
chromatography. 
8.3 Conclusion 
The results presented in this chapter confirm for the first time that ZnII-LnII PCCs may be useful 
as catalysts for FC alkylation and MCR reactions with low catalyst loadings and mild reaction 
conditions. ZnII2LnIII2 defect dicubane PCCs (1ZnLn-NO3) were synthesised and characterised. 
By substituting the 4f elements in the isoskeletal frame and substituting the 3d ion to the 
diamagnetic ZnII, it was possible to confirm the solution stability of these 3d-4f bimetallic species 
via EPR, NMR and ESI-MS studies. This also allowed mechanistic insights into possible reaction 
mechanisms of both MCR and FC reactions. UV-Vis binding studies further support the proposed 
mechanisms and give insights into possible substrate-core interactions. In addition, it was possible 
to tune the 4f ion to optimise efficient conversion to a broad variety of products, with both 1ZnDy-
NO3 and 1ZnY-NO3 found to be the optimal PCC for either MCR or FC reactions. The fine-
tuning of the organic periphery and further extending mechanistic studies of these catalysts will 
be the focus of chapter nine.  
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Chapter 9: Co-operative ZnII2LnIII2 PCC catalysts for a 
diastereoselective Michael addition reaction 
Abstract: Michael Additions (MA) are one of the most well-studied chemical transformations 
in synthetic chemistry. Herein, the synthesis and crystal structures of a library of 3d-4f 
polynuclear coordination clusters (PCCs) formulated [MII2LnIII2(L1)4(solv)X(Z)Y] (LMLn-NO3) 
and a study of their catalytic properties towards a MA reaction are reported. All these PCCs 
combine a hard and a borderline hard/soft Lewis acid within a defect dicubane framework that 
brings the two metals within 3.3 Å. Valuable mechanistic information for the co-operative 
catalytic character can be extracted via 1H NMR, electrospray ionisation mass spectrometry, 
electron paramagnetic resonance, UV-Vis studies and theoretical studies. This chapter 
demonstrates for the first time the successful use of 3d-4f PCCs as efficient and highly 
diastereoselective catalysts in a MA reaction. Density functional theory calculations shed light on 
the possible catalytic mechanism.  
9.1 Introduction 
Chapters seven and eight reported the ease of ambient and high yielding synthesis of a library of 
heterometallic 3d-4f PCCs possessing a rigid defect dicubane topology (Figure 9.1) with the 
general formula [MII2LnIII2(L1)4(solv)X(Z)Y] (1MLn), where M is Co/Ni/Zn, Ln is 
Y/Sm/Eu/Gd/Dy/Tb/Yb, solv is EtOH/CH3CN/DMF, Z = Cl/NO3/ClO4, when Z = Cl, (X = 2, Y 
= 2), Z = NO3 (X = 2, Y = 2) and Z = ClO4 (X = 6, Y = 2). In addition, the solution stability of 
these 3d-4f PCCs and their effectiveness to construct organic building blocks, at room 
temperature and low catalyst 1% loading, in domino (chapter seven) as well FC alkylation, and 
PBR (chapter eight) reactions were presented. Chapter eight also suggested a co-operative effect 
between 3d and 4f metal centres, an observation which is absent in chapter seven.  
ZnO
Dy O
O Zn O
DyO
O
4f
3d
4f
3d
 
Figure 9.1. A pictorial representation of the present catalytic system (LMLn). Colour code: O, 
red.  
This well-defined and crystallographically characterised bimetallic catalytic system, in addition 
to having characterisation handles, brings the two metals in a proximity of 3.3 Å, lower than 
recommended,285 and offers the unique possibility to combine a hard and a borderline hard/soft 
Lewis acid. Therefore, by retaining the hard 4f centre and upon tuning the 3d centre (CoII, NiII, 
CuII, or ZnII, Figure 9.1), valuable mechanistic information can be extracted by correlating product 
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distributions/selectivities vs. metal properties, e.g. CoII and NiII that have a lower preference to O-
atoms in comparison to ZnII and CuII (Pearson table).502 Such information cannot be obtained by 
the use of homometallic polynuclear 3d-3d or 4f-4f catalysts. 
The employment of the previously described 1MLn PCCs in a Michael Addition (MA) reaction 
was considered, as these are one of the most well-studied chemical transformations in synthetic 
chemistry and various catalytic protocols including organocatalysts,503,504 simple salts, and 
complexes505,506 have been developed. Inspired by Shibasaki's pioneering study of a dinuclear 
CuII-SmIII PCC in nitro Mannich reactions,296,297 in which binding of both substrates on both metal 
centres is recommended, and having all the above in mind, it was envisaged that the present library 
of catalysts will co-operatively catalyse a MA reaction.  
The catalytic MA reaction of trans-β-nitrostyrene and 1,3-dimethyl barbituric was identified as 
an ideal system to be studied. Previously this reaction has been tested to elucidate the catalytic 
mechanism of a “molecular prism” and investigate the binding properties to these substrates.507 
The reaction proceeds smoothly and is not very well explored.507–509 There is also no previous 
report into the use of bimetallic 3d-4f PCCs as catalysts in MA reactions.  
Modification of the ligand and metal centres as well as in situ studies of the catalytic reaction with 
UV-Vis, NMR and EPR spectroscopic techniques to gain mechanistic aspects and theoretical 
support are provided.  
9.2 Results and discussion 
9.2.1 Synthetic aspects  
One of the objectives of this chapter is to further optimise the catalytic efficacy of the previously 
described 1MLn catalysts, more specifically the 1ZnLn-NO3 analogues towards the previously 
discussed MA reaction. It was envisioned that by modifying the organic periphery of H2L1, this 
may result in ZnII2LnIII2 PCCs with increased solubility and steric effects, which could lead to 
improved catalytic efficacy.  
With sixteen of the Schiff base ligands described in chapter five and an additional six synthesised 
in this chapter (H2L24 - H2L29), twenty-one novel ZnII2LnIII2 PCCs (LZnY-NO3) with a defect 
dicubane core topology (2,3M4-1) were synthesised according to the following synthetic 
procedure.  
LZnY-NO3 PCCs were synthesized from the one-step reaction of H2LX (Figure 9.2) (0.2 mmol), 
Et3N (0.5 mmol), Zn(NO3)2·6H2O (0.1 mmol) and Ln(NO3)3·x(H2O) (0.1 mmol), in EtOH, under 
reflux for 2 h with very high yields of solid (over 90%). Crystals suitable for single-crystal XRD 
studies were obtained by dissolving solid in DMF followed by VD with Et2O.  
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H H2L1 H2L8 H2L12 H2L2 H2L19 H2L27 H2L24 
CH2-CH=CH2 H2L6 H2L9 H2L13 H2L16 H2L20 H2L28 H2L25 
Br H2L5 H2L11 H2L15 H2L18 H2L22 H2L29 H2L26 
Figure 9.2. The organic ligands (H2LX) used in this chapter. 
9.2.2 Molecular structures  
In chapter five the term “isoskeletal” was introduced to describe PCCs that possess the same 
topology. All PCCs synthesised in this study were isoskeletal and possess a defect dicubane 
topology. The 3d metal is in the centre and the 4f in the wings. The 3d and 4f ions are within a 
proximity of 3.3 Å. Five out of six and six out of eight positions of the 3d and 4f centres are 
occupied by the ligand, respectively. The ligands used in this study display a similar coordination 
environment, aiming always to yield the same 2,3M4-1 motif as to identify the influence of the 
second coordination sphere on the catalysis.  
In total, twenty-one ligands (Figure 9.2) were used, to synthesise the PCCs formulated as 
[MII2LnIII2(LX)4(NO3)2(DMF)2], which were isoskeletal analogues to 1ZnLn-NO3 described in 
chapter eight. All these PCCs were characterised by FT-IR spectra (Appendix B, Figures S9.1-
S9.20), TGA (Appendix B, Figures S9.21-S9.40), EA (chapter 11), ESI-MS (Appendix B, Figure 
S9.41-9.51) and several were characterised via single-crystal XRD studies including LZnY-NO3, 
where L = 2, 6, 8, 9, 12, 13, 22, 24 and 27. Crystallographic representations are given in Figure 
9.3. The crystallographic characterization of 1ZnLn-NO3, where Ln = Y, Sm, Eu, Gd, Dy, Tb 
and Yb, have been reported been previously discussed in chapter eight.  
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22ZnY-NO3     24ZnY-NO3 
 
27ZnY-NO3 
Figure 9.3. The crystal structures of LZnY-NO3, where L = 2, 6, 8, 9, 12, 13, 22, 24 and 27. 
Colour code: ZnII, grey; YIII, light blue; O, red; N, blue; C, white. 
TGAs for compounds 2ZnY - 21ZnY (Appendix B, Figure S9.21-S9.40) display similar 
behaviour. Initially, the PCCs mass decreases slowly up to 280 - 320 oC, this decrease is between 
6 - 13% depending on overall molecule weight. Which corresponds to a loss of the two solvent 
DMF molecules co-ordinated to YIII and ZnII metal centres. Once this temperature is exceeded the 
molecular weight rapidly decreases up to 400 oC, which is indicative of the organic ligands 
decomposing and the overall structure breaking down. This decrease becomes less significant and 
plateaus after 600 oC and with all examples, the remaining mass is unchanging by 800 oC. The 
remaining % mass is between 19 - 25% depending on initial molecular mass and corresponds to 
the remaining metal oxides (ZnO and Y2O3).  
9.2.3 Catalytic testing 
9.2.3.1 Initial studies and benchmarking 
For benchmarking studies, trans-β-nitrostyrene (C9S1) and 1,3-dimethyl barbituric acid (C9S2) 
were selected as reactants to form the MA product C9a, using 1ZnLn-NO3 as the catalyst with a 
2.5 mol% loading in EtOH. 
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The reaction parameters were subsequently optimized with numerous reaction parameters 
including metal salt catalyst (Table 9.1), 1ZnLn-NO3 catalyst (Table 9.2), solvent (Table 9.3), 
temperature (Table 9.4) and modification of the catalysts organic periphery (Table 9.6 and 9.7). 
Firstly, metal salts of ZnII and LnIII were tested with the above reaction procedure, albeit with a 
10 mol% loading. A blank experiment was performed where a low yield was obtained (Table 9.1, 
entry 1), increased reaction time to 24 h did show any additional conversion to C9a. ZnII salts do 
not promote the transformation (Table 9.1, entries 2 - 5), whereas the reactions with LnIII salts 
gave low yields (Table 9.1, entries 7 - 11) in comparison to the blank (Table 9.1). Noticeably, 
nitrate analogues significantly lower the conversion to C9a in comparison to the blank (Table 9.1, 
entries 4 and 8). This indicates a single ZnII or LnIII metal ion may not be sufficient for high 
conversion to the product in this MA reaction. 
Table 9.1. Comparison of efficacy for YIII and ZnII metal salts. 
 
Entry Loading / mol% Metal salt[n] Yield/ %[b] Time/ h 
1 n/a None 40 2 
2 10 Zn(OTf)2 41 2 
3 10 ZnCl2 44 2 
4 10 Zn(NO3)2 Trace 2 
5 10 ZnBr2 43 2 
6 10 Dy(OTf)3 49 2 
7 10 DyCl3 48 2 
8 10 Dy(NO3)3 3 2 
9 10 DyBr3 39 2 
10 10 YCl3 39 2 
11 10 Y(OTf)3 48 2 
12 10 Y(OTf)3 51 24 
[a] C9S1 (0.5 mmol), C9S2(0.5 mmol); solvent (EtOH 10 mL); stirred at r.t.[b] Yields calculated 
via 1H NMR spectroscopy. 
The previously described isoskeletal lanthanide analogues (1ZnLn-NO3) were tested to 
determine which had the highest efficacy of conversion from reactants to C9a. 1ZnLn-NO3, 
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(where Ln is Sm, Eu, Tb and Gd) analogues displayed a comparable performance to 1ZnDy-NO3, 
however, the use of 1ZnY-NO3 and 1ZnYb-NO3 at 2.5 mol% loading afforded the desired 
material in quantitative yield (Table 9.2, entries 8 and 7 respectively). All PCCs significantly 
outcompete the single LnIII or MII salts tested in Table 9.1. Due to the diamagnetic nature of the 
PCC and lower cost of lanthanide salt, 1ZnY-NO3 was chosen for the following optimization 
tests.  
Table 9.2. Optimisation of LnIII ion of 1ZnLn-NO3 catalysts. 
 
Entry Loading / mol% Catalyst Yield/ %[b] Time/min 
1 0 None 35 60 
2 2.5 1ZnSm-NO3 75 15 
3 2.5 1ZnEu-NO3 81 15 
4 2.5 1ZnGd-NO3 89 15 
5 2.5 1ZnTb-NO3 88 15 
6 2.5 1ZnDy-NO3 94 15 
7 2.5 1ZnYb-NO3 quantitative 15 
8 2.5 1ZnY-NO3 quantitative 15 
[a] C9S1 (0.5 mmol), C9S2(0.5 mmol); solvent (EtOH 10 mL); stirred at r.t [b] Yields calculated 
via 1H NMR spectroscopy. 
Next, after screening several solvents (Table 9.3), an ethanol/water (6/4) (Table 9.3, entry 9) 
solvent system was identified to provide the best catalytic yield, however other protic solvents 
also demonstrated a high efficacy. Solvents, where 1ZnY-NO3 had a low solubility, had an 
equally low yield (Table 9.3, entries 2, 3 and 7), suggesting the catalysis may be homogenous. 
Additionally, The use of a mixed EtOH/H2O solution had some advantages from the 
environmental point of view.510 Finally, it was identified that the reactions at room temperature 
yield excellent results (Table 9.4) in comparison with (-5 oC or reflux).  
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Equation 9.1. General catalytic scheme for catalyst optimisation. 
Table 9.3 Optimisation of solvent. 
[a] C9S1 (0.5 mmol), C9S2(0.5 mmol); [b] solvent 10 mL); stirred at r.t for 15 min.). [c] Yields 
calculated via 1H NMR spectroscopy. 
Table 9. 4. Optimisation of temperature. 
Entry T Catalyst Loading /mol%[n] Yield/ %[b] 
1 -5 1ZnY-NO3 2.5 23 
2 0 1ZnY-NO3 2.5 41 
3 15 1ZnY-NO3 2.5 89 
4 r.t 1ZnY-NO3 2.5 quantitative 
5 40 1ZnY-NO3 2.5 97 
6 Reflux 1ZnY-NO3 2.5 95 
[a] C9S1 (0.5 mmol), C9S2(0.5 mmol); EtOH 10 mL); stirred at r.t for 15 min.). [b] Yields 
calculated via 1H NMR spectroscopy. 
The scope of the reaction was then extended and explored (Table 9.5) with 1ZnY-NO3, with 
barbituric acids (Table 9.5, entries 1 - 7), 6-amino-1,3-dimethyluracil (Table 9.5, entries 8 - 14), 
1,3-diethyl-2-thiobarbituric acid (Table 9.5, entries 15 - 21) and a range of nitrostyrenes, 
functionalised with groups at the R3 and R4 positions.  
Entry Catalyst Solvent [b] Yield / % [c] Loading/ mol%[n] 
1 1ZnY-NO3 MeOH 95 2.5 
2 1ZnY-NO3 Water 27 2.5 
3 1ZnY-NO3 DCM trace 2.5 
4 1ZnY-NO3 DMF 98 2.5 
5 1ZnY-NO3 DMSO trace 2.5 
6 1ZnY-NO3 iPrOH 71 2.5 
7 1ZnY-NO3 CHCl3 trace 2.5 
8 1ZnY-NO3 EtOH 99 2.5 
9 1ZnY-NO3 EtOH/H2O quantitative 2.5 
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1ZnY-NO3 affords C9S2 and 6-amino-1,3-dimethyluracil products in very good to quantitative 
yields (Table 9.5, entries 1 - 14), with 1,3-diethyl-2-thiobarbituric acid products slightly lower 
(79 - 81%). This may be due to the lower acidity of the α-C. The structure of compounds C9f, 
C9h and C9l were confirmed by single-crystal XRD studies (Figure 9.4).  
 
C9f        C9h 
 
C9i 
Figure 9.4. Molecular structures of C9f (upper left), C9h (upper right) and C9i (lower). Colour 
code: C, gold; H, pink; O, red; N, pale blue; Cl, green. 
After determining the scope of reaction, the next step was to substitute 1ZnY-NO3 with the 
isoskeletal analogues (2ZnY-NO3 - 29ZnY-NO3) to identify how the altered organic periphery 
of the ligand determines the efficacy of the ZnII2YII2 core in promoting the MA reaction (Table 
9.6 and 9.7). 
 
 
 
174 
 
 
Table 9.5. The scope of the reaction (1ZnY-NO3, 2.5 mol% loading). 
 
Entry Compound R1 R2 R3 R4 X Yield / %[b] Time /min 
1 C9a CH3 O C6H5 H O quantitative 15 
2 C9b CH3 O p-CH3O-C6H4 H O 75 15 
3 C9c CH3 O p-CH3-C6H4 H O 99 15 
4 C9d CH3 O p-Br-C6H4 H O 99 15 
5 C9e CH3 O p-F-C6H4 H O 99 15 
6 C9f CH3 O C6H5 CH3 O 94 15 
7 C9g CH3 O C4H4O H O quantitative 15 
8 C9h CH3 NH2 C6H5 H O quantitative 15 
9 C9i CH3 NH2 p-CH3O-C6H4 H O 95 20 
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10 C9j CH3 NH2 p-CH3-C6H4 H O 80 20 
11 C9k CH3 NH2 p-Br-C6H4 H O quantitative 20 
12 C9l CH3 NH2 p-F-C6H4 H O 96 20 
13 C9m CH3 NH2 C6H5 CH3 O 81 15 
14 C9n CH3 NH2 C4H4O H O 96 15 
15 C9o CH2CH3 O C6H5 H S 81 60 
16 C9p CH2CH3 O p-CH3O-C6H4 H S 80 60 
17 C9q CH2CH3 O p-CH3-C6H4 H S 76 60 
18 C9r CH2CH3 O p-Br-C6H4 H S 79 60 
19 C9s CH2CH3 O p-F-C6H4 H S 80 60 
20 C9t CH2CH3 O C6H5 CH3 S 78 60 
21 C9u CH2CH3 O C4H4O H S 79 60 
[a] barbituric acid (0.5 mmol), nitrostyrene (0.5 mmol), EtOH/H2O 6/4 mL); stirred at r.t. [b] Yields calculated via 1H NMR spectroscopy. 
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Table 9.6. Comparison of efficacy of 1ZnY-NO3-21YZn-NO3 catalysts.  
 
Entry Catalyst Yield /% [b] Entry Catalyst Yield /% [b] 
1 1ZnY-NO3 100 13 19ZnY-NO3 90 
2 6ZnY-NO3 100 14 20ZnY-NO3 86 
3 4ZnY-NO3 76 15 22ZnY -NO3 42 
4 8ZnY-NO3 43 16 27ZnY- NO3 100 
5 9ZnY-NO3 56 17 28ZnY- NO3 100 
6 11ZnY-NO3 56 18 29ZnY- NO3 95 
7 12ZnY-NO3 55 19 24ZnY- NO3 98 
8 13ZnY-NO3 73 20 25ZnY- NO3 100 
9 15ZnY-NO3 59 21 26ZnY -NO3 89 
10 2ZnY-NO3 86    
11 16ZnY-NO3 100    
12 18ZnY-NO3 54    
[a] C9S1 (0.25 mmol), C9S2 (0.25mmol); solvent (EtOH 6 mL: H2O 4 mL); stirred at r.t for 15 min. [b] Yields calculated by 1H NMR spectroscopy.
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The results indicated that 28ZnY-NO3 (R1 = allyl, R2/R3 = t-butyl) affords the highest conversion 
to the product (C9a) (Table 9.6, entry 17). The presence of the allyl groups and t-butyl groups in 
the R1 and R2/R3 (Figure 9.2), generally improved the catalytic efficacy in comparison to Br and 
H analogues, this may be due to an increase in solubility of the PCC leading to more of the active 
species for homogeneous catalysis. Whereas PCCs with Br and NO2 groups significantly 
decreased the yields obtained (Table 9.7, 2ZnY-NO3 - 29ZnY-NO3). The catalyst loading was 
further lowered (Table 9.7), and 28ZnY -NO3 gave excellent yields with a 0.5 mol% loading, a 
five-fold reduction in efficacy.  
Table 9.7. Comparison of efficacy for compounds LZnY-NO3 (where L = 1, 6, 27 and 28) at 
lower loading.  
 
Entry Catalyst Loading / mol%[n] Yield of Product/ %[b] 
1 1ZnY-NO3 1 91 
2 6ZnY- NO3 1 98 
3 27ZnY- NO3 1 100 
4 28ZnY- NO3 1 100 
5 25ZnY- NO3 1 95 
6 27ZnY- NO3 0.5 95 
7 28ZnY- NO3 0.5 99 
[a] C9S1 (0.5 mmol), C9S2 (0.5 mmol); solvent (EtOH 6 mL: H2O 4 mL);; stirred at r.t for 15 
min. [b] Yields calculated via 1H NMR spectroscopy.  
The scope of reaction, with the optimised catalyst (28ZnY-NO3), was further investigated at 0.5 
mol% loading (Figure 9.5). Conversion to the respective products was good, with all conversions 
above 60%. In comparison with the previous results with 1ZnY-NO3 at 2.5 mol% loading, the 
conversion to product was generally similar, with a notable exception where 28ZnY-NO3 
significantly outperformed 1ZnY-NO3 (C9b and C9j).  
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Figure 9.5. A comparative study of the performance of 1ZnY-NO3 and 28ZnY-NO3 for the 
conversion of substrates to products (C9a-C9u). 1ZnY-NO3 (orange), 28ZnY-NO3 (yellow). 
C9S2 (0.25 mmol), C9S1 (0.25 mmol); solvent (EtOH 6 mL: H2O 4 mL); 2.5 mol% loading of 
1ZnY-NO3 and 0.5 mol% loading of 28ZnY-NO3; stirred at r.t for 15 min.) Yields calculated via 
1H NMR spectroscopy. 
9.2.3.2 Mechanistic investigation of LMLn-NO3 catalysts towards the MA reaction.  
To gain further information on the plausible mechanism and to identify the limitations of the 
present 3d-4f PCC catalysts, the following sets of reactions and experimental techniques were 
explored. 
These include the influence of base on reaction, substitution of the 3d ion of MII2LnIII2 (LMLn) 
PCCs, 1H NMR titration of ZnII2LnIII2 PCCs with substrates, EPR in situ binding studies, ESI-MS 
studies of 1ZnLn-NO3 and in situ ESI-MS 1ZnLn-NO3 with substrate studies. DFT studies 
further support the presented mechanism.  
9.2.3.2.1 Base influence. 
Two sets of reactions were performed in presence of base (Table 9.8, entries 2 - 6 (NaOH) and 
entries 7 - 11 (Et3N)), however with both sets of reactions, with an increasing amount of base the 
catalytic conversion to C9a significantly lowered. NaOH had a more detrimental effect per 
equivalent of base to the catalyst. This influence could be attributed to the instability of the 
catalyst when exposed to basic conditions.  
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Table 9.8. Influence of base on the efficacy of 1ZnY-NO3. 
 
Entry (Substrate: base)[c] Time/ min Yield / %[b] 
1 No base 15 quantitative 
2 NaOH 15 
 
3 (1:0.025) 15 83 
4 (1:1) 15 79 
5 (1:2) 15 52 
6 (1:5) 15 33 
7 Et3N 15 
 
8 (1:0.025) 15 91 
9 (1:1) 15 85 
10 (1:2) 15 76 
11 (1:5) 15 61 
[a] C9S1 (0.5 mmol), C9S2 (0.5 mmol); solvent (EtOH 6 mL: H2O 4 mL). [b] Yields calculated via 
1H NMR spectroscopy. 
9.2.3.2.2 Tuning the 3d ion.  
To further determine and understand the role of the bimetallic catalyst the isoskeletal compounds 
1NiDy-NO3, 1CoDy-NO32,50 and 1CuDy-NO3 were tested (Table 9.9). 
[CuII2DyIII2(L1)4(NO3)2]·2MeCN (1CuDy-NO3, Figure 9.6) was synthesised following a 
modified synthetic procedure which is fully described in chapter eleven. Single-crystal XRD 
studies (chapter twelve) show the molecular structure is isoskeletal to the previously described 
1MLn PCCs described in chapters seven, eight and this chapter.  
Interestingly, unlike the previously reported PCCs, solvent (MeCN) molecules do not coordinate 
to the 3d (CuII) ion, instead, the CuII ion adopts a square planar geometry. The PCC was 
characterised by EA (chapter eleven), TGA (Appendix B) and FT-IR spectra (Appendix B). 
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Figure 9.6. The molecular structure of 1CuDy-NO3. Colour code: CuII, dark blue; DyIII, light 
blue; C, black; N, pale blue; O, red. Hydrogen atoms omitted for clarity. 
According to the Pearson table, CuII and ZnII have a higher preference to O atoms, whereas NiII 
and CoII have a higher preference for N atoms. The reactions of 1CuDy-NO3 and 1ZnDy-NO3 
yielded the desired product in very good yields (90%) (Table 9.9, entry 2 and 4 respectively) 
whereas 1NiDy-NO3 and 1CoDy-NO3 displayed a poor efficacy. This may be an indication that 
activation (binding) of both substrates at the same time is required. These results suggest that the 
catalytic action between metals is co-operative and that not only one metal centre is active in the 
transformation of reactants to C9a. 
Table 9.9. Comparison of efficacy for compounds 1MLn-NO3. 
 
Entry Catalyst Yield/ %[b] Time/min 
1 1ZnY-NO3 quantitative 15 
2 1ZnDy-NO3 94 15 
3 1NiDy-NO3 29 15 
4 1CoDy-NO3 34 15 
5 1CuDy-NO3 85 15 
[a] C9S1 (0.5 mmol), C9S2 (0.5 mmol); solvent (EtOH 6 mL: H2O 4 mL; stirred at r.t for 15 min.) 
[b] Yields calculated via 1H NMR spectroscopy. 
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9.2.3.2.3 Simple salts. 
Reactions with ZnII salts do not promote the MA reaction however the use of LnIII salts form the 
desired product in good yields (Table 9.1). This may indicate that the LnIII ion in 1MLn-NO3 is 
essential for catalytic action towards the MA reaction and that the 3d ion is only synergistic (Table 
9.1). 
9.2.3.2.4 Diastereoselectivity tests.  
trans-β-methyl-nitrostyrene (C9S3) instead C9S1 was employed in the reaction with C9S2, 
which gave excellent yields of the expected product (C9f). 1H NMR spectra showed the presence 
of one diastereoisomer (> 20:1 dr).  
Crystallographic determination of the crystalline material C9f, derived after the filtration of the 
reaction in the presence of the catalyst, revealed the formation of the R* R* derivative. The 
influence of the lanthanide radii on the diastereoselectivity of the PCC was then explored, thus 
1ZnLn-NO3, (where Ln is Sm, Eu, Tb, Gd, Dy and Yb) were tested (Table 9.10, entries 1 - 7). 
Slightly different diastereoselectivity behaviour was observed (20:1 for 1ZnY-NO3 to >20:1 for 
1ZnSm-NO3) which can be attributed to the different ionic the radii of the LnIII.  
Subsequently, 1CoDy-NO3 and 1NiDy-NO3 were studied and a similar diastereoselectivity 
behaviour (20:1) was observed, but with significantly lower yields (Table 9.10, entries 8 and 9). 
The use of 1CuDy-NO3 (Table 9.10, entry 10) gave a similar diastereoselectivity and yield to that 
of 1ZnY-NO3.  
To further obtain mechanistic information, the reaction of cis-β-methyl-4-methoxy-nitrostyrene 
(C9S4) with C9S2 and 1ZnY-NO3 as a catalyst was investigated, this yielded product C9v 
(Figure 9.7). The 1H NMR data displays the presence of only one diastereoisomer, while the 
single-crystal XRD characterisation revealed the formation of the S*, S* derivative (Figure 9.8). 
Incorporation of 1ZnLn-NO3, (where Ln is Sm, Eu, Tb, Gd, Dy and Yb), 1CoDy-NO3, 1NiDy-
NO3 and 1CuDy-NO3 as catalysts showed similar dr and conversion behaviour in comparison to 
the trans (Table 9.10, entries 1 and 8 - 10). This data indicates a syn addition. 
 
Figure 9.7. Structure of C9f (left) and C9v (right). 
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Table 9.10. Comparison of efficacy for compounds 1ZnLn-NO3, 1NiDy-NO3, 1CoDy-NO3 and 1CuDy-NO3. 
Entry Catalyst Yield of C9f / %[b] dr [b] (R*, R*/R*, S*) Yield of C9v / %[b] dr [b] (R*, R*/R*, S*) 
1 1ZnY-NO3 quantitative 20:1 96 20:1 
2 1ZnSm-NO3 75 >20:1 69 >20:1 
3 1ZnEu-NO3 81 >20:1 74 >20:1 
4 1ZnGd-NO3 89 >20:1 77 >20:1 
5 1ZnDy-NO3 94 >20:1 89 >20:1 
6 1ZnTb-NO3 88 >20:1 85 >20:1 
7 1ZnYb-NO3 quantitative 20:1 93 20:1 
8 1CoDy-NO3 24 20:1 41 20:1 
9 1NiDy-NO3 19 20:1 30 20:1 
10 1CuDy-NO3 71 20:1 94 20:1 
[a] C9S3 (0.5 mmol), C9S2 (0. 5mmol); solvent (EtOH 6 mL: H2O 4 mL); 1 mol% loading of 1MLn-NO3; stirred at r.t for 15 min.) [b] Yields calculated via 1H 
NMR spectroscopy.
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Figure 9.8. Molecular Structure of C9v. Colour code: C, gold; H, pink; O, red; N, pale blue. 
9.2.3.2.5 1H NMR in situ studies 
To gain insights to how 1MLn-NO3 PCCs interact with substrates, DMF solutions of 1ZnY-NO3 
were titrated with 0.25-10 eq. of Michael acceptor (C9S1 and C9S3) or donors (1,3-
cyclohexanedione or 6-amino-1,3-dimethyluracil) which lead to no significant observable 
changes in the 1H NMR spectra. Dimedone gave no apparent changes for 1ZnY-NO3 but the 
dimedone peaks that were initially twice as broad then narrowed with more equivalents (i.e. 
intermediate-fast exchange). 
C9S2 showed significant differences for both the C9S2 and 1ZnY-NO3 peaks. Evidently binding 
of the individual substrates to the 1ZnY-NO3 is not strong but is no impediment to the catalytic 
activity of the complex. Owing to the difficulty in characterising 1ZnY-NO3 alone in the solution 
state, a more detailed mechanistic was not possible in this investigation. 
9.2.3.2.6 In situ EPR studies.  
As previously demonstrated in chapter eight, the [ZnII2GdIII2(L1)4(NO3)2] core of 1ZnGd-NO3 
was found to give the same EPR signal in solution to the solid state, suggesting the coordination 
environment around the GdIII ion remains unchanged and the core topology is retained.  
To gain further insights into LMLn-NO3 interaction with substrates, the following Q-band EPR 
studies at 15 K of 1ZnGd-NO3 in solution were performed. C9S1 or C9S2, dissolved in EtOH, 
were added to solutions of 1ZnGd-NO3 in ratios (1:1, 20:1 and 40:1). Finally, a mixture of C9S1 
and C9S2, dissolved in EtOH, in a 1:1 ratio, and then added to ethanolic solutions of 1ZnGd-
NO3 in ratios (1:1, 20:1 and 40:1) (Figure 9.9). The experiments in ratios 20:1 and 40:1 were 
performed to mimic the catalytic conversion (100:5 and 100:2.5) conditions and identify the 
stability of the bimetallic system. 
From these studies, it can be concluded that the coordination environment of Gd in 1ZnGd-NO3 
alters (shifted signals) but its coordination number (eight) remains intact in the ratios of 1:1 and 
20:1, with C9S1, C9S2 and C9S1/ C9S2 and in 40:1 for C9S2 and C9S1/ C9S2.
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1ZnGd-NO3 with C9S2 (1:1)  1ZnGd-NO3 with C9S1 (1:1)   1ZnGd-NO3 with C9S1 and C9S2 (1:1) 
 
1ZnGd-NO3 with C9S2 (1:20)  1ZnGd-NO3 with C9S1 (1:20)   1ZnGd-NO3with C9S1 and C9S2 (1:20) 
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       1ZnGd-NO3 with C9S2 (1:40)  1ZnGd-NO3 with C9S1 (1:40)   1ZnGd-NO3 with C9S1 and C9S2(1:40) 
Figure 9.9. In situ EPR studies with C9S1, C9S2 and 1ZnGd-NO3. 
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9.2.3.2.7 UV-Vis studies 
To further understand how the substrates interact with 1MLn-NO3, the reaction between C9S1 
and C9S2 was followed with UV-Vis spectroscopy. Solutions of 1 x 10-5 mmol of C9S1 and C9a 
were (in 9:1 H2O/EtOH solution) recorded initially to determine their maximum absorbance peak 
positions, these were found to be at 320 nm and 347 nm respectively. The absorbance of the 
product (C9a) peak was found to be much weaker than C9S1. C9S2 did not show any absorbance 
in the 250 - 450 nm range.  
A solution of C9S1 (1 x 10-5 mmol in 9:1 H2O/EtOH) was prepared and an equimolar amount of 
C9S2 was added, the uncatalyzed solution was followed for 2 h with measurements at 5 min 
intervals (Appendix B, S9.2). The 320 nm C9S1 peak decreased marginally over the 2 h period 
(0.66 - 0.61), which could be attributed to the conversion of substrate to product, albeit the C9a 
peak was not observable due to the strength of the C9S1 absorbance.  
A similar solution of C9S1 (1 x 10-5 mmol) and 1ZnY-NO3 (1.25 x 10-6 mmol) in 9:1 H2O/EtOH 
was prepared and an equimolar amount of C9S2 was added, the catalysed solution was followed 
for 2 h with measurements at 5 min intervals (Appendix B, S9.3). The 320 nm peak decreased far 
more drastically over the 2 h period than the uncatalyzed solution (0.71 - 0.18). In addition, during 
reaction the 320 nm peak shifts to the 347 nm peak position of the product C9S1, which is 
indicative of product formation. Due to the imposition of both C9S1 and C9a peaks, it was not 
possible to determine the rate of reaction under these conditions.  
9.2.3.2.8 ESI-MS studies of LZnY-NO3 
The identity of the LZnY-NO3 analogues was confirmed by ESI-MS studies. In most cases, two 
peaks (positive-ion mode) were observed in the MS at an m/z which correspond to monocationic 
[ZnII2LnIII2(L1)4(NO3)]+ and the dicationic [ZnII2LnIII2(L1)4(NO3)]2+ fragments.  
The fragments corresponding peak value for each PCC is shown in Table 9.11 and Figures are 
included in Appendix B S9.41 - 9.51. Some of the PCCs had many other peaks, however, these 
correspond to the [ZnII2YIII2(LX)4]2/1+ core with various solvent molecules (MeOH/ H2O) 
associated with the molecule. PCCs whose ligands were modified with Br in the R1 position were 
not soluble enough in MeOH to obtain an ESI-MS spectrum. In all successfully measured 1ZnY-
NO3 PCCs the defect dicubane core is retained when dissolved in solution.  
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Table 9.11. ESI-MS data for LZnY-NO3 PCCs 
 Observed peaks and corresponding fragments 
 [ZnII2YIII2(LX)4(NO3)]2+ [ZnII2YIII2(LX)4(NO3)]1+ 
6Zn-NO3 n/a +(CH3OH)2 1561.1385 
8Zn-NO3 789.0073 n/a 
9Zn-NO3 n/a Multiple species with [ZnII2LnIII2(LX)4]+ 
core 
2Zn-NO3 769.0489 1534.0425 
16Zn-NO3 849.1129 1696.2066 
19Zn-NO3 821.0808 1640.0883 
20Zn-NO3 901.1491 1800.2494 
27Zn-NO3 781.1411 1560.2788 
28Zn-NO3 861.2108 1720.4364 
24Zn-NO3 +(H2O) 710.0302 1336.9400 
25Zn-NO3 749.0456 1500.0715 
9.2.3.2.9 Theoretical studies.  
To complement the practical studies discussed in this chapter and gain further insights into the 
plausible mechanism of the MA reaction of C9S2 acid with trans-nitrostyrenes catalysed by 3d-
4f co-operative catalysts, a series of calculations was performed on possible reaction pathways 
employing DFT methods and monitoring the Natural Atomic Charge (NAC) distribution and the 
nature of the FMOs on both the catalyst and the substrates.  
Barbiturate substrates were selected the C9S2 and 6-amino-1,3-dimethyl barbituric acid and for 
the trans-nitrostyrenes the C9S1, (Z)-(2-nitroprop-1-enyl)benzene and (Z)-1-methoxy-4-(2-
nitroprop-1-enyl)benzene. The thermodynamics of the uncatalyzed MA reactions in aqueous 
solution employing the PBE0/6-311++G(d,p) computational protocol were calculated. The NACs 
calculated by the Natural Bond Orbital (NBO) population analysis scheme and the relevant FMOs 
are shown in Figure 9.10.  
It is well established that the α-carbon of barbituric acid has a reactive hydrogen atom and is quite 
acidic (pKa = 4.01) because of the additional aromatic stabilization of the carbanion. DFT 
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calculations at the PBE0/6-311++G(d,p) level of theory revealed that the keto form of 1,3-
dimethyl barbituric acid in aqueous solution can co-exist in equilibrium with the diketo-enol form, 
which is found at 8.7 kcal mol-1 higher in energy than the triketo form (Figure 9.10). Notice that 
ab initio and DFT calculations on the tautomers of barbituric acid showed that the triketo form is 
found to be the most stable form in the gas phase and in solution, which is in agreement with the 
experimental result.511–515 On the other hand, the aminodiketo form of 6-amino-1,3-dimethyl 
barbituric acid is the most stable form relative to the aminoketo-enol and diketo-ammonium 
forms, which are found 47.0 and 63.6 kcal mol-1 higher in energy. 
 
Figure 9.10. NACs and the relevant FMOs of the triketo and diketo-enol forms of C9S2, the 
aminodiketo, aminoketo-enol and diketo-ammonium forms of 6-amino 1,3-dimethyl barbituric 
acid and the C9S1, (Z)-(2-nitroprop-1-enyl)benzene and (Z)-1-methoxy-4-(2-nitroprop-1-
enyl)benzene calculated at the PBE0/6-311++G(d,p) level of theory in aqueous solutions. 
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According to NBO population analysis, the keto and enolic oxygen atoms of the diketo-enolic 
tautomer acquire higher negative NACs by 0.03 up to 0.06 |e| relative to the corresponding oxygen 
atoms of the triketo tautomer. On the other hand, the α-carbon atom in the enolic tautomer 
acquires less negative NAC by 0.114 |e| relative to the α-carbon atom of the triketo tautomer. In 
the 6-amino 1,3-dimethyl barbiturate substrate the keto oxygen atoms of the acquire higher 
negative NACs by 0.055 up to 0.080 |e| relative to the corresponding oxygen atoms of the triketo 
tautomer of the 1,3-dimethyl barbiturate substrate. Alternatively, the α-carbon atom in the enolic 
tautomer acquires less negative NAC by 0.114 |e| relative to the α-carbon atom of the triketo 
tautomer. In the 6-amino 1,3-dimethyl barbiturate substrate the α-carbon atom acquires less 
negative NAC by 0.12 |e| relative to the α-carbon atom of the triketo tautomer of the 1,3-dimethyl 
barbiturate substrate. 
The Highest Occupied Molecular Orbital (HOMO) in the triketo tautomer is mainly localized on 
the keto oxygen atoms adjacent to the α-carbon atom (64.4% having 2p character), while in the 
diketo-enolic tautomer is mainly localized on the α-carbon atom (44.6% having 2p character) and 
the adjacent keto- oxygen atom (13.5% with 2p character). Both the nature of the HOMOs and 
the negative charge distribution suggest that the triketo form of the 1,3-dimethyl barbiturato 
ligand could be coordinated to a metal centre through the keto- oxygen donor atoms, while the 
diketo-enolic form through the α-carbon atom. Similarly, the nature of HOMO of the 6-amino-
1,3-dimethyl barbiturate substrate supports coordination through the α-carbon atom. 
The uncatalyzed MA reactions of the triketo tautomer of C9S2 to (Z)-(2-nitrovinyl)benzene, (Z)-
(2-nitroprop-1-enyl)benzene and (Z)-1-methoxy-4-(2-nitroprop-1-enyl)benzene are predicted to 
be exothermic by 11.9, 9.9 and 10.9 kcal mol-1 respectively. The exothermicity of the addition of 
the diketo-enol tautomer of 1 C9S2 to (Z)-(2-nitrovinyl)benzene, (Z)-(2-nitroprop-1-
enyl)benzene and (Z)-1-methoxy-4-(2-nitroprop-1-enyl)benzene are 20.7, 18.6 and 19.6 kcal mol-
1 respectively at the PBE0/6-311++G(d,p) level of theory.  
The uncatalyzed MA reactions of the 6-amino-1,3-dimethyl barbiturate substrate to (Z)-(2-
nitrovinyl)benzene, is predicted to be also exothermic by 13.2 kcal mol-1. Considering the nature 
of the Lowest Unoccupied Molecular Orbital (LUMO) of the (Z)-(2-nitrovinyl)benzene, (Z)-(2-
nitroprop-1-enyl)benzene and (Z)-1-methoxy-4-(2-nitroprop-1-enyl)benzene being a π* MO 
mainly localized on the NO2 moiety (51.2%, 57.5% and 56.9%) and on the C(7) unsaturated 
carbon atom (22.8%, 21.4% and 21.8%), the MA reactions under study are FMO controlled 
supported by HOMO-LUMO interactions.  
An alternative plausible reaction pathway involves the nucleophilic attack of the C(2) 
electrophilic centre of the protonated trans-nitrostyrenes, namely C9S1, (Z)-(2-nitroprop-1-
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enyl)benzene and (Z)-1-methoxy-4-(2-nitroprop-1-enyl)benzene and by the nucleophilile 1,3-
dimethyl barbiturate carbanion (Figure 9.11). 
 
Figure 9.11. NACs and relevant FMOs of the 1,3-dimethyl barbiturate carbanion and the 
protonated C9S1, (Z)-1-methoxy-4-(2-nitrovinyl)benzene and (Z)-(2-nitroprop-1-enyl)benzene 
calculated at the PBE0/6-311++G(d,p) level of theory in aqueous solutions. 
The deprotonation of the triketo form of C9S2 to form the 1,3-dimethyl barbiturate carbanion is 
predicted to be endothermic by 45.1 kcal mol-1. Notice a remarkable increase of the negative 
atomic charge of the keto oxygen atoms in the carbanion relative to the corresponding keto oxygen 
atoms of the triketo tautomer. On the other hand, the negative NAC on the deprotonated α-carbon 
atom of the carbanion decreases by 0.04|e|. Interestingly, the HOMO of the nucleophile is 
primarily localized on the deprotonated α-carbon atom (52.3%) and the two adjacent keto oxygen 
atoms (28.9%) being π*-type MOs, while the LUMOs of the protonated C9S1, (Z)-(2-nitroprop-
1-enyl)benzene and (Z)-1-methoxy-4-(2-nitrovinyl)benzene are mainly localized on the 
electrophilic C(2) carbon atom (42.0%; 36.1% and 42.3% respectively) (Figure 9.11).  
It is obvious that the nucleophilic attack at the electrophilic C(2) carbon atom by the carbanion is 
a FMO controlled process, supported by the interaction of the HOMO (nucleophile) with the 
LUMO (electrophile). The nucleophilic attack at the electrophilic C(2) carbon atom of the 
protonated C9S1, (Z)-(2-nitroprop-1-enyl)benzene and (Z)-1-methoxy-4-(2-nitrovinyl)benzene 
by the 1,3-dimethyl barbiturate carbanion are predicted to be strongly exothermic by 61.4, 58.7 
and 49.1 kcal mol-1 respectively. 
To probe the electrophilic/nucleophilic character of the trans-nitrostyrene molecules selected 
electronic descriptors (condensed Fukui function, f-C(7), condensed dual descriptor ΔfC(7), 
proton affinity, PA and chemical potential, μ) were calculated by the PBE0/6-311++G(d,p)/PCM 
computational protocol in order to find out how the electrophilic/nucleophilic character of the 
electrophilic/nucleophilic centres of the trans-nitrostyrenes affect the efficacy of the MA reaction. 
The results are summarized in Table 9.12. 
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Table 9.12. Selected electronic descriptors related to the nucleophilic character of the trans-
nitrostyrene molecules calculated at the PBE0/6-311++G(d,p) level of theory in aqueous 
solutions. 
trans-nitrostyrene Yield /%[a] Yield /%[b] ΔfC(7) f-C(7) PA μ 
C9S1 100 100 0.213( -0.017 130.97 -5.168 
p-Me-Nitrovinylbenzene 88 80 0.226 -0.029 135.74 -5.015 
p-MeO-
Nitrovinylbenzene 
75 80 0.234 -0.037 
140.93 
-4.788 
p-F-Nitrovinylbenzene 99 96 0.214 -0.018 131.90 -5.134 
p-Br-Nitrovinylbenzene 99 100 0.213 -0.023 130.93 -5.132 
[a] For the addition of C9S2. [b] For the addition of 6-amino-1,3-dimethyl barbituric acid. 
Excellent linear relationships (Figure 9.12) are obtained for the yield (%) vs ΔfC(7) and yield (%) 
vs f-C(7) correlations. Good linear relationships are also obtained for the yield (%) vs PA and 
yield (%) vs μ correlations (μ = (εΗΟΜΟ + εLUMO)/2). These correlations show that the nucleophilic 
character of the C(7) carbon atom of the trans-nitrostyrenes affects the efficacy of the MA 
reaction. Upon protonation the C(2) carbon atom in the protonated trans-nitrostyrenes becomes 
an electrophilic centre. The calculated electronic descriptors related to the electrophilic character 
of the C(2) carbon atom in the protonated trans-nitrostyrene molecules are compiled in Tables 
9.13.  
Table 9.13. Selected electronic descriptors related to the electrophilic character of the C(2) carbon 
atom in the protonated trans-nitrostyrene molecules calculated at the PBE0/6-311++G(d,p) level 
of theory in aqueous solutions. 
Protonated trans-nitrostyrenes Yield / %[a] Yield / %[b] f+C(2) f-C(2) QC(2) 
[C6H5CHCH(Me)NO2]+ 100 100 0.306 0.08 0.166 
[p-Me-C6H4CHCH(Me)NO2]+ 99 n/a 0.285 0.081 0.129 
[p-MeO-C6H4CHCH(Me)NO2]+ 75 80 0.424 0.167 0.071 
[p-F-C6H4CHCH(Me)NO2]+ 99 96 0.297 0.083 0.147 
[p-Br-C6H4CHCH(Me)NO2]+ 99 100 0.28 0.123 0.143 
[a] For the addition of C9S2. [b] For the addition of 6-amino-1,3-dimethyl barbituric acid. 
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Figure 9.12. Linear relationships between yield (%) vs ΔfC(7), yield (%) vs f-C(7), yield (%) vs 
PA and yield (%) vs μ correlations calculated at the PBE0/6-311++G(d,p) level of theory in 
aqueous solutions. 
Excellent linear relationships (Figure 9.13) are obtained for the yield (%) vs f-C(2) and yield (%) 
vs QC(2) correlations (f+C(2) is the condensed Fukui function for electrophilic attack). However, 
the poor linear relationship is obtained for the yield (%) vs f-C(2) correlation, since the C(2) 
carbon atom in the protonated trans-nitrostyrene molecules is not susceptible to electrophilic 
attack. 
 
Figure 9.13. Linear relationships between yield (%) vs f-C(2) and yield (%) vs QC(2) correlations 
calculated at the PBE0/6-311++G(d,p) level of theory in aqueous solutions. 
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The above correlations show that the electrophilic character of the C(2) carbon atom would affect 
the efficacy of the MA reaction since it determines the strength of the nucleophilic attack by the 
1,3-dimethyl barbiturate carbanion nucleophile. In summary, the MA reaction should involve 
first a proton transfer from the 1,3-dimethyl barbituric acid to the C(NO2)Me carbon atom, which 
is accompanied by charge density redistribution rendering the C(2) carbon atom electrophilic 
centre that is attacked by the nucleophile 1,3-dimethyl barbiturate carbocation formed. 
To gain insights into the activation of the substrates of the MA reaction catalysed by the bimetallic 
ZnIIYIII catalysts, all possible coordination modes of the substrates to the metal centres of the 
catalysts were explored by means of DFT calculations at the PBE0/Def2-TZVP(Zn,Y) 6-
31G(d,p)(E) (E = main group element) level of theory in aqueous solution using a representative 
catalyst, 12ZnY-NO3.  
Firstly, the NACs on the metal centres of the 12ZnY-NO3 bimetallic catalysts were calculated, 
using their crystal structures in aqueous solution and analysed the MOs for only the representative 
catalyst 12ZnY-NO3. The NACs along with the efficacy for these catalysts are compiled in Table 
9.14, while the 3D plots of FMOs of the representative catalyst 12ZnY-NO3 are shown in the 
Appendix B (S9.6). 
Table 9.14. NACs on the metal centres of 3d-4f ZnY bimetallic catalyst calculated at the 
PBE0/Def2-TZVP(Zn,Y) 6-31G(d,p)(E) (E = main group element) level of theory in aqueous 
solutions. 
Catalyst Yield /% [a] QZn QY 
6ZnY-NO3 100 1.308 1.935 
8ZnY-NO3 43 1.331 1.926 
12ZnY-NO3 55 1.330 1.927 
13ZnY-NO3 73 1.322 1.937 
2ZnY-NO3 86 1.320 1.945 
20ZnY-NO3 86 1.325 1.932 
22ZnY-NO3 42 1.307 1.935 
27ZnY-NO3 100 1.311 1.929 
24ZnY-NO3 98 1.326 1.942 
[a] For the addition of C9S2.  
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A perusal of the FMOs of the 12ZnY-NO3 catalyst reveals that the virtual acceptor FMOs 
(LUMO, LUMO+1, LUMO+2, LUMO+3, etc) are of π*-type located on the ligands. As no 
acceptor orbital is located on the metal centres of the ZnY bimetallic catalyst, coordination of the 
MA substrates to the metal centres supported by the interaction of the acceptor orbitals with the 
donor orbitals (HOMO, HOMO-1, HOMO-2, etc) of the substrates is not feasible. Therefore, the 
substrates interact with the bimetallic catalyst through non-covalent interactions (electrostatic and 
dispersion forces).  
All attempts to optimize the geometry of the 12ZnY-NO3 -barbiturate substrate adducts, with the 
barbiturate substrate approaching the YIII centre failed. In contrast, a local minimum was located 
on the Potential Energy Surface (PES) of a 12ZnY-NO3 barbiturate adduct involving coordination 
of barbiturate to Zn metal atom of the catalyst upon dissociation of the coordinated DMF ligand. 
Notice that the estimated binding energy of DMF to ZnII metal centre is 10.7 kcal mol-1 at the 
PBE0/Def2-TZVP(Zn,Y) 6-31G(d,p)(E) (E = main group element) level of theory in aqueous 
solutions.  
The binding of the barbiturate substrate to ZnII centre is very weak, the estimated binding energy 
found to be 2.8 kcal mol-1, which is indicative of weak non-covalent interactions. The calculated 
distance between the ZnII and the keto O atom of the triketo form of C9S2 was found to be 2.140 
Å. On the other hand, trans-nitro-styrene substrates showed a preference to be coordinated to YIII 
centre of the 12ZnY-NO3 catalyst, via a unidentate coordination mode,469 the estimated binding 
energy is predicted to be 4.3 kcal mol-1 at the PBE0/Def2-TZVP(Zn,Y) 6-31G(d,p)(E) (E = 
main group element) level of theory in aqueous solutions. 
The calculated distance between the Y and the O atom of the unidentate trans-nitro-styrene 
substrate was found to be 2.445 Å. On approaching the trans-nitro-styrene substrate to Zn central 
atom resulted in a local minimum corresponding to a very weak association of the barbiturate 
substrate with the 12ZnY-NO3 catalyst, but the binding energy is marginal (0.2 kcal mol-1).  
The geometry of the adduct formed upon interaction of the trans-nitro-styrene substrate was 
optimised with the Y metal centre of the 12ZnY-NO3 barbiturate adduct. In this adduct the 
barbiturate and trans-nitro-styrene substrates are both coordinated to the Zn and Y metal centres 
of the 12ZnY-NO3 -catalyst respectively. The estimated Zn···O and Y···O bond distances are 
predicted to be 2.135 and 2.454 Å respectively. For this adduct, the estimated binding energy of 
the trans-nitro-styrene-yttrium interaction is 4.1 kcal mol-1. The equilibrium geometries of the 
12ZnY-NO3 barbiturate and 12ZnY-NO3 trans-nitro-styrene adducts optimized at the 
PBE0/Def2-TZVP(Zn,Y) 6-31G(d,p)(E) (E = main group element) level of theory in aqueous 
solutions are given in Appendix B (S9.7). 
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It can be concluded that that the barbiturate and trans-nitro-styrene substrates of the MA reaction 
catalysed by the ZnIIYIII bimetallic catalyst are co-operatively activated through their interaction 
with the ZnII and YIII centres of the catalyst following the proposed mechanism is shown in Figure 
9.14. 
 
Figure 9.14. A proposed mechanism involving the co-operative activation of both the barbiturate 
and trans-nitro-styrene substrates. Colour code: ZnII, green; YIII, pale blue; C, grey; N, blue; O, 
red.  
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In the proposed mechanism, initially, the barbiturate substrate is coordinated to ZnII centre of the 
12ZnY-NO3 catalyst after dissociation of the coordinated DMF solvent molecule followed by the 
coordination of the trans-nitro-styrene substrate to the YIII centre of the catalyst. This could be a 
stepwise process or both substrates are simultaneously coordinated to the metal centres of the 
catalyst.  
The two substrates upon coordination to the metal centres are brought into proximity where a 
proton can be transferred from the a-carbon atom of the barbiturate substrate to the CH(NO2) 
carbon atom of the coordinated trans-nitro-styrene substrate, followed by the nucleophilic attack 
of the electrophilic C (7) carbon atom of the trans-nitro-styrene substrate by the barbiturate 
carbanion releasing the product of the MA reaction. 
 
Figure 9.15. The 3D plot of the RDG of the LZnY-NO3 substrates molecule. 
The diastereoselectivity could be explained by considering the very loose association of the two 
substrates with the catalyst, where their orientation is mainly determined by maximization of the 
non-covalent interactions between the substrates leading always to the formation of R*/ R* or S*/ 
S* enantiomers irrespective of what isomer of the nitro-styrene is used. These non-covalent 
interactions are shown in the 3D plot of the Reduced Density Gradient (RDG) of the catalyst-
substrates molecule (Figure 9.15) 
9.2.3.2.10 In situ-ESI-MS studies  
In situ ESI-MS studies were performed to confirm the dissociation of the tetranuclear core to the 
two dinuclear moieties, on the addition of substrate and to identify any possible adducts.  
Firstly, 1ZnGd-NO3 and C9S2 were dissolved in a 1:1 ratio in MeOH, a peak was observed at 
946.0920 m/z which perfectly corresponds to a [ZnIIGdIII(L1)2(C9S2)(NO3)(H2O)]+ (Appendix 
B, S9.10) fragment, which would support the coordination of C9S2 to a dinuclear species of 
1ZnGd-NO3.  
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Furthermore, a [ZnIIGdIII(L1)2(C9S3)(NO3)(CH3OH)2(H2O)] fragment at 1009.0995 m/z is 
observed when C9S2 is substituted C9S1, indicating that both substrates have the ability to 
coordinate to the dinuclear species (Appendix B, S9.9). 
On addition of both substrates, a peak at 1345.2556 m/z is observed, which may correspond to 
[ZnIIGdIII(L1)2(C9S2)(C9S1)2(NO3)(CH3OH)3] fragment (Appendix B, S9.12). 
9.3 Conclusion 
In summary, this chapter presents a multidisciplinary study that for the first time demonstrates 
the successful use of 3d-4f PCCs as efficient and highly diastereoselective catalysts in a MA 
reaction.  
The synthesis of a library of twenty-one isoskeletal ZnII2YIII2 PCCs (LZnY-NO3) with a modified 
organic periphery, demonstrated that the modification of the ligand sterics does not compromise 
the electrostatic properties of the catalyst. By tuning the metal centres, it was possible to obtain 
useful mechanistic information and reveal the co-operative character of the proposed catalytic 
system, through the use of a pallet of spectroscopic techniques.  
 
Finally, by altering the structural character of the 1MLn-NO3 catalysts it was possible to tune the 
PCCs to maximise efficacy. DFT calculations throw light on the possible mechanism of the MA 
reaction catalyzed by the 1MLn-NO3 catalysts. Such information cannot be obtained by the use 
of homometallic polynuclear 3d-3d, 4f-4f catalysts or organocatalysts. The successful 
employment of this library of co-operative catalysts paves the way to expand this approach to 
other 3d-4f PCCs and catalytic reactions.  
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Chapter 10: Summary and conclusions 
This chapter summarizes the thesis, discusses its findings and contributions, points out limitations 
of the current work and also outlines directions for potential future research. 
This thesis aimed to investigate two main ideas: 
1) to use structurally related Schiff base ligands to synthesise novel high nuclearity 3d-4f 
PCCs that display interesting magnetic and luminescent behaviour. 
 
2) to develop the first tetranuclear 3d-4f PCCs, supported by Schiff base ligands, used as 
catalysts in organic transformations and to understand and manipulate their structure to 
maximise catalytic efficacy.  
A summary of the main findings of the thesis are presented below. 
10.1 Summary 
The attempts to synthesise novel high nuclearity 3d-4f PCCs with structurally similar 
compartmental Schiff base ligands (H2L1-H2L5), through a systematic variation of the reaction 
conditions, formed a wealth of 3d-4f PCCs with novel structures and topologies. 
Herein, the first examples of the 2,3,4M6-1 core topology in ZnII-LnIII chemistry, the first 
examples of CoII4LnIII2 PCCs which display the 2,3,4M6-1 core topology and the first examples 
of NiII-LnIII PCCs with a 3,6M7-1 core topology are reported. Perhaps most importantly, the first 
examples of the 1,2,3,4,5,5,5,8M15-1 topology in PCC chemistry are also described. However, 
the limitations of the methodology are evident as the synthesis of PCCs with the 2,3,4M6-1 and 
1,2,3,4,5,5,5,8M15-1 core topologies could not be predicted and ZnII4DyIII7 (13) and ZnII6DyIII4 
(14) PCCs could only be identified by single-crystal XRD studies and were not isolated 
independently.  
Though a myriad of novel structures with new topologies were formed, only a few have been 
confirmed to display SMM behaviour. Of the reported PCCs in this thesis, only ZnII4DyIII2 (7), 
CoII4DyIII2 (17) and ZnII4DyIII11 (43) were shown to display a slow relaxation of magnetisation. 
The Ueff and τ0 of these PCCs are 10.2 cm-1, τ0 = 7.1·10-6 s; 13.4 K, τ0 = 8.5×10-7 s and 4.7 K, τ0 = 
4.4.10-5 s respectively. Previously, higher nuclearity 3d-4f Schiff base supported PCC SMMs, 
with similar 3d metal ions (CuII, NiII, ZnII, CoII) display enhanced SMM properties when 
compared to the examples described herein., with Ueff values ranging from 3 K – 85 K and τ0 
values between 1 x 10-9 s to 5.5 x 10-3 s.56,103,318,516 
Furthermore, low nuclearity 3d-4f Schiff base supported PCC SMMs have been reported which 
display comparable SMM properties to the larger examples.170,517–520 Therefore, synthesising high 
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nuclearity 3d-4f PCCs may be a counter-intuitive route to SMM behaviour. Moreover, structurally 
simple monometallic complexes have been reported with greatly enhanced SMM properties all 
of which surpass the values observed in 3d-4f PCC chemistry.174,521–524 The synthetic control over 
the symmetry of the lanthanide coordination site, and therefore over magnetic axial field, gives 
rise to these exceptional properties. This degree of synthetic control has not yet been demonstrated 
with 3d-4f PCCs and the synthetic protocols employed in this study are far from this level. 
The development of the first tetranuclear 3d-4f PCC catalysts has been detailed and in comparison 
to the previously reported 3d-4f PCC catalysts, which were prepared in situ,296–299 these are 
characterised in both the solid and solution state with a wide range of techniques. This thesis has 
demonstrated the range of catalytic reactions that they can be successfully employed in which 
include FC alkylations, a MA reaction, a PBR and a domino ring-opening cyclization. The 
optimised catalytic protocols provides mild conditions, reduced catalytic loading and high 
catalytic efficacies which improves on many of the previously reported procedures. 412,422,427–
430,451,457–461,465,466,498,499 
The synthesis of the series of isoskeletal defect dicubane MII2LnIII2 PCC catalysts did not prove 
straightforward and many variables determined the structure of the targeted PCC (chapter five). 
Chapter seven demonstrated that the catalytic conditions could alter the structure of the catalyst 
(transformation from 1NiDy-ClO4 to 1NiDy-Cl), the targeted substitution of LnIII ions could 
result in a myriad of by-products (1NiSm-A, B, C) and that certain PCCs could not reliably 
crystallise (1NiLn-Cl). Furthermore, the substitution of the NiII/CoII ion to ZnII, in chapter eight, 
required a significant adaption of the synthetic procedure. However, with the insights from these 
chapters, a reliable synthetic protocol was developed to synthesise a library of isoskeletal 
ZnII2LnIII2 (LZnLn-NO3) PCCs with modified Schiff base ligands (H2LX).  
The ratio of reactants (MII: LnIII: H2LX: Et3N) is the most important variable for reliably 
synthesising MII2LnIII2 PCCs, with the NiII/CoII2LnIII2 ratio, 1:1:2:5, and the CuII/ZnII2LnIII2 ratio, 
1:2:2:4.5, the most successful. Other synthetic variables such as solvent or metal salt can be 
carefully altered depending on the desired structure of the targeted tetranuclear PCC. Whereas 
long reaction times, mixed or non-polar solvents and high temperatures either led to significant 
impurities or formation of undesired species. The crystallisation of the MII2LnIII2 PCCs from 
DMF/Et2O via VD was the most successful method of isolating MII2LnIII2 PCCs, with well-defined 
crystals forming without impurities co-crystallising.  
With the MII2LnIII2 PCCs the catalytic effects of the substitution of 3d and 4f ions within the 
framework, the replacement of modified Schiff base ligands and altered coordination 
environments were studied. With these insights and a range of characterisation techniques (ESI-
MS, UV-Vis, EPR, 1H NMR) and DFT studies, the coordination of substrates to either 3d or 4f 
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metal centres was rationalised and the co-operative nature of the 3d-4f PCC catalysts was 
confirmed, an effect which had not previously fully studied. 
10.2 Discussion 
It is felt the most significant contribution of this thesis to the already existing literature is the 
development and methodology for studying the MII2LnIII2 Schiff base ligand framework for 
catalytic reactions. With this framework, it was possible to tune the PCCs to obtain the highest 
possible catalytic efficacy and manipulate the magnetic character of the PCC so that both the 
framework and mechanistic aspects could be studied with EPR and NMR spectroscopy. While 
the magnetic character of a 3d-4f PCC framework has been previously altered to study SMM and 
magnetic coupling interactions, this has never been studied in 3d/4f/ligand in situ organic 
transformations. This thesis emphasises that 3d-4f PCCs offer a unique opportunity for the study 
of catalytic reactions, due to their exploitable dual nature and the number of structural aspects 
which can be tuned. The adaption of this methodology to pre-existing or newly synthesised 3d-4f 
PCCs provides a new avenue for the continued development of 3d-4f PCCs, in general, and 
specifically to catalyse organic transformations.  
Synthetic methods. Two broad synthetic methodologies have been employed. The first, 
serendipitous assembly, has led to the discovery of novel 3d-4f PCCs with an array of interesting 
properties. However, none of these structures could be predicted and required a large number of 
reactions and subsequent crystallisation procedures to synthesise them. This is a highly time-
consuming process which could be partially avoided by employing rational/ targeted design.  
Secondly, the targeted synthesis of defect dicubane 3d-4f PCCs, based on the CoII2DyIII2 PCC 
reported by Powell,2 resulted in a series of catalytically active PCCs with tunable properties. This 
work shows that this approach is far more applicable for the study of catalytic behaviour and 
correlating magnetic behaviour in PCC cores, whereas serendipitous assembly should only be 
applied as the initial stage for the discovery of new 3d-4f PCCs.  
Even so, it is very difficult to predict the nuclearity or the core topology of a 3d-4f PCC with 
either method. Nevertheless, with a move away from serendipitous assembly and towards 
rational/targeted design, a deeper understanding of the relationships between synthesis, structure 
and physical properties will be developed.  
Topological implications. The topological approach employed throughout this thesis has 
identified similarities between the core structures of 3d-4f PCCs within the thesis and in the 
literature. Though some relationships between ligand structure and core topology are identified it 
could not be used to predict the synthesis of compounds with specific properties. Additionally, 
the NDk-m notation does not discriminate between O, N, S and P donors which are assigned as 
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linkers. The type of donor will significantly affect the coupling between 3d/3d, 4f/4f and 3d/4f 
ions which will influence the magnetic properties.  
While this approach has been useful for the identification of related core motifs (such as the 
diabolo in chapter six), it is not yet developed enough to rationally predict the synthesis of 3d-4f 
PCCs with specific properties and relating the existing properties of 3d-4f PCCs to their core 
motif is tenuous at best.  
Ligand selection – high nuclearity 3d-4f PCCs. The ligands used for the synthesis of high 
nuclearity 3d-4f PCCs (H2L1, H2L2, H3L3 and HL4) did not manage to generate a 3d-4f PCC 
whose core nuclearity was greater than seven. The common structure of these ligands contains 
three identical pockets for the selective binding of 3d and 4f ions and are structurally rigid. In 
addition, co ligands were not introduced into the reactions. These factors may have restricted the 
growth of larger 3d-4f PCCs due to the limited number of coordination and bridging modes of the 
ligands.  
The use of structurally flexible Schiff bases and co-ligands, which have extensive bridging modes, 
has resulted in some of the highest nuclearity 3d-4f PCCs such as those reported by Milios,205 
Li525 and Powell119 which resulted in ZnII12DyIII18, CoII2DyIII10 and CuII9DyIII2 PCCs respectively. 
Considering these examples and the results obtained, more flexible Schiff base ligands which 
retain the salicylaldehyde or o-vanillin moieties should be used for future studies and combined 
with co-ligands such as azides, acetates and carboxylic acids.  
Ligand selection – catalysis. The use of H2L1 and the modified (H2LX) ligands for the synthesis 
of catalytically active defect dicubane 3d-4f PCCs proved very successful. These ligands could 
reliably synthesise isoskeletal MII2LnIII2 PCCs which host a variety of guest 3d and 4f ions. 
However, the ligands reported by Shibasaki may have provided a better starting point for this type 
of research, as the system is already known and partially defined. In addition, the previously 
reported in situ 3d-4f / Schiff base catalytic systems all demonstrate their potential efficacy in 
catalysing enantioselective transformations.296–299 Although unexpected diastereoselectivity was 
observed in the MII2LnIII2 series for the MA catalysis (chapter nine), it was not possible to develop 
an enantioselective 3d-4f tetranuclear PCC catalyst, which is a noticeable omission from this 
work.  
Though these ligands reliably synthesised the targeted MII2LnIII2 PCCs, the use of a tetranuclear 
PCC over the previously reported dinuclear examples presented many challenges. It is 
recommended that 3d-4f catalysis is further explored with low nuclearity 3d-4f PCCs, with metal 
ions held within a single Schiff base ligand frame, before extending these studies to more complex 
examples. Though as an initial foray into the area of 3d-4f PCC catalysis, the development of the 
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catalytic system was much more successful than initially anticipated and provides a solid 
foundation for future work. 
Ligand Modification- The modified ligands (H2LX) allowed a wide range of MII2LnIII2 PCCs 
with modified organic peripheries to be studied. However, ligand modification had little or no 
impact on the efficacy of the studied catalytic reactions, instead changes in efficacy were due to 
the solubility of the respective PCC. Though it is disappointing that ligand modification does not 
change the efficacy, considering some of the limitations 3d-4f PCC catalysts have which include 
their poor solubility, lack of enantioselectivity and limited recoverability, this opens new 
perspectives for 3d-4f PCC catalysis. With the astute selection of modified ligand, these 
limitations could be overcome without altering the underlying effectiveness of the MII2LnIII2 core. 
This discovery was unexpected, however, it uncovers a new feature in 3d-4f PCC catalysis one 
which may lead to applications which have not yet been considered and with this toolkit of 
modification methods a 3d-4f PCC may be tailored for a variety of catalytic procedures. 
Characterisation – solid state. The combination of characterisation methods for materials in the 
solid state in this thesis is consistent with the characterisation described in 3d-4f PCC literature. 
Single-crystal XRD studies are unparalleled in determining the molecular structure of crystalline 
materials and without it, much of the subject matter in this thesis would be indiscernible. The 
combination of this technique with other characterisation methods which measure the bulk 
material (CHN, FT-IR and TGA) ensure that the structure of these materials is as reported.  
Characterisation – solution state. The measurement of MII2LnIII2 PCCs in the solution state 
proved much more difficult. For previously reported in situ 3d/4f / Schiff base catalytic reactions 
ESI-MS was used to confirm the formation of the proposed 3d-4f PCC, however many of these 
spectra displayed several peaks which corresponded to 3d-4f and homometallic 3d fragments. 
Using the same technique but with defect dicubane 3d-4f PCCs structure determined in the solid 
state, only peaks identified as the [MII2LnIII2(LX)4] core were observed. This observation 
emphasises the importance of ensuring the purity of 3d-4f PCCs and questions the previously 
reported results.  
EPR and 1H NMR studies were employed to confirm the structure of the series in solution, by 
substitution of the 3d and 4f ion. The characterisation of the 3d-4f PCC structure and substrate 
interaction in this way is unique and offers a completely new way of analysing 3d-4f PCCs in 
solution. However, these methods have their limitations and several issues must be overcome for 
these methods to become commonplace.  
Impact. The effort to synthesise novel 3d-4f PCCs from Schiff base ligands has expanded upon 
the many reported examples where a serendipitous approach has resulted in 3d-4f PCCs with 
novel topologies and interesting magnetic behaviour. Though the compounds in these chapters do 
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not display outstanding SMM or luminescent properties, many contain structural motifs and core 
configurations which have not been observed before in 3d-4f PCC chemistry. Although the 
selection of organic ligands and co-ligands could have been more astute, it is believed with the 
synthetic approach employed the outcome of this research has fulfilled the original criteria, helped 
to further explore topological relationships between 3d-4f PCCs, as well as to further develop the 
topological approach. 
Impact. The demonstration that 3d-4f PCCs can be used as catalysts for organic transformations 
opens a new pathway in 3d-4f PCC chemistry. Currently, the drive to synthesise new 3d-4f PCCs 
is dominated by investigating the SMM properties that they display. While the work by Shibasaki 
and others,296 did demonstrate that the combination of 3d and 4f ions with Schiff base ligands can 
successfully catalyse asymmetric organic transformations, there was little evidence that the active 
species was a 3d-4f PCC. With the methodology employed in this thesis, it is certain that a 3d-4f 
PCC is successfully catalysing the organic transformations studied. The demonstration of this 
behaviour may generate a new impetus for the synthesis of catalytically active 3d-4f PCCs 
following the methodology employed in this thesis. It is hoped that this avenue of research helps 
to further broaden the field of 3d-4f PCC chemistry and a new generation of 3d-4f PCC catalysts 
will be developed. 
10.3 Future work 
Rational design is essential for the targeting of 3d-4f PCCs with specific properties, however there 
are few reported examples of targeting the same core topology with specific ligand cavities. 
Previously, H2L10.1 (Figure 10.1) has been used to synthesise 3d-4f PCCs with nonanuclear 
[MII6LnIII3(OH)6] cores,189,526,527 where DyIII analogues all display SMM behaviour. The H2L10.1 
ligand has coordination pockets which are similar to the ligands shown in Figure 10.1. 
The aim of this study would be to determine whether, with the same reaction conditions, if 
substituting Schiff base ligands (Figure 10.1) with the same coordination pockets would allow for 
the targeting of [CuII6LnIII3(OH)6] cores. Which would demonstrate that ligands with specific 
pockets can be applied to reliably form a desired core topology. 
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Figure 10.1. Schiff base ligands for targeting [CuII6LnIII3(OH)6] PCCs. 
As enantioselectivity was one of the most significant omissions from the studied MII2LnIII2 PCCs 
behaviour, further efforts to study this system should concentrate on this. To develop an 
enantioselective 3d-4f PCC catalyst based on the isoskeletal defect dicubane PCC described 
herein, it may be possible to employ chiral Schiff base ligands which are structurally similar to 
H2L1, with the same coordination pockets but with bulkier functional groups added.  
However, the ligands used in Shibasaki’s work may provide a better starting point. Instead of 
following an in situ protocol, synthetic inspiration taken from this thesis could be applied to fully 
characterise the dinuclear species, substitute MII and LnIII ions and to use a pallet of spectroscopic 
techniques to probe the asymmetric organic transformations. Some potential organic 
transformations that these catalysts could be applied in include the MA addition discussed in 
chapter nine or the oxa Michael reaction between 2-acyl-imidazole with indoles. This new 
generation of catalysts may also be applicable in the multicomponent synthetic strategy that is 
currently gaining a lot of interest from research industrially and in academia. 
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Chapter 11: Synthetic part 
11.1 General methods 
Materials. Chemicals (reagent grade) were purchased from Sigma Aldrich and Alfa Aesar. All 
experiments were performed under aerobic conditions using materials and solvents as received.  
Instrumentation. 1H and 13C NMR spectra were recorded on a Varian VNMRS solution-state 
spectrometer at 500 MHz at 30 °C using a residual isotopic solvent (DMSO, δH = 2.50 ppm) as 
an internal reference. Chemical shifts are quoted in ppm. Coupling constants (J) are recorded in 
Hz.  
FT-IR spectra of the samples were recorded over the range of 4000-650 cm-1 on a Perkin Elmer 
Spectrum One FT-IR spectrometer fitted with a UATR polarization accessory.  
ESI-MS data were obtained on a VG Autospec Fissions instrument (EI at 70 eV).  
TGAs weres performed on a TA Instruments Q-50 model (TA, Surrey, UK) under nitrogen and 
at a scan rate of 10 °C/min.  
All steady-state UV−Vis absorbance measurements (University of Kent) were made by use of a 
Shimadzu UV-1800 UV−Vis spectrophotometer in DMF as indicated with quartz cuvettes, while 
all steady-state solution fluorescence emission measurements were carried out using a Cary 
Eclipse fluorescence spectrometer in either acetonitrile or DMF as indicated with quartz cuvettes. 
Crystallography. Data was obtained either at the University of Sussex by use of an Agilent 
Xcalibur Eos Gemini Ultra diﬀractometer with CCD plate detector under a ﬂow of nitrogen gas 
at 173(2) K using Mo Kα radiation (λ = 0.71073 Å). CRYSALIS CCD or RED software programs 
were used, respectively, for data collection and processing. Reﬂection intensities were corrected 
for absorption by the multiscan method. Other data was collected at the UK National 
Crystallography Service, University of Southampton, on a Rigaku Saturn 724+ area detector 
mounted at the window of an FR-E+ rotating anode generator with a Mo anode (λ = 0.71075 Å) 
under a ﬂow of nitrogen gas at 100(2) K. The X-ray data was collected and processed using 
Rigaku CrystalClear or where Rigaku Oxford Diﬀraction CrystallisPro was used for data 
processing. Crystal structures were solved by dual-space methods with SHELXT or using charge 
ﬂipping methods with Superﬂip. All crystal structures were then reﬁned on Fo2 by full-matrix 
least-squares reﬁnements using SHELXL. All non-H atoms were reﬁned with anisotropic thermal 
parameters, and H atoms were introduced at calculated positions and allowed to ride on their 
carrier atoms. Geometric/crystallographic calculations were performed using PLATON, Olex2 
and WINGX packages; graphics were prepared with Crystal Maker.  
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Magnetic Studies. Chapter 2, 3, 4 and 6- Variable-temperature magnetic studies were made by 
use of an MPMS-5 Quantum Design magnetometer operating at 0.03 T in the 300 2.0 K range. 
Magnetization measurements were made under a magnetic field range of 0 − 5 T. Diamagnetic 
corrections were applied to the observed paramagnetic susceptibility using Pascal’s constants. 
Chapter 4 - Heat capacity measurements were carried out by using a Quantum Design PPMS 
system, equipped with a 3He cryostat. The experiments were performed on a thinly pressed pellet 
(ca. 1 mg) of a polycrystalline sample, thermalized by ca. 0.2 mg of Apiezon N grease, whose 
contribution was subtracted by using a phenomenological expression. 
Continuous wave EPR measurements. Chapter 8 and 9-The continuous wave EPR spectra were 
recorded on a Bruker EMX spectrometer operating at X-band with a microwave frequency of ~ 
9.4 GHz. The microwave frequency and magnetic field were measured using the Bruker internal 
frequency counter and field controller, respectively. To avoid a saturation of signals, an optimized 
microwave power of 0.8 and 1 mW (23 and 24 dB) was applied for all measurements. Modulation 
amplitude of 2 – 4 G was applied to prevent an artificial signal broadening, combined with a fixed 
modulation frequency of 100 KHz applying a receiver gain of 3.2 × 103 depending upon the 
signal-to-noise ratio. The Bruker SHQE (ER 4122) resonator was used for measurements at 
variable temperatures. The applied magnetic field was calibrated using a Bruker standard sample 
with a well-known g-value, and all the measurements were performed at 3400 G.  
Computational details. Chapter 5 and 7- Energy minimization on strategically designed model 
compounds were conducted within the Kohn-Sham DFT approach at the B3LYP/SDD and 
B3LYP/6-311G* levels.528–538 Calculations were carried using the Gaussian09 software. The Jmol 
program was used for visualization purposes.  
Chapter 9 - All DFT calculations were performed using the Gaussian09, D.01 program suite. The 
geometry of all organic molecules and of representative ZnY dinuclear complexes were fully 
optimized, employing the Perdew, Burke and Ernzerhof,539–545 PBE0 (also called PBE1PBE) 
hybrid density functional. Calculations on the organic molecules are performed by the PBE0/6-
311++G(d,p) computational protocol, while for the ZnY dinuclear complexes the PBE0/Def2-
TZVP(Zn,Y) 6-31G(d,p)(E) (E = main group element) computational protocol was used. 
Notice the use of the Def2-TZVP basis set546 for Zn and Y. The stationary points were identified 
as local minima by the absence of imaginary frequencies (NImag = 0). Water solvent effects were 
taken into account employing the polarizable continuum model (PCM) using the integral equation 
formalism variant (IEFPCM) being the default self-consistent reaction field (SCRF) method.547 
The NBO population analysis was performed using Weinhold’s methodology as implemented in 
the NBO 6.0 software.548,549 
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11.2 Ligand synthesis 
Supporting Figures for 1H NMR spectra, 13C NMR spectra and ESI-MS are found in Appendix 
B. 
Preparation of H2L1 
O-vanillin (0.025mol, 3.35g) and 2-amino-phenol (0.025mol, 2.73g) were dissolved in MeOH (5 
mL). The suspension was refluxed for 1 h, during which time a bright orange solid precipitated. 
After cooling to room temperature, the solid was filtered off and washed with cold MeOH and 
Et2O. The solid was dried in vacuo. Yield 95%. 1H NMR (500 MHz, DMSO-d6) δ 9.75 – 9.71 (m, 
1H), 8.95 (s, 1H), 7.36 (dd, J = 8.0, 1.6 Hz, 1H), 7.21 – 6.99 (m, 3H), 6.96 (dd, J = 8.1, 1.4 Hz, 
1H), 6.91 – 6.81 (m, 2H), 3.80 (s, 3H). 13C NMR (126 MHz, DMSO) δ 162.01, 152.27, 151.42, 
148.63, 134.95, 128.46, 124.26, 120.05, 119.96, 119.70, 118.37, 116.97, 115.71, 56.34, 40.62, 
40.53, 40.45, 40.36, 40.28, 40.19, 40.11, 40.03, 39.95, 39.86, 39.69, 39.53. 
Preparation of H2L2 
o-vanillin (0.025 mol, 3.35 g) and 3-amino-2-napthol (0.025 mol, 3.98 g) were dissolved in 
MeOH (5 mL). The suspension was refluxed for 1 h, during which time a bright orange solid 
precipitated. After cooling to room temperature, the solid was filtered off and washed with cold 
MeOH and Et2O. The solid was dried in vacuo. Yield 88 %. 1H NMR (500 MHz, DMSO-d6) δ 
13.78 (s, 0H), 10.12 (s, 0H), 9.07 (s, 1H), 7.85 – 7.77 (m, 2H), 7.69 (d, J = 8.2 Hz, 1H), 7.41 – 
7.34 (m, 1H), 7.33 – 7.22 (m, 3H), 7.12 (dd, J = 8.0, 1.3 Hz, 1H), 6.89 (t, J = 7.9 Hz, 1H), 3.83 
(s, 3H); 13C NMR (126 MHz, DMSO-d6) δ 163.49 , 152.35 , 150.36 , 128.07 , 126.38 , 126.17 , 
124.37 , 123.85 , 118.60 , 117.52 , 116.06 , 110.42 , 56.38 , 40.56 , 40.31 (d, J = 20.9 Hz), 40.06  
Preparation of H3L3 
o-vanillin (0.025 mol, 3.35 g) and 1,3-diamino-2-propanol (0.025 mol, 2.73 g) were dissolved in 
MeOH (50 mL). The suspension was refluxed for 1 h, during which time the solution became a 
bright yellow. The solution was reduced under pressure to form a yellow oil. The oil was treated 
with hot toluene (20 mL) and stirred. Upon treatment, a bright yellow precipitate formed and was 
filtered and washed with cold MeOH (15 mL) and Et2O (3 x 15 mL). The solid was dried in vacuo. 
Yield 96 %. 1H NMR (500 MHz, chloroform-d) δ 8.37 (d, J = 1.5 Hz, 2H), 6.94 – 6.84 (m, 4H), 
6.79 (tt, J = 7.9, 0.9 Hz, 2H), 4.24 (h, J = 4.8, 4.3 Hz, 1H), 3.93 – 3.82 (m, 8H), 3.75 (dd, J = 
12.5, 6.3 Hz, 2H), 2.78 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 167.40, 152.08, 148.48, 145.81, 
123.20, 118.42, 118.00, 117.73, 114.35, 77.28, 77.03, 76.77, 70.29, 62.42, 56.10, -0.04. 
Preparation of H2L16 
5-bromo-3-methoxy salilcyldahyde (0.025 mol, 4.666 g) and 2-amino-phenol (0.025mol, 2.73 g) 
were dissolved in MeOH (5 mL). The suspension was refluxed for 1 h, during which time a red 
solid precipitated. After cooling to room temperature, the solid was filtered off and washed with 
208 
 
 
Et2O and dried in vacuo. Yield 84 %. 1H NMR (500 MHz, DMSO-d6) δ 9.85 (s, 1H), 8.94 (d, J = 
1.7 Hz, 1H), 7.42 – 7.34 (m, 2H), 7.18 – 7.10 (m, 2H), 6.96 (dd, J = 8.0, 1.5 Hz, 1H), 6.88 (t, J = 
7.6 Hz, 1H), 3.82 (s, 3H), 2.49 (s, 1H); 13C NMR (126 MHz, DMSO d6) δ 160.11, 152.85, 151.42, 
150.09, 133.98, 128.85, 125.58, 120.42, 120.10, 119.68, 117.71, 117.01, 108.62, 56.64, 40.62, 
40.53, 40.45, 40.36, 40.28, 40.20, 40.11, 40.03, 39.95, 39.86, 39.70, 39.53. 
Preparation of HL4 
o-vanillin (0.025 mol) and 4-aminoantipyrine (0.025 mol) were refluxed in MeOH (20 mL) to 
form a clear bright yellow solution. The solution was reduced under pressure to form a viscous 
yellow oil. The oil was recrystallized from toluene to form a bright yellow powder the powder 
was collected via filtration and washed with MeOH (20 mL x 2) and Et2O (15 ml) before being 
dried over night. (Yield 74 %) 1H NMR (500 MHz, chloroform-d) δ 9.81 (s, 1H), 7.52 – 7.44 (m, 
2H), 7.41 – 7.29 (m, 3H), 6.98 (dd, J = 7.9, 1.7 Hz, 1H), 6.91 (dd, J = 8.0, 1.7 Hz, 1H), 6.83 (td, 
J = 7.9, 1.3 Hz, 1H), 3.92 (d, J = 1.3 Hz, 3H), 3.16 (d, J = 1.2 Hz, 3H), 2.40 (d, J = 1.3 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 160.41, 160.19, 150.42, 149.89, 148.08, 134.32, 129.28, 127.31, 
124.66, 123.58, 120.15, 118.47, 117.73, 115.97, 113.60, 77.33, 77.07, 76.82, 56.06, 35.57, 28.60, 
10.10, -0.02. {338.15 m/z} M+ 
Preparation of H2L6 
2-hydroxy-3-methoxy-5-allyl-benzaldehyde (0.025 mol, 4.81 g) and 2-aminophenol (0.025 mol, 
2.73 g) were dissolved in MeOH (5 mL). The suspension was refluxed for 1 h, during which time 
a bright red solid precipitated. After cooling to room temperature, the solid was filtered off and 
washed with cold MeOH and Et2O. The solid was dried in vacuo. Yield 70 %. 1H NMR (500 
MHz, chloroform-d ) δ 13.80 (s, 1H), 9.71 (s, 1H), 8.90 (s, 1H), 7.38 – 7.32 (m, 1H), 7.14 – 7.07 
(m, 1H), 7.01 – 6.83 (m, 4H), 6.04 – 5.92 (m, 1H), 5.14 – 5.03 (m, 2H), 3.79 (d, J = 1.2 Hz, 3H), 
3.35 – 3.28 (m, 3H). 13C NMR (126 MHz, DMSO d6) δ 192.25, 149.64, 148.79, 145.41, 142.08, 
137.90, 133.24, 131.18, 122.66, 120.71, 119.51, 118.56, 116.44, 113.68, 111.69, 56.56, 40.61, 
40.52, 40.44, 40.35, 40.27, 40.19, 40.11, 40.02, 39.94, 39.85, 39.68, 39.52, 39.19. 
Preparation of H2L7 
2-hydroxy-3-methoxy-5-nitro benzaldehyde (0.025 mol, 3.853 g) and 2-amino-phenol (0.025 
mol, 2.73 g) were dissolved in MeOH (5 mL). The suspension was refluxed for 1 h, during which 
time a clay brown solid precipitated. After cooling to room temperature, the solid was filtered off 
and washed with cold MeOH and Et2O. The solid was dried in vacuo. Yield 93%. 1H NMR (500 
MHz, DMSO-d6) δ 15.63 (d, J = 10.3 Hz, 1H), 10.68 (s, 1H), 9.33 (d, J = 9.1 Hz, 1H), 8.25 (d, J 
= 2.6 Hz, 1H), 7.70 (d, J = 8.1 Hz, 1H), 7.47 (d, J = 2.7 Hz, 1H), 7.22 (t, J = 7.4 Hz, 1H), 7.11 – 
6.86 (m, 2H), 3.83 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 171.05, 158.90, 151.81, 149.73, 
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134.62, 129.63, 127.09, 125.03, 120.44, 118.44, 116.92, 113.36, 106.48, 56.17, 40.61, 40.52, 
40.44, 40.35, 40.28, 40.19, 40.11, 40.02, 39.94, 39.85, 39.69, 39.52. 
Preparation of H2L8 
o-vanillin (0.025 mol, 3.35 g) and 2-amino-5-nitrophenol (0.025 mol, 3.30 g) were dissolved in 
MeOH (5 mL). The suspension was refluxed for 1 h, during which time a dark brown to red solid 
separated. After cooling to room temperature, the solid was filtered off and washed with cold 
MeOH and Et2O. The solid was dried in vacuo. Yield 66%. 1H NMR (500 MHz, DMSO-d6) δ 
13.18 (s, 1H), 10.72 (s, 1H), 9.01 (s, 1H), 7.77 (dd, J = 8.4, 1.7 Hz, 2H), 7.57 – 7.51 (m, 1H), 7.26 
(dd, J = 7.9, 1.5 Hz, 1H), 7.15 (dd, J = 8.0, 1.5 Hz, 1H), 6.90 (t, J = 7.9 Hz, 1H), 3.82 (s, 3H). 
Preparation of H2L9 
5-allyl-2 hydroxy-3-methoxy benzaldehyde (0.0125 mol, 2.290 g) and 2-amino-5-nitrophenol 
(0.0125 mol, 1.926 g) were dissolved in MeOH (5 mL). The suspension was refluxed for 1 h, 
during which time the dark brown solution had formed a dark red precipitate. After cooling to 
room temperature, the solid was filtered off and washed with cold MeOH and Et2O. The solid 
was dried in vacuo. Yield 72%. 1H NMR (500 MHz, DMSO-d6) δ 12.94 (s, 1H), 10.69 (s, 1H), 
8.97 (s, 1H), 7.79 – 7.73 (m, 2H), 7.56 – 7.50 (m, 1H), 7.07 (d, J = 1.9 Hz, 1H), 6.98 (d, J = 2.1 
Hz, 1H), 5.98 (ddt, J = 16.7, 9.7, 6.6 Hz, 1H), 5.15 – 5.04 (m, 2H), 3.81 (s, 3H), 3.37 – 3.31 (m, 
2H). 
Preparation of H2L10 
2-hydroxy-3-methoxy-5-nitro benzaldehyde (0.025 mol, 3.853 g) and 2-amino-5-nitrophenol 
(0.025 mol, 4.923 g) were dissolved in MeOH (5 mL). The suspension was refluxed for 1 h, 
during which time the orange solution had formed a deep orange precipitate. After cooling to 
room temperature, the solid was filtered off and washed with cold MeOH and Et2O. The solid 
was dried in vacuo. Yield 95.69%. 1H NMR (500 MHz, DMSO-d6) δ 13.79 (s, 1H), 9.71 (s, 1H), 
8.90 (s, 1H), 7.35 (d, J = 7.8 Hz, 1H), 7.11 (t, J = 7.8 Hz, 1H), 7.01 – 6.83 (m, 4H), 6.04 – 5.92 
(m, 1H), 5.14 – 5.03 (m, 2H), 3.79 (d, J = 1.3 Hz, 3H); 13C NMR (126 MHz, DMSO-d6) δ 189.82, 
149.55, 145.99, 142.88, 122.04, 118.73, 116.25, 111.63, 110.78, 109.12, 57.28, 40.61, 40.52, 
40.44, 40.35, 40.27, 40.18, 40.10, 40.02, 39.94, 39.85, 39.68, 39.51. 
Preparation of H2L11 
5-bromo-3-methoxy salilyldahyde (0.0125 mol, 2.333 g) and 2-amino-5-nitrophenol (0.0125 mol, 
1.926 g) were dissolved in MeOH (5 mL). The suspension was refluxed for 1 h, during which 
time the orange solution had formed a red precipitate. After cooling to room temperature, the solid 
was filtered off and washed with cold MeOH and Et2O. The solid was dried in vacuo. Yield 79%. 
1H NMR (500 MHz, DMSO-d6) δ 13.16 (s, 1H), 10.76 (s, 1H), 8.98 (s, 1H), 7.81 – 7.73 (m, 2H), 
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7.55 – 7.47 (m, 2H), 7.25 (d, J = 2.3 Hz, 1H), 3.85 (s, 3H);13C NMR (126 MHz, DMSO-d6) δ 
190.35, 150.67, 150.30, 145.99, 142.89, 121.73, 120.18, 118.73, 111.63, 110.89, 109.12, 57.07, 
40.53, 40.45, 40.36, 40.29, 40.19, 40.12, 40.03, 39.95, 39.86, 39.69, 39.53. 
Preparation of H2L12 
o-vanillin (0.01 mol, 1.541 g) and 2-amino-4-chloro-5-nitro phenol (0.01 mol, 1.541 g) were 
suspended in MeOH (5 mL). The suspension was refluxed for 1 h, during which time the dark 
brown solution had formed a grey precipitate. After cooling to room temperature, the solid was 
filtered off and washed with cold MeOH and Et2O. The solid was dried in vacuo. Yield 76%. 1H 
NMR (500 MHz, DMSO-d6) δ 12.95 (s, 1H), 10.89 (s, 1H), 9.02 (s, 1H), 7.72 (s, 1H), 7.59 (s, 
1H), 7.25 (dd, J = 7.9, 1.5 Hz, 1H), 7.16 (dd, J = 8.0, 1.5 Hz, 1H), 6.92 (t, J = 7.9 Hz, 1H), 3.82 
(s, 3H), 2.49 (s, 3H); 13C NMR (126 MHz, DMSO-d6) δ 192.46, 142.07, 122.97, 120.62, 119.65, 
119.11, 118.10, 113.68, 111.69, 109.99, 56.57, 56.42, 40.62, 40.53, 40.45, 40.36, 40.29, 40.20, 
40.12, 40.03, 39.96, 39.86, 39.69, 39.53. 
Preparation of H2L13 
2-hydroxy-3-methoxy-5-allyl-benzaldehyde (0.025 mol, 4.81 g) and 2-amino-4-chloro-5-nitro 
phenol (0.025 mol, 4.71 g) were dissolved in MeOH (4 mL). The suspension was refluxed for 1 
h, during which time a cream brown solid precipitated. After cooling to room temperature, the 
solid was filtered off and washed with Et2O and dried in vacuo. Yield 70%. 1H NMR (500 MHz, 
DMSO-d6) δ 12.70 (s, 1H), 10.86 (s, 1H), 8.97 (s, 1H), 7.71 (s, 1H), 7.59 (s, 1H), 7.06 (d, J = 2.0 
Hz, 1H), 6.99 (d, J = 2.0 Hz, 1H), 5.98 (ddt, J = 16.7, 9.8, 6.6 Hz, 1H), 5.15 – 5.04 (m, 2H), 3.81 
(s, 3H), 3.34 (d, J = 6.6 Hz, 2H); 13C NMR (126 MHz, DMSO-d6) δ 192.25, 149.64, 148.79, 
145.41, 142.08, 137.90, 133.24, 131.18, 122.66, 120.71, 119.51, 118.56, 116.44, 113.68, 111.69, 
56.56, 40.61, 40.52, 40.44, 40.35, 40.27, 40.19, 40.11, 40.02, 39.94, 39.85, 39.68, 39.52, 39.19. 
Preparation of H2L14 
2-hydroxy-3-methoxy-5-nitro benzaldehyde (0.025 mol, 3.853 g) and 2-amino-4-chloro-5-nitro 
phenol (0.025 mol, 4.71 g) were dissolved in MeOH (4 mL). The suspension was refluxed for 1 
h, during which time dark brow solid precipitated. After cooling to room temperature, the solid 
was filtered off and washed with Et2O and dried in vacuo. Yield 80%. 1H NMR (500 MHz, 
DMSO-d6 ) δ 12.70 (s, 1H), 10.86 (s, 1H), 8.97 (s, 1H), 7.71 (s, 1H), 7.59 (s, 1H), 7.06 (d, J = 2.0 
Hz, 1H), 6.99 (d, J = 2.0 Hz, 1H), 5.98 (ddt, J = 16.7, 9.8, 6.6 Hz, 1H), 5.15 – 5.04 (m, 2H), 3.81 
(s, 3H), 3.34 (d, J = 6.6 Hz, 2H). 
Preparation of H2L15 
5-bromo-3-methoxy saliyladehyde (0.0072 mol, 1.650 g) and 2-amino-4-chloro-5-nitro phenol 
were dissolved in MeOH (4 mL). The suspension as refluxed for 1 h, during which time orange-
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red solid precipitated. After cooling to room temperature, the solid was filtered off and washed 
with Et2O and dried in vacuo. Yield 35 %. 1H NMR (500 MHz, DMSO-d6) δ 12.85 – 12.80 (m, 
2H), 10.91 (s, 2H), 8.97 (d, J = 1.4 Hz, 2H), 7.69 (d, J = 1.6 Hz, 2H), 7.59 (s, 2H), 7.48 (d, J = 
2.2 Hz, 2H), 7.27 (d, J = 2.2 Hz, 2H), 3.85 (s, 6H), 3.29 (s, 2H), 3.19 – 3.14 (m, 1H); 13C NMR 
(126 MHz, DMSO-d6) δ 190.35, 164.19, 150.67, 150.30, 145.41, 142.07, 125.41, 124.07, 122.71, 
121.73, 120.71, 120.17, 118.70, 113.68, 113.63, 111.69, 110.89, 57.06, 56.80, 40.62, 40.53, 
40.45, 40.36, 40.28, 40.19, 40.12, 40.03, 39.94, 39.86, 39.69, 39.52. 
Preparation of H2L16 
2-hydroxy-3-methoxy-5-allyl-benzaldehyde (0.025 mol, 4,81 g) and 3-amino-2-napthol (0.025 
mol, 3.98 g) were dissolved in MeOH (5 mL). The suspension was refluxed for 1 h, during which 
time a dark red solid precipitated. After cooling to room temperature, the solid was filtered off 
and washed with cold MeOH and Et2O. The solid was dried in vacuo. Yield 61%. 1H NMR (500 
MHz, Chloroform-d) δ 10.96 (s, 0H), 9.89 (d, J = 0.9 Hz, 0H), 8.80 (s, 1H), 7.77 (d, J = 8.2 Hz, 
1H), 7.72 (d, J = 8.3 Hz, 1H), 7.55 (s, 1H), 7.47 – 7.30 (m, 4H), 7.23 (s, 0H), 7.02 – 6.92 (m, 2H), 
6.88 (d, J = 1.6 Hz, 1H), 6.06 – 5.92 (m, 2H), 5.18 – 5.08 (m, 3H), 3.93 (d, J = 7.8 Hz, 4H), 3.39 
(dd, J = 7.0, 5.0 Hz, 3H). 
Preparation of H2L18 
5-bromo-3-methoxy salilcyldahyde (0.025 mol, 4.666 g) and 3-amino-2-napthol (0.025 mol, 3.98 
g) were dissolved in MeOH (5 mL). The suspension was refluxed for 1 h, during which time a 
dark red solid precipitated. After cooling to room temperature, the solid was filtered off and 
washed with cold MeOH and Et2O. The solid was dried in vacuo. Yield 79%. 1H NMR (500 MHz, 
DMSO-d6) δ 13.90 (s, 1H), 10.14 (s, 1H), 9.06 (s, 1H), 7.86 – 7.77 (m, 2H), 7.70 (d, J = 8.2 Hz, 
1H), 7.50 – 7.45 (m, 1H), 7.39 (t, J = 7.5 Hz, 1H), 7.34 – 7.26 (m, 2H), 7.21 (dd, J = 2.2, 1.1 Hz, 
1H), 3.85 (s, 3H); 13C NMR (126 MHz, DMSO-d6) δ 161.63, 128.11, 126.55 , 126.23 , 125.63 , 
123.98 , 118.06 , 117.46 , 56.71 , 40.55 , 40.30 (d, J = 21.0 Hz). 
Preparation of H2L19 
o-vanillin (0.025 mol, 3.35 g) and 2-amino-5-phenylphenol (0.025 mol,4.63 g) were dissolved in 
MeOH (5 mL). The suspension was refluxed for 1 h, during which time a dark orange solid 
precipitated. After cooling to room temperature, the solid was filtered off and washed with cold 
MeOH and Et2O. The solid was dried in vacuo. Yield 91%. 1H NMR (500 MHz, DMSO-d6) δ 
9.92 (s, 1H), 9.10 (d, J = 2.0 Hz, 1H), 7.72 – 7.65 (m, 3H), 7.50 – 7.27 (m, 4H), 7.21 (dt, J = 7.8, 
1.4 Hz, 1H), 7.12 – 7.02 (m, 2H), 6.87 (tt, J = 7.8, 1.3 Hz, 1H), 3.84 – 3.80 (m, 3H), 3.17 (s, 1H), 
-1.96 (s, 0H); 13C NMR (126 MHz, DMSO-d6) δ 162.56 , 152.41 , 151.14 , 140.22 , 135.32 , 
129.22 , 127.17 , 126.64 (d, J = 9.2 Hz), 124.37 , 119.77 , 118.39 , 118.05 , 117.39 , 115.83 , 
56.37 , 40.55 , 40.38 , 40.21 , 40.05 . 
212 
 
 
Preparation of H2L20 
2-hydroxy-3-methoxy-5-allyl-benzaldehyde (0.025 mol, 4.8 1g) and 2-amino-5-phenylphenol 
(0.025 mol, 4.63 g) were dissolved in MeOH (5 mL). The suspension was refluxed for 1 h, during 
which time a dark orange solid precipitated. After cooling to room temperature, the solid was 
filtered off and washed with cold MeOH and Et2O. The solid was dried in vacuo. Yield 69%. 1H 
NMR (500 MHz, Chloroform-d) δ 10.96 (s, 0H), 8.76 (s, 1H), 7.61 – 7.51 (m, 2H), 7.49 – 7.41 
(m, 2H), 7.40 – 7.30 (m, 2H), 7.27 (s, 1H), 7.12 (d, J = 8.3 Hz, 1H), 7.02 – 6.94 (m, 1H), 6.89 
(dd, J = 21.8, 1.9 Hz, 2H), 5.99 (ddt, J = 17.4, 9.2, 6.7 Hz, 1H), 5.13 (ddq, J = 12.9, 4.1, 1.9 Hz, 
2H), 3.93 (d, J = 6.5 Hz, 3H), 3.39 (d, J = 6.6 Hz, 2H). 
Preparation of H2L22 
5-bromo-3-methoxy salilcyldahyde (0.025 mol, 4.666 g) and 2-amino-5-phenylphenol (0.025 
mol, 4.63 g) were dissolved in MeOH (5 mL). The suspension was refluxed for 1 h, during which 
time a dark orange solid precipitated. After cooling to room temperature, the solid was filtered 
off and washed with cold MeOH and Et2O. The solid was dried in vacuo. Yield 83%. 1H NMR 
(500 MHz, DMSO-d6) δ 10.03 (s, 1H), 9.10 (s, 1H), 7.74 – 7.65 (m, 3H), 7.50 – 7.39 (m, 4H), 
7.35 – 7.27 (m, 1H), 7.18 (d, J = 2.3 Hz, 1H), 7.06 (d, J = 8.4 Hz, 1H), 4.07 (p, J = 5.1, 4.3 Hz, 
1H), 3.84 (s, 3H), 3.20 – 3.15 (m, 2H); 13C NMR (126 MHz, DMSO-d6) δ 160.71 , 152.98 , 151.11 
, 150.14 , 140.11 , 134.39 , 132.31 , 129.24 , 127.24 , 126.97 , 126.65 , 125.73 , 120.46 , 117.82 , 
117.45 , 56.67 , 40.46 (d, J = 21.1 Hz), 40.21 . 
Preparation of H2L23 – Only synthesised in situ 
Preparation of H2L24 
o-vanillin (6.5 mmol, 1 g) and 2-amino-3-hydroxy-pyridine (6.5 mmol,0.72 g) were refluxed in 
MeOH (25 mL) for 2 h. The cloudy orange solution was filtered and the bright orange precipitate 
collected. The precipitate was washed with cold MeOH (15 mL x 3) and Et2O (15 mL x 3). The 
solid was dried in vacuo. Yield 81%. 1H NMR (500 MHz, Chloroform-d) δ 9.45 (s, 1H), 8.09 – 
8.04 (m, 1H), 7.39 (s, 1H), 7.22 – 7.13 (m, 2H), 7.03 (d, J = 7.9 Hz, 1H), 6.90 (t, J = 7.9 Hz, 1H), 
3.94 (s, 3H), 1.29 – 1.24 (m, 0H). 
Preparation of H2L25 
5-allyl-2-hydroxy-3-methoxy-benzaldehyde (5.2 mmol, 1 g) and 2-amino-3-hydroxy-pyridine 
(5.2 mmol, 0.57 g) were refluxed in MeOH (25 mL) for 2 h. The cloudy orange solution was 
filtered and the bright orange precipitate collected. The precipitate was washed with cold MeOH 
(15 mL x 3) and Et2O (15 mL x 3). The solid was dried in vacuo. Yield 81%. 1H NMR (500 MHz, 
Chloroform-d) δ 9.25 (s, 1H), 7.95 (s, 1H), 7.37 (s, 1H), 7.27 (d, J = 1.1 Hz, 1H), 7.12 (s, 1H), 
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6.88 – 6.84 (m, 1H), 6.76 (s, 1H), 5.97 (dq, J = 16.4, 7.2 Hz, 1H), 5.16 – 5.08 (m, 2H), 3.91 – 
3.81 (m, 19H), 3.36 – 3.30 (m, 2H). 
Preparation of H2L26 
5-bromo-2-hydroxy-3-methoxy-benzaldehyde (4.3 mmol, 1 g) and 2-amino-3-hydroxy-pyridine 
(4.3 mmol, 0.47 g) were refluxed in MeOH (25 mL) for 2 h. The cloudy orange solution was 
filtered and the bright orange precipitate collected. The precipitate was washed with cold MeOH 
(15 mL x 3) and Et2O (15 mL x 3). The solid was dried in vacuo. Yield 81%.  
Preparation of H2L27 
o-vanillin (6.5 mmol, 1 g) and 4-tert-butyl-2-amino-phenol (6.5 mmol, 1.07 g) were refluxed in 
MeOH (25 mL) for 2 h. The cloudy orange solution was filtered and the bright orange precipitate 
collected. The precipitate was washed with cold MeOH (15 mL x 3) and Et2O (15 mL x 3). The 
solid was dried in vacuo. Yield 71%. 1H NMR (500 MHz, Chloroform-d) δ 13.08 (s, 1H), 8.67 
(s, 1H), 7.27 – 7.21 (m, 1H), 7.16 (d, J = 2.3 Hz, 1H), 7.07 – 6.95 (m, 3H), 6.88 (t, J = 7.8 Hz, 
1H), 3.89 (s, 3H), 1.35 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 162.47, 151.69, 148.59, 147.64, 
143.97, 134.38, 125.70, 123.92, 119.24, 118.69, 115.72, 115.16, 115.10, 77.32, 77.06, 76.81, 
56.15, 34.36, 31.52. 
Preparation of H2L28 
5-allyl-2-hydroxy-3-methoxy-benzaldehyde (5.2 mmol, 1 g) and 4-tert-butyl-2-amino-phenol 
(5.2 mmol, 0.86 g) were refluxed in MeOH (25 mL) for 2 h. The cloudy orange solution was 
filtered and the bright orange precipitate collected. The precipitate was washed with cold MeOH 
(15 mL x 3) and Et2O (15 mL x 3). The solid was dried in vacuo Yield 81%. 1H NMR (500 MHz, 
Chloroform-d) δ 8.66 (s, 1H), 7.25 (dd, J = 8.5, 2.3 Hz, 1H), 7.15 (d, J = 2.2 Hz, 1H), 6.97 (d, J 
= 8.5 Hz, 1H), 6.90 (d, J = 1.8 Hz, 1H), 6.86 – 6.82 (m, 1H), 5.99 (ddt, J = 17.6, 9.6, 6.6 Hz, 1H), 
5.17 – 5.09 (m, 2H), 3.91 (s, 3H), 3.38 (d, J = 6.5 Hz, 2H), 1.34 (s, 8H), 1.26 (s, 1H). 13C NMR 
(126 MHz, CDCl3) δ 162.79, 149.52, 148.40, 147.62, 144.01, 137.20, 134.69, 130.60, 125.68, 
123.27, 119.00, 116.09, 115.92, 115.54, 115.07, 109.99, 77.28, 77.02, 76.77, 56.21, 39.58, 34.36, 
31.52. 
Preparation of H2L29 
5-bromo-2-hydroxy-3-methoxy-benzaldehyde (4.3 mmol, 1 g) and 4--tert-butyl -2-amino-phenol 
(4.3 mmol, 0.71 g) were refluxed in MeOH (25 mL) for 2 h. The cloudy orange solution was 
filtered and the bright orange precipitate collected. The precipitate was washed with cold MeOH 
(15 mL x 3) and Et2O (15 mL x 3). The solid was dried in vacuo. Yield 86%. 1H NMR (500 MHz, 
Chloroform-d) δ 12.95 (s, 1H), 8.62 (s, 1H), 7.27 (d, J = 4.0 Hz, 1H), 7.22 (s, 1H), 7.17 – 7.13 
(m, 1H), 7.07 (s, 1H), 6.97 (s, 1H), 5.90 (s, 1H), 3.93 (s, 3H), 1.63 (s, 2H), 1.34 (s, 9H). 
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11.3 Synthetic protocols for PCCs 
Supporting Figures for TGA, FT-IR and ESI-MS are found in Appendix B. 
Preparation of [ZnII2LnIII2(L1)4(EtOH)4](ClO4)2 (1-3)  
To a solution of H2L1 (48.2 mg, 0.2 mmol) in EtOH (20 mL), Zn(ClO4)2·6H2O (74 mg, 0.2 mmol) 
and Ln(OTf)3 (61 mg, 0.1 mmol) were added and the resultant solution was stirred for 5 min, Et3N 
(62 µL, 0.45 mmol) was added and the mixture was stirred for a further 1 h. The resulting cloudy 
yellow solution was filtered and allowed to stand at room temperature. After 4 days, small yellow 
crystals were obtained with yields in the range of 52% based on Zn. For 1, CHN 
[ZnII2DyIII2(L1)4(EtOH)6](ClO4)2 observed: C-43.19%, H-4.06%, N-2.79%; expected: C-43.08%, 
H-4.26%, N-2.96%. For 2 CHN [ZnII2TbIII2(L1)4(EtOH)6](ClO4)2 observed: C-43.21%, H-4.44%, 
N-3.04%; expected: C-43.30%, H-4.28%, N-2.97%. For 3 CHN [ZnII2EuIII2(L1)4(EtOH)6](ClO4)2 
observed: C-43.53%, H-4.26%, N-2.92%; expected: C-43.59%, H-4.31%, N-2.99%. 
Preparation of [ZnII5LnIII(L1)6(OH)(H2O)] (4-6) 
To a solution of H2L1 (48.2 mg, 0.2 mmol) in MeCN (20 mL), LnCl3·xH2O (37 mg, 0.1 mmol) 
and ZnCl2 (27.2 mg, 0.2 mmol) were added and the mixture was stirred for 5 min, Et3N (62 µL, 
0.45 mmol) was added and the mixture stirred for a further 1 h. The resulting cloudy yellow 
solution was filtered and allow to stand at room temperature. After 3 days, small yellow crystals 
were collected with yields in the range of 67% based on Zn. CHN for (4) [ZnII5DyIII(L1)6(OH) 
(H2O)] observed: C-51.32%, H-3.41%, N-4.19%; expected C-51.29%, H-3.53%, N-4.27%. For 5 
[ZnII5TbIII(L1)6(OH)(H2O)] observed: C-51.41%, H-3.50%, N-4.35%; expected C-51.29%, H-
3.53%, N-4.27%. For 6 [ZnII5EuIII(L1)6(OH)(H2O)] observed: C-51.45%, H-3.60%, N-4.14%; 
expected C-51.58%, H-3.55%, N-4.29%. 
Preparation of [ZnII4LnIII2(OH)2(L2)4(OAc)2(NO3)2(DMF)3]·DMF (7-9) 
To a solution of H2L2 (52 mg, 0.2 mmol) in DMF (10 mL), Ln(NO3)3·5H2O (44 mg, 0.1 mmol), 
Zn(CH3CO2)2·4H2O (45 mg, 0.2 mmol) and Et3N (62 µL, 0.45 mmol) were added and the solution 
was stirred for 1h. The clear yellow solution was filtered and underwent VD with Et2O. After 7 
days, yellow needle-like crystals were obtained with yields of 44%. CHN for 
[ZnII4DyIII2(OH)2(L2)4(OAc)2(NO3)2(DMF)3]·DMF (7) observed: C-45.41%, H-3.86%, N-
6.19%; expected C-45.59%, H-3.83%, N-6.05%. For 
[ZnII4TbIII2(OH)2(L2)4(OAc)2(NO3)2(DMF)3]·DMF (8) observed: C-45.67%, H-3.79%, N-6.11%; 
expected C-45.79%, H- 3.85%, N-6..07%. For [ZnII4EuIII2(OH)2(L2)4(OAc)2(NO3)2(DMF)3] 
·DMF (9) observed: C-45.99%, H-3.90%, N-6.15%; expected C-46.03%, H- 3.86%, N-6.10%.  
Preparation of [ZnII2LnIII2(L3)2(CO3)2(NO3)2(CH3OH)2] (10-12) 
To a solution of H3L3 (71.6 mg, 0.1 mmol) in MeOH (20 mL), Et3N (61.5 µL, 0.45 mmol) was 
added and the solution was stirred for 10 min. Ln(NO3)3·5H2O (44 mg, 0.1 mmol) and 
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Zn(NO3)2·6H2O (58 mg, 0.2 mmol) were added and the resultant solution was stirred for a further 
40 min. The clear yellow solution was filtered and left to stand at room temperature. After 5 days, 
small yellow crystals were obtained with a yield of 80% based on Zn. CHN for (10) 
[ZnII2DyIII2(L3)2(CO3)2(NO3)2(CH3OH)2] observed C-34.89%, H-3.16%; N-5.88%; expected C-
34.95%, H-3.21%, N-5.83%. For (11) [ZnII2TbIII2(L3)2(CO3)2(NO3)2(CH3OH)2] observed C-
35.21%, H-3.34%; N-5.81%; expected C-35.19%, H-3.23%, N-5.86%. For (12) 
[ZnII2EuIII2(L3)2(CO3)2(NO3)2(CH3OH)2] observed C-34.55%, H-3.24%; N-5.89%; expected C-
35.49%, H-3.26%, N-5.91%. 
Preparation of 13 and 14 (mixed product) 
To a solution of H2L1 (48 mg, 0.2 mmol) in EtOH/THF (1:1 10 mL), Dy(Cl)3·xH2O (35 mg, 0.1 
mmol), ZnCl2 (24 mg, 0.2 mmol) and Et3N (62 µL, 0.45 mmol) were added and the solution was 
stirred for 1 h. The clear yellow solution was filtered and left for SE. After 9 days, a mixture of 
crystals of 13 and 14 were identified. 
Preparation of [CoII4LnIII2(μ3-OH)2(L1)4Cl2(NO3)2(MeOH)4]·3(Et2O) (15-18) 
H2L1 (48 mg, 0.2 mmol) was suspended in a mixture of CH2Cl2 (10 mL) and MeOH (5 mL) and 
stirred for 5 min before the addition of Co(NO3)2·6 H2O (58 mg, 0.2 mmol), LnCl3·xH2O (37 mg 
,0.1 mmol) and Et3N (0.42 mmol, 59.2 μL). The resultant solution was stirred for 2 h, upon which 
time it was filtered and the filtrate underwent vapor diffusion with Et2O. After 9 d small red 
crystals were collected with a yield of 68% based on Gd. IR: ν ˜ = 3293, 1782, 1609, 1552, 1454, 
1388, 1291, 1224, 1182, 1073, 1033, 964, 820, 733, 635 cm–1. CHN for (15) [CoII4YIII2(μ3-
OH)2(L1)4Cl2(NO3)2(MeOH)4] observed C-41.48%, H-3.59%; N-4.83%; expected C-41.53%, H-
3.60%, N-4.85%. CHN for (16) [CoII4YIII2(μ3-OH)2(L1)4Cl2(NO3)2(MeOH)4] observed C-
38.41%, H-3.30%; N-4.52%; expected C-38.46%, H-3.34%, N-4.49%. CHN for (17) 
[CoII4DyIII2(μ3-OH)2(L1)4Cl2(NO3)2(MeOH)4] observed C-38.25%, H-3.41%; N-4.39%; expected 
C-38.22%, H-3.32%, N-4.46%. CHN for (18) [CoII4TbIII2(μ3-OH)2(L1)4Cl2(NO3)2(MeOH)4] 
observed C-38.41%, H-3.39%; N-4.45%; expected C-38.42%, H-3.33%, N-4.48%. 
Preparation of [CoII4DyIII2(μ3-OH)2(L5)4Cl2(NO3)2(MeOH)4]·3(Et2O) (19) 
H2L1 (48 mg, 0.2 mmol) was suspended in a mixture of CH2Cl2 (10 mL) and MeOH (5 mL) and 
stirred for 5 min before the addition of Co(NO3)2·6H2O (58 mg, 0.2 mmol), DyCl3·xH2O (37 
mg,0.1 mmol), and Et3N (0.42 mmol, 59.2 μL). The resultant solution was stirred for 2 h, upon 
which time it was filtered and the filtrate underwent vapor diffusion with Et2O. After 9 days small 
red crystals were collected with a yield of 68% based on Dy. IR: ν ˜ = ˜ 3290, 1605, 1551, 1452, 
1389, 1295, 1228, 1183, 1076, 1035, 965, 819, 735, 638 cm–1. CHN for (18) [CoII4DyIII2(μ3-
OH)2(L5)4Cl2(NO3)2(MeOH)4] observed C-32.59%, H-3.11%; N-3.77%; expected C-32.67%, H-
3.02%, N-3.81%. 
216 
 
 
Preparation of [CoII3LnIII4(µ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 (20-21) 
Ln(OTf)3 (0.2 mmol), Co(NO3)2·6H2O (0.1 mmol, 58 mg), HL1 (0.2 mmol, 34 mg) and Et3N (1.2 
mmol, 26.8 μL) were refluxed for 2 h in EtOH (20 mL). The reaction mixture was subsequently 
cooled and filtered. The filtrate was left for SE between 4-8 days before green crystals suitable 
for single-crystal XRD data were collected. These were dried overnight. CHN for (20) 
[CoII3GdIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 (expected) C-37.68%, H-3.01%, N-6.60% 
(observed) C-37.59%, H.3.04%, N-6.71%. CHN for (21) [CoII3YIII4(μ3-
OH)6(L4)6(CF3SO3)](CF3SO3)5 (expected) C-40.62%, H-3.24%, N-7.11% (observed) C-40.71%, 
H-3.33%, N-7.21%. 
Preparation of [NiII3LnIII4(µ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 (22-24) 
Ln(OTf)3 (0.2 mmol), Ni(NO3)2.6H2O (0.1 mmol, 58 mg), HL1 (0.2 mmol, 34 mg) and Et3N (1.2 
mmol, 26.8 μL) were refluxed for 2 h in EtOH (20 mL). The reaction mixture was subsequently 
cooled and filtered. The filtrate was left for SE between 4-8 days before green crystals suitable 
for single-crystal XRD data were collected. These were dried overnight. CHN for (23) 
[NiII3GdIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 (expected) C-37.71%, H-3.01%, N-6.60% 
(observed) C-37.82%, H-2.98%, N-6.55%; CHN for (22) [NiII3DyIII4(μ3-OH)6(L4)6(CF3SO3)] 
(CF3SO3)5 (expected) C-37.47%, H-2.99%, N-6.56% (observed) C-37.50%, H-3.09%, N-6.46% 
.CHN for (24) [NiII3YIII4(μ3-OH)6(L4)6(CF3SO3)](CF3SO3)5 (expected) C-40.66%, H-3.24%, N-
7.12% (observed) C-40.59%, H-3.23%, N-7.15%. 
Preparation of (Et3NH)[CoIII(L8)2]·3MeOH (25·3MeOH) 
H2L8 (0.2 mmol, 56 mg) was suspended in a methanolic solution (20 mL), to which 
Co(ClO4)2·6H2O (0.1 mmol), Dy(OTf)3 (0.1 mmol, 61 mg) and Et3N (0.5 mmol, 69μL) was 
added. The resultant solution was stirred for 1 h and on completion filtered. The filtrate was left 
for SE and after 3 days dark red crystals formed.  
Preparation of (Et3NH)[CoIII(L18)2] [26·2MeOH] 
H2L18 (0.2 mmol, 74 mg) was suspended in a methanolic solution (20 mL), to which 
Co(ClO4)2·6H2O (0.1 mmol), Dy(OTf)3 (0.1 mmol, 61 mg) and Et3N (0.5 mmol, 69 μL) was 
added. The resultant solution was stirred for 1 h and on completion filtered. The filtrate was left 
for SE and after 6 days dark red crystals formed.  
Preparation of [NiII2DyIII2(L20)4(allyl-o-vanillin)2(EtOH)2]·3CH2Cl2 [27·3CH2Cl2] 
H2L20 (0.2 mmol, 72 mg) was suspended in EtOH (10 mL) and Et3N (0.5 mmol, 69 μL) was 
immediately added. The solution was left to stir and Ni(ClO4)2·6H2O (0.1 mmol, 37 mg) and 
Dy(Of)3 (0.1 mmol, 61 mg) were added after 5 min. The resultant solution was refluxed for 1 h, 
before CH2Cl2 (5 mL) was added and left for SE. After 3 days’ brown, block-like crystals had 
formed.  
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Preparation of [NiII2DyIII2(L20)4(DMF)6](ClO4)2·4DMF [28·4DMF] 
H2L20 (0.2 mmol, 72 mg), Ni(ClO4)2·6H2O (0.1 mmol, 37 mg), Dy(OTf)3 (0. 1mmol, 61 mg) and 
Et3N (0.5 mmol, 69 μL) were added to DMF (10 mL) and left to stir for 1 h. The solution was 
filtered and filtrate underwent VD with Et2O. After 7 days large brown crystals were formed.  
Preparation of [NiII2DyIII2(L22)4(bromo-o-vanillin)2(EtOH)2]·6EtOH [29·6EtOH] 
H2L22 (0.2 mmol, 80 mg) was suspended in EtOH (15 mL) and Et3N (0.5 mmol, 69 μL) was 
immediately added. The solution was left to stir and Ni(ClO4)2·6H2O (0.1 mmol, 37 mg) and 
Dy(OTf)3 (0.1 mmol, 61 mg) were added after 5 min. The resultant solution was stirred for 1 h, 
before THF (5 mL) was added and left for SE. After 5 days brown, block-like crystals had formed. 
Preparation of [NiII2Dy
III
2(L16)4(allyl-o-vanillin)2(EtOH)2]·2THF·2EtOH  
[30·2THF·2EtOH] 
H2L16 (0.2 mmol, 66 mg), Ni(ClO4)2·6H2O (0.1 mmol, 37 mg), Dy(OTf)3 (0.1 mmol, 61 mg) and 
Et3N (0.5 mmol, 69 μL) were added to a mixture a 1:1 of CH2Cl2 and THF (20 mL). The reaction 
mixture was stirred for 1 h and on completion filtered. The filtrate was left for 6 days after which 
time small red block crystals had formed. 
Preparation of [NiII2DyIII2(L16)4(DMF)2](ClO4)2 [31] 
H2L16 (0.2 mmol, 66 mg), Ni(ClO4)2·6H2O (0.1 mmol, 37 mg), Dy(OTf)3 (0.1 mmol, 61 mg) and 
Et3N (0.5 mmol, 69 μL) were added to DMF (10 mL) and left to stir for 1 h. The solution was 
filtered and filtrate underwent VD with Et2O. After 9 days, large brown cuboid crystals were 
formed.  
Preparation of [NiII2DyIII2(L1)4(EtOH)4(H2O)2](ClO4)2 (32) 
H2L1 (0.6 mmol, 144 mg), Ni(ClO4)2·6H2O (0.3 mmol, 111 mg), Dy(OTf)3 (0.3 mmol, 183 mg) 
and Et3N (1.5 mmol, 205.5 μL) were added to EtOH (20 mL) and left to stir for 1 h. The solution 
was filtered and left for SE. After 5 days’ brown needle-like crystals had formed.  
Preparation of [NiII2DyIII2(L1)4(DMF)6] (OTf3)2·2DMF (33·2DMF) 
H2L1 (0.6 mmol, 144 mg), Ni(ClO4)2·6H2O (0.3 mmol, 111 mg), Dy(OTf)3 (0.3 mmol, 183 mg) 
and Et3N (1.5 mmol, 205.5 μL) were added to DMF (10 mL) and left to stir for 1 h. The solution 
was filtered and underwent VD with Et2O. After 3 days’ brown block-like crystals had formed.  
Preparation of [NiII2DyIII2(L18)4(DMF)4(H2O)2](ClO4)4·5DMF (34·5DMF). 
H2L18 (0.2 mmol, 74 mg), Ni(ClO4)2·6H2O (0.1 mmol, 37 mg), Dy(OTf)3 (0.1 mmol, 61 mg) and 
an excess of Et3N were added to DMF(10 mL) and left to sir for 1 h. The solution was filtered 
and underwent VD with Et2O. After 2 weeks, light brown crystals were formed.  
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Preparation of [NiII4(L2)4(MeOH)4]·6MeOH (35·6MeOH) 
H2L2 (0.1 mmol, 58 mg), Ni(ClO4)2·6H2O (0.1 mmol, 37 mg), Dy(OTf3)3 (0.1 mmol, 61 mg) and 
Et3N (0.5 mmol) were suspended in methanol forming a light-yellow solution. The solution was 
stirred for 1 h before being filtered and the filtrate left for SE. After 2 days’ light green crystals 
were collected.  
Preparation of [NiII2DyIII2(L2)4(EtOH)6](ClO4)2·4EtOH (36·4EtOH) 
H2L2 (0.2 mmol, 58 mg), Ni(ClO4)2·6H2O (0.1 mmol, 37 mg), Dy(OTf)3 (0.1 mmol, 61 mg) and 
Et3N (0.5 mmol, 69 μL) were added to EtOH (20 mL) and left to stir for 1 h. The solution was 
filtered and left for SE. After 13 days’ brown cuboid crystals were formed. 
Preparation of [NiII2Dy
III
2(L19)4(DMF)6](ClO4)2·2Et2O (37·2Et2O) 
H2L19 (0.2 mmol, 64 mg), Ni(ClO4)2·6H2O (0.1 mmol, 37 mg), Dy(OTf)3 (0.1 mmol, 61 mg) and 
Et3N (0.5 mmol, 69 μL) were added to DMF (10 mL) and left to stir for 1 h. The solution was 
filtered and the filtrate underwent VD with Et2O. After 4 days, brown cuboid crystals were 
formed. 
Preparation of [NiII2DyIII2(L1)4(OAc)2(MeOH)2]·2MeOH (38·2MeOH) 
H2L1 (0.1 mmol, 25 mg), Dy(OTf)3 (122 mg, 0.2 mmol) and Et3N (27.6 µL) were added to MeOH 
(20 mL) and left to stir for 20 min. Ni(OAc)2·4H2O (0.1 mmol, 25 mg) was added at the end of 
this time and left to stir for a further 20 min. The solution was filtered and left for SE. Small 
rectangular black crystals formed after 3 days.  
Preparation of [CoII2DyIII2(L9)4(M1)2(DMF)2] (39) 
H2L9 (0.25 mmol, 65 mg) and 3,5-dinirtobenzoic acid (0.5 mmol,) was suspended in DMF (10 
mL) to form a cloudy brown solution. Upon addition of Co(ClO4)2.6H2O (0.1 mmol, 37 mg), 
Dy(OTf3)3 (0.1 mmol, 61 mg) and Et3N (0.9 mmol, 121 μL) the solution became a clear porter 
red. The solution was stirred for 1 h and upon completion filtered. The filtrate underwent VD with 
Et2O and after 2 weeks large dark red crystals were collected. 
Preparation of [CoII2DyIII2(L9)4(M2)2(DMF)2]·2DMF (40·2DMF), 
H2L9 (0.25 mmol, 85 mg) and 3-nirtobenzoic acid (0.5 mmol) were suspended in DMF (10 mL) 
to form a cloudy brown solution. Upon addition of Co(ClO4)2·6H2O (0.1 mmol, 37 mg), 
Dy(OTf3)3 (0.1 mmol, 61 mg) and Et3N (0.9 mmol, 121 μL) the solution became a clear porter 
red. The solution was stirred for 1 h and upon completion filtered. The filtrate underwent VD with 
Et2O and after 2 weeks large dark red crystals were collected. 
Preparation of [DyIII(M1)3(DMF)2] (20) 
H2L9 (0.25 mmol, 85 mg) and 3,5-dinirtobenzoic acid (0.5 mmol) were suspended in DMF (10 
mL) to form a cloudy brown solution. Upon addition of Co(ClO4)2·6H2O (0.1 mmol, 37 mg), 
219 
 
 
Dy(OTf3)3 (0. 1mmol, 61 mg) and Et3N (0.9 mmol, 121 μL) the solution became a clear porter 
red. The solution was stirred for 1 h and upon completion filtered. The filtrate underwent VD with 
Et2O and after 3 days’ clear needle-like crystals were collected. 
Preparation of [NiII2DyIII2(OH)(L2)3(M1)3(DMF)2]·1.5DMF·Et2O (42·1.5DMF·Et2O) 
H2L2 (0.2 mmol, 58 mg), Ni(ClO4)2·6H2O (0.1 mmol, 37 mg), Dy(OTf)3 (0.1 mmol, 61 mg), 3,5 
-dintrobenzoic acid (0.5 mmol, 70 mg) and Et3N (0.5 mmol, 69 μL) were added to DMF(10 mL) 
and left to stir for 1 h. The solution was filtered and underwent VD with Et2O. After 8 days, black 
small cube crystals were formed. 
Preparation of [ZnII4LnIII11(µ4-OH)2(µ3-OH)8(µ2-OH2)2(µ3-
NO3)2(NO3)6Cl4(HL23)2(L23’)4(µ2-MeO)7(µ3-MeO)2(MeOH)2(H2O)2] (43-44) 
O-vanillin (0.2 mmol) and trans-2-amino-cyclohexanol (0.2 mmol) were stirred in MeOH (20 
mL) for 2 h to form a clear light-yellow solution. LnCl3·5H2O (0.1 mmol) and Zn(NO3)2·6H2O 
(0.2 mmol, 56 mg) were subsequently added with Et3N (0.45 mmol, 61 µL). The solution was 
stirred for a further 1 h upon which the solution had become colourless. The solution was filtered 
and the filtrate left for SE. After 13-27 days’ colourless needle like crystals were collected. 43 
(15%), 44 (21%) based on LnIII. CHN for C80H135Cl4Dy11N10O70Zn4 (43) (expected) C-21.08%, 
H-2.99, N-3.07% (observed) C-20.95%, H-3.27%, N-3.11%. CHN for C80H135Cl4Gd11N10O70Zn4 
(44) (expected) C-21.39%, H-3.03, N-3.12% (observed) C-21.52%, H-2.88%, N-3.00%. 
Preparation of [NiII2Dy
III
2(L1)4(EtOH)6](ClO4)2·2EtOH(1NiDy-ClO4) 
Dy(OTf)3·xH2O (61 mg, 0.1 mmol), Ni(ClO4)2·6H2O (37 mg, 0.1 mmol), H2L1 (48 mg, 0.2 mmol) 
and Et3N (69 µl, 0.5 mmol) were added in EtOH (20 mL), and the resulting mixture was stirred 
for 1 hour. After filtration, yellow-greenish crystals were obtained in 49 % yield and collected by 
filtration, washed with Et2O and dried in air.  
Preparation of [CoII2DyIII2(L1)4(EtOH)6](ClO4)2·2EtOH (1CoDy-ClO4) 
Dy(OTf)3·xH2O (61 mg, 0.1 mmol), Co(ClO4)2·6H2O (37 mg, 0.1 mmol), H2L1 (48 mg, 0.2 
mmol) and Et3N (69 µl, 0.5 mmol) were added in EtOH (20 mL), and the resulting mixture was 
stirred for 1 hour. After filtration, orange crystals were obtained in 57 % yield and collected by 
filtration, washed with Et2O and dried in air.  
Preparation of [Ni2Ln2(L1)4Cl2(CH3CN)2]·2CH3CN (1NiLn-Cl) 
To a solution of acetonitrile (20 mL), H2L1 (0.2 mmol, 48 mg) and Et3N (0.5 mmol, 69 µL) were 
added and stirred for 10 min. On completion, NiCl2·6H2O (0.1 mmol, 24 mg) and LnCl3·xH2O 
(0.1 mmol) (Ln = Y, Sm, Eu, Gd, Tb, Dy) were added and the resultant solution was heated under 
reflux for 2 h. In this time the clear yellow solutions precipitated and on completion were left to 
cool where a green precipitate settled. The solution was filtered and washed with cold MeCN (20 
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mL) and Et2O (10 mL). The precipitate (1NiLn-Cl) was then collected and dried overnight at 60 
°C. Yield = 69 - 95% based on Ln for 1NiLn-Cl. Elemental analysis for 
[Ni2Dy2(C14H11NO3)4Cl2(CH3CN)2] (1NiDy-Cl): expected C-46.55%, H-3.23%, N-5.38%; found 
C-46.84%, H-3.21%, N-5.16%. Elemental analysis for [Ni2Y2(C14H11NO3)4Cl2(CH3CN)2] (1NiY-
Cl): C-51.06%, H-3.57%, N-5.95%.; found C-51.32%, H-3.51%, N-6.09%. Elemental analysis 
for [Ni2Gd2(C14H11NO3)4Cl2(CH3CN)2] (1NiGd-Cl): C-46.15%, H-3.25%, N-5.42%; found C-
46.51%, H-3.18%, N-4.82%. Elemental analysis for [Ni2Eu2(C14H11NO3)4Cl2(CH3CN)2] (1NiEu-
Cl): C-46.81%, H-3.47%, N-5.46%.; found C-47.08%, H-3.79%, N-5.52%. Elemental analysis 
for [Ni2Tb2(C14H11NO3)4-Cl2(CH3CN)2] (1NiTb-Cl): C-46.85%, H-3.25%, N-5.42%.; found C-
47.20%, H-3.33%, N-4.98%. Elemental analysis for [Ni2Sm2(C14H11NO3)4Cl2(CH3CN)2] 
(1NiSm-Cl): C-46.87%, H-3.28%, N-5.16%; found: C-46.81%, H-3.22%, N-4.91%. 
Preparation of [NiII5SmIII2(CO3)(L1)7(L1’)(H2O)3] (1NiSm-A), [NiII2SmIII2(L1)4(O-
Van)2(H2O)2]·4CH3CN (1NiSm-B) and [SmIII4(OH)2(L1)4(HL1)2]·2CH3CN (1NiSm-C) 
To a solution of acetonitrile (20 mL), H2L1 (0.2 mmol, 48 mg) and Et3N (0.5 mmol, 69 µL) were 
added and stirred for 10 min. On completion, NiCl2·6H2O (0.1 mmol, 24 mg) and SmCl3·xH2O 
(0.1 mmol) were added and the resultant solution was heated under reflux for 2 h. In this time, 
the clear yellow solutions precipitated and on completion were left to cool where a green 
precipitate settled. The filtrate underwent SE and from 3-15 days mixed crystals of 1NiSm-A, 
1NiSm-B and 1NiSm-C were collected.  
Preparation of 1NiEu-A 
To a solution of acetonitrile (20 mL), H2L1 (0.2 mmol, 48 mg) and Et3N (0.5 mmol, 69 µL) were 
added and stirred for 10 min. On completion, NiCl2·6H2O (0.1 mmol, 24 mg) and EuCl3·xH2O 
(0.1 mmol) were added and the resultant solution was heated under reflux for 2 h. In this time, 
the clear yellow solutions precipitated and on completion were left to cool where a green 
precipitate settled. The filtrate underwent SE and from 6 days mixed crystals of 1NiSm-Eu were 
collected.  
Preparation of [Co2Dy2(C14H11NO3)4Cl2(CH3CN)2] (1CoLn-Cl) 
To a solution of acetonitrile (20 mL), H2L1 (0.2 mmol, 48 mg) and Et3N (0.5 mmol, 69 µL) were 
added and stirred for 10 min. On completion, CoCl2 (0.1 mmol, 18 mg) and DyCl3·xH2O (0.1 
mmol, 35 mg) were added and the resultant solution was heated under reflux for 2 h. In this time, 
the clear yellow solutions precipitated and on completion were left to cool where a pink precipitate 
settled. The solution was filtered and washed with cold MeCN (20 mL) and Et2O (10 mL). The 
precipitate (1CoLn-Cl) was then collected and dried overnight at 60 °C.). Crystals were obtained 
by recrystallization in MeCN (10 mL) Yield = 69-95% based on Ln (for 1CoLn-Cl). Elemental 
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analysis for [Co2Dy2(C14H11NO3)4Cl2(CH3CN)2] (1CoLn-Cl): C-46.55%, H-3.23%, N-5.38%; 
found C-46.84%, H-3.21%, N-5.16%. 
Preparation of [ZnII2LnIII2(L1)4(NO3)2(DMF)2] (1ZnLn-NO3) 
H2L1 (0.2 mmol, 48 mg) and Et3N (61 µL,0.4 mmol) were added to EtOH (20 mL) and the 
resultant solution was stirred for 5 min under reflux. Upon completion, Zn(NO3)2·6H2O (56, 0.2 
mmol) and Ln(NO3)3·xH2O were added and the solution was refluxed for a further 2 h. After 
cooling, the yellow precipitate was filtered, washed with Et2O and dissolved in DMF (10mL). 
The resultant solution underwent vapour diffusion and after 1 week long yellow crystals with the 
formula [ZnII2LnIII2(C14H11NO3)4(NO3)2(DMF)2] had formed. Yield 45-71%.  
Compound 1ZnDy-NO3 - [ZnII2DyIII2(C14H11NO3)4(NO3)2(DMF)2] CHN (expected) -C-44.02%, 
H-3.46%, N-6.63. (measured): C-41.90%, H-2.84%, N-5.61% corresponding to 
[ZnII2DyIII2(C14H11NO3)4(NO3)2(H2O)2]·2H2O: C-41.58%; H-3.24%; N-5.19%.  
Compound 1ZnY-NO3 - [ZnII2YIII2(C14H11NO3)4(NO3)2(DMF)2] CHN (Expected) – C-48.31%, 
H-3.80%, N-7.27%. (measured): C-45.34%, H-3.12%, N-5.90% corresponding to a formula 
[ZnII2YIII2(C14H11NO3)4(NO3)2(H2O)2]·2H2O: C-45.84%, H-3.57%, N-5.73%.  
Compound 1ZnGd-NO3 - [ZnII2GdIII2(C14H11NO3)4(NO3)2-(DMF)2] CHN (expected) C-44.33%, 
H-3.48%, N-6.68%. (measured): C-41.50%, H-2.86%, N-5.20% corresponding to a formula 
[ZnII2GdIII2(C14H11NO3)4(NO3)2-(H2O)2]·2H2O: C-41.89%, H-3.26%, N-5.24%. 
Preparation of [(ZnII2YIII2(L6)4(NO3)2(C3H7NO)2] (6ZnY-NO3) 
H2L6 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2mmol, 58mg) and Y(NO3)3·5H2O (0.1mmol, 39mg) were added and the 
solution was refluxed for a further 1h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20ml) and 
Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Square yellow crystals of (6ZnY) were collected after 8 days and dried overnight. 60% yield 
calculated via YIII. CHN (expected) [(ZnII2YIII2(L6)4(NO3)2(C3H7NO)2] C-52.23%; H-4.38%, N-
6.59%. CHN (observed) [(ZnII2YIII2(L6)4(NO3)2(C3H7NO)2] C-51.50%; H-4.12%; N-5.34%. 
Preparation of [(ZnII2YIII2(L4)4(NO3)2(C3H7NO)2] (4ZnY-NO3) 
H2L4 (0.2 mmol) and Et3N (0.45 mmol, 61 μl) was stirred under reflux for 5 min. Zn(NO3)2·6H2O 
(0.2 mmol, 58mg) and Y(NO3)3·5H2O (0.1 mmol, 39mg) were added and the solution was 
refluxed for a further 1 h. The cloudy yellow solution was left to cool to room temperature and 
filtered. The yellow precipitate was collected and washed with EtOH (20 ml) and Et2O (15 ml). 
The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. Square brown 
crystals were collected after 14 days and dried overnight. 41% yield calculated via YIII. CHN 
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(expected) [(ZnII2YIII2(L4)4(NO3)2(C3H7NO)2] C-40.17%, H-2.93%, N-6.04%. CHN (observed) 
C-39.99%, H-3.02%, N 5.98. 
Preparation of [(ZnII2YIII2(L8)4(NO3)2(C3H7NO)2] (8ZnY-NO3) 
H2L8 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy red solution was left to cool to room 
temperature and filtered. The dark red precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Square red crystals of (8ZnY) were collected after 8 days and dried overnight. 71% yield 
calculated via YIII. CHN (expected) [(ZnII2YIII2(L8)4(NO3)2(C3H7NO)2] C-43.26. %; H-3.16%, N-
9.76%. CHN (observed) [(ZnII2YIII2(L8)4(NO3)2(H2O)2] C-41.67%; H-2.80%; N-8.75%. 
Preparation of [(ZnII2YIII2(L9)4(NO3)2(C3H7NO)2] (9ZnY-NO3) 
H2L9 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy red solution was left to cool to room 
temperature and filtered. The dark red precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF(10ml) and underwent VD with Et2O. 
Square red crystals were collected after 8 days and dried overnight. 91% yield calculated via YIII. 
CHN (expected) [(ZnII2YIII2(L9)4(NO3)2(C3H7NO)2] C-47.23%, H-3.75%, N-8.90%. CHN 
(Observed) C-47.31%. H-3.90%, N-8.95% 
Preparation of [(ZnII2YIII2(L11)4(NO3)2(C3H7NO)2] (11ZnY-NO3) 
H2L11 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy red solution was left to cool to room 
temperature and filtered. The dark red precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Square light brown crystals were collected after 8 days and dried overnight. 91% yield calculated 
via YIII. CHN (expected) [(ZnII2YIII2(L11)4(NO3)2(C3H7NO)2] C-36.62%, H-2.48%, N-8.27%. 
CHN(observed) C-36.48%, H-2.31%, N-8.26%. 
Preparation of [(ZnII2YIII2(L12)4(NO3)2(C3H7NO)2] (12ZnY-NO3) 
H2L12 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy red solution was left to cool to room 
temperature and filtered. The dark red precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
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Square red crystals of (12ZnY) were collected after 6 days and dried overnight. 65% yield 
calculated via YIII. CHN (expected) [(ZnII2YIII2(L12)4(NO3)2(C3H7NO)2] C-40.08%, H-2.72%, N-
9.05%. CHN (observed) [(ZnII2YIII2(L12)4(NO3)2(H2O)2] C-38.40%; H-2.29%; N-7.98%. 
Preparation of [(ZnII2YIII2(L13)4(NO3)2(C3H7NO)2] (13ZnY-NO3) 
H2L13 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy red solution was left to cool to room 
temperature and filtered. The dark red precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Square red crystals of (13ZnY) were collected after 6 days and dried overnight. 71% yield 
calculated via YIII. CHN (expected) [(ZnII2YIII2(L13)4(NO3)2(C3H7NO)2] C-44.05%, H-3.29%, N-
8.34%. CHN (observed) [(ZnII2YIII2(L13)4(NO3)2(C3H7NO)2] C-43.98%, H-3.28%, N-8.29%. 
Preparation of [(ZnII2YIII2(L15)4(NO3)2(C3H7NO)2] (15ZnY-NO3) 
H2L15 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy red solution was left to cool to room 
temperature and filtered. The dark red precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Square red crystals were collected after 6 days and dried overnight. 66% yield calculated via YIII. 
CHN (expected) [(ZnII2YIII2(L15)4(NO3)2(C3H7NO)2] C-34.20%, H-2.50%, N-7.72%. CHN 
(observed) [(ZnII2YIII2(L15)4(NO3)2(C3H7NO)2] C-34.27%, H-2.61%, N.81%. 
Preparation of [(ZnII2YIII2(L2)4(NO3)2(C3H7NO)2] (2ZnY-NO3) 
H2L2 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20ml) and 
Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Square yellow crystals of (2ZnY) were collected after 8 days and dried overnight. 58% yield 
calculated via YIII. CHN (expected) [(ZnII2YIII2(L2)4(NO3)2(C3H7NO)2] C-53.78%; H-3.82%, N-
6.43%. CHN (observed) [(ZnII2YIII2(L2)4(NO3)2(H2O)2] C-53.01%; H-3.47%; N-5.18%. 
Preparation of [(ZnII2YIII2(L16)4(NO3)2(C3H7NO)2] (16ZnY-NO3) 
H2L16 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
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and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Square yellow crystals were collected after 8 days and dried overnight. 81% yield calculated via 
YIII. CHN (expected) [(ZnII2YIII2(L16)4(NO3)2(C3H7NO)2] C-56.76%; H-4.29%, N-5.76%. CHN 
(observed) [(ZnII2YIII2(L16)4(NO3)2(H2O)2] C-56.29%; H-4.74%; N-4.66%. 
Preparation of [(ZnII2YIII2(L18)4(NO3)2(C3H7NO)2] (18ZnY-NO3) 
H2L18 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Square brown crystals were collected after 8 days and dried overnight. 56% yield calculated via 
YIII. CHN (expected) [(ZnII2YIII2(L18)4(NO3)2(C3H7NO)2] C-45.44%; H-3.24%, N-5.43%. CHN 
(observed) [(ZnII2YIII2(L18)4(NO3)2(C3H7NO)2] C-45.49%; H-3.18%; N-5.29%. 
Preparation of [(ZnII2YIII2(L19)4(NO3)2(C3H7NO)2] (19ZnY-NO3) 
H2L19 (0.2 mmol) and Et3N (0.45 mmol, 61μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
jagged Yellow crystals were collected after 4 days and dried overnight. 89% yield calculated via 
YIII. CHN (expected) [(ZnII2YIII2(L19)4(NO3)2(C3H7NO)2] C-55.96%; H-4.04%, N-6.07%. CHN 
(observed) [(ZnII2YIII2(L19)4(NO3)2(C3H7NO)2] C-55.86%; H-3.92%; N-6.06%. 
Preparation of [(ZnII2YIII2(H2L20)4(NO3)2(C3H7NO)2] (20ZnY-NO3) 
H2L20 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF(10 mL) and underwent VD with Et2O. 
Square yellow crystals of (20ZnY-NO3) were collected after 9 days and dried overnight. 81% 
yield calculated via YIII. CHN (expected) [(ZnII2YIII2(H2L20)4(NO3)2(C3H7NO)2] C-58.67%; H-
4.52%, N-5.59%. CHN (observed) [(ZnII2YIII2(H2L20)4(NO3)2(H2O)2] C-58.21%; H-4.33%; N-
4.52%. 
Preparation of [(ZnII2YIII2(H2L22)4(NO3)2(C3H7NO)2] (22ZnY-NO3) 
H2L22 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
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solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Jagged brown crystals of (22ZnY-NO3) were collected after 3 days and dried overnight. 44% 
yield calculated via YIII. CHN (expected) [(ZnII2YIII2(H2L22)4(NO3)2(C3H7NO)2] C-47.87%; H-
3.27%, N-5.19%. CHN (observed) [(ZnII2YIII2(H2L22)4(NO3)2(C3H7NO)2] C-47.92%; H-3.39%; 
N-5.14%. 
Preparation of [(ZnII2YIII2(H2L27)4(NO3)2(C3H7NO)2] (27ZnY-NO3) 
H2L27 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Square yellow crystals of (27ZnY-NO3) were collected after 12 days and dried overnight. 71% 
yield calculated via YIII. CHN (expected) [(ZnII2YIII2(H2L27)4(NO3)2(C3H7NO)2] C-53.05%; H-
5.14%, N-6.34%. CHN (observed) [(ZnII2YIII2(H2L27)4(NO3)2(C3H7NO)2] C-52.98%; H-5.12%; 
N-6.40%. 
Preparation of [(ZnII2YIII2(H2L28)4(NO3)2(C3H7NO)2] (28ZnY-NO3) 
H2L28 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Square yellow crystals were collected after 15 days and dried overnight. 66% yield calculated via 
YIII. CHN (expected) [(ZnII2YIII2(H2L28)4(NO3)2(C3H7NO)2] C-56.12%; H-5.55%, N-5.82%. 
CHN (observed) [(ZnII2YIII2(H2L28)4(NO3)2(C3H7NO)2] C-56.10%; H-5.52%; N-5.79%. 
Preparation of [(ZnII2YIII2(H2L29)4(NO3)2(C3H7NO)2] (29ZnY-NO3) 
H2L29 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Cubic orange crystals were collected after 7 days and dried overnight. 51% yield calculated via 
YII. CHN (expected) [(ZnII2YIII2(H2L29)4(NO3)2(C3H7NO)2] C-45.09%; H-4.18%, N-5.39%. 
CHN (observed) [(ZnII2YIII2(H2L29)4(NO3)2(C3H7NO)2] C-44.98%; H-4.09%; N-5.28%. 
226 
 
 
Preparation of [(ZnII2YIII2(H2L24)4(NO3)2(C3H7NO)2] (24ZnY-NO3) 
H2L19 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Needle like yellow crystals of (24ZnY) were collected after 5 days and dried overnight. 80% yield 
calculated via YII. CHN (expected) [(ZnII2YIII2(H2L24)4(NO3)2(C3H7NO)2] C-45.08%; H-3.52%, 
N-10.88%. CHN (observed) [(ZnII2YIII2(H2L24)4(NO3)2(H2O)2] C-43.58%, H- 3.12%, N-9.96% 
Preparation of [(ZnII2YIII2(H2L25)4(NO3)2(C3H7NO)2] (25ZnY-NO3) 
H2L25 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Needle like yellow crystals were collected after 4 days and dried overnight. 91% yield calculated 
via YII. CHN (expected) [(ZnII2YIII2(H2L25)4(NO3)2(C3H7NO)2] C-49.29%; H-4.13%, N-9.86%. 
CHN (observed) [(ZnII2YIII2(H2L25)4(NO3)2(H2O)2] C-48.25%, H- 3.83%, N-8.73% 
Preparation of [(ZnII2YIII2(H2L26)4(NO3)2(C3H7NO)2] (26ZnY-NO3) 
H2L26 (0.2 mmol) and Et3N (0.45 mmol, 61 μL) was stirred under reflux for 5 min. 
Zn(NO3)2·6H2O (0.2 mmol, 58 mg) and Y(NO3)3·5H2O (0.1 mmol, 39 mg) were added and the 
solution was refluxed for a further 1 h. The cloudy yellow solution was left to cool to room 
temperature and filtered. The yellow precipitate was collected and washed with EtOH (20 mL) 
and Et2O (15 mL). The precipitate was dissolved in DMF (10 mL) and underwent VD with Et2O. 
Needle-like yellow crystals were collected after 4 days and dried overnight. 91% yield calculated 
via YII. CHN (expected) [(ZnII2YIII2(H2L26)4(NO3)2(C3H7NO)2] C-37.51%; H-2.72%, N-9.06%. 
CHN (observed) [(ZnII2YIII2(H2L26)4(NO3)2(H2O)2] C-35.87%, H- 2.37%, N-8.09%. 
11.4 Catalytic protocols 
Supporting Figures for 1H NMR, 13CNMR and ESI-MS are found in Appendix B. 
Synthesis of trans-4,5-dimorpholin-4-yl-cyclopent-2-enone (C7a) 
In air, powdered 4 Å molecular sieves (100mg) were weighed into a 10 mL capped vial equipped 
with a magnetic stirbar. MeCN (dry, 4 mL), furfural (0.5 mmol, 41 μL), morpholine (1 mmol) 
and the appropriate amount of catalyst (10 -1 mol% total of Dy) were added. The resultant mixture 
was stirred at room temperature for 24 h. The reaction mixture was diluted with DCM (20 mL) 
and filtered through Celite. The resultant solution was concentrated under reduced pressure and 
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the residue purified by column chromatography (30 % ethyl acetate in 70 % hexanes). The product 
was obtained as a yellow oil which solidified on standing. 1H NMR (500 MHz, CDCl3) δ 7.59 
(1H, dd, J = 6.0, 2.0 Hz), 6.22 (1H, dd, J = 6.0, 2.0Hz), 3.79 (1H, ddd, J = 3.0, 2.0, 2.0 Hz), 3.71 
(4H, t, J = 4.5 Hz), 3.67 (4H, t, J = 4.5 Hz), 3.28(1H, d, J = 3.0 Hz), 2.84-2.79 (2H, m), 2.67-2.55 
(6H, m)  
Synthesis of trans-4,5-bis-diallylaminocyclopent-2-enone (C7b) 
In air, powdered 4 Å molecular sieves (100 mg) were weighed into a 10 mL capped vial equipped 
with a magnetic stirbar. MeCN (dry, 4 mL), furfural (0.5 mmol, 41 μL), diallylamine (1 mmol) 
and the appropriate amount of catalyst (10 -1 mol% total of Dy) were added. The resultant mixture 
was stirred at room temperature for 24 h. The reaction mixture was diluted with DCM (20 mL) 
and filtered through Celite. The resultant solution was concentrated under reduced pressure and 
the residue purified by column chromatography (5% ethyl acetate in 95% hexanes). The product 
was obtained as a yellow oil which solidified on standing. 1H NMR (500 MHz, CDCl3) δ 7.46 
(1H, dd, J = 6.0, 2.0 Hz), 6.16 (1H, dd, J = 6.0, 2.0 Hz), 5.91-5.77 (4H, m), 5.26-5.10 (8H, m), 
4.11 (1H, ddd, J = 3.0, 2.0, 2.0 Hz), 3.59 (1H, d, J = 3.0Hz), 3.38-3.31 (2H, m), 3.23-3.10 (6H, 
m)  
Synthesis of trans-4,5-bis-(2,3-dihydroindol-1-yl)-cyclopent-2-enone (C7c) 
In air, powdered 4 Å molecular sieves (100 mg) were weighed into a 10 mL capped vial equipped 
with a magnetic stirbar. MeCN (dry, 4 mL), furfural (0.5 mmol, 41 μL), indoline (1 mmol) and 
the appropriate amount of catalyst (10 -1 mol% total of Dy) were added. The resultant mixture 
was stirred at room temperature for 24 h. The reaction mixture was diluted with DCM (20 mL) 
and filtered through Celite. The resultant solution was concentrated under reduced pressure and 
the residue purified by column chromatography (20% ethyl acetate in 80% hexanes). The product 
was obtained a yellow oil which solidified on standing. 1H NMR (500 MHz, CDCl3) δ 7.68 (1H, 
dd, J = 6.0, 2.0 Hz), 7.08 (1H, d, J = 7.0 Hz), 7.05 (1H, d, J = 7.5 Hz),6.96 (1H, dd, J = 7.5, 7.5 
Hz), 6.91 (1H, dd, J = 7.5, 7.5 Hz), 6.67 (1H, dd, J = 7.5, 7.5 Hz), 6.63(1H, dd, J = 7.5, 7.5 Hz), 
6.49 (1H, dd, J = 6.0, 2.0 Hz), 6.35 (1H, d, J = 8.0 Hz), 6.07 (1H, d, J =8.0 Hz), 5.01-4.99 (1H, 
m), 4.40 (1H, d, J = 3.5 Hz), 3.52 (1H, ddd, J = 7.5, 7.5, 7.5 Hz), 3.50(1H, ddd, J = 8.0, 8.0, 8.0 
Hz), 3.41 (1H, ddd, J = 8.0, 8.0, 8.0 Hz), 3.34 (1H, ddd, J = 8.0, 8.0,8.0 Hz), 3.06-2.90 (4H, m)  
Synthesis of trans-4,5-bis-(3,4-dihydro-2H-quinolin-1-yl)-cyclopent-2-enone (C7d) 
In air, powdered 4 Å molecular sieves (100 mg) were weighed into a 10 mL capped vial equipped 
with a magnetic stirbar. MeCN (dry, 4 mL), furfural (0.5 mmol, 41 μL), 1,2,3,4-
tetrahydroquinoline (1 mmol) and the appropriate amount of catalyst (10 -1 mol% total of Dy) 
were added. The resultant mixture was stirred at room temperature for 24 h. The reaction mixture 
was diluted with DCM (20 mL) and filtered through Celite. The resultant solution was 
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concentrated under reduced pressure and the residue purified by column chromatography (20% 
ethyl acetate in 80% hexanes). The product was obtained a yellow oil which solidified on 
standing. 1H NMR (500 MHz, CDCl3) δ 7.67 (1H, dd, J = 6.0, 2.0 Hz), 6.99-6.87 (4H, m), 6.65-
6.50 (4H, m), 6.09 (1H, d, J = 8.0 Hz),5.38 (1H, br s), 4.32 (1H, br s), 3.33-3.15 (4H, m), 2.822.66 
(4H, m), 2.00-1.88 (4H, m)  
Synthesis of trans-4,5-Bis-(3,4-dihydro-1H-isoquinolin-2-yl)-cyclopent-2-enone (C7e) 
In air, powdered 4 Å molecular sieves (100 mg) were weighed into a 10 mL capped vial equipped 
with a magnetic stirbar. MeCN (dry, 4 mL), furfural (0.5 mmol, 41 μL), 1,2,3,4- 
tetrahydroisoquinoline (1 mmol) and the appropriate amount of catalyst (10 -1 mol% total of Dy) 
were added. The resultant mixture was stirred at room temperature for 24 h. The reaction mixture 
was diluted with DCM (20 mL) and filtered through Celite. The resultant solution was 
concentrated under reduced pressure and the residue purified by column chromatography (30% 
ethyl acetate in 70% hexanes). The product was obtained a yellow oil which solidified on 
standing. 1H NMR (500 MHz, CDCl3) δ 7.70 (1H, dd, J = 6.0, 2.0 Hz), 7.16-7.00 (8H, m), 6.32 
(1H, dd, J= 6.0, 2.0 Hz), 4.25-4.13 (2H, m), 3.95-3.90 (3H, m), 3.62 (1H, d, J = 3.0 Hz), 3.12-
2.86 (8H, m)  
Synthesis of (1E,2Z,4E)-5-(phenylamino)-1-(phenyliminio)penta-2,4-dien-2-olate (C7f) 
In air, powdered 4 Å molecular sieves (100 mg) were weighed into a 10 mL capped vial equipped 
with a magnetic stirbar. MeCN (dry, 4 mL), furfural (0.5 mmol, 41 μL), aniline (1 mmol) and the 
appropriate amount of catalyst (10 -1 mol% total of Dy) were added. The resultant mixture was 
stirred at room temperature for 24 h. The reaction mixture was diluted with DCM (20 mL) and 
filtered through Celite. The resultant solution was concentrated under reduced pressure. The 
residue was purified by column chromatography (10% ethyl acetate in 90% hexanes). The product 
was obtained as red oil which solidified on standing. 1H NMR (500 MHz, DMSO-d6) δ 7.68 (dd, 
J = 6.1, 1.9 Hz, 1H), 7.11 – 7.01 (m, 4H), 6.63 – 6.44 (m, 6H), 6.39 (dd, J = 6.1, 1.5 Hz, 1H), 6.20 
(d, J = 8.6 Hz, 1H), 6.06 (d, J = 7.5 Hz, 1H), 4.63 – 4.57 (m, 1H), 4.01 (dd, J = 7.6, 3.4 Hz, 1H), 
1.22 (s, 1H) 13C NMR (126 MHz, DMSO-d6) δ 205.12, 161.93, 152.43, 151.61, 149.03, 148.77, 
146.81, 132.63, 129.66, 129.53, 129.22, 126.47, 121.37, 117.33, 116.75, 116.12, 114.36, 113.17, 
112.93, 64.86, 40.56, 40.40, 40.23, 40.06, 39.90, 39.73, 39.56, 28.28  
Synthesis of (1E,2Z,4E)-5-((2-methoxyphenyl)amino)-1-((2-methoxyphenyl)iminio)penta-
2,4-dien-2olate (C7g) 
 In air, powdered 4 Å molecular sieves (100 mg) were weighed into a 10 mL capped vial equipped 
with a magnetic stirbar. MeCN (dry, 4 mL), furfural (0.5 mmol, 41 μL), O-anisidine (1 mmol) 
and the appropriate amount of catalyst (10 -1 mol% total of Dy) were added. The resultant mixture 
was stirred at room temperature for 24 h. The reaction mixture was diluted with DCM (20 mL) 
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and filtered through Celite. The resultant solution was concentrated under reduced pressure. The 
residue was purified by column chromatography (10% ethyl acetate in 90% hexanes). The product 
was obtained as red oil. 1H NMR (500 MHz, DMSO-d6 ) δ 8.35 (s, 1H), 7.61 (dt, J = 6.1, 1.7 Hz, 
2H), 7.29 – 7.17 (m, 2H), 7.07 (d, J = 7.8 Hz, 1H), 7.02 – 6.94 (m, 3H), 6.89 – 6.69 (m, 19H), 
6.55 (dt, J = 3.5, 1.7 Hz, 1H), 6.41 (dt, J = 6.1, 1.4 Hz, 1H), 3.96 – 3.69 (m, 23H).  
Synthesis of (1E,2Z,4E)-5-((2-fluorophenyl)amino)-1-((2-fluorophenyl)iminio)penta-2,4-
dien-2-olate (C7h) 
In air, powdered 4 Å molecular sieves (100 mg) were weighed into a 10 mL capped vial equipped 
with a magnetic stirbar. MeCN (dry, 4 mL), furfural (0.5 mmol, 41 μL), 2-fluoroanaline (1 mmol) 
and the appropriate amount of catalyst (10 -1 mol% total of Dy) were added. The resultant mixture 
was stirred at room temperature for 24 h. The reaction mixture was diluted with DCM (20 mL) 
and filtered through Celite. The resultant solution was concentrated under reduced pressure. The 
residue was purified by column chromatography (5% ethyl acetate in 95% hexanes). The product 
was obtained as yellow oil. 1H NMR (500 MHz, DMSO-d6 ) δ 8.35 (s, 1H), 7.61 (dt, J = 6.1, 1.7 
Hz, 2H), 7.29 – 7.17 (m, 2H), 7.07 (d, J = 7.8 Hz, 1H), 7.02 – 6.94 (m, 4H), 6.89 – 6.69 (m, 22H), 
6.55 (dt, J = 3.5, 1.7 Hz, 1H), 6.41 (dt, J = 6.1, 1.4 Hz, 1H), 3.96 – 3.69 (m, 27H)  
Synthesis of (1E,2Z,4E)-5-((2-(trifluoromethyl)phenyl)amino)-1-
((2(trifluoromethyl)phenyl)iminio)penta-2,4-dien-2-olate (C7i) 
In air, powdered 4 Å molecular sieves (100 mg) were weighed into a 10 mL capped vial equipped 
with a magnetic stirbar. MeCN (dry, 4 mL), furfural (0.5 mmol, 41 μL), 2(trifluoromethyl)- 
analine (1 mmol) and the appropriate amount of catalyst (10 -1% total of Dy) were added. The 
resultant mixture was stirred at room temperature for 24 h. The reaction mixture was diluted with 
DCM (20 mL) and filtered through Celite. The resultant solution was concentrated under reduced 
pressure. The residue was purified by column chromatography (20% ethyl acetate in 80% 
hexanes). The product was obtained as red oil which solidified on standing. 1H NMR (500 MHz, 
DMSO-d6) δ 9.71 – 9.66 (m, 3H), 8.19 (s, 1H), 8.01 – 7.94 (m, 1H), 7.75 – 7.44 (m, 13H), 7.36 – 
7.23 (m, 11H), 7.06 (d, J = 7.5 Hz, 1H), 6.94 – 6.84 (m, 6H), 6.64 – 6.57 (m, 4H), 4.13 (qd, J = 
7.2, 1.6 Hz, 5H), 3.94 (d, J = 1.5 Hz, 2H), 2.18 (q, J = 0.8 Hz, 2H). 
Synthesis of 3,3'-(phenylmethylene)bis(1H-indole) (C8aa) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), benzaldehyde (0.5 mmol) and indole (1 mmol) 
were added followed by catalyst (2.5 mol% with respect to benzaldehyde). The resultant solution 
was stirred for 12 h, upon which time product had precipitated. The cloudy solution was filtered 
and precipitate washed with hexanes (3 x 10 mL) and water (3 x 10 mL). 1H NMR (500 MHz, 
CDCl3) δ 7.74 (s, 2H), 7.47 – 7.17 (m, 10H), 7.05 (ddd, J = 8.0, 7.0, 1.0 Hz, 2H), 6.61 (dd, J = 
2.5, 1.1 Hz, 2H), 5.92 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 165.91, 144.07, 136.72, 128.75, 
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128.23, 127.13, 126.15, 123.63, 123.61, 121.93, 119.95, 119.72, 119.26, 117.73, 111.06, 77.30, 
77.04, 76.79, 40.26, 40.24, -8.79.  
Synthesis of 3,3'-((4-(trifluoromethyl)phenyl)methylene)bis(1H-indole) (C8ab) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 4-(trifluroro) benzaldehyde (0.5 mmol) and 
indole (1 mmol) were added followed by catalyst (2.5 mol% with respect to benzaldehyde). The 
resultant solution was stirred for 12 h, upon which time product had precipitated. The cloudy 
solution was filtered and precipitate washed with hexanes (3 x 10 mL) and water (3 x 10 mL). 1H 
NMR (500 MHz, CDCl3 ) δ 8.28 (s, 2H), 7.53 (d, J = 8.1 Hz, 2H), 7.45 (d, J = 8.1 Hz, 2H), 7.36 
(t, J = 7.8 Hz, 4H), 7.18 (ddd, J = 8.0, 7.0, 1.2 Hz, 2H), 7.02 (ddd, J = 8.0, 7.0, 1.1 Hz, 2H), 6.62 
(dd, J = 2.5, 1.1 Hz, 2H), 5.95 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 136.71, 128.99, 126.85, 
125.22, 125.19, 125.16, 123.59, 122.17, 119.70, 119.45, 118.83, 111.10, 77.23, 76.97, 76.72, 
40.12. ESI-MS expected C24H17F3N2: 390.1; observed 389.1243.  
Synthesis of 3,3'-(naphthalen-1-ylmethylene)bis(1H-indole) (C8ac) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 1-naphthaldehyde (0.5 mmol) and indole (1 
mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). The clear solution 
was concentrated under reduced pressure and extracted in ethyl acetate (30 mL) from water (20 
mL). The ethyl acetate layer was dried with MgSO4 and concentrated under reduced pressure. 
The resulting oil was washed with hexanes (60 mL) resulting in a red solid which was further 
washed with water (3 x 10 mL).1H NMR (500 MHz, CDCl3) δ 8.21 – 8.15 (m, 1H), 7.89 (d, J = 
8.0 Hz, 3H), 7.75 (d, J = 8.1 Hz, 1H), 7.37 (pd, J = 20.9, 20.4, 10.5 Hz, 8H), 7.19 (t, J = 7.7 Hz, 
2H), 7.01 (t, J = 7.9 Hz, 2H), 6.68 (s, 1H), 6.59 (s, 2H).  
Synthesis of 3,3'-((4-chlorophenyl)methylene)bis(1H-indole) (C8ae) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 4-chlorobenzaldehyde (0.5 mmol) and indole 
(1 mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). The clear solution 
was concentrated under reduced pressure and extracted in ethyl acetate (30 mL) from water (20 
mL). The ethyl acetate layer was dried with MgSO4 and concentrated under reduced pressure. 
The resulting oil was washed with hexanes (60 mL) resulting in a red solid which was further 
washed with water (3 x 10mL). 1H NMR (500 MHz, CDCl3) 7.90 (s, 2H), 7.37 (t, J = 8.5 Hz, 5H), 
7.31 – 7.15 (m, 6H), 7.03 (t, J = 7.5 Hz, 2H), 6.63 (d, J = 2.4 Hz, 2H), 5.87 (s, 1H), 1.29. 13C 
NMR (126 MHz, CDCl3) δ 142.57, 136.72, 131.79, 130.05, 128.33, 126.91, 123.55, 122.06, 
119.79, 119.35, 119.23, 111.08, 77.24, 76.99, 76.73, 39.65. ESI-MS expected C23H17ClN2: 356.1; 
observed 355.0977.  
Synthesis of 3,3'-(naphthalen-2-ylmethylene)bis(1H-indole) (C8ad) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 2-napthaldehyde (0.5 mmol) and indole (1 
mmol) were added followed by catalyst (2.5 mol% with respect to benzaldehyde). The resultant 
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solution was stirred for 12 h, upon which time product had precipitated. The cloudy solution was 
filtered and precipitate washed with hexanes (3 x 10 mL) and water (3 x 10 mL). 1H NMR (500 
MHz, CDCl3 ) δ 7.89 (s, 2H), 7.75 (td, J = 29.9, 24.9, 5.8 Hz, 4H), 7.55 – 7.49 (m, 1H), 7.41 (d, 
J = 7.9 Hz, 4H), 7.35 (d, J = 8.2 Hz, 2H), 7.20 – 7.13 (m, 2H), 6.99 (d, J = 7.9 Hz, 2H), 6.67 (s, 
2H), 6.06 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 141.58, 136.73, 133.61, 132.37, 127.88, 127.72, 
127.70, 127.53, 127.13, 126.74, 125.63, 125.23, 123.72, 121.96, 119.94, 119.60, 119.29, 110.99, 
77.23, 76.98, 76.78, 76.73, 40.34, 1.00.  
Synthesis of 3,3'-(furan-2-ylmethylene)bis(1H-indole) (C8af) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), furaldehyde (0.5 mmol) and indole (1 mmol) 
were added followed by catalyst (2.5 mol% with respect to aldehyde). The clear solution was 
concentrated under reduced pressure and extracted in ethyl acetate (30 mL) from water (20 mL). 
The ethyl acetate layer was dried with MgSO4 and concentrated under reduced pressure. The 
resulting oil was washed with hexanes (60 mL) resulting in a white solid which was further 
washed with water (3 x 10 mL). 1H NMR (500 MHz, CDCl3) δ 7.64 – 7.54 (m, 5H), 7.43 (dd, J = 
1.8, 0.9 Hz, 1H), 7.18 (ddd, J = 7.9, 6.6, 1.5 Hz, 3H), 6.75 – 6.70 (m, 2H), 6.39 (dd, J = 3.2, 1.8 
Hz, 1H), 6.18 – 6.13 (m, 1H), 6.06 – 6.02 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 157.04, 153.87, 
141.19, 131.74, 127.23, 123.81, 116.89, 112.06, 111.73, 110.12, 109.99, 106.64, 101.73, 77.24, 
76.99, 76.74, 34.21. ESI-MS expected C21H16N2O: 312.1; observed 311.1173.  
Synthesis of 3,3'-(phenylmethylene)bis(5-methoxy-1H-indole) (C8aj) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), benzaldehyde (0.5 mmol) and 5- 
methoxyindole (1 mmol) were added followed by catalyst (2.5 mol% with respect to 
benzaldehyde). The resultant solution was stirred for 12 h, upon which time product had 
precipitated. The cloudy solution was filtered and precipitate washed with hexanes (3 x 10mL) 
and water (3 x 10 mL). 1H NMR (500 MHz, CDCl3) δ 7.80 (s, 2H), 7.35 (d, J = 7.7 Hz, 2H), 7.25 
(dt, J = 21.8, 10.3 Hz, 5H), 6.86 – 6.78 (m, 4H), 6.67 (d, J = 2.3 Hz, 2H), 5.77 (s, 1H), 3.69 (s, 
6H). 13C NMR (126 MHz, CDCl3) δ 153.75, 143.91, 131.90, 128.71, 128.17, 127.55, 126.08, 
124.37, 119.36, 111.92, 111.59, 102.08, 77.22, 76.97, 76.94, 76.72, 55.85, 40.32. ESI-MS 
expected C25H22N2O2: 382.2; observed 381.1582. 
Synthesis of 3,3'-((4-(trifluoromethyl)phenyl)methylene)bis(5-methoxy-1H-indole) (C8ak) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 4-(trifluoromethyl)benzaldehyde (0.5 mmol) 
and 5-methoxyindole (1 mmol) were added followed by catalyst (2.5 mol% with respect to 
benzaldehyde). The resultant solution was stirred for 12 h, upon which time product had 
precipitated. The cloudy solution was filtered and precipitate washed with hexanes (3 x 10 mL) 
and water (3 x 10mL).1H NMR (500 MHz, CDCl3) δ 7.83 (s, 2H), 7.52 (d, J = 8.0 Hz, 2H), 7.47 
– 7.41 (m, 2H), 7.22 (s, 1H), 6.87 – 6.81 (m, 2H), 6.75 (s, 2H), 6.62 (s, 2H), 5.82 (s, 1H), 3.68 (s, 
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6H). 13C NMR (126 MHz, CDCl3) δ 162.17, 153.90, 148.12, 131.91, 129.02, 128.60, 128.34, 
127.31, 125.46, 125.22, 125.19, 125.15, 125.13, 124.46, 123.30, 118.37, 112.09, 111.89, 111.80, 
109.99, 101.92, 77.25, 76.99, 76.74, 55.88, 40.19. ESI-MS expected C26H21F3N2O2: 450.2; 
observed 449.1446.  
Synthesis of 3,3'-(naphthalen-1-ylmethylene)bis(5-methoxy-1H-indole) (C8al) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 1-napthaldehyde (0.5 mmol) and 5- 
methoxyindole (1 mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). 
The clear solution was concentrated under reduced pressure and extracted in ethyl acetate (30 
mL) from water (20 mL). The ethyl acetate layer was dried with MgSO4 and concentrated under 
reduced pressure. The resulting oil was washed with hexanes (60 mL) resulting in a pink solid 
which was further washed with water (3 x 10 mL). 1H NMR (500 MHz, CDCl3) δ 8.16 (d, J = 8.5 
Hz, 1H), 7.87 (d, J = 8.2 Hz, 1H), 7.80 – 7.71 (m, 3H), 7.47 – 7.22 (m, 4H), 6.87 – 6.78 (m, 4H), 
6.58 (s, 2H), 6.52 (s, 1H), 3.66 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 153.83, 131.96, 128.60, 
126.94, 126.14, 125.71, 125.44, 125.17, 125.06, 124.34, 119.01, 111.87, 111.63, 109.99, 102.04, 
88.22, 77.22, 76.97, 76.72, 55.92, 36.03. ESI-MS expected C29H24O2N2: 432.2; observed 
431.1744.  
Synthesis of 3,3'-((4-chlorophenyl)methylene)bis(5-methoxy-1H-indole) (C8an) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 4-chlorobenzaldehyde (0.5 mmol) and 5- 
methoxyindole (1 mmol) were added followed by catalyst (2.5 mol% with respect to 
benzaldehyde). The resultant solution was stirred for 12 h, upon which time product had 
precipitated. The cloudy solution was filtered and precipitate washed with hexanes (3 x 10 mL) 
and water (3 x 10 mL).1H NMR (500 MHz, CDCl3) δ 7.81 (s, 2H), 7.24 (p, J = 9.0 Hz, 5H), 6.87 
– 6.81 (m, 2H), 6.78 (s, 2H), 6.60 (s, 2H), 5.74 (s, 1H), 3.70 (s, 6H). 13C NMR (126 MHz, CDCl3) 
δ 206.29, 153.82, 142.50, 131.92, 131.77, 130.05, 128.32, 127.36, 124.42, 118.76, 111.99, 
111.74, 102.04, 89.91, 77.25, 77.00, 76.75, 55.90, 39.71. ESI-MS expected C25H21ClO2N2: 416.1; 
observed 415.118.  
Synthesis of 3,3'-(naphthalen-2-ylmethylene)bis(5-methoxy-1H-indole) (C8am) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 2-napthadehyde (0.5 mmol) and 5- 
methoxyindole (1 mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). 
The clear solution was concentrated under reduced pressure and extracted in ethyl acetate (30 
mL) from water (20 mL). The ethyl acetate layer was dried with MgSO4 and concentrated under 
reduced pressure. The resulting oil was washed with hexanes (60 mL) resulting in a pink solid 
which was further washed with water (3 x 10 mL). 1H NMR (500 MHz, CDCl3) δ 7.77 (s, 3H), 
7.72 (s, 2H), 7.68 (s, 1H), 7.49 (s, 1H), 7.38 (s, 2H), 6.80 (s, 4H), 6.64 (s, 2H), 6.37 (s, 1H), 5.91 
(s, 1H), 3.64 – 3.60 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 165.91, 144.07, 136.72, 128.75, 
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128.23, 127.13, 126.15, 123.63, 123.61, 121.93, 119.95, 119.72, 119.26, 117.73, 111.06, 77.30, 
77.04, 76.79, 40.26, 40.24, -8.79. ESI-MS expected C29H24O2N2: 432.2; observed 431.1734.  
Synthesis of 3,3'-(furan-2-ylmethylene)bis(5-methoxy-1H-indole) (C8ao) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), furfural (0.5 mmol) and 5-methoxyindole (1 
mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). The clear solution 
was concentrated under reduced pressure and extracted in ethyl acetate (30 mL) from water (20 
mL). The ethyl acetate layer was dried with MgSO4 and concentrated under reduced pressure. 
The resulting oil was washed with hexanes (60 mL) resulting in a pink solid which was further 
washed with water (3 x 10 mL) 1H NMR (500 MHz, CDCl3) δ 7.85 (s, 2H), 7.38 (s, 1H), 7.24 (d, 
J = 8.8 Hz, 2H), 6.92 (s, 2H), 6.85 (d, J = 7.8 Hz, 4H), 6.32 (s, 1H), 6.09 (s, 1H), 5.85 (s, 1H), 
3.75 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 157.04, 153.87, 141.19, 131.74, 127.23, 123.81, 
116.89, 112.06, 111.73, 110.12, 109.99, 106.64, 101.73, 77.24, 76.99, 76.74, 55.87, 34.21.  
Synthesis of  3,3'-((5-methylfuran-2-yl)methylene)bis(5-methoxy-1H-indole) (C8ap)  
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 5-methyl-2-furaldehyde (0.5 mmol) and 5- 
methoxyindole (1 mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). 
The clear solution was concentrated under reduced pressure and extracted in ethyl acetate (30 
mL) from water (20 mL). The ethyl acetate layer was dried with MgSO4 and concentrated under 
reduced pressure. 1H NMR (500 MHz, CDCl3) δ 7.82 (s, 2H), 7.25 – 7.19 (m, 2H), 6.95 (s, 2H), 
6.84 (d, J = 9.9 Hz, 4H), 5.93 (s, 1H), 5.89 (s, 1H), 5.79 (s, 1H), 3.75 (s, 6H), 2.27 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 153.77, 153.72, 145.68, 131.76, 127.35, 123.76, 117.32, 114.23, 
111.94, 111.60, 109.85, 101.93, 77.23, 76.98, 76.72, 55.86, 34.13, 11.42, 9.93.  
Synthesis of 3,3'-((5-nitrofuran-2-yl)methylene)bis(5-methoxy-1H-indole) (C8ar)  
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 2-nitro-2-furaldehyde (0.5 mmol) and 5- 
methoxyindole (1 mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). 
The clear solution was concentrated under reduced pressure and extracted in ethyl acetate (30 
mL) from water (20 mL). The ethyl acetate layer was dried with MgSO4 and concentrated under 
reduced pressure. 1H NMR (500 MHz, CDCl3) δ 8.03 (s, 2H), 7.32 – 7.22 (m, 4H), 6.96 (d, J = 
2.5 Hz, 2H), 6.93 – 6.85 (m, 4H), 6.35 – 6.30 (m, 1H), 5.91 (d, J = 1.4 Hz, 1H), 3.77 (d, J = 1.9 
Hz, 6H).  
Synthesis of 3,3'-((5-methylfuran-2-yl)methylene)bis(1H-indole) (C8ag) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 5-methyl-furaldehyde (0.5 mmol) and indole 
(1 mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). The clear solution 
was concentrated under reduced pressure and extracted in ethyl acetate (30 mL) from water 
(20mL). The ethyl acetate layer was dried with MgSO4 and concentrated under reduced pressure. 
1H NMR (500 MHz, CDCl3) δ 7.86 (s, 2H), 7.23 (d, J = 8.7 Hz, 2H), 6.95 (d, J = 2.7 Hz, 2H), 
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6.90 – 6.81 (m, 4H), 5.83 (s, 1H), 5.74 (s, 1H), 3.75 (s, 6H), 2.18 (d, J = 3.9 Hz, 6H). 13C NMR 
(126 MHz, CDCl3) δ 155.06, 153.79, 150.59, 132.28, 131.76, 127.31, 123.82, 117.17, 111.98, 
111.66, 107.33, 105.96, 101.87, 77.25, 77.00, 76.74, 55.87, 34.24, 13.69.  
Synthesis of 3,3'-((5-nitrofuran-2-yl)methylene)bis(1H-indole) (C8ai) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 2-nitro-2-furaldehyde (0.5 mmol) and indole 
(1 mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). The clear solution 
was concentrated under reduced pressure and extracted in ethyl acetate (30 mL) from water (20 
mL). The ethyl acetate layer was dried with MgSO4 and concentrated under reduced pressure. 1H 
NMR (500 MHz, CDCl3) δ 8.08 (s, 2H), 7.50 – 7.44 (m, 2H), 7.43 – 7.31 (m, 3H), 7.29 – 7.19 
(m, 4H), 7.16 – 7.05 (m, 2H), 6.96 (dd, J = 2.5, 1.2 Hz, 2H), 6.34 – 6.29 (m, 1H), 6.01 (s, 1H). 
13C NMR (126 MHz, CDCl3) δ 161.40, 136.58, 126.29, 123.35, 122.42, 119.79, 119.20, 114.73, 
112.72, 111.35, 110.59, 77.23, 76.98, 76.72, 60.35, 34.77.  
Synthesis of 3,3'-((4,5-methylfuran-2-yl)methylene)bis(1H-indole) (C8ah) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 2-nitro-2-furaldehyde (0.5 mmol) and indole 
(1 mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). The clear solution 
was concentrated under reduced pressure and extracted in ethyl acetate (30 mL) from water 
(20mL). The ethyl acetate layer was dried with MgSO4 and concentrated under reduced pressure. 
1H NMR (500 MHz, CDCl3) δ 7.90 (s, 2H), 7.58 (d, J = 7.9 Hz, 2H), 7.36 (d, J = 7.9 Hz, 4H), 
7.04 (dd, J = 16.9, 8.9 Hz, 3H), 6.95 (s, 2H), 5.87 (d, J = 17.3 Hz, 1H), 4.69 (s, 1H), 1.83 (s, 3H). 
ESI-MS expected C22H17N2O: 326.1; observed 325.1326  
Synthesis of 3,3'-((4,5-dimethylfuran-2-yl)methylene)bis(1H-indole) (C8aq) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), 2-nitro-2-furaldehyde (0.5 mmol) and indole 
(1 mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). The clear solution 
was concentrated under reduced pressure and extracted in ethyl acetate (30 mL) from water (20 
mL). The ethyl acetate layer was dried with MgSO4 and concentrated under reduced pressure. 1H 
NMR (500 MHz, CDCl3) δ 7.72 (d, 1H), 7.63 – 7.54 (m, 2H), 7.39 (d, 1H), 7.37 – 7.16 (m, 7H), 
7.14 – 7.04 (m, 2H), 6.60 (s, 1H), 5.89 (s, 1H), 2.20 (s, 3H), 1.92 (s, 3H). ESI-MS expected 
C23H19N2O: 340.1; observed 360.1475.  
Synthesis of 3,3'-(cyclohexylmethylene)bis(1H-indole) (C8as) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL), cyclohexanecarboxaldehyde (0.5 mmol) and 
indole (1 mmol) were added followed by catalyst (2.5 mol% with respect to aldehyde). The clear 
solution was concentrated under reduced pressure and extracted in ethyl acetate (30 mL) from 
water (20 mL). The ethyl acetate layer was dried with MgSO4 and concentrated under reduced 
pressure. The compound was isolated via column chromatography (40 ethyl acetate: 60 hexanes) 
and concentrated under reduced pressure to yield a colourless oil. 12%. 1H NMR (500 MHz, 
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CDCl3) δ 7.89 (s, 2H), 7.67 (ddd, J = 7.9, 1.6, 0.8 Hz, 2H), 7.41 – 7.25 (m, 2H), 7.21 – 7.02 (m, 
6H), 4.29 (d, J = 8.8 Hz, 1H), 2.27 (dtt, J = 11.8, 8.7, 3.3 Hz, 1H), 1.85 (dd, J = 13.9, 4.0 Hz, 2H), 
1.67 (ddt, J = 17.4, 12.3, 3.9 Hz, 3H), 1.20 – 1.01 (m, 3H), 0.94 – 0.84 (m, 3H). ESI-MS expected 
C23H24N2: 328.2; observed 351.1837 (C23H24N2Na). 
Synthesis of 3,3'-(phenylmethylene)bis(2-methyl-1H-indole) (C8at) 
To a mixed solution of EtOH/H2O (2:1 in 10 mL),) benzaldehyde (0.5 mmol) and 5- 
methoxyindole (1 mmol) were added followed by catalyst (2.5 mol% with respect to 
benzaldehyde). The resultant solution was stirred for 12 h, upon which time product had 
precipitated. The cloudy solution was filtered and precipitate washed with hexanes (3 x 10mL) 
and water (3 x 10mL). 1H NMR (500 MHz, CDCl3) δ 7.72 (s, 2H), 7.32 – 7.18 (m, 6H), 7.08 – 
6.96 (m, 4H), 6.86 (t, J = 7.9 Hz, 2H), 6.02 (s, 1H), 2.07 (d, J = 2.5 Hz, 6H), 1.27 (s, 1H). 
Synthesis of 3-(2-nitro-1-phenylethyl)-1H-indole (C8ba) 
Indole (58 mg, 0.5 mmol), trans-β-nitrostyrene (74 mg, 0.5 mmol), 1.0 mol% pre-catalyst 
(1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column chromatography 
with silica (20% ethyl acetate in hexanes) to afford the title compound C8ba. 1H NMR (CDCl3, 
500 MHz): = 8.10 (s, 1H), 7.45 (d, J= 8.0 Hz, 1H), 7.35-7.26 (m, 5H), 7.21-7.18(m, 1H), 7.08-
7.02 (m ,2H), 5.21 (t, J= 8.0 Hz, 1H), 5.08 (dd, J= 7.5 Hz, 2.5Hz, 1H), 4.96 (dd, J=8.5 Hz, 8.0 
Hz, 1H). 13C NMR (CDCl3, 126 MHz): 139.46, 136.41, 128.88, 127.73, 127.52, 125.90, 122.71, 
121.56, 119.98, 118.93, 114.66, 111.32, 79.52, 41.56. 
Synthesis of 3-(2-nitro-1-(p-tolyl)ethyl)-1H-indole (C8bb) 
Indole (58 mg, 0.5 mmol), trans-4-methyl-β-nitrostyrene (81 mg, 0.5 mmol), 1.0 mol% pre-
catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bb 
(274 mg, 0.98 mmol, 98%). 1H NMR (CDCl3, 500 MHz): = 8.08 (s, 1H), 7.46 (d, J= 7.2 Hz, 1H), 
7.37 (d, J = 8.0, 1H), 7.21-7.16(m, 3H), 7.15-7.10 (m ,2H), 7.09 (d, J = 2.5 Hz, 1H) 7.04 (d, J= 
2.0 Hz, 1H), 5.17 (t, J= 7.8 Hz, 1H), 5.06 (dd, J= 7.0 Hz, 2.5Hz, 1H), 4.95 (dd, J=8.2 Hz, 8.1 Hz, 
1H), 2.32 (s, 1H). 13C NMR (CDCl3, 126 MHz): 139.60, 137.17, 134.62, 129.56, 127.59, 126.15, 
124.76, 122.66, 121.49, 119.93, 118.96, 114.68, 111.29, 79.63, 41.21, 20.99. 
Synthesis of 3-(1-(4-methoxyphenyl)-2-nitroethyl)-1H-indole (C8bc) 
Indole (58 mg, 0.5 mmol), trans-4-methoxy-β-nitrostyrene (89 mg, 0.5 mmol), 1.0 mol% pre-
catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bc. 1H 
NMR (CDCl3, 500 MHz): = 8.09 (s, 1H), 7.45 (d, J= 6.9 Hz, 1H), 7.37 (d, J = 8.2, 1H), 7.26-
7.19(m, 3H), 7.09 (d, J = 3.0 Hz, 1H) 7.03 (d, J = 2.8 Hz, 1H), 6.86 – 6.78 (m, 2H), 5.15 (t, J = 
7.2 Hz, 1H), 5.06 (dd, J= 7.0 Hz, 2.5Hz, 1H), 4.91 (dd, J=7.8 Hz, 7.6 Hz, 1H), 3.79 (s, 3H).13C 
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NMR (CDCl3, 126 MHz): 158.93, 131.30, 128.78, 122.68, 121.42, 119.93, 118.99, 114.30, 
111.31, 109.99, 107.75, 103.39, 79.75, 55.23, 40.87. 
Synthesis of 3-(1-(4-fluorophenyl)-2-nitroethyl)-1H-indole (C8bd) 
Indole (58 mg, 0.5 mmol), trans-4-fluoro-β-nitrostyrene (83 mg, 0.5 mmol), 1.0 mol% pre-
catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bd. 1H 
NMR (CDCl3, 500 MHz): = 8.11 (s, 1H), 7.40 – 7.34 (m, 2H), 7.31 – 7.26 (m, 2H), 7.22 (dd, J = 
6.8 Hz, , 2.4 Hz, 1H), 7.10 (dd, J = 7.1 Hz, 3.0 Hz, 1H) 7.02 – 6.94 (m, 3H), 5.19 (t, J = 6.6 Hz, 
1H), 5.07 (dd, J= 7.2 Hz, 2.4 Hz, 1H), 4.92 (dd, J=7.6 Hz, 7.3 Hz, 1H). 13C NMR (CDCl3, 126 
MHz): 161.1, 136.5, 131.3, 129.4, 128.3, 125.9, 122.8, 121.4, 120.0, 118.8, 115.8 (2C), 115.7, 
114.3, 79.5, 40.8. 
Synthesis of 3-(1-(4-bromophenyl)-2-nitroethyl)-1H-indole (C8be) 
Indole (58 mg, 0.5 mmol), trans-4-bromo-β-nitrostyrene (114 mg, 0.5 mmol), 1.0 mol% pre-
catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8be. 1H 
NMR (CDCl3, 500 MHz): = 8.15 (s, 1H), 7.46 – 7.38 (m, 2H), 7.37 – 7.30 (m, 2H), 7.22 – 7.14(m, 
3H), 7.10 (dd, J = 6.8 Hz, J = 2.6 Hz, 1H), 7.03 (d, J = 3.0 Hz, 1H), 5.16 (t, J = 7.4 Hz, 1H), 5.06 
(dd, J= 6.9 Hz, 2.8 Hz, 1H), 4.92 (dd, J=8.0 Hz, 7.7 Hz, 1H).13C NMR (CDCl3, 126 MHz): 138.2, 
136.8, 132.0, 131.3, 129.4, 122.8, 121.5 (2C), 120.1, 118.7, 115.1, 111.5, 79.1, 41.0. 
Synthesis of 3-(1-(2-furanyl)-2-nitroethyl)-1H-indole (C8bf) 
Indole (58 mg, 0.5 mmol), trans-2-furanyl-β-nitrostyrene (69 mg, 0.5 mmol), 1.0 mol% pre-
catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bf. 1H 
NMR (CDCl3, 500 MHz): = 8.12 (s, 1H), 7.58 (d, J= 5.8 Hz, 1H), 7.39 – 7.33 (m, 2H), 7.25-
7.18(m, 1H), 7.16-7.10 (m, 2H), 6.33 (d, J = 4.2 Hz, 1H), 6.18 (d, J= 4.0 Hz, 1H), 5.27 (t, J = 8.2 
Hz, 1H), 5.07 (dd, J= 6.8 Hz, 2.8Hz, 1H), 4.92 (dd, J=7.2 Hz, 7.0 Hz, 1H). 13C NMR (CDCl3, 126 
MHz): 152.2, 142.2, 136.3, 125.7, 122.6 (2C), 120.3, 120.1, 118.7, 111.8, 111.4, 110.4, 107.3, 
77.8, 35.7. 
Synthesis of 5-methoxy-3-(2-nitro-1-phenylethyl)-1H-indole (C8bg) 
5-methoxyindole (73 mg, 0.5 mmol), trans-β-nitrostyrene (74 mg, 0.5 mmol), 1.0 mol% pre-
catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bg. 1H 
NMR (CDCl3, 500 MHz): = 8.00 (s, 1H), 7.34 (d, J= 8.0 Hz, 4H), 7.26-7.18 (m, 2H), 7.21-7.18(m, 
1H), 7.02 – 6.92 (m ,2H), 5.15 (t, J= 7.2 Hz, 1H), 5.06 (dd, J= 8.0 Hz, 2.8 Hz, 1H), 4.95 (dd, 
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J=7.6 Hz, 6.8 Hz, 1H), 3.78 (s, 3H).13C NMR (CDCl3, 126 MHz): 154.39, 139.06, 131.46, 128.75, 
127.30, 127.05, 126.22, 123.77, 112.81, 112.19, 111.45, 110. 45, 100.68, 77.83, 55.91, 40.85. 
Synthesis of 5-bromo-3-(2-nitro-1-phenylethyl)-1H-indole (C8bh) 
5-bromoindole (98 mg, 0.5 mmol), trans-β-nitrostyrene (74 mg, 0.5 mmol), 1.0 mol% pre-catalyst 
(1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column chromatography 
with silica (20% ethyl acetate in hexanes) to afford the title compound C8bh. 1H NMR (CDCl3, 
500 MHz): = 8.22 (s, 1H), 7.6 (d, J = 1Hz, 1H), 7.33-7.18 (m ,7H), 7.03 (d, J = 2.5 Hz, 1H), 5.12 
(t, J = 8.0 Hz, 1H), 5.01 (dd, J = 8.0 Hz, 8.0 Hz, 1H), 4.91(dd, J = 8.0 Hz, 8.0 Hz, 1H). 13C NMR 
(CDCl3, 126 MHz):138.29, 136.54, 132.05, 129.46, 127.86, 126.95, 125.90, 122.88, 121.51, 
120.12, 118.78, 113.96, 111.43, 79.19, 41.04. 
Synthesis of 5-iodo-3-(2-nitro-1-phenylethyl)-1H-indole (C8bi) 
5-iodoindole (121 mg, 0.5 mmol), trans-β-nitrostyrene (74 mg, 0.5 mmol), 1.0 mol% pre-catalyst 
(1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column chromatography 
with silica (20% ethyl acetate in hexanes) to afford the title compound C8bi. 1H NMR (CDCl3, 
500 MHz): = 8.15 (s, 1H), 7.77 (d, J = 2.0 Hz, 1H), 7.45 (d, J = 2.8 Hz, 1H ), 7.33-7.24 (m ,5H), 
7.15 (d, J = 2.8 Hz, 1H), 7.04 (d, J = 2.0 Hz, 1H), 5.14 (t, J = 7.6 Hz, 1H), 5.03 (dd, J = 8.2 Hz, 
8.0 Hz, 1H), 4.93(dd, J = 8.1 Hz, 7.8 Hz, 1H). 13C NMR (CDCl3, 126 MHz): 138.63, 135.5, 
131.18, 129.02, 128.6, 127.7 (2C), 127.63, 127.63, 126.13, 122.33, 120.88, 114.47, 113.9, 113.26, 
79.39, 41.26. 
Synthesis of 5-nitro-3-(2-nitro-1-phenylethyl)-1H-indole (C8bj) 
5-nitroindole (81 mg, 0.5 mmol), trans-β-nitrostyrene (74 mg, 0.5 mmol), 1.0 mol% pre-catalyst 
(1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column chromatography 
with silica (20% ethyl acetate in hexanes) to afford the title compound C8bj. 1H NMR (CDCl3, 
500 MHz): = 8.47 (s, 1H), 8.38 (d, J = 2.5 Hz, 1H), 8.13 (dd, J = 3.5 Hz, 3.0 Hz, 1H ), 7.35-7.22 
(m ,7H), 5.25 (t, J = 7.2 Hz, 1H), 5.08 (dd, J = 7.8 Hz, 7.6 Hz, 1H), 4.97 (dd, J = 8.0 Hz, 7.8 Hz, 
1H) .13C NMR (CDCl3, 126 MHz): 142.6, 139.0, 132.30, 128.7, 126.5, 126.23, 124.10, 122.18, 
117.3, 114.2, 113.2, 111.58, 79.78, 40.85. 
Synthesis of 5-benzoxy-3-(2-nitro-1-phenylethyl)-1H-indole (C8bk) 
5-benzoxyindole (111 mg, 0.5 mmol), trans-β-nitrostyrene (74 mg, 0.5 mmol), 1.0 mol% pre-
catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bk 
(357 mg, 0.96 mmol, 96%). 1H NMR (CDCl3, 500 MHz): = 7.98 (s, 1H), 7.48 – 7.42 (m, 2H), 
7.38 – 7.34 (m, 2H), 7.33 - 7.26 (m ,4H), 7.25 (d, J = 2.5 Hz, 1H), 7.02 (d, J = 2.0 Hz, 1H), 6.94 
(d, J = 3.0 Hz, 2H), 5.12 (t, J = 6.5 Hz, 1H), 5.02 - 4.98 (m, 3H), 4.93 (dd, J = 8.0 Hz, 7.8 Hz, 
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1H). 13C NMR (CDCl3, 126 MHz): 153.4, 152.1, 142.2, 137.4, 131.6, 128.5, 127.8, 127.5, 126.1, 
123.3, 122.18, 113.5, 112.1, 111.5, 110.4, 107.3, 102.4, 77.7, 71.03, 35.7. 
Synthesis of 5-methoxy- 3-(1-(2-furanyl)-2-nitroethyl)-1H-indole (C8bl) 
5-methoxyindole (73 mg, 0.5 mmol), trans-2-furanyl-β-nitrostyrene (69 mg, 0.5 mmol), 1.0 mol% 
pre-catalyst (1ZnDy-NO3), 3 mL EtOH, rt, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bl. 1H 
NMR (CDCl3, 500 MHz): = 8.08 (s, 1H), 7.40 (d, J = 4.2 Hz, 1H), 7.27- 7.21 (m, 1H), 7.10 (d, J 
= 2.8 Hz, 1H), 6.97 (d, J = 2.5 Hz, 1H), 6.89 (d, J = 3.0, 1H), 6.33 (d, J = 3.0 Hz, 1H), 6.19 (d, 
J= 3.8 Hz, 1H), 5.22 (t, J = 7.6 Hz, 1H), 5.05 (dd, J = 7.4 Hz, 7.3 Hz, 1H), 4.91(dd, J = 7.6 Hz, 
7.4 Hz, 1H), 3.85 (s, 3H).13C NMR (CDCl3, 126 MHz): 154.39, 152.25, 142.20, 131.46, 126.22, 
123.27, 112.81, 112.19, 111.45, 110.45, 107.33, 100.68, 77.83, 55.91, 35.69. 
Synthesis of 5-bromo- 3-(1-(2-furanyl)-2-nitroethyl)-1H-indole (C8bm) 
5-bromoindole (98 mg, 0.5 mmol), trans-2-furanyl-β-nitrostyrene (69 mg, 0.5 mmol), 1.0 mol% 
pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bm. 
1H NMR (CDCl3, 500 MHz): = 8.20 (s, 1H), 7.56 (d, J = 5.8 Hz, 1H), 7.44 (d, J = 4.2 Hz, 1H), 
7.38 – 7.34 (m, 1H), 7.25-7.18(m, 1H), 7.04 (d, J = 2.0 Hz, 1H), 6.28 (d, J = 3.8 Hz, 1H), 6.18 
(d, J= 4.0 Hz, 1H), 5.16 (t, J = 7.4 Hz, 1H), 5.06 (dd, J = 8.2 Hz, 8.0 Hz, 1H), 4.94(dd, J = 8.1 
Hz, 8.0 Hz, 1H). 13C NMR (CDCl3, 126 MHz): 155.37, 142.22, 136.34, 129.40, 122.6 (2C), 
120.11, 118.71, 115.81, 111.47, 110.44, 107.36, 77.87, 35.72. 
Synthesis of 5- benzoxy-3-(1-(2-furanyl)-2-nitroethyl)-1H-indole (C8bn) 
5-benzoxyindole (111 mg, 0.5 mmol), trans-2-furanyl-β-nitrostyrene (69 mg, 0.5 mmol), 1.0 
mol% pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by 
column chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound 
C8bn. 1H NMR (CDCl3, 500 MHz): = 8.04 (s, 1H), 7.48 – 7.41 (m, 2H), 7.39 – 7.34 (m, 3H), 
7.33 - 7.28 (m ,1H), 7.27 – 7.22 (m, 1H), 7.10 (t, J = 4.2 Hz, 1H), 7.06 (t, J = 3.6 Hz, 1H), 6.97 
(d, J = 2.8 Hz, 2H), 6.31 (d, J = 4.0 Hz, 1H), 6.15 (d, J= 3.8 Hz, 1H), 5.20 (t, J = 7.0 Hz, 1H), 
5.10 – 5.03 (m, 3H), 4.87 (dd, J = 7.6 Hz, 7.4 Hz, 1H). 13C NMR (CDCl3, 126 MHz): 153.4, 
152.1, 142.2, 137.4, 131.6, 128.5, 127.8, 127.5, 126.1, 123.3, 122.18, 113.5, 112.1, 111.5, 110.4, 
107.3, 102.4, 77.7, 71.03, 35.7. 
Synthesis of 5- iodo -3-(1-(2-furanyl)-2-nitroethyl)-1H-indole (C8bo) 
5-iodoindole (137 mg, 0.5 mmol), trans-2-furanyl-β-nitrostyrene (69 mg, 0.5 mmol), 1.0 mol% 
pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bo. 1H 
NMR (CDCl3, 500 MHz): = 8.22 (s, 1H), 7.89 (d, J = 4.0 Hz, 1H), 7.48 (dd, J = 6.2 Hz, 4.0 Hz, 
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1H), 7.40 – 7.35 (m, 1H), 7.15 – 7.08 (m, 2H), 6.33 (d, J = 4.0 Hz, 1H), 6.16 – 6.10 (m, 1H), 5.19 
(t, J = 8.0 Hz, 1H), 5.04 – 4.98 (m, 1H), 4.90 (dd, J = 8.2 Hz, 8.0 Hz, 1H). 13C NMR (CDCl3, 126 
MHz): 156.58, 142.37, 131.14, 127.61, 126.15, 123.43, 119.91, 113.38, 110.51, 107.51, 88.11, 
35.47. 
Synthesis of 3-(2-nitro-1-phenylethyl)-1-methyl-indole (C8bp) 
N-methylindole (39 mg, 0.3 mmol), trans-β-nitrostyrene (44 mg, 0.3 mmol), 1.0 mol% pre-
catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bp. 1H 
NMR (CDCl3, 500 MHz): = 7.45 (d, J= 7.6 Hz, 1H), 7.33-7.26 (m, 5H), 7.24-7.18(m, 1H), 7.08-
7.02 (m , 2H), 6.87 (s, 1H), 5.19 (t, J= 7.8 Hz, 1H), 5.06 (dd, J= 7.2 Hz, 2.8Hz, 1H), 4.95 (dd, J 
= 8.0 Hz, 7.8 Hz, 1H), 3.76 (s, 3H). 13C NMR (CDCl3, 126 MHz): 139.46, 136.41, 128.88, 127.73, 
127.52, 125.90, 122.71, 121.56, 119.98, 118.93, 114.66, 111.32, 79.52, 41.56. 
Synthesis of 3-(1-(4-methoxyphenyl)-2-nitroethyl)-1-methyl-indole (C8bq) 
N-methylindole (39 mg, 0.3 mmol), trans-4-methoxy-β-nitrostyrene (54 mg, 0.3 mmol), 1.0 
mol% pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by 
column chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound 
C8bq. 1H NMR (CDCl3, 500 MHz): = 7.48 (d, J= 7.0 Hz, 1H), 7.35 – 7.28 (m, 4H), 7.25-7.18 
(m, 1H), 6.89 (d, J = 3.0 Hz, 3H), 5.18 (t, J = 7.0 Hz, 1H), 5.06 (dd, J= 7.2 Hz, 2.8Hz, 1H), 4.86 
(dd, J=8.2 Hz, 7.8 Hz, 1H), 3.67 (s, 3H), 3.62 (s, 3H). 13C NMR (CDCl3, 126 MHz): 158.90, 
137.35, 131.41, 128.75, 126.56, 126.23, 124.10, 122.18, 119.40, 119.03, 117.73, 114.28, 113.22, 
109.45, 79.78, 55.23, 40.85, 32.76. 
Synthesis of 3-(1-(4-fluorophenyl)-2-nitroethyl)-1-methyl-indole (C8br) 
N-methylindole (39 mg, 0.3 mmol), trans-4-fluoro-β-nitrostyrene (50 mg, 0.3 mmol), 1.0 mol% 
pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8br. 1H 
NMR (CDCl3, 500 MHz): = 7.42 – 7.37 (m, 1H), 7.32 – 7.24 (m, 3H), 7.24 (dd, J = 7.0 Hz, , 2.6 
Hz, 1H), 7.09 (dd, J = 7.4 Hz, 2.8 Hz, 1H) 7.02 – 6.96 (m, 2H), 6.86 (s, 1H) 5.18 (t, J = 7.2 Hz, 
1H), 5.05 (dd, J= 8.0 Hz, 2.5 Hz, 1H), 4.91 (dd, J=8.0 Hz, 8.1 Hz, 1H), 3.77 (s, 3H). 13C NMR 
(CDCl3, 126 MHz): 161.09, 137.37, 135.20, 135.17, 129.35, 129.29, 126.42, 126.19, 122.35, 
119.55, 118.90, 115.86, 115.69, 109.56, 79.57, 40.87, 32.80. 
Synthesis of 3-(1-(4-bromophenyl)-2-nitroethyl)-1-methyl-indole (C8bs) 
N-methylindole (39 mg, 0.3 mmol), trans-4-bromo-β-nitrostyrene (68 mg, 0.3 mmol), 1.0 mol% 
pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bs. 1H 
NMR (CDCl3, 500 MHz): = 7.46 – 7.42 (m, 2H), 7.41 – 7.34 (m, 1H), 7.31 (dd, J = 2.8 Hz, 1H), 
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7.24 – 7.16 (m, 3H), 7.09 (dd, J = 7.0 Hz, J = 2.8 Hz, 1H), 6.85 (s, 1H), 5.15 (t, J = 7.6 Hz, 1H), 
5.04 (dd, J= 7.2 Hz, 2.5 Hz, 1H), 4.91 (dd, J=8.0 Hz, 7.8 Hz, 1H), 3.76 (s, 3H) . 13C NMR (CDCl3, 
126 MHz): 139.46, 136.26, 134.43, 132.03, 129.26, 126.26, 125.27, 122.39, 119.60, 118.82, 
109.99, 109.57, 79.21, 41.01, 32.82. 
Synthesis of 3-(1-(2-furanyl)-2-nitroethyl)-1-methyl-indole (C8bt) 
N-methylindole (39 mg, 0.3 mmol), trans-2-furanyl-β-nitrostyrene (42 mg, 0.3 mmol), 1.0 mol% 
pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bt (267 
mg, 0.99 mmol, 99%). 1H NMR (CDCl3, 500 MHz): = 7.56 – 7.48 (m, 1H), 7.40 (dd, J = 4.3 Hz, 
1H), 7.32 – 7.29 (m, 1H), 7.27 – 7.21 (m, 1H), 7.14 (dd, J = 7.1 Hz, J = 2.8 Hz, 1H), 6.99 (s, 1H), 
6.33 (d, J = 4.0 Hz, 1H), 6.18 (d, J= 4.2 Hz, 1H), 5.25 (t, J = 8.0 Hz, 1H), 5.05 (dd, J= 7.0 Hz, 
3.0 Hz, 1H), 4.92 (dd, J=7.2 Hz, 7.0 Hz, 1H), 3.77 (s, 3H). 13C NMR (CDCl3, 126 MHz): 152.38, 
142.16, 137.16, 127.25, 126.19, 122.17, 119.58, 118.76, 110.42, 110.05, 109.60, 107.23, 77.99, 
35.68, 32.80. 
Synthesis of 3-(2-nitro-1-phenylethyl)-2-methyl-1H-indole (C8bu) 
2-methylindole (39 mg, 0.3 mmol), trans-β-nitrostyrene (44 mg, 0.3 mmol), 1.0 mol% pre-
catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bu. 1H 
NMR (CDCl3, 500 MHz): = 7.86 (s, 1H), 7.39 (d, J= 8.1 Hz, 1H), 7.30-7.21 (m, 6H), 7.13-7.08(m, 
1H), 7.05 (dd, J = 6.0 Hz, 1H), 5.23 – 5.16 (m, 2H), 5.13 (dd, J= 8.0 Hz, 2.6Hz, 1H), 2.40 (s, 3H) 
.13C NMR (CDCl3, 126 MHz): 139.54, 135.44, 132.77, 128.75, 127.30, 127.73, 127.05, 126.91, 
122.71, 121.36, 119.77, 110.67, 109.99, 108.98, 78.63, 41.47, 11.99. 
Synthesis of 3-(1-(4-fluorophenyl)-2-nitroethyl)- 2-methyl-1H-indole (C8bv) 
2-methylindole (39 mg, 0.3 mmol), trans-4-fluoro-β-nitrostyrene (50 mg, 0.3 mmol), 1.0 mol% 
pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bv. 1H 
NMR (CDCl3, 500 MHz): = 7.89 (s, 1H), 7.35 (d, J= 7.8 Hz, 1H), 7.29-7.20 (m, 3H), 7.14-7.08(m, 
1H), 7.05 (dd, J = 6.2 Hz, 1H), 6.99 – 6.92 (m, 2H), 5.20 – 5.12 (m, 2H), 5.09 (dd, J= 8.2 Hz, 3.0 
Hz, 1H), 2.42 (s, 3H).13C NMR (CDCl3, 126 MHz): 162.74, 135.42, 132.69, 128.90, 128.84, 
126.72, 121.50, 119.89, 118.44, 115.69, 115.52, 115.69, 110.72, 109.99, 108.83, 78.66, 40.87, 
39.85, 12.03. 
Synthesis of 3-(1-(4-bromophenyl)-2-nitroethyl)- 2-methyl-1H-indole (C8bw) 
2-methylindole (39 mg, 0.3 mmol), trans-4-bromo-β-nitrostyrene (68 mg, 0.3 mmol), 1.0 mol% 
pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bw. 
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1H NMR (CDCl3, 500 MHz): = 7.91 (s, 1H), 7.43 – 7.38 (m, 2H), 7.30 - 7.24 (m, 2H), 7.20 - 
7.15(m, 2H), 7.14 – 7.09 (m, 1H), 7.05 – 6.99 (m, 1H), 5.21 (d, J = 8.0 Hz, 7.8 Hz, 1H), 5.15 – 
5.10 (m, 1H), 5.08 (dd, J= 7.6 Hz, 3.2 Hz, 1H), 2.42 (s, 3H). 13C NMR (CDCl3, 126 MHz): 138.59, 
135.43, 132.79, 131.85, 130.50, 129.02, 126.65, 124.79, 121.04, 119.94, 118.38, 110.75, 108.46, 
78.32, 41.01, 39.97, 12.02. 
Synthesis of 3-(1-(2-furanyl)-2-nitroethyl)- 2-methyl-1H-indole (C8bx) 
2-methylindole (39 mg, 0.3 mmol), trans-2-furanyl-β-nitrostyrene (42 mg, 0.3 mmol), 1.0 mol% 
pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8bx. 1H 
NMR (CDCl3, 500 MHz): = 7.90 (s, 1H), 7.39 – 7.32 (m, 2H), 7.28 - 7.22 (m, 1H), 7.14 – 7.08 
(m, 1H), 7.06 – 6.99 (m, 1H), 6.31 (d, J = 3.8 Hz, 1H), 6.10 (d, J = 4.0 Hz, 1H), 5.20 – 5.12 (m, 
2H), 4.95 – 4.88 (m, 1H), 2.41 (s, 3H). 13C NMR (CDCl3, 126 MHz): 152.31, 141.94, 135.40, 
133.07, 126.63, 121.47, 119.75, 118.53, 110.63, 110.43, 109.99, 107.21, 78.71, 35.68, 35.29, 
11.77. 
Synthesis of 3-(2-nitro-1-(p-tolyl)ethyl)-2-methyl-1H-indole (C8by) 
2-methylindole (39 mg, 0.3 mmol), trans-4-methyl-β-nitrostyrene (49 mg, 0.3 mmol), 1.0 mol% 
pre-catalyst (1ZnDy-NO3), 3 mL EtOH, r.t, 24 h. The crude product was purified by column 
chromatography with silica (20% ethyl acetate in hexanes) to afford the title compound C8by. 1H 
NMR (CDCl3, 500 MHz): = 7.85 (s, 1H), 7.38 (d, J = 4.2 Hz, 1H), 7.32 - 7.25 (m, 3H), 7.20 - 
7.12(m, 3H), 7.08 – 7.01 (m, 1H), 5.20 – 5.08 (m, 3H), 2.46 (s, H), 2.42 (s, 3H). 13C NMR (CDCl3, 
126 MHz): 136.66, 136.45, 135.42, 132.64, 129.41, 127.16, 126.93, 121.31, 119.72, 118.65, 
110.60, 109.60, 78.73, 41.01, 40.14, 20.91, 12.02. 
Synthesis of compound (C8ca) 
Salicylaldehyde (61 mg, 0.5 mmol), indoline (59 mg, 0.5 mmol), benzene boronic acid (61 mg, 
0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude product was purified by 
column chromatography with silica (10% ethyl acetate in hexanes) to afford the title compound 
C8ca (289 mg, 0.96 mmol, 96%). 1H NMR (CDCl3, 500 MHz): δ = 11.03 (s, 1H), 7.54 – 7.48 (m, 
1H), 7.46 – 7.39 (m, 2H), 7.32 – 7.26 (m, 3H), 7.19 – 7.15 (m, 1H), 7.14 – 7.11 (m, 1H), 6.99 – 
6.92 (m , 3H), 6.90 (dd, J = 5.2 Hz, 3.8 Hz, 1H), 6.83 – 6.78 (m, 2H), 6.49 (d, J=6.0 Hz, 1H), 5.34 
(s, 1H), 3.21 (m, 1H), 3.01 (m, 1H), 2.93 (m, 1H). 13C NMR (CDCl3, 126 MHz): δ = 156.22, 
151.08, 139.54, 132.12, 128.50, 128.02, 127.37, 124.60, 121.08, 119.79, 117.02, 111.76, 69.98, 
53.00, 28.51. 
Synthesis of compound (C8cb) 
Salicylaldehyde (61 mg, 0.5 mmol), morpholine (43 mg, 0.5 mmol), benzene boronic acid (61 
mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude product was purified by 
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column chromatography with silica (10% ethyl acetate in hexanes) to afford the title compound 
C8cb (255 mg, 0.95 mmol, 95%). 1H NMR (CDCl3, 500 MHz): δ = 10.36 (s, 1H), 7.43 – 7.38 
(m, 2H), 7.46 – 7.39 (m, 2H), 7.28 – 7.24 (m, 3H), 7.19 – 7.16 (m, 1H), 7.01 – 6.96 (m, 1H), 6.74 
– 6.69 (m ,2H), 4.64 (s, 1H), 3.60 (t, J = 5.2, 4H), 2.34 – 2.26 (m, 4H). 13C NMR (DMSO-d6, 126 
MHz): δ = 155.74, 147.70, 128.90, 128.88, 128.82, 128.58, 128.47, 128.14, 127.53, 127.36, 
119.65, 116.31, 66.69, 52.50. 
Synthesis of compound (C8cc) 
Salicylaldehyde (61 mg, 0.5 mmol), N-methylaniline (53 mg, 0.5 mmol), benzene boronic acid 
(61 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude product was purified 
by column chromatography with silica (10% ethyl acetate in hexanes) to afford the title compound 
C8cc (271 mg, 0.94 mmol, 94%). 1H NMR (CDCl3, 500 MHz): δ = 9.79 (s, 1H), 7.24 – 7.12 (m, 
8H), 7.03 – 6.94 (m, 2H), 6.96 – 6.89 (m, 3H), 6.79 – 6.74 (m, 1H), 5.86 (s, 1H), 2.83 (s, 3H). 13C 
NMR (CDCl3, 126 MHz): δ = 157.63, 149.45, 142.71, 131.90, 128.14, 26.88, 123.99, 121.72, 
119.60, 117.33, 114.66, 68.55, 37.50. 
Synthesis of compound (C8cd) 
Salicylaldehyde (61 mg, 0.5 mmol), N-benzylmethylamine (60 mg, 0.5 mmol), benzene boronic 
acid (61 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude product was 
purified by column chromatography with silica (10% ethyl acetate in hexanes) to afford the title 
compound C8cd (282 mg, 0.93 mmol, 93%). 1H NMR (CDCl3, 500 MHz): δ = 12.31 (s, 1H), 7.50 
– 7.54 (m, 2H), 7.33 – 7.23 (m, 8H), 7.16 – 7.10 (m, 1H), 6.93 – 6.84 (m, 2H), 6.73 – 6.68 (m, 
1H), 4.72 (s, 1H), 3.58 (s, 2H), 2.19 (s, 3H). 13C NMR (CDCl3, 126 MHz): δ = 156.94, 138.79, 
136.90, 129.25, 129.10, 128.94, 128.76, 128.63, 128.55, 128.02, 127.51, 125.24, 122.58, 118.83, 
117.21, 75.53, 59.65, 38.92. 
Synthesis of compound (C8ce) 
Salicylaldehyde (61 mg, 0.5 mmol), diallylamine (48 mg, 0.5 mmol), benzene boronic acid (61 
mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude product was purified by 
column chromatography with silica (10% ethyl acetate in hexanes) to afford the title compound 
C8ce (251 mg, 0.90 mmol, 90%). 1H NMR (CDCl3, 500 MHz): δ = 12.08 (s, 1H), 7.43 – 7.37 (m, 
2H), 7.37 – 7.32 (m, 2H), 7.31 – 7.27 (m, 1H), 7.13 – 7.09 (m, 1H), 6.86 – 6. 78 (m, 2H), 6.69 (t, 
J = 6.2, 1H), 5.91 – 5.83 (m, 2H), 5.25 – 5.18 (m, 2H), 5.16 – 5.08 (m, 2H), 5.06 (s, 1H), 3.38 – 
3.32 (m, 2H), 3.07 – 3.02 (m, 2H). 13C NMR (CDCl3, 126 MHz): δ = 143.32, 133.50, 130.18, 
129.53, 128.36, 127.83, 126.76, 121.28, 119.48, 118.41, 116.12, 71.39, 56.22. 
Synthesis of compound C8cf 
2-methoxybenzaldehyde (68 mg, 0.5 mmol), indoline (59 mg, 0.5 mmol), benzene boronic acid 
(61 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude product was purified 
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by column chromatography with silica (10% ethyl acetate in hexanes) to afford the title compound 
C8cf (314 mg, 0.95 mmol, 95%). 1H NMR (CDCl3, 500 MHz): δ = 7.56 (s, 1H), 7.44 – 7.36 (m, 
2H), 7.31 – 7.24 (m, 3H), 7.10 (dd, J = 4.5, J = 3.6, 1H), 6.95 – 6.90 (m, 1H), 6.82 – 6.75 (m, 
3H), 6.72 – 6.68 (m, 1H), 6.33 (d, J = 4.8 Hz), 5.72 (s, 1H), 3.90 (s, 3H), 3.21- 3.14 (m, 2H), 2.95 
(t, J = 6.2 Hz, 2H). 13C NMR (CDCl3, 126 MHz): δ = 151.78, 147.15, 144.31, 140.67, 130.87, 
128.55, 128.41, 127.32, 127.19, 124.22, 121.14, 120.65, 119.42, 118.70, 109.88, 109.53, 63.54, 
55.98, 52.32, 28.43. 
Synthesis of compound (C8cg) 
2-methoxybenzaldehyde (68 mg, 0.5 mmol), indoline (59 mg, 0.5 mmol), benzene boronic acid 
(61 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude product was purified 
by column chromatography with silica (10% ethyl acetate in hexanes) to afford the title compound 
C8cg (287 mg, 0.93 mmol, 93%).1H NMR (CDCl3, 500 MHz): δ = 12.32 (s, 1H), 7.48 – 7.37 (m, 
4H), 6.58 – 6.52 (m, 1H), 6. 51 – 6. 44 (m, 3H), 5.86 – 6.77 (m, 2H), 5.24 – 5. 12 (m, 5H), 3.78 
(s, 3H), 3.44 – 3. 38 (m, 2H), 3.24 – 2.17 (m, 2H). 13C NMR (CDCl3, 126 MHz): δ = 148.68, 
144.39, 142.91, 134.23, 129.35, 128.49, 127.98, 126.99, 123.60, 121.15, 118.47, 110.72, 73.03, 
58.13, 52.28. 
Synthesis of compound (C8ch) 
2-methoxybenzaldehyde (68 mg, 0.5 mmol), indoline (59 mg, 0.5 mmol), 4-
Methoxyphenylboronic acid (76 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. 
The crude product was purified by column chromatography with silica (10% ethyl acetate in 
hexanes) to afford the title compound C8ch (354 mg, 0.98 mmol, 98%). 1H NMR (CDCl3, 500 
MHz): δ = 7.36 – 7.28 (m, 2H), 7.13 – 7.08 (m, 1H), 7.05 – 6.99 (m, 1H), 6.96 - 6.88 (m, 3H), 
6.87 – 6. 82 (m, 2H), 6.80 – 6. 74 (m, 1H), 6.36 (d, J = 4.8 Hz, 1H), 5.64 (s, 1H), 3.90 (s, 3H), 
3.81 (s, 3H), 3.21 – 3.14 (m, 2H), 2.95 (t, J = 5.2 Hz, 2H). 13C NMR (CDCl3, 126 MHz): δ = 
158.61, 151.92, 147.43, 144.20, 132.39, 130.89, 129.80, 126.81, 124.21, 120.76, 119.26, 118.39, 
113.27, 109.69, 109.46, 63.58, 55.96, 55.20. 
Synthesis of compound (C8cl) 
2-methoxybenzaldehyde (68 mg, 0.5 mmol), diallylamine (48 mg, 0.5 mmol), 4-
Methoxyphenylboronic acid (76 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. 
The crude product was purified by column chromatography with silica (10% ethyl acetate in 
hexanes) to afford the title compound C8cl (315 mg, 0.93 mmol, 93%). 1H NMR (CDCl3, 500 
MHz): δ = 12.45 (s, 1H), 7.34 –7. 27 (m, 2H), 6.88 – 6.80 (m, 2H), 6.77 – 6.72 (m, 1H), 6.65 (t, 
1H), 6.46 – 6.39 (m, 1H), 5.91 – 5. 84 (m, 2H), 5.22 -5.15 (m, 3H), 5.02 (s, 1H), 3.89 (s, 3H), 
3.81 (s, 3H), 3.37 – 3.31 (m, 2H), 3.06 – 2.99 (m, 2H). 13C NMR (CDCl3, 126 MHz): δ = 159.30, 
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148.30, 146.97, 135.50, 130.61, 130.18, 125.51, 121.20, 119.35, 118.41, 113.93, 113.56, 110.68, 
69.24, 55.20, 52.27. 
Synthesis of compound (C8cj) 
5-allyl-2-hydroxy-3-methoxybenzaldehyde (96 mg, 0.5 mmol), indoline (59 mg, 0.5 mmol), 
benzene boronic acid (61 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude 
product was purified by column chromatography with silica (10% ethyl acetate in hexanes) to 
afford the title compound C8cj (322 mg, 0.87 mmol, 87%). 1H NMR (CDCl3, 500 MHz): δ = 7.45 
(dd, J = 6.4 Hz, 4.5 Hz, 2H), 7.31 – 7.24 (m, 3H), 7.20 – 7.15 (m, 1H), 7.13 – 7.06 (m, 3H), 6.95 
– 6.88 (m, 1H), 6.55 – 6.48 (m, 2H), 5.91 – 5. 86 (m, 1H), 5.65 (s, 1H), 5.02 – 4.94 (m, 2H), 3.88 
(s, 3H), 3.29 – 3.23 (m, 2H), 3.20 – 3.08 (m, 3H), 2.94 – 2.87 (m, 2H). 13C NMR (CDCl3, 126 
MHz): δ = 151.87, 147.13, 142.58, 140.72, 137.81, 131.06, 128.54, 128.40, 128.16, 127.30, 
127.19, 124.19, 120.88, 119.56, 118.82, 115.47, 110.34, 109.75, 64.13, 56.04, 52.45, 39.95, 
28.45. 
Synthesis of compound (C8ck) 
5-allyl-2-hydroxy-3-methoxybenzaldehyde (96 mg, 0.5 mmol), diallylamine (48 mg, 0.5 mmol), 
benzene boronic acid (61 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude 
product was purified by column chromatography with silica (10% ethyl acetate in hexanes) to 
afford the title compound C8ck (293 mg, 0.84 mmol, 84%). 1H NMR (CDCl3, 500 MHz): δ = 
12.08 (s, 1H), 7.44 – 7.38 (m, 2H), 7.32 – 7.24 (m, 3H), 6.59 (d, 1H), 6.31 (d, 1H), 5.89 – 5.81 
(m, 3H), 5.22 – 5.17 (m, 2H), 5.13 – 5.09 (m, 2H), 5.00 – 4.94 (m, 3H), 3.88 (s, 3H), 3.44 – 3.39 
(m, 2H), 3.19 – 3.14 (m, 2H), 3.10 – 3.05 (m, 2H). 13C NMR (CDCl3, 126 MHz): δ = 148.19, 
144.87, 137.80, 133.29, 129.24, 127.91, 123.71, 122.48, 120.92, 119.38, 110.09, 70.39, 55.91, 
52.28. 
Synthesis of compound (C8cl) 
5-allyl-2-hydroxy-3-methoxybenzaldehyde (96 mg, 0.5 mmol), indoline (59 mg, 0.5 mmol), 4-
methoxyphenylboronic acid (76 mg, 0.5 mmol),1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The 
crude product was purified by column chromatography with silica (10% ethyl acetate in hexanes) 
to afford the title compound C8cl (357 mg, 0.89 mmol, 89%). 1H NMR (CDCl3, 500 MHz): δ = 
7.90 (s, 1H), 7.34 – 7.28 (m, 2H), 7.10 – 7.04 (m, 2H), 6.95 – 6.91 (m, 1H), 6.88 – 6.82 (m, 2H), 
6.66 – 6.56 (m, 4H), 6.35 – 6.30 (m, 1H), 5.94 – 5.90 (m, 1H), 5.54 (s, 1H), 5.05 – 4.94 (m, 2H), 
3.87 (m, 3H), 3.80 (m, 3H) 3.28 – 3.24 (m, 2H), 3.11 – 3. 05 (m, 3H), 2.98 (t, J = 4.6 Hz, 2H). 
13C NMR (CDCl3, 126 MHz): δ = 158.86, 151.68, 146.99, 142.72, 137.83, 132.72, 131.14, 129.75, 
129.46, 127.20, 124.20, 121.37, 120.63, 119.03, 115.54, 113.94, 113.81, 110.33, 110.03, 64.11, 
55.11, 52.70, 40.32, 28.53. 
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Synthesis of compound (C8cm) 
5-allyl-2-hydroxy-3-methoxybenzaldehyde (96 mg, 0.5 mmol), diallylamine (48 mg, 0.5 mmol), 
4-methoxyphenylboronic acid (76 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. 
The crude product was purified by column chromatography with silica (10% ethyl acetate in 
hexanes) to afford the title compound C8cm (326 mg, 0.86 mmol, 86%).1H NMR (CDCl3, 500 
MHz): δ = 9.98 (s, 1H), 7.33 (dd, J = 6.2 Hz, 4.5Hz, 2H), 6.85 – 6.79 (m, 2H), 6.64 (t, J = 4.8 Hz, 
1H), 6.59 – 6.54 (m, 1H), 5.85 – 5. 79 (m, 3H), 5.14 – 5.08 (m, 2H), 5.04 – 4.94 (m, 5H), 3.71 (s, 
3H), 3.69 (s, 3H), 3.32 (s, 2H), 3.20 – 3.14 (m, 2H), 3.09 – 3.02 (m, 3H). 13C NMR (CDCl3, 126 
MHz): δ = 158.76, 148.08, 143.29, 138.45, 134.66, 133.60, 130.29, 129.64, 127.87, 127.63, 
120.13, 118.59, 115.93, 114.40, 111.32, 65.70, 56.01, 55.36, 52.23. 
Synthesis of compound (C8cn) 
Salicylaldehyde (122 mg, 1.0 mmol), indoline (118 mg, 1.0 mmol), benzene 1, 4-diboronic acid 
(83 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude product was purified 
by column chromatography with silica (10% ethyl acetate in hexanes) to afford the title compound 
C8cn (482 mg, 0.92 mmol, 92%).1H NMR (CDCl3, 500 MHz): δ = 9.99 (s, 2H), 7.43 (s, 3H), 
7.21 – 7.17 (m, 2H), 7.15 – 7.10 (m, 2H), 6.98 – 6.93 (m , 3H), 6.91 – 6.87 (m, 2H), 6.85 – 6.80 
(m, 3H), 6.44 – 6.40 (m, 2H), 5.31 (s, 2H), 3.17 – 3.13 (m, 2H), 3.07 – 3.02 (m, 2H), 2.93 – 2.86 
(m, 4H) . 13C NMR (CDCl3, 126 MHz): δ = 156.24, 151.01, 150.99, 139.38, 139.37, 132.10, 
129.30, 129.26, 128.92, 128.47, 127.36, 126.19, 126.13, 124.63, 121.30, 120.06, 117.73, 117.10, 
112.06, 69.84, 69.81, 53.57, 53.52, 28.51. 
Synthesis of compound (C8co) 
2-methoxybenzaldehyde (136 mg, 1.0 mmol), indoline (118 mg, 1.0 mmol), benzene 1, 4-
diboronic acid (83 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude 
product was purified by column chromatography with silica (10% ethyl acetate in hexanes) to 
afford the title compound C8co (555 mg, 0.95 mmol, 95%). 1H NMR (CDCl3, 500 MHz): δ = 
7.35 (s, 4H), 7.08 (d, 2H), 6.92 (t, 2H), 6.79 – 6. 72 (m, 6H), 6.69 (t, 2H), 6.30 (d, 2H), 5.69 (d, 
2H), 3.89 (s, 6H), 3.18 – 3.12 (m, 4H), 2.92 (t, 4H). 13C NMR (CDCl3, 126 MHz): δ = 151.78, 
147.15, 144.31, 140.67, 130.87, 128.55, 128.41, 127.32, 127.19, 124.22, 121.14, 120.65, 119.42, 
118.70, 109.88, 109.53, 63.54, 55.98, 52.32, 28.43. 
Synthesis of compound (C8cp) 
Salicylaldehyde (122 mg, 1.0 mmol), diallylamine (96 mg, 1.0 mmol), benzene 1, 4-diboronic 
acid (83 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude product was 
purified by column chromatography with silica (10% ethyl acetate in hexanes) to afford the title 
compound C8cp (413 mg, 0.86 mmol, 86%).1H NMR (CDCl3, 500 MHz): δ = 11.97 (s, 2H), 7.40 
(s, 4H), 7.14 – 7.10 (m, 2H), 6.84 – 6. 79 (m, 4H), 6.70 – 6.65 (m, 2H), 5.88 – 5. 81 (m, 4H), 5.22 
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– 5. 16 (m, 4H), 5.13 – 5.08 (m, 4H), 5.00 (m, 2H), 3.34 – 3.29 (m, 4H), 3.07 – 2.97 (m, 4H). 13C 
NMR (CDCl3, 126 MHz): δ = 157.43, 137.73, 133.28, 129.64, 129.20, 128.64, 124.80, 119.46, 
119.04, 116.92, 69.99, 51.91. 
Synthesis of compound (C8cq) 
2-methoxybenzaldehyde (136 mg, 1.0 mmol), diallylamine (96 mg, 1.0 mmol), benzene 1, 4-
diboronic acid (83 mg, 0.5 mmol), 1.0 mol% 1ZnDy-NO3, 5 mL DME, r.t, 16 h. The crude 
product was purified by column chromatography with silica (10% ethyl acetate in hexanes) to 
afford the title compound C8cq (475 mg, 0.88 mmol, 88%).1H NMR (CDCl3, 500 MHz): δ = 
12.15 (s, 2H), 7.40 (s, 4H), 6.78 – 6.73 (m, 2H), 6.66 – 6.60 (m, 2H), 6.47 – 6.42 (m, 2H), 5.88 – 
5.79 (m, 4H), 5.16 – 5. 05 (m, 8H), 4.98 (d, 2H), 3.89 (s, 6H), 3.33 – 3.27 (m, 4H), 3.09 – 3.04 
(m, 4H). 13C NMR (CDCl3, 126 MHz): δ = 148.21, 146.94, 141.78, 133.24, 129.74, 123.78, 
121.16, 119.43, 110.64, 69.79, 55.92, 52.23. 
Synthesis of 1,3-dimethyl-5-(2-nitro-1-phenyl-ethyl)-pyrimidine-2,4,6-trione (C9a) 
trans-β-nitrostyrene (44 mg, 0.3 mmol), 1,3-dimethylbarbituric acid (47 mg ,0.3 mmol), 2.5 mol% 
1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 15 min. The crude product 
was purified by column chromatography with silica (20% ethyl acetate in hexanes) to afford the 
title compound C9a. 1H NMR (500 MHz, Chloroform-d) δ 7.35 – 7.23 (m, 3H), 7.07 – 6.97 (m, 
2H), 5.28 (ddd, J = 14.3, 7.9, 1.3 Hz, 1H), 4.99 (ddd, J = 14.2, 7.6, 1.4 Hz, 1H), 4.48 (td, J = 7.7, 
3.5 Hz, 1H), 3.88 – 3.81 (m, 1H), 3.18 – 3.02 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 166.82, 
166.79, 150.46, 133.76, 129.73,129.12, 127.61, 51.47, 45.47, 39.36, 28.34, 28.1 
Synthesis of 5-[1-(4-methoxy-phenyl)-2-nitro-ethyl]-1,3-dimethyl-pyrimidine-2,4,6-trione 
(C9b) 
trans-4-methoxy-β-nitrostyrene (48 mg, 0.3 mmol), 1,3-dimethylbarbituric acid (47 mg ,0.3 
mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 15 min. 
The crude product was purified by column chromatography with silica (15% ethyl acetate in 
hexanes) to afford the title compound C9c. 1H NMR (500 MHz, CDCl3) δ 7.12 – 7.03 (m, 2H), 
6.93 – 6.84 (m, 2H), 5.30 – 5.20 (m, 1H), 4.95 (ddd, J = 14.2, 7.8, 1.7 Hz, 1H), 4.43 (td, J = 7.9, 
3.3 Hz, 1H), 3.83 (dd, J = 3.5, 1.8 Hz, 1H), 3.18 – 3.04 (m, 6H), 2.34 – 2.25 (m, 3H). 13C NMR 
(126 MHz, CDCl3) δ 167.12, 150.54, 149.29, 139.74, 130.59, 129.76, 127.47 53.57, 45.24, 28.34, 
28.15, 21.00. 
Synthesis of 5-[1-(4-fluoro-phenyl)-2-nitro-ethyl]-1,3-dimethyl-pyrimidine-2,4,6-trione 
(C9e) 
trans-4-fluoro-β-nitrostyrene (50 mg, 0.3 mmol), 1,3-dimethylbarbituric acid (47 mg ,0.3 mmol), 
2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 15 min. The crude 
product was purified by column chromatography with silica (10% ethyl acetate in hexanes) to 
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afford the title compound C9e.1H NMR (500 MHz, CDCl3) δ 7.09 (ddd, J = 8.6, 5.4, 2.8 Hz, 2H), 
7.05 – 6.94 (m, 2H), 5.27 (dd, J = 14.2, 7.7 Hz, 1H), 5.05 – 4.97 (m, 1H), 4.55 (td, J = 7.8, 3.3 
Hz, 1H), 3.85 (d, J = 3.4 Hz, 1H), 3.18 (s, 3H), 3.13 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
166.63, 166.49, 163.89, 150.36, 129.50, 129.44, 116.36, 116.18, 51.42, 44.32, 28.53, 28.33. 
Synthesis of 5-[1-(4-Methyl-phenyl)-2-nitro-ethyl]-1,3-dimethyl-pyrimidine-2,4,6-trione 
(C9c) 
trans-4-methyoxy-β-nitrostyrene (54 mg, 0.3 mmol), 1,3-dimethylbarbituric acid (47 mg ,0.3 
mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 15 min. 
The crude product was purified by column chromatography with silica (10% ethyl acetate in 
hexanes) to afford the title compound C9b. 1H NMR (500 MHz, CDCl3) δ 6.97 (d, J = 8.5 Hz, 
2H), 6.83 – 6.77 (m, 2H), 5.25 (dd, J = 14.0, 7.9 Hz, 1H), 4.97 (dd, J = 14.0, 7.8 Hz, 1H), 4.47 
(td, J = 7.9, 3.4 Hz, 1H), 3.82 (d, J = 3.5 Hz, 1H), 3.77 (d, J = 1.0 Hz, 3H), 3.16 (d, J = 1.0 Hz, 
3H), 3.11 (d, J = 1.0 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 167.12, 166.90, 150.54, 129.76, 
127.47, 127.27, 53.57, 51.50, 45.24, 39.35, 28.79, 28.67 
Synthesis of 5-[1-(4-Bromo-phenyl)-2-nitro-ethyl]-1,3-dimethyl-pyrimidine-2,4,6-trione 
(C9d) 
trans-4-bromo-β-nitrostyrene (66 mg, 0.3 mmol), 1,3-dimethylbarbituric acid (47 mg ,0.3 mmol), 
2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 15 min. The crude 
product was purified by column chromatography with silica (5% ethyl acetate in hexanes) to 
afford the title compound C9d. 1H NMR (500 MHz, CDCl3) δ 7.47 – 7.41 (m, 2H), 7.03 – 6.97 
(m, 2H), 5.28 (dd, J = 14.2, 7.8 Hz, 1H), 5.01 (dd, J = 14.2, 7.8 Hz, 1H), 4.55 (td, J = 7.8, 3.4 Hz, 
1H), 3.87 (d, J = 3.4 Hz, 1H), 3.68 (s, 3H), 3.18 (d, J = 19.1 Hz, 6H). 13C NMR (126 MHz, CDCl3) 
δ 166.71, 166.53, 162.73, 130.22, 129.27, 116.36, 109.98, 101.25, 77. 24, 76.81, 76.94, 51.35, 
43.91, 29.01 
Synthesis of C9f 
trans-β-methyl-β-nitrostyrene (48 mg, 0.3 mmol), 1,3-dimethylbarbituric acid (47 mg ,0.3 mmol), 
2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 15 min. The crude 
product was purified by column chromatography with silica (15% ethyl acetate in hexanes) to 
afford the title compound C9f. 1H NMR (500 MHz, CDCl3) δ 7.29 (dd, J = 4.9, 2.0 Hz, 3H), 7.05 
– 6.99 (m, 2H), 5.61 (dd, J = 11.6, 6.6 Hz, 1H), 4.13 (dd, J = 11.5, 3.6 Hz, 1H), 3.72 (d, J = 3.6 
Hz, 1H), 3.14 (s, 3H), 3.01 (s, 3H), 1.39 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
166.81, 166.75, 150.54, 133.73, 129.24, 129.21, 129.13, 128.17, 88.25, 82.93, 77.31, 77.05, 
76.80, 51.86, 50.81, 28.27, 28.15, 19.50 
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Synthesis of 5-(1-Furan-2-yl-2-nitro-ethyl)-1,3-dimethyl-pyrimidine-2,4,6-trione (C9g) 
2-(2-Nitrovinyl) furan (45 mg, 0.3 mmol), 1,3-dimethylbarbituric acid (47 mg ,0.3 mmol), 2.5 
mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1 h. The crude product 
was purified by column chromatography with silica (15% ethyl acetate in hexanes) to afford the 
title compound C9g.1H NMR (500 MHz, CDCl3) δ 7.29 (s, 1H), 6.32 – 6.27 (m, 1H), 6.18 – 6.14 
(m, 1H), 5.18 (dd, J = 14.3, 7.6 Hz, 1H), 4.97 (dd, J = 14.3, 7.5 Hz, 1H), 4.69 (td, J = 7.6, 3.2 Hz, 
1H), 3.88 – 3.83 (m, 1H), 3.23 (s, 6H).13C NMR (126 MHz, CDCl3) δ 166.34, 150.81, 147.88, 
143.22, 110.86, 108.82, 77.27, 77.02, 76.76, 74.72, 49.79, 46.33, 39.04, 28.69, 28.51, 8.61. 
Synthesis of C9h 
trans-β-nitrostyrene (44 mg, 0.3 mmol), 6-amino-1,3-dimethyluracil (47 mg ,0.3 mmol), 2.5 
mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 15 min. The crude 
product was purified by column chromatography with silica (15% ethyl acetate in hexanes) to 
afford the title compound C9h. 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.23 (m, 5H), 5.42 (dd, J = 
13.2, 8.0 Hz, 1H), 5.10 (dd, J = 13.4, 6.7 Hz, 1H), 4.84 (d, J = 12.3 Hz, 2H), 4.67 (t, J = 7.5 Hz, 
1H), 3.39 (d, J = 5.1 Hz, 4H), 3.28 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 162.05, 151.69, 151.00, 
138.63, 128.98, 127.63, 127.22, 109.99, 77.32, 77.06, 77.00, 76.81, 60.42, 40.21, 29.48, 29.04, 
28.06, 21.01, 14.15. ESI-MS [C14H16N4Na1O4] – 327.1064 
Synthesis of C9i 
trans-4-methoxy-β-nitrostyrene (54 mg, 0.3 mmol), 6-amino-1,3-dimethyluracil (47 mg ,0.3 
mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 15 min. 
The crude product was purified by column chromatography with silica (15% ethyl acetate in 
hexanes) to afford the title compound C9i. 1H NMR (500 MHz, CDCl3 ) δ 7.00 – 6.90 (m, 2H), 
6.90 – 6.83 (m, 2H), 5.41 (dd, J = 13.4, 7.7 Hz, 1H), 5.08 (dd, J = 13.3, 6.9 Hz, 1H), 4.65 – 4.56 
(m, 1H), 4.54 (s, 2H), 3.43 (s, 3H), 3.32 (s, 3H), 1.25 (d, J = 0.6 Hz, 3H). ESI-MS 
[C15H18N4Na1O4] – 357.1169 
Synthesis of C9j 
trans-4-methyl-β-nitrostyrene (48 mg, 0.3 mmol), 6-amino-1,3-dimethyluracil (47 mg ,0.3 
mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 15 min. 
The crude product was purified by column chromatography with silica (5% ethyl acetate in 
hexanes) to afford the title compound C9j. 1H NMR (500 MHz, CDCl3) δ 7.30 – 7.24 (m, 2H), 
7.21 (s, 0H), 7.15 (d, J = 7.8 Hz, 2H), 5.45 – 5.37 (m, 1H), 5.13 – 5.05 (m, 1H), 4.63 (t, J = 7.4 
Hz, 1H), 4.53 (s, 2H), 3.43 (d, J = 2.9 Hz, 3H), 3.32 (d, J = 2.9 Hz, 3H), 2.33 (d, J = 2.9 Hz, 3H), 
13C NMR (126 MHz, CDCl3) δ 161.91, 150.98, 137.54, 135.50, 129.79, 127.17, 87.85, 77.23, 
77.10, 76.98, 76.72, 40.18, 29.26, 28.10, 20.98. ESI-MS [C15H18N4Na1O4] – 341.1222 
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Synthesis of C9k 
trans-4-bromo-β-nitrostyrene (66 mg, 0.3 mmol), 6-amino-1,3-dimethyluracil (47 mg ,0.3 mmol), 
2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 15 min. The crude 
product was purified by column chromatography with silica (7% ethyl acetate in hexanes) to 
afford the title compound C9k. 1H NMR (500 MHz, CDCl3) δ 7.48 – 7.41 (m, 2H), 7.29 – 7.21 
(m, 2H), 5.43 (ddd, J = 13.6, 8.0, 2.7 Hz, 1H), 5.09 (ddd, J = 13.5, 6.6, 2.7 Hz, 1H), 4.71 (s, 2H), 
4.57 – 4.46 (m, 1H), 3.44 (d, J = 2.6 Hz, 3H), 3.29 (d, J = 2.7 Hz, 3H. 13C NMR (126 MHz, 
CDCl3) δ 161.98, 151.64, 134.44, , 128.99, 115.83, 77.31, 77.19, 77.05, 76.80, 60.45, 39.72, 
29.54, 29.06, 28.04 
Synthesis of C9l 
trans-4-fluoro-β-nitrostyrene (50 mg, 0.3 mmol), 6-amino-1,3-dimethyluracil (47 mg ,0.3 mmol), 
2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10mL) for 15 min. The crude 
product was purified by column chromatography with silica (10% ethyl acetate in hexanes) to 
afford the title compound C9l. 1H NMR (500 MHz, CDCl3) δ 7.34 (dd, J = 8.2, 4.6 Hz, 2H), 7.05 
– 6.97 (m, 2H), 5.47 – 5.39 (m, 1H), 5.14 – 5.05 (m, 1H), 4.70 (s, 2H), 4.59 – 4.52 (m, 1H), 3.42 
(d, J = 2.0 Hz, 3H), 3.30 (d, J = 2.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 162.97, 161.98, 
161.00, 151.64, 150.96, 134.44, 129.05, 128.99, 127.17, 115.83, 115.66, 86.83, 77.31, 77.19, 
77.05, 76.80, 60.45, 29.54, 29.06, 28.04, 21.01. ESI-MS [C14H16FN4Na1O4] – 357.1169 
Synthesis of C9m 
trans- β -methyl-β-nitrostyrene (48 mg, 0.3 mmol), 6-amino-1,3-dimethyluracil (47 mg ,0.3 
mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1 h. The 
crude product was purified by column chromatography with silica (10% ethyl acetate in hexanes) 
to afford the title compound C9m.1H NMR (500 MHz, CDCl3) δ 7.34 (dd, J = 8.2, 4.6 Hz, 2H), 
7.27 (d, J = 2.2 Hz, 1H), 7.05 – 6.97 (m, 2H), , 5.47 – 5.39 (m, 1H), 5.14 – 5.05 (m, 1H), 4.70 (s, 
2H), 4.59 – 4.52 (m, 1H), 3.50 – 3.40 (m, 5H), 3.30 (d, J = 2.3 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 161.91, 150.98, 137.54, 135.50, 129.79, 127.17, 87.85, 77.23, 77.10, 76.98, 76.72, 
40.18, 29.26, 28.10, 20.98. ESI-MS [C15H18N4Na1O4] – 341.1553 
Synthesis of C9n 
2-(2-Nitrovinyl) furan (45 mg, 0.3 mmol), 6-amino-1,3-dimethyluracil (47 mg ,0.3 mmol), 2.5 
mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1 h. The crude product 
was purified by column chromatography with silica (15% ethyl acetate in hexanes) to afford the 
title compound C9n. 1H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 1.6 Hz, 1H), 7.27 (s, 1H), 6.35 
(dd, J = 3.2, 1.7 Hz, 1H), 6.31 – 6.26 (m, 1H), 5.18 – 4.99 (m, 3H), 4.80 (s, 2H), 3.56 – 3.42 (m, 
8H). 13C NMR (126 MHz, CDCl3) δ 151.28, 141.95, 110.87, 107.18, 88.29, 77.23, 76.98, 76.73, 
74.79, 34.47, 29.27, 28.15 
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Synthesis of C9o 
trans-β-nitrostyrene (44 mg, 0.3 mmol), 1,3-diethyl-2-thiobarbituric acid (60 mg ,0.3 mmol), 2.5 
mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1 h. The crude product 
was purified by column chromatography with silica (20% ethyl acetate in hexanes) to afford the 
title compound C9o. 1H NMR (500 MHz, CDCl3) δ 7.32 – 7.25 (m, 3H), 7.10 – 7.04 (m, 2H), 
5.28 (dd, J = 14.2, 7.9 Hz, 1H), 4.99 (dd, J = 14.1, 7.6 Hz, 1H), 4.52 (d, J = 3.9 Hz, 1H), 4.33 – 
4.19 (m, 4H), 3.90 (d, J = 3.8 Hz, 1H), 1.17 (t, J = 6.9 Hz, 3H), 1.03 (t, J = 7.0 Hz, 3H). 13C NMR 
(126 MHz, CDCl3) δ 165.93, 149.82, 133.56, 127.63, 126.96, 88.34, 75.09, 53.91, 44.86, 38.57, 
27.09. CHN C16H19N3O4S (observed) C-54.91%, H-5.33%, N-11.99% (expected) C-54.99%, H-
5.49%, N-12.03%. 
Synthesis of C9p 
trans-4-methoxy-β-nitrostyrene (54 mg, 0.3 mmol), 1,3-diethyl-2-thiobarbituric acid (60 mg ,0.3 
mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1h. The 
crude product was purified by column chromatography with silica (25% ethyl acetate in hexanes) 
to afford the title compound C9p. 1H NMR (500 MHz, CDCl3 ) δ 6.97 (dd, J = 11.4, 8.1 Hz, 3H), 
6.81 – 6.75 (m, 2H), 5.24 (dd, J = 14.0, 7.8 Hz, 1H), 4.96 (dd, J = 14.1, 7.7 Hz, 1H), 4.47 (td, J = 
7.9, 3.8 Hz, 1H), 4.27 (ddt, J = 34.0, 13.3, 6.6 Hz, 4H), 3.89 – 3.84 (m, 1H), 2.19 – 2.15 (m, 3H), 
1.18 (dd, J = 7.6, 6.4 Hz, 3H), 1.06 (dd, J = 7.5, 6.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
168.43, 149.76, 188.43, 129.70, 126.54, 87.09, 75.01, 52.69, 45.13, 27.84, 19.99 
Synthesis of C9s 
trans-4-fluoro-β-nitrostyrene (54 mg, 0.3 mmol), 1,3-diethyl-2-thiobarbituric acid (60 mg ,0.3 
mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1 h. The 
crude product was purified by column chromatography with silica (20% ethyl acetate in hexanes) 
to afford the title compound C9s.1H NMR (500 MHz, CDCl3) δ 7.14 – 7.07 (m, 2H), 7.02 – 6.94 
(m, 2H), 5.26 (dd, J = 14.0, 7.6 Hz, 1H), 5.00 (dd, J = 14.1, 7.9 Hz, 1H), 4.56 (dt, J = 7.9, 4.0 Hz, 
1H), 4.36 – 4.22 (m, 4H), 3.91 – 3.86 (m, 1H), 1.22 – 1.15 (m, 3H), 1.11 – 1.04 (m, 3H). 13C 
NMR (126 MHz, CDCl3) δ 166.76, 151.23, 128.22, 117.53, 88.91, 53.06, 43.09, 27.62 
Synthesis of C9t 
trans- β -methyl-β-nitrostyrene (48 mg, 0.3 mmol) 1,3-diethyl-2-thiobarbituric acid (60 mg, 0.3 
mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1 h. The 
crude product was purified by column chromatography with silica (15% ethyl acetate in hexanes) 
to afford the title compound C9t. 1H NMR (500 MHz, CDCl3) δ 7.32 – 7.25 (m, 3H), 7.04 (dt, J 
= 7.9, 1.6 Hz, 2H), 5, 4.36 – 4.28 (m, 2H), 4.20 – 4.10 (m, 3H), 3.80 (dd, J = 3.9, 1.3 Hz, 1H), 
2.03 (d, J = 1.3 Hz, 1H), 1.43 – 1.38 (m, 3H), 1.20 (td, J = 7.1, 1.3 Hz, 3H), 0.95 (td, J = 7.1, 1.3 
Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 167.79, 150.93, 134.22, 128.55, 128.03, 87.11, 83.45, 
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52.78, 49.82, 28.45, 19.29. CHN C17H21N3O4S (observed) C-56.15%, H-5.81%, N-11.60% 
(expected) C-56.18%, H-5.83%, N-11.56%. 
Synthesis of C9u 
2-(2-Nitrovinyl) furan (45 mg, 0.3 mmol), 1,3-diethyl-2-thiobarbituric acid (60 mg ,0.3 mmol), 
2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1 h. The crude 
product was purified by column chromatography with silica (15% ethyl acetate in hexanes) to 
afford the title compound C9u.1H NMR (500 MHz, CDCl3) 6.28 (s, 1H), 6.18 – 6.13 (m, 1H), 
5.15 (dd, J = 14.5, 7.6 Hz, 1H), 4.94 (dd, J = 14.4, 7.9 Hz, 1H), 4.69 – 4.62 (m, 1H), 4.33 (q, J = 
6.8, 6.4 Hz, 4H), 1.16 (dt, J = 21.0, 7.4 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 164.44, 147.51, 
143.23, 110.82, 109.19, 77.27, 77.01, 76.76, 74.78, 50.20, 43.66, 43.45, 39.58, 11.91. 
Synthesis of C9r 
trans-4-bromo-β-nitrostyrene (66 mg, 0.3 mmol), 1,3-diethyl-2-thiobarbituric acid (60 mg 
,0.3mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1 h. 
The crude product was purified by column chromatography with silica (20% ethyl acetate in 
hexanes) to afford the title compound C9r.1H NMR (500 MHz, CDCl3) δ 7.12 – 7.05 (m, 2H), 
7.01 – 6.95 (m, 2H), 5.31 (dd, J = 14.0, 7.5 Hz, 1H), 5.00 (dd, J = 14.1, 7.9 Hz, 1H), 4.60(dt, J = 
7.9, 4.0 Hz, 1H), 4.34 – 4.21 (m, 4H), 3.91 – 3.88 (m, 1H), 1.20 – 1.17 (m, 3H), 1.12 – 1.06 (m, 
3H). 13C NMR (126 MHz, CDCl3) δ 167.81, 153.01, 130.47, 116.21, 87.88, 54.12, 44.39, 28.61 
Synthesis of C9q 
trans-4-methyl-β-nitrostyrene (48 mg, 0.3 mmol), 1,3-diethyl-2-thiobarbituric acid (60 mg, 0.3 
mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1 h. The 
crude product was purified by column chromatography with silica (25% ethyl acetate in hexanes) 
to afford the title compound C9q. 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.29 (2H), 7.03 – 7.01 
(2H), 5.30 – 5.20 (1H), 5.01 (1H), 4.47 (1H), 3.99(1H), 3.19 – 3.10 (6H), 2.41 – 2.39 (3H). 13C 
NMR (126 MHz, CDCl3) δ 169.32, 154.49, 150.21, 142.67, 132.99, 125.69, 122.81, 51.78, 43.67, 
28.76, 28.01, 22.06. 
Synthesis of C9v 
cis-4-methoxy- β-methyl- β-nitrostyrene (58 mg, 0.3 mmol), 1,3-dimethylbarbituric acid (47 mg 
,0.3 mmol), 2.5 mol% 1ZnY-NO3 were stirred in a mixture of EtOH/H2O (2:1) (10 mL) for 1 h. 
The crude product was purified by column chromatography with silica (15% ethyl acetate in 
hexanes) to afford the title compound C9v. 1H NMR (500 MHz, Chloroform-d) δ 6.97 – 6.91 (m, 
2H), 6.83 – 6.77 (m, 2H), 5.64 – 5.54 (m, 1H), 4.13 – 4.06 (m, 1H), 3.76 (t, J = 1.1 Hz, 3H), 3.69 
(dd, J = 3.6, 1.4 Hz, 1H), 3.17 (d, J = 1.3 Hz, 3H), 3.05 (d, J = 1.3 Hz, 3H), 1.41 – 1.35 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 166.91, 166.85, 159.92, 150.60, 129.33, 125.32, 114.60, 83.18, 
77.29, 77.04, 76.78, 55.22, 51.13, 50.81, 28.36, 28.21, 19.
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Chapter 12: Crystallographic data 
13.1 Crystallographic tables of PCCs 
13.1.1 Chapter 2  
Table 13.1 Crystallographic table of compounds 1-3. 
Identification code 1 2 3 
Empirical formula 
C72H92Cl2Dy2N4O28Zn
2 
C72H92Cl2Tb2N4O28Zn
2 
C72H92Cl2Eu2N4O28Zn
2 
Formula weight 1988.14 1976.23 1964.22 
Temperature/K 173 173 173 
Crystal system monoclinic monoclinic monoclinic 
Space group P21/n P21/n P21/n 
a/Å 12.8750(3) 12.8759(4) 12.9329(7) 
b/Å 20.9336(5) 20.9432(5) 20.8123(4) 
c/Å 15.2275(2) 15.2346(4) 15.2261(8) 
α/° 90 90 90 
β/° 108.549(2) 108.395(6) 108.824(2) 
γ/° 90 90 90 
Volume/Å3 3890.93(14) 3898.29(12) 3901.37(19) 
Z 2 2 2 
ρcalcg/cm3 1.697   
μ/mm-1 12.141   
F(000) 2004   
Crystal size/mm3 0.14 × 0.1 × 0.04   
Radiation Cu Kα (λ = 1.54184)   
2Θ range for data 
collection/° 
7.44 to 141.24 
  
Index ranges 
-13 ≤ h ≤ 15, 
 -25 ≤ k ≤ 14, 
 -18 ≤ l ≤ 15 
  
Reflections collected 10935   
Independent reflections 
7014  
[Rint = 0.0222,  
Rsigma = 0.0374] 
  
Data/restraints/parameter
s 
7014/9/512 
  
Goodness-of-fit on F2 1.019   
Final R indexes [I>=2σ 
(I)] 
R1 = 0.0371, 
 wR2 = 0.0925 
  
Final R indexes [all data] 
R1 = 0.0414, 
 wR2 = 0.0965 
  
Largest diff. peak/hole / e 
Å-3 
1.18/-1.08 
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Table 13.2 Crystallographic table of compounds 4-6. 
Identification code 4 5 6 
Empirical formula C86H73DyN7O21Zn5 C86H74N7O21TbZn5 C86H73N7O21EuZn5 
Formula weight 2029.86 2027.29 2012.15 
Temperature/K 173 173 173 
Crystal system triclinic triclinic triclinic 
Space group P-1 P-1 P-1 
a/Å 13.1526(9) 13.1739(7) 13.1746(12) 
b/Å 16.8229(12) 16.8279(12) 16.8285(10) 
c/Å 20.5069(14) 20.5073(13) 20.5092(9) 
α/° 72.907(2) 73.274(6) 72.998(5) 
β/° 72.829(2) 72.920(5) 72.908(7) 
γ/° 68.596(2) 68.553(6) 68.582(3) 
Volume/Å3 3946.8(5) 3960.8(5) 3959.3(6) 
Z 2 2 2 
ρcalcg/cm3 1.708 1.7  
μ/mm-1 2.511 2.452  
F(000) 2044 2044  
Crystal size/mm3 0.21 × 0.15 × 0.12 0.2 × 0.18 × 0.12  
Radiation MoKα (λ = 0.71075) MoKα (λ = 0.71073)  
2Θ range for data 
collection/° 
4.252 to 55.092 6.996 to 51.362  
Index ranges 
-17 ≤ h ≤ 17, 
 -21 ≤ k ≤ 21, 
 -25 ≤ l ≤ 26 
-16 ≤ h ≤ 15, 
 -20 ≤ k ≤ 17, 
 -24 ≤ l ≤ 15 
 
Reflections collected 72629 14632  
Independent 
reflections 
18032 
 [Rint = 0.0457,  
Rsigma = 0.0315] 
10744  
[Rint = 0.0401, 
 Rsigma = 0.0869] 
 
Data/restraints/parame
ters 
18032/0/1092 10744/0/1092  
Goodness-of-fit on F2 1.042 1.002  
Final R indexes 
[I>=2σ (I)] 
R1 = 0.0257, 
 wR2 = 0.0669 
R1 = 0.0425, 
 wR2 = 0.0743 
 
Final R indexes [all 
data] 
R1 = 0.0283, 
 wR2 = 0.0682 
R1 = 0.0647,  
wR2 = 0.0854 
 
Largest diff. peak/hole 
/ e Å-3 
0.89/-0.99 1.07/-0.82  
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Table 13.3 Crystallographic table of compound 7. 
Identification code 7-Squeezed 7-Unsqueezed 
Empirical formula C88H89Dy2N8.5O24Zn4 C88H87.99Dy2N8.51O24.01Zn4 
Formula weight 2236.15 2235.4 
Temperature/K 100(2) 100(2) 
Crystal system monoclinic monoclinic 
Space group P21/c P21/c 
a/Å 19.17440(10) 19.17440(10) 
b/Å 19.54640(10) 19.54640(10) 
c/Å 31.9584(2) 31.9584(2) 
α/° 90 90 
β/° 103.2960(10) 103.2960(10) 
γ/° 90 90 
Volume/Å3 11656.64(12) 11656.64(12) 
Z 4 4 
ρcalcg/cm3 1.274 1.274 
μ/mm-1 2.136 2.136 
F(000) 4482 4478 
Crystal size/mm3 0.1 × 0.08 × 0.006 0.1 × 0.08 × 0.006 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.312 to 54.97 3.776 to 54.97 
Index ranges 
 
-24 ≤ h ≤ 24,  
-25 ≤ k ≤ 25, 
 -41 ≤ l ≤ 41 
-24 ≤ h ≤ 24, 
 -25 ≤ k ≤ 25,  
-41 ≤ l ≤ 41 
Reflections collected 255761 255761 
Independent reflections 
26535  
[Rint = 0.0274, 
 Rsigma = 0.0120] 
26544  
[Rint = 0.0274, 
 Rsigma = 0.0120] 
Data/restraints/parameters 26535/43/1171 26544/43/1172 
Goodness-of-fit on F2 0.983 1.936 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0340, 
 wR2 = 0.1050 
R1 = 0.1051,  
wR2 = 0.3834 
Final R indexes [all data] 
 
R1 = 0.0377,  
wR2 = 0.1079 
R1 = 0.1108,  
wR2 = 0.3939 
Largest diff. peak/hole / e Å-3 1.54/-0.69 20.05/-1.59 
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Table 13.4 Crystallographic table of compounds 8 and 9. 
Identification code 8 -Squeezed 8 -Unsqueezed 9 
Empirical formula C88H89N8.5O24Tb2Zn4 C88H89N8.5O24Tb2Zn4 C88H88Eu2N9O25Zn4 
Formula weight 2228.99 2228.99 2232.14 
Temperature/K 100(2) 100(2) 173 
Crystal system monoclinic monoclinic monoclinic 
Space group P21/c P21/c P21/c 
a/Å 19.2227(6) 19.2227(6) 19.2415(13) 
b/Å 19.5355(5) 19.5355(5) 19.4913(5) 
c/Å 31.9960(7) 31.9960(7) 32.1383(15) 
α/° 90 90 90 
β/° 103.254(3) 103.254(3) 104.401(9) 
γ/° 90 90 90 
Volume/Å3 11695.3(6) 11695.3(6) 11883.1(10) 
Z 4 4 4 
ρcalcg/cm3 1.266 1.266  
μ/mm-1 2.061 2.061  
F(000) 4474 4474  
Crystal size/mm3 0.1 × 0.09 × 0.04 0.1 × 0.09 × 0.04  
Radiation MoKα (λ = 0.71075) MoKα (λ = 0.71075)  
2Θ range for data 
collection/° 4.534 to 50.054 4.534 to 50.054  
Index ranges 
 
-22 ≤ h ≤ 22,  
-16 ≤ k ≤ 23,  
-30 ≤ l ≤ 38 
-22 ≤ h ≤ 22, 
 -16 ≤ k ≤ 23, 
 -30 ≤ l ≤ 38  
Reflections collected 64883 64883  
Independent reflections 
 
20622  
[Rint = 0.0925, 
 Rsigma = 0.1067] 
20622 
 [Rint = 0.0925, 
 Rsigma = 0.1067]  
Data/restraints/paramet
ers 20622/43/1165 20622/43/1165  
Goodness-of-fit on F2 0.973 0.973  
Final R indexes [I>=2σ 
(I)] 
R1 = 0.0588,  
wR2 = 0.1478 
R1 = 0.0588,  
wR2 = 0.1478  
Final R indexes [all 
data] 
R1 = 0.0962, 
 wR2 = 0.1620 
R1 = 0.0962,  
wR2 = 0.1620  
Largest diff. peak/hole 
/ e Å-3 1.61/-0.85 1.61/-0.85   
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Table 13.5 Crystallographic table of compounds 10-12. 
Identification code 10 11 12 
Empirical formula C42H48Dy2N6O24Zn2 C42H48N6O23Tb2Zn2 C42H46Eu2N6O24Zn2 
Formula weight 1476.6 1453.44 1453.51 
Temperature/K 173 172 173 
Crystal system monoclinic monoclinic monoclinic 
Space group P21/n P21/n P21/n 
a/Å 14.415(2) 14.4046(7) 14.3947(6) 
b/Å 11.9895(10) 12.0096(8) 12.0517(8) 
c/Å 14.4978(9) 14.5335(6) 14.5717(6) 
α/° 90 90 90 
β/° 92.014(6) 92.016(5) 91.998(4) 
γ/° 90 90 90 
Volume/Å3 2504.0(5) 2512.6(2) 2526.4(2) 
Z 2 2 2 
ρcalcg/cm3 1.958 1.921 1.911 
μ/mm-1 17.581 15.427 19.373 
F(000) 1452 1432 1436 
Crystal size/mm3 0.26 × 0.2 × 0.12 0.21 × 0.18 × 0.12 0.21 × 0.17 × 0.14 
Radiation 
CuKα (λ = 
1.54184) 
CuKα (λ = 1.54184) CuKα (λ = 1.54184) 
2Θ range for data 
collection/° 
12.288 to 133.198 9.556 to 143.164 9.574 to 140.114 
Index ranges 
-12 ≤ h ≤ 10,  
-10 ≤ k ≤ 14, 
 -15 ≤ l ≤ 17 
-17 ≤ h ≤ 17, 
 -13 ≤ k ≤ 14, 
 -15 ≤ l ≤ 17 
-13 ≤ h ≤ 17, 
 -14 ≤ k ≤ 11, 
 -17 ≤ l ≤ 14 
Reflections collected 5442 9661 6153 
Independent reflections 
 
3208  
[Rint = 0.0345, 
 Rsigma = 0.0549] 
4788 
 [Rint = 0.0856, 
 Rsigma = 0.1009] 
3871 
 [Rint = 0.0712,  
Rsigma = 0.1007] 
Data/restraints/parameters 3208/505/348 4788/23/349 3871/504/349 
Goodness-of-fit on F2 1.061 1.049 1.046 
Final R indexes [I>=2σ 
(I)] 
R1 = 0.0787,  
wR2 = 0.1917 
R1 = 0.1058, 
 wR2 = 0.2759 
R1 = 0.0855, 
 wR2 = 0.2241 
Final R indexes [all data] 
 
R1 = 0.0884,  
wR2 = 0.2006 
R1 = 0.1246, 
 wR2 = 0.3029 
R1 = 0.1190,  
wR2 = 0.2570 
Largest diff. peak/hole / e 
Å-3 
2.49/-1.50 2.74/-2.87 1.34/-1.19 
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Table 13.6 Crystallographic table of compounds 13 and 14. 
Identification code 13 14 
Empirical formula C112H100Cl4Dy7N8O36Zn4 C71H64Dy2N5O19Zn3 
Formula weight 3674.77 1812.38 
Temperature/K 100(2) 100(2) 
Crystal system monoclinic monoclinic 
Space group C2/c P21/c 
a/Å 35.4471(14) 17.2803(10) 
b/Å 16.1080(7) 22.8749(9) 
c/Å 28.2724(12) 20.9155(8) 
α/° 90 90 
β/° 113.449(5) 110.500(5) 
γ/° 90 90 
Volume/Å3 14809.8(12) 7744.0(7) 
Z 4 4 
ρcalcg/cm3 1.648 1.555 
μ/mm-1 4.257 2.89 
F(000) 7064 3596 
Crystal size/mm3 0.1 × 0.05 × 0.05 0.04 × 0.04 × 0.01 
Radiation MoKα (λ = 0.71075) MoKα (λ = 0.71075) 
2Θ range for data collection/° 4.276 to 50.056 5.034 to 50.054 
Index ranges 
 
-40 ≤ h ≤ 42, 
 -19 ≤ k ≤ 19, 
 -29 ≤ l ≤ 33 
-20 ≤ h ≤ 20, 
 -26 ≤ k ≤ 27, 
 -24 ≤ l ≤ 24 
Reflections collected 43506 84485 
Independent reflections 
 
13082  
[Rint = 0.0435, 
 Rsigma = 0.0480] 
13646 
 [Rint = 0.2122,  
Rsigma = 0.1532] 
Data/restraints/parameters 13082/1109/777 13646/1039/922 
Goodness-of-fit on F2 1.06 0.945 
Final R indexes [I>=2σ (I) 
] 
R1 = 0.0877,  
wR2 = 0.1966 
R1 = 0.0628, 
 wR2 = 0.1446 
Final R indexes [all data] 
 
R1 = 0.1038,  
wR2 = 0.2036 
R1 = 0.1226,  
wR2 = 0.1683 
Largest diff. peak/hole / e Å-3 2.32/-3.31 1.93/-1.53 
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13.1.2 Chapter 3 
Table 13.7 Crystallographic table of compounds 16 and 17. 
Identification code 16 17 
Empirical formula C132H154Cl4Co8Gd4N12O51 C120H124Cl4Co8Dy4N12O48 
Formula weight 3966.9 3765.54 
Temperature/K 173(2) 173 
Crystal system monoclinic monoclinic 
Space group P21/c P21/c 
a/Å 15.7924(10) 15.8067(10) 
b/Å 21.4805(10) 21.4624(15) 
c/Å 25.0254(15) 25.0731(16) 
α/° 90 90 
β/° 98.932(5) 99.651(5) 
γ/° 90 90 
Volume/Å3 8386.4(8) 8385.7(10) 
Z 2 2 
ρcalcg/cm3 1.571 1.491 
μ/mm-1 2.468 2.663 
F(000) 3956 3720 
Crystal size/mm3 0.300 × 0.240 × 0.140 0.14 × 0.12 × 0.08 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data collection/° 5.024 to 50.216 4.744 to 50.248 
Index ranges 
? ≤ h ≤ ?,  
? ≤ k ≤ ?, 
 ? ≤ l ≤ ? 
-16 ≤ h ≤ 18,  
-23 ≤ k ≤ 25, 
 -29 ≤ l ≤ 29 
Reflections collected ? 37054 
Independent reflections 
 
14651  
[Rint = ?, 
 Rsigma = 0.0568] 
14593  
[Rint = 0.1405, 
 Rsigma = 0.2390] 
Data/restraints/parameters 14651/180/1044 14593/2484/788 
Goodness-of-fit on F2 0.916 0.767 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0372, 
 wR2 = 0.0827 
R1 = 0.0857,  
wR2 = 0.1791 
Final R indexes [all data] 
 
R1 = 0.0565,  
wR2 = 0.0868 
R1 = 0.1960, 
 wR2 = 0.2112 
Largest diff. peak/hole / e Å-3 1.20/-1.46 1.47/-1.02 
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Table 13.8 Crystallographic table of compounds 18 and 19. 
Identification code 18 19 
Empirical formula 
C132H152Cl4Co8N12O51Tb4 C62H59.33Br4Cl3.33Co4Dy2N6O25.33 
Formula weight 3971.57 2292.34 
Temperature/K 173 173 
Crystal system monoclinic trigonal 
Space group 
P21/c P3121 
a/Å 15.7073(6) 16.2445(5) 
b/Å 21.4916(12) 16.2445(5) 
c/Å 24.8869(10) 29.8880(11) 
α/° 90 90 
β/° 98.906(3) 90 
γ/° 90 120 
Volume/Å3 
8299.9(7) 6830.3(5) 
Z 2 3 
ρcalcg/cm3 
1.589 1.672 
μ/mm-1 
2.6 4.251 
F(000) 3960 3338 
Crystal size/mm3 
0.25 × 0.2 × 0.18 0.12 × 0.1 × 0.08 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data collection/° 3.446 to 51.424 5.198 to 49.528 
Index ranges 
 
-19 ≤ h ≤ 17, 
 -26 ≤ k ≤ 26,  
-30 ≤ l ≤ 30 
-17 ≤ h ≤ 19, 
 -17 ≤ k ≤ 5,  
-31 ≤ l ≤ 35 
Reflections collected 51035 16320 
Independent reflections 
 
 
15507  
[Rint = 0.0809,  
Rsigma = 0.0660] 
6621  
[Rint =  
0.0844, 
 Rsigma = 0.1090] 
Data/restraints/parameters 15507/354/1020 6621/46/394 
Goodness-of-fit on F2 
0.901 0.915 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0389,  
wR2 = 0.0900 
R1 = 0.0563, 
 wR2 = 0.1187 
Final R indexes [all data] 
 
R1 = 0.0612, 
 wR2 = 0.0960 
R1 = 0.1317, 
 wR2 = 0.1451 
Largest diff. peak/hole / e Å-3 
1.08/-0.94 0.54/-0.54 
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13.1.3 Chapter 4  
Table 13.9 Crystallographic table of compounds 20, 22 and 22’. 
Identification code 20 22 22' 
Empirical formula C120H114Co3F18N18O42S
6Y4 
C120H116Dy4F18N18Ni3O4
3S6 
C114H114Cl3Dy4N18Ni3
O37 
Formula weight 3547.08 3858.79 3260.71 
Temperature/K 100(2) 100(2) 100(2) 
Crystal system orthorhombic orthorhombic trigonal 
Space group Pbca Pbca R3c 
a/Å 36.2555(6) 22.6480(2) 20.9581(2) 
b/Å 22.6457(4) 35.8769(6) 20.9581(2) 
c/Å 36.5878(8) 36.2728(3) 58.0341(8) 
α/° 90 90 90 
β/° 90 90 90 
γ/° 90 90 120 
Volume/Å3 30039.7(10) 29473.1(6) 22075.9(5) 
Z 8 8 6 
ρcalcg/cm3 1.569 1.739 1.472 
μ/mm-1 2.038 2.569 2.508 
F(000) 14328 15296 9714 
Crystal size/mm3 0.25 × 0.13 × 0.01 0.1 × 0.08 × 0.06 0.14 × 0.13 × 0.11 
Radiation MoKα (λ = 0.71075) MoKα (λ = 0.71075) MoKα (λ = 0.71075) 
2Θ range for data 
collection/° 
4.23 to 50.058 3.936 to 50.056 4.42 to 55.118 
Index ranges -43 ≤ h ≤ 40, 
 -25 ≤ k ≤ 26, 
 -43 ≤ l ≤ 42 
-26 ≤ h ≤ 26, 
 -33 ≤ k ≤ 42, 
 -41 ≤ l ≤ 43 
-27 ≤ h ≤ 27, 
 -27 ≤ k ≤ 27, 
 -75 ≤ l ≤ 75 
Reflections collected 162614 147024 164374 
Independent reflections 26516  
[Rint = 0.1027, 
 Rsigma = 0.0755] 
26026  
[Rint = 0.0767, 
 Rsigma = 0.0459] 
11346 
 [Rint = 0.0372, 
 Rsigma = 0.0114] 
Data/restraints/paramet
ers 
26516/2783/1855 26026/2734/1849 11346/535/521 
Goodness-of-fit on F2 1.031 1.111 1.058 
Final R indexes [I>=2σ 
(I)] 
R1 = 0.0982, 
 wR2 = 0.2643 
R1 = 0.0881, 
 wR2 = 0.2198 
R1 = 0.0374, 
 wR2 = 0.1038 
Final R indexes [all 
data] 
R1 = 0.1745, 
 wR2 = 0.3165 
R1 = 0.1121,  
wR2 = 0.2322 
R1 = 0.0382, 
 wR2 = 0.1048 
Largest diff. peak/hole 
/ e Å-3 
1.18/-0.70 2.11/-2.00 1.46/-0.53 
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Table 13.10 Crystallographic table of compounds 25-27. 
Identification code 25 26 27 
Empirical formula C36H44CoN5O12 C45H52Br2CoN3O9 C120.5H115Cl5Dy2N4Ni2O20 
Formula weight 797.69 997.64 2558.83 
Temperature/K 100 173 173 
Crystal system monoclinic monoclinic monoclinic 
Space group P21/c P21/n C2/c 
a/Å 18.8624(5) 13.0590(8) 22.1776(15) 
b/Å 17.0300(4) 22.7258(11) 18.8940(11) 
c/Å 25.6461(18) 15.4472(13) 27.8333(11) 
α/° 90 90 90 
β/° 108.353(8) 109.616(8) 100.127(4) 
γ/° 90 90 90 
Volume/Å3 7819.2(7) 4318.3(5) 11481.1(11) 
Z 8 4 4 
ρcalcg/cm3 1.355 1.535 1.48 
μ/mm-1 0.505 2.307 1.795 
F(000) 3344 2048 5196 
Crystal size/mm3 
0.24 × 0.13 × 
0.02 0.12 × 0.1 × 0.06 0.1 × 0.05 × 0.02 
Radiation 
MoKα (λ = 
0.71075) MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data 
collection/° 6.104 to 54.962 4.88 to 52.742 5.564 to 58.632 
Index ranges 
 
-24 ≤ h ≤ 24, 
 -19 ≤ k ≤ 22, 
 -26 ≤ l ≤ 33 
-14 ≤ h ≤ 16, 
 -27 ≤ k ≤ 26, 
 -14 ≤ l ≤ 19 
? ≤ h ≤ ?,  
? ≤ k ≤ ? 
, ? ≤ l ≤ ? 
Reflections collected 61781 13404 ? 
Independent reflections 
 
 
17458 
 [Rint = 0.0518, 
 Rsigma = 0.0621] 
8410  
[Rint = 0.0365, 
 Rsigma = 0.0800] 
12896 
 [Rint = ?,  
Rsigma = 0.1362] 
Data/restraints/paramete
rs 17458/93/955 8410/0/543 12896/264/535 
Goodness-of-fit on F2 1.054 1.041 1.041 
Final R indexes [I>=2σ 
(I)] 
R1 = 0.0855,  
wR2 = 0.2181 
R1 = 0.0590, 
 wR2 = 0.1182 
R1 = 0.1138,  
wR2 = 0.2803 
Final R indexes [all 
data] 
R1 = 0.1216, 
 wR2 = 0.2379 
R1 = 0.1023, 
 wR2 = 0.1402 
R1 = 0.1828,  
wR2 = 0.3192 
Largest diff. peak/hole / 
e Å-3 1.40/-1.25 0.77/-0.81 2.48/-2.56 
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Table 13.11 Crystallographic table of compounds 28-30. 
Identification code 28 29 30 
Empirical formula C122H146Cl2Dy2N14Ni2O30 C112H114Br6Dy2N4Ni2O26 C122H130Dy2N4Ni2O24 
Formula weight 2801.84 2848.01 2478.64 
Temperature/K 173 173 100 
Crystal system triclinic monoclinic trigonal 
Space group P-1 C2/c R-3 
a/Å 12.5403(7) 20.4620(7) 38.159(3) 
b/Å 14.7915(10) 20.8069(7) 38.159(3) 
c/Å 18.880(2) 27.3553(7) 18.7654(13) 
α/° 100.291(8) 90 90 
β/° 106.198(7) 98.444(3) 90 
γ/° 105.143(5) 90 120 
Volume/Å3 3124.5(5) 11520.3(7) 23664(4) 
Z 1 4 9 
ρcalcg/cm3 1.489 1.592 1.507 
μ/mm-1 1.602 3.754 1.832 
F(000) 1438 5472 10962 
Crystal size/mm3 0.38 × 0.32 × 0.24 0.12 × 0.08 × 0.03 0.15 × 0.12 × 0.06 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71075) 
2Θ range for data 
collection/° 4.956 to 58.074 5.06 to 58.266 4.992 to 54.966 
Index ranges 
 
 
-15 ≤ h ≤ 10, 
 -9 ≤ k ≤ 18, 
 -24 ≤ l ≤ 6 
-27 ≤ h ≤ 14, 
 -14 ≤ k ≤ 26,  
-29 ≤ l ≤ 37 
-38 ≤ h ≤ 49, 
 -49 ≤ k ≤ 39, 
 -24 ≤ l ≤ 22 
Reflections collected 9418 22076 56666 
Independent reflections 
 
 
 
7781  
[Rint = 0.0478, 
 Rsigma = 0.0683] 
12759  
[Rint = 0.0281,  
Rsigma = 0.0604] 
11972 
 [Rint = 0.0483, 
 Rsigma = 0.0370] 
Data/restraints/parameters 7781/23/779 12759/7/652 11972/73/638 
Goodness-of-fit on F2 1.083 1.018 0.992 
Final R indexes [I>=2σ 
(I)] 
R1 = 0.0437,  
wR2 = 0.1070 
R1 = 0.0501,  
wR2 = 0.1310 
R1 = 0.0408,  
wR2 = 0.1095 
Final R indexes [all data] 
 
R1 = 0.0524,  
wR2 = 0.1165 
R1 = 0.0746,  
wR2 = 0.1431 
R1 = 0.0553, 
 wR2 = 0.1157 
Largest diff. peak/hole / e 
Å-3 1.03/-0.62 2.77/-3.54 1.46/-0.90 
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Table 13.12Crystallographic table of compounds 31-32. 
Identification code 31 32 33 
Empirical formula 
C102H110Cl2Dy2N10Ni2
O26 
C64H72Cl2Dy2N4Ni2
O26 
C82H100Dy2F6N12Ni2O2
6S2 
Formula weight 2405.31 1826.57 2290.27 
Temperature/K 173 173 173 
Crystal system monoclinic monoclinic monoclinic 
Space group P21/n P21/n P21/c 
a/Å 15.8855(6) 12.1724(12) 16.6632(4) 
b/Å 17.2105(11) 14.1352(15) 18.8674(3) 
c/Å 20.5903(11) 19.123(2) 15.7017(3) 
α/° 90 90 90 
β/° 96.747(4) 99.425(11) 109.993(3) 
γ/° 90 90 90 
Volume/Å3 5590.3(5) 3245.9(6) 4638.96(19) 
Z 2 2 2 
ρcalcg/cm3 1.429 1.869 1.64 
μ/mm-1 1.774 3.019 2.13 
F(000) 2444 1828 2316 
Crystal size/mm3 0.36 × 0.28 × 0.2 0.12 × 0.1 × 0.04 0.26 × 0.2 × 0.06 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data 
collection/° 5.072 to 58.376 5.184 to 58.058 6.762 to 52.744 
Index ranges 
 
-21 ≤ h ≤ 19, 
 0 ≤ k ≤ 23,  
0 ≤ l ≤ 26 
-15 ≤ h ≤ 13, 
 -10 ≤ k ≤ 18,  
-13 ≤ l ≤ 25 
-20 ≤ h ≤ 20, 
 -23 ≤ k ≤ 23, 
 -18 ≤ l ≤ 19 
Reflections collected 13138 12310 17646 
Independent reflections 
 
 
13129  
[Rint = 0.0000, 
 Rsigma = 0.0495] 
7192  
[Rint = 0.1031, 
 Rsigma = 0.2047] 
9384 
 [Rint = 0.0267, 
 Rsigma = 0.0449] 
Data/restraints/parameters 13129/446/664 7192/5/462 9384/0/599 
Goodness-of-fit on F2 1.075 0.872 1.039 
Final R indexes [I>=2σ 
(I)] 
R1 = 0.0464,  
wR2 = 0.1115 
R1 = 0.0650,  
wR2 = 0.0947 
R1 = 0.0382, 
 wR2 = 0.0885 
Final R indexes [all data] 
 
R1 = 0.0708, 
 wR2 = 0.1220 
R1 = 0.1319, 
 wR2 = 0.1300 
R1 = 0.0501, 
 wR2 = 0.0976 
 
Largest diff. peak/hole / e 
Å-3 1.24/-1.24 1.35/-1.82 1.03/-1.20 
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Table 13.13 Crystallographic table of compounds 34-33. 
Identification code 34 35 36 
Empirical formula 
C174H170Br8Cl4Dy4N18Ni4O5
2 C164H184N8Ni8O44 
C92H112Cl2Dy2N4Ni2
O30 
Formula weight 5011.19 3432.72 2267.18 
Temperature/K 100 100 173 
Crystal system triclinic triclinic monoclinic 
Space group P-1 P-1 P21/n 
a/Å 13.4199(5) 18.0377(13) 12.19560(19) 
b/Å 19.4201(7) 18.3422(13) 19.3817(6) 
c/Å 20.7033(15) 29.900(2) 20.2019(7) 
α/° 88.220(6) 71.347(2) 90 
β/° 85.020(6) 71.670(2) 98.464(2) 
γ/° 84.859(6) 67.774(2) 90 
Volume/Å3 5352.1(5) 8462.6(11) 4723.1(2) 
Z 1 2 2 
ρcalcg/cm3 1.555 1.262 1.594 
μ/mm-1 3.34 0.941 2.095 
F(000) 2480 3348 2308 
Crystal size/mm3 0.12 × 0.08 × 0.04 0.22 × 0.08 × 0.03 0.28 × 0.14 × 0.1 
Radiation MoKα (λ = 0.71075) 
MoKα (λ = 
0.71075) Mo Kα (λ = 0.71073) 
2Θ range for data 
collection/° 6.118 to 54.97 4.49 to 55.226 5.32 to 58.32 
Index ranges 
 
-17 ≤ h ≤ 16,  
-25 ≤ k ≤ 25, 
 -26 ≤ l ≤ 26 
-23 ≤ h ≤ 23, 
 -23 ≤ k ≤ 23, 
 -38 ≤ l ≤ 38 
-14 ≤ h ≤ 16, 
 -26 ≤ k ≤ 22, 
 -26 ≤ l ≤ 25 
Reflections collected 72585 106354 29019 
Independent reflections 
 
 
24304  
[Rint = 0.0441,  
Rsigma = 0.0524] 
38045  
[Rint = 0.0854,  
Rsigma = 0.0739] 
11050  
[Rint = 0.0320,  
Rsigma = 0.0412] 
Data/restraints/parameter
s 24304/1/1203 38045/206/1922 11050/9/613 
Goodness-of-fit on F2 1.112 1.049 1.053 
Final R indexes [I>=2σ 
(I)] 
R1 = 0.0480, 
 wR2 = 0.1253 
R1 = 0.0643,  
wR2 = 0.1750 
R1 = 0.0322, 
 wR2 = 0.0687 
Final R indexes [all data] 
 
R1 = 0.0603, 
 wR2 = 0.1312 
R1 = 0.0845, 
 wR2 = 0.1896 
R1 = 0.0451, 
 wR2 = 0.0755 
Largest diff. peak/hole / 
e Å-3 2.65/-3.19 0.91/-1.15 1.18/-0.54 
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Table 13.14 Crystallographic table of compounds 37-39. 
Identification code 37 38 39 
Empirical formula C106H122Cl2Dy2N10Ni2O28 C62H58Dy2N4Ni2O18 C88H76Co2Dy2N14O34 
Formula weight 2497.46 1589.54 2316.48 
Temperature/K 173 173 100 
Crystal system monoclinic monoclinic triclinic 
Space group P21/c P21/c P-1 
a/Å 15.0768(5) 10.4776(4) 13.1490(9) 
b/Å 20.6499(5) 21.3408(8) 13.6200(10) 
c/Å 17.8256(8) 14.3681(5) 15.4701(11) 
α/° 90 90 68.869(5) 
β/° 103.010(4) 106.977(4) 65.650(4) 
γ/° 90 90 63.614(4) 
Volume/Å3 5407.3(3) 3072.7(2) 2207.1(3) 
Z 2 2 1 
ρcalcg/cm3 1.534 1.718 1.743 
μ/mm-1 1.838 14.105 2.141 
F(000) 2548 1580 1160 
Crystal size/mm3 0.28 × 0.24 × 0.12 0.08 × 0.06 × 0.03 0.03 × 0.03 × 0.01 
Radiation Mo Kα (λ = 0.71073) 
CuKα (λ = 
1.54184) MoKα (λ = 0.71075) 
2Θ range for data 
collection/° 5.08 to 58.5 9.75 to 140.882 4.986 to 55.256 
Index ranges 
 
-19 ≤ h ≤ 19,  ? ≤ h ≤ ?,  -17 ≤ h ≤ 17, 
-26 ≤ k ≤ 27, ? ≤ k ≤ ?,  -17 ≤ k ≤ 17 
 -23 ≤ l ≤ 16  ? ≤ l ≤ ? , -20 ≤ l ≤ 20 
Reflections collected 27684 ? 49522 
Independent 
reflections 
 
12547  
[Rint = 0.0313,  
Rsigma = 0.0458] 
5641  
[Rint = ?, 
 Rsigma = 0.0927] 
10202 
 [Rint = 0.1033, 
 Rsigma = 0.0580] 
Data/restraints/param
eters 12547/0/686 5641/3/386 10202/15/621 
Goodness-of-fit on 
F2 1.065 0.99 1.078 
Final R indexes 
[I>=2σ (I)] 
R1 = 0.0362, 
 wR2 = 0.0816 
R1 = 0.0666, wR2 = 
0.1672 
R1 = 0.0745, wR2 = 
0.1889 
Final R indexes [all 
data] 
 
R1 = 0.0899,  
wR2 = 0.1837 
R1 = 0.0859,  
wR2 = 0.1971 
R1 = 0.0491, 
wR2 = 0.0908 
Largest diff. 
peak/hole / e Å-3 1.05/-0.94 3.24/-1.36 4.51/-2.63 
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13.1.4 Chapter 5  
Table 13.15. Crystallographic table of compounds 40-42. 
Identification code 40 41 42 
Empirical formula C94H90Co2Dy2N14O32 C81H69Dy3N24O60 C181H171Dy4N27Ni4O66 
Formula weight 2370.65 2826.1 4665.28 
Temperature/K 100 100 173 
Crystal system triclinic triclinic triclinic 
Space group P-1 P-1 P-1 
a/Å 12.7821(9) 16.5657(12) 14.1586(6) 
b/Å 13.5743(10) 17.6842(12) 17.2590(7) 
c/Å 14.1583(10) 18.4698(13) 22.3936(8) 
α/° 106.940(3) 81.572(2) 98.527(3) 
β/° 91.065(2) 80.148(2) 98.268(3) 
γ/° 97.754(2) 83.020(2) 111.403(4) 
Volume/Å3 2324.2(3) 5247.5(6) 4920.7(4) 
Z 1 2 1 
ρcalcg/cm3 1.694 1.789 1.574 
μ/mm-1 2.034 2.233 1.966 
F(000) 1194 2802 2350 
Crystal size/mm3 0.14 × 0.12 × 0.04 0.13 × 0.1 × 0.05 0.2 × 0.18 × 0.14 
Radiation MoKα (λ = 0.71075) MoKα (λ = 0.71075) MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.98 to 55.026 4.68 to 55.01 6.714 to 58.828 
Index ranges 
 
-16 ≤ h ≤ 16, 
 -17 ≤ k ≤ 16, 
 -18 ≤ l ≤ 16 
-21 ≤ h ≤ 21,  
-22 ≤ k ≤ 22, 
 -22 ≤ l ≤ 23 
-18 ≤ h ≤ 19, 
 -23 ≤ k ≤ 21,  
-30 ≤ l ≤ 25 
Reflections collected 37052 76415 33792 
Independent reflections 
 
 
10595  
[Rint = 0.0498,  
Rsigma = 0.0413] 
23648 
 [Rint = 0.0367, 
 Rsigma = 0.0304] 
21989  
[Rint = 0.0315, 
 Rsigma = 0.0630] 
Data/restraints/parameters 10595/112/653 23648/0/1489 21989/19/1284 
Goodness-of-fit on F2 1.047 1.05 1.053 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0427,  
wR2 = 0.1152 
R1 = 0.0314, 
 wR2 = 0.0764 
R1 = 0.0425, 
 wR2 = 0.0968 
Final R indexes [all data] 
 
R1 = 0.0469,  
wR2 = 0.1197 
R1 = 0.0360, 
 wR2 = 0.0797 
R1 = 0.0618, 
 wR2 = 0.1096 
Largest diff. peak/hole / e Å-3 2.80/-1.53 2.10/-1.47 1.32/-0.93 
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13.1.5 Chapter 6 
Table 13.16 Crystallographic table of compounds 43 and 44. 
Identification code 43 44 
Empirical formula C79H137Cl4Dy11N10O71Zn4 C79H135Cl4Gd11N10O71Zn4 
Formula weight 4553.76 4493.99 
Temperature/K 100(2) 100(2) 
Crystal system monoclinic monoclinic 
Space group C2/c C2/c 
a/Å 21.5114(3) 21.5153(3) 
b/Å 35.0488(4) 35.0390(3) 
c/Å 22.5248(3) 22.6388(2) 
α/° 90 90 
β/° 101.3200(10) 101.2930(10) 
γ/° 90 90 
Volume/Å3 16652.2(4) 16736.4(3) 
Z 4 4 
ρcalcg/cm3 1.816 1.784 
μ/mm-1 5.574 4.994 
F(000) 8652 8556 
Crystal size/mm3 0.18 × 0.08 × 0.03 0.25 × 0.14 × 0.03 
Radiation MoKα (λ = 0.71075) Mo Kα (λ = 0.71075) 
2Θ range for data collection/° 4.36 to 54.97 4.544 to 54.972 
Index ranges -27 ≤ h ≤ 27,  
-45 ≤ k ≤ 45, 
 -29 ≤ l ≤ 25 
-27 ≤ h ≤ 27,  
-45 ≤ k ≤ 45, 
 -29 ≤ l ≤ 29 
Reflections collected 107258 109848 
Independent reflections 19099  
[Rint = 0.0369, 
 Rsigma = 0.0244] 
19130  
[Rint = 0.0342, 
 Rsigma = 0.0215] 
Data/restraints/parameters 19099/1659/879 19130/40/881 
Goodness-of-fit on F2 1.01 1.082 
Final R indexes [I>=2σ (I)] R1 = 0.0328,  
wR2 = 0.0833 
R1 = 0.0333, 
 wR2 = 0.0804 
Final R indexes [all data] R1 = 0.0392,  
wR2 = 0.0859 
R1 = 0.0387,  
wR2 = 0.0823 
Largest diff. peak/hole / e Å-3 2.98/-1.14 1.92/-1.37 
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13.1.6 Chapter 7 
Table 13.17 Crystallographic table of compounds 1MDy-ClO4. 
Identification code 1CoDy-ClO4 1NiDy-ClO4 
Empirical formula C72H88Cl2Co2Dy2N4O28 C72H90Cl2Dy2N4Ni2O28 
Formula weight 1971.28 1972.79 
Temperature/K 173 173 
Crystal system monoclinic monoclinic 
Space group P21/n P21/n 
a/Å 12.8227(4) 12.7440(4) 
b/Å 20.9384(5) 20.9329(5) 
c/Å 15.3817(5) 15.3458(5) 
α/° 90 90 
β/° 108.995(4) 108.920(4) 
γ/° 90 90 
Volume/Å3 3904.9(2) 3872.6(2) 
Z 2 2 
ρcalcg/cm3 1.6764 1.692 
μ/mm-1 14.67 2.539 
F(000) 1943 1992 
Crystal size/mm3 0.24 × 0.2 × 0.18 0.5604 × 0.5354 × 0.2879 
Radiation Cu Kα (λ = 1.54184) MoKα (λ = 0.71073) 
2Θ range for data 
collection/° 7.4 to 142.92 4.798 to 58.67 
Index ranges 
 
-14 ≤ h ≤ 15, 
 -25 ≤ k ≤ 25, 
 -18 ≤ l ≤ 17 
-16 ≤ h ≤ 13, 
 -25 ≤ k ≤ 28, 
 -18 ≤ l ≤ 21 
Reflections collected 26009 19340 
Independent reflections 
 
 
7576  
[Rint = 0.0490,  
Rsigma = 0.0482] 
8980 
 [Rint = 0.0330, 
 Rsigma = 0.0510] 
Data/restraints/parameters 7576/9/511 8980/9/512 
Goodness-of-fit on F2 1.033 1.055 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0388,  
wR2 = N/A 
R1 = 0.0375, 
 wR2 = 0.0814 
Final R indexes [all data] 
 
R1 = 0.0469, 
 wR2 = 0.1028 
R1 = 0.0508, 
 wR2 = 0.0887 
Largest diff. peak/hole / e 
Å-3 1.94/-1.00 1.69/-0.87 
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Table 13.17 Crystallographic table of compounds 1MDy-Cl. 
Identification code 1NiDy-Cl 1CoDy-Cl 
Empirical formula C66H59Cl2Dy2N9Ni2O12 C68H56Cl2Co2Dy2N10O12 
Formula weight 1683.54 1719.03 
Temperature/K 273(2) N/A 
Crystal system triclinic triclinic 
Space group P-1 P-1 
a/Å 11.696(3) 11.6965(3) 
b/Å 11.973(4) 12.0424(3) 
c/Å 13.084(4) 13.1724(3) 
α/° 88.597(16) 89.1070(19) 
β/° 64.494(10) 64.281(3) 
γ/° 81.504(15) 81.938(2) 
Volume/Å3 1633.9(9) 1652.92(8) 
Z 1 1 
ρcalcg/cm3 1.711 1.7268 
μ/mm-1 2.978 2.879 
F(000) 836 851.1 
Crystal size/mm3 0.01 × 0.01 × 0.01 N/A × N/A × N/A 
Radiation MoKα (λ = 0.71075) Mo Kα (λ = 0.71075) 
2Θ range for data collection/° 4.768 to 50.166 3.42 to 55.12 
Index ranges 
 
-13 ≤ h ≤ 13, 
 -14 ≤ k ≤ 14, 
 -15 ≤ l ≤ 15 
-15 ≤ h ≤ 14, 
 -14 ≤ k ≤ 15,  
-17 ≤ l ≤ 16 
Reflections collected 17528 20820 
Independent reflections 
 
 
5748  
[Rint = 0.1337, 
 Rsigma = 0.1331] 
7623 
 [Rint = 0.0193, 
 Rsigma = 0.0173] 
Data/restraints/parameters 5748/1/423 7623/0/429 
Goodness-of-fit on F2 1.111 1.248 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0671, 
 wR2 = 0.1265 
R1 = 0.0211, 
 wR2 = 0.0684 
Final R indexes [all data] 
 
R1 = 0.1124,  
wR2 = 0.1492 
R1 = 0.0250,  
wR2 = 0.0876 
Largest diff. peak/hole / e Å-3 1.70/-1.01 1.84/-1.24 
  
270 
 
 
Table 13.18 Crystallographic table of compounds LNiY-Cl. 
Identification code 2NiY-Cl 6NiY-Cl 16NiY-Cl 
Empirical formula 
C328H302Cl8N28Ni8O61Y
8 
C74H74Cl2N6Ni2O14Y
2 
C90H82Cl2N6Ni2O14Y
2 
Formula weight 7076.52 1637.53 1837.75 
Temperature/K 173 173 173 
Crystal system monoclinic triclinic triclinic 
Space group C2/c P-1 P-1 
a/Å 28.0407(5) 11.9923(4) 12.4631(7) 
b/Å 13.00973(16) 12.8768(4) 12.9437(6) 
c/Å 24.9789(6) 16.6543(6) 15.0457(10) 
α/° 90 107.146(3) 100.653(4) 
β/° 111.550(3) 107.314(3) 101.291(5) 
γ/° 90 95.136(3) 103.269(4) 
Volume/Å3 8475.4(3) 2301.43(14) 2248.5(2) 
Z 1 1 1 
ρcalcg/cm3 1.386 1.182 1.357 
μ/mm-1 3.392 3.067 3.204 
F(000) 3626 840 944 
Crystal size/mm3 0.12 × 0.1 × 0.06 0.12 × 0.08 × 0.06 0.12 × 0.08 × 0.06 
Radiation CuKα (λ = 1.54184) CuKα (λ = 1.54184) CuKα (λ = 1.54184) 
2Θ range for data 
collection/° 11.61 to 133.2 11.62 to 133.202 10.584 to 102.16 
Index ranges 
 
-34 ≤ h ≤ 34, 
 -9 ≤ k ≤ 15,  
-30 ≤ l ≤ 29 
-9 ≤ h ≤ 14, 
 -15 ≤ k ≤ 15, 
 -20 ≤ l ≤ 19 
-10 ≤ h ≤ 12,  
-13 ≤ k ≤ 9,  
-14 ≤ l ≤ 15 
Reflections collected 29597 15855 8229 
Independent reflections 
 
 
7467 
 [Rint = 0.0331,  
Rsigma = 0.0293] 
8024  
[Rint = 0.0587, 
 Rsigma = 0.0785] 
4659 
 [Rint = 0.0348,  
Rsigma = 0.0479] 
Data/restraints/parameters 7467/54/475 8024/48/455 4659/58/527 
Goodness-of-fit on F2 1.077 1.04 1.015 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0721, 
 wR2 = 0.2106 
R1 = 0.0870,  
wR2 = 0.2350 
R1 = 0.0476,  
wR2 = 0.1253 
Final R indexes [all data] 
 
R1 = 0.0791, 
 wR2 = 0.2205 
R1 = 0.1003, 
 wR2 = 0.2471 
R1 = 0.0542, 
 wR2 = 0.1292 
Largest diff. peak/hole / e Å-
3 2.55/-1.51 2.09/-2.04 1.14/-0.83 
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Table 13.19 Crystallographic tables of compounds 1ZnDy-NO3.and 1ZnY-NO3. 
Identification code 1ZnDy-NO3 1ZnY-NO3 
Empirical formula C62H58Dy2N8O20Zn2 C62H58N8O20Y2Zn2 
Formula weight 1690.9 1543.72 
Temperature/K 173 173 
Crystal system monoclinic monoclinic 
Space group P21/c P21/c 
a/Å 13.75033(18) 13.7448(6) 
b/Å 14.3147(2) 14.3133(7) 
c/Å 16.9418(2) 16.9268(7) 
α/° 90 90 
β/° 95.2801(12) 95.068(5) 
γ/° 90 90 
Volume/Å3 3320.55(8) 3317.0(3) 
Z 2 2 
ρcalcg/cm3 1.691 1.546 
μ/mm1 3.016 2.525 
F(000) 1676 1568 
Crystal size/mm3 0.32 × 0.20 × 0.18 0.28 × 0.22 × 0.16 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data collection/° 6.766 to 54.964 6.77 to 58.646 
Index ranges 
 
-17 ≤ h ≤ 18, 
 -18 ≤ k ≤ 12, 
 -23 ≤ l ≤ 13 
-18 ≤ h ≤ 15, 
 -18 ≤ k ≤ 14, 
 -22 ≤ l ≤ 20 
Reflections collected 14238 10546 
Independent reflections 
 
 
7145  
[Rint = 0.0295,  
Rsigma = 0.0479] 
6364 
 [Rint = 0.0364, 
 Rsigma = 0.0586] 
Data/restraints/parameters 7145/0/428 6364/0/428 
Goodness-of-fit on F2 1.064 1.162 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0367, 
 wR2 = 0.0946 
R1 = 0.0558, 
 wR2 = 0.1467 
Final R indexes [all data] 
 
R1 = 0.0462,  
wR2 = 0.0992 
R1 = 0.0791,  
wR2 = 0.1627 
Largest diff. peak/hole / e Å-3 2.51/-0.60 2.25/-0.71 
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Table 13.20 Crystallographic tables of compounds 1ZnGd-NO3.and 1ZnEu-NO3. 
Identification code 1ZnGd-NO3 1ZnEu-NO3 
Empirical formula C62H58Gd2N8O20Zn2 C62H58Eu2N8O20Zn2 
Formula weight 1678.1 1669.91 
Temperature/K 173 173 
Crystal system monoclinic monoclinic 
Space group P21/c P21/c 
a/Å 13.8175(6) 13.8125(4) 
b/Å 14.3074(6) 14.3087(5) 
c/Å 16.9999(8) 16.9783(5) 
α/° 90 90 
β/° 95.503(4) 95.498(3) 
γ/° 90 90 
Volume/Å3 3345.3(3) 3340.12(18) 
Z 2 2 
ρcalcg/cm3 1.668 1.6603 
μ/mm1 14.089 14.709 
F(000) 1668 1627.8 
Crystal size/mm3 0.30 × 0.24 × 0.20 0.34 × 0.22 × 0.20 
Radiation CuKα (λ = 1.54184) Cu Kα (λ = 1.54184) 
2Θ range for data collection/° 8.092 to 122.2 8.1 to 122.28 
Index ranges 
 
-15 ≤ h ≤ 14, 
 -16 ≤ k ≤ 15, 
 -19 ≤ l ≤ 17 
-12 ≤ h ≤ 15, 
 -15 ≤ k ≤ 16,  
-19 ≤ l ≤ 19 
Reflections collected 17350 16615 
Independent reflections 
 
 
5096  
[Rint = 0.0723,  
Rsigma = 0.0602] 
5100 
 [Rint = 0.0717 
, Rsigma = 0.0651] 
Data/restraints/parameters 5096/0/428 5100/0/427 
Goodness-of-fit on F2 1.053 1.072 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0644, 
 wR2 = 0.1795 
R1 = 0.0572, 
 wR2 = 0.1605 
Final R indexes [all data] 
 
R1 = 0.0701,  
wR2 = 0.1883 
R1 = 0.0619, 
 wR2 = 0.1685 
Largest diff. peak/hole / e Å-3 3.02/-1.79 3.06/-1.19 
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Table 13.21 Unit Cell parameters for 1ZnLn-NO3 
Identification code 1ZnSm-NO3 1ZnYb-NO3 1ZnTb-NO3 
Temperature/K 173 173 173 
Crystal system monoclinic monoclinic monoclinic 
Space group P21/c P21/c P21/c 
a/Å 13.803(5) 13.53(2) 13.758(13) 
b/Å 14.26(4) 14.06(4) 14.344(12) 
c/Å 16.98(2) 17.98(6) 16.952(8) 
α/° 90.00 90.00 90.00 
β/° 95.56(6) 95.21(13) 95.56(6) 
γ/° 89.94(8) 90.12(4) 90.21(8) 
Volume/Å3 3326(10) 3329(11) 3333(3) 
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Table 13.22 Crystallographic table of compounds 2ZnLn-NO3 and 6ZnLn-NO3. 
Identification code 2ZnY-NO3 6ZnY-NO3 
Empirical formula C84H80N10O22Y2Zn2 C74H74N8O20Y2Zn2 
Formula weight 1890.14 1703.97 
Temperature/K 100(2) 173 
Crystal system monoclinic triclinic 
Space group I2/c P-1 
a/Å 30.1992(13) 12.2132(7) 
b/Å 13.1382(3) 12.5056(8) 
c/Å 24.8811(12) 13.6386(8) 
α/° 90 107.799(6) 
β/° 120.298(6) 94.432(5) 
γ/° 90 113.574(6) 
Volume/Å3 8523.5(7) 1769.7(2) 
Z 4 1 
ρcalcg/cm3 1.473 1.599 
μ/mm-1 1.983 3.579 
F(000) 3872 872 
Crystal size/mm3 0.13 × 0.05 × 0.04 0.18 × 0.16 × 0.12 
Radiation MoKα (λ = 0.71073) CuKα (λ = 1.54184) 
2Θ range for data collection/° 5.38 to 54.968 9.426 to 143.07 
Index ranges 
 
-39 ≤ h ≤ 38,  
-17 ≤ k ≤ 17,  
-28 ≤ l ≤ 32 
-14 ≤ h ≤ 14, 
 -14 ≤ k ≤ 15,  
-16 ≤ l ≤ 16 
Reflections collected 37307 10989 
Independent reflections 
 
 
9751 [ 
Rint = 0.0482,  
Rsigma = 0.0452] 
6649  
[Rint = 0.0676,  
Rsigma = 0.0954] 
Data/restraints/parameters 9751/66/547 6649/0/482 
Goodness-of-fit on F2 1.033 1.047 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0548, 
 wR2 = 0.1535 
R1 = 0.0563, 
 wR2 = 0.1315 
Final R indexes [all data] 
 
R1 = 0.0739,  
wR2 = 0.1642 
R1 = 0.0740,  
wR2 = 0.1509 
Largest diff. peak/hole / e Å-3 1.91/-0.74 1.24/-0.79 
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Table 13.22 Crystallographic table of compounds 8ZnLn-NO3 and 9ZnLn-NO3. 
Identification code 8ZnY-NO3 9ZnY-NO3 
Empirical formula C62H54N12O28Y2Zn2 C80H84N14O30Y2Zn2 
Formula weight 1723.73 2030.17 
Temperature/K 100 173 
Crystal system monoclinic monoclinic 
Space group P21/c P21/c 
a/Å 15.5167(6) 20.4636(14) 
b/Å 14.3778(5) 15.5850(6) 
c/Å 15.9946(5) 27.6252(15) 
α/° 90 90 
β/° 93.649(3) 102.669(6) 
γ/° 90 90 
Volume/Å3 3561.1(2) 8595.8(8) 
Z 2 4 
ρcalcg/cm3 1.608 1.569 
μ/mm-1 2.371 3.163 
F(000) 1744 4160 
Crystal size/mm3 0.1 × 0.09 × 0.05 0.18 × 0.1 × 0.08 
Radiation MoKα (λ = 0.71073) CuKα (λ = 1.54184) 
2Θ range for data collection/° 5.104 to 52.744 8.858 to 142.702 
Index ranges 
 
-20 ≤ h ≤ 20, 
 -18 ≤ k ≤ 16, 
 -20 ≤ l ≤ 20 
-24 ≤ h ≤ 25,  
-18 ≤ k ≤ 10,  
-33 ≤ l ≤ 32 
Reflections collected 23681 31658 
Independent reflections 
 
 
7255 
 [Rint = 0.0408, 
 Rsigma = 0.0576] 
16320  
[Rint = 0.0947,  
Rsigma = 0.1491] 
Data/restraints/parameters 7255/0/482 16320/126/1156 
Goodness-of-fit on F2 1.052 1.005 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0442, 
 wR2 = 0.1075 
R1 = 0.0793, 
 wR2 = 0.1733 
Final R indexes [all data] 
 
R1 = 0.0680, 
 wR2 = 0.1150 
R1 = 0.1505,  
wR2 = 0.2190 
Largest diff. peak/hole / e Å-3 0.76/-0.44 0.81/-0.68 
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Table 13.23 Crystallographic table of compounds 12ZnLn-NO3 and 13ZnLn-NO3. 
Identification code 12ZnY-NO3 13ZnY-NO3 
Empirical formula C68H64Cl4N14O30Y2Zn2 C80H80Cl4N14O30Y2Zn2 
Formula weight 2007.69 2167.94 
Temperature/K 100(2) 100(2) 
Crystal system triclinic monoclinic 
Space group P-1 P21/c 
a/Å 11.4670(6) 14.6309(5) 
b/Å 14.2497(5) 21.5296(4) 
c/Å 14.3350(7) 14.1004(3) 
α/° 114.638(4) 90 
β/° 112.569(5) 96.537(3) 
γ/° 94.342(3) 90 
Volume/Å3 1886.96(16) 4412.7(2) 
Z 1 2 
ρcalcg/cm3 1.767 1.632 
μ/mm-1 2.39 2.051 
F(000) 1016 2208 
Crystal size/mm3 0.07 × 0.04 × 0.03 0.08 × 0.04 × 0.02 
Radiation MoKα (λ = 0.71075) MoKα (λ = 0.71075) 
2Θ range for data collection/° 4.408 to 54.968 4.246 to 52.744 
Index ranges 
 
-14 ≤ h ≤ 14, 
 -18 ≤ k ≤ 18, 
 -18 ≤ l ≤ 18 
-18 ≤ h ≤ 17, 
 -26 ≤ k ≤ 26, 
 -17 ≤ l ≤ 15 
Reflections collected 22827 27584 
Independent reflections 
 
 
8613 
 [Rint = 0.0668,  
Rsigma = 0.0740] 
9009  
[Rint = 0.0516, 
 Rsigma = 0.0694] 
Data/restraints/parameters 8613/0/547 9009/0/601 
Goodness-of-fit on F2 0.983 1.023 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0513, 
 wR2 = 0.1234 
R1 = 0.0459,  
wR2 = 0.0829 
Final R indexes [all data] 
 
R1 = 0.0773 
, wR2 = 0.1344 
R1 = 0.0781, 
 wR2 = 0.0923 
Largest diff. peak/hole / e Å-3 1.98/-0.67 1.07/-0.57 
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Table 13.23 Crystallographic table of compounds 20ZnLn-NO3 and 22ZnLn-NO3. 
Identification code 20ZnY-NO3 22ZnY-NO3 
Empirical formula C98H90Dy2N8Ni2O20 C86H70Br4N8O20Y2Zn2 
Formula weight 2142.19 2163.7 
Temperature/K 100(2) 100 
Crystal system triclinic monoclinic 
Space group P-1 C2/c 
a/Å 11.64167(16) 26.7727(5) 
b/Å 14.56081(18) 16.6603(2) 
c/Å 14.80148(19) 20.4411(3) 
α/° 70.2523(12) 90 
β/° 77.1776(11) 92.4692(16) 
γ/° 68.9971(12) 90 
Volume/Å3 2190.02(5) 9109.1(3) 
Z 1 4 
ρcalcg/cm3 1.624 1.578 
μ/mm-1 2.189 3.608 
F(000) 1082 4320 
Crystal size/mm3 0.05 × 0.05 × 0.02 0.24 × 0.16 × 0.02 
Radiation MoKα (λ = 0.71075) MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.864 to 54.97 5.282 to 52.742 
Index ranges 
 
-15 ≤ h ≤ 15, 
 -18 ≤ k ≤ 18, 
 -19 ≤ l ≤ 19 
-34 ≤ h ≤ 34,  
-21 ≤ k ≤ 21, 
 -26 ≤ l ≤ 26 
Reflections collected 66515 78750 
Independent reflections 
 
 
10027  
[Rint = 0.0357, 
 Rsigma = 0.0181] 
9234  
[Rint = 0.0380,  
Rsigma = 0.0195] 
Data/restraints/parameters 10027/0/590 9234/219/526 
Goodness-of-fit on F2 1.054 1.089 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0207,  
wR2 = 0.0519 
R1 = 0.0592, 
 wR2 = 0.1817 
Final R indexes [all data] 
 
R1 = 0.0231, 
 wR2 = 0.0528 
R1 = 0.0680, 
 wR2 = 0.1901 
Largest diff. peak/hole / e Å-3 0.83/-0.37 2.00/-1.06 
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Table 13.24 Crystallographic table of compounds 24 ZnLn-NO3,27ZnLn-NO3 and 1CuDy-NO3 
Identification code 24ZnY-NO3 27ZnY-NO3 1CuDy-NO3 
Empirical formula C64H68N14O22Y2Zn2 C78H90N8O20Y2Zn2 C64H56Cu2Dy2N10O18 
Formula weight 1693.88 1768.13 1705.26 
Temperature/K 173 100(2) 173 
Crystal system monoclinic monoclinic orthorhombic 
Space group P21/c P21/c Pbca 
a/Å 11.012(2) 14.15839(16) 14.0995(4) 
b/Å 21.610(3) 13.05838(14) 16.9713(6) 
c/Å 14.825(2) 25.7485(3) 25.9304(8) 
α/° 90 90 90 
β/° 100.762(19) 90.8307(10) 90 
γ/° 90 90 90 
Volume/Å3 3466.0(10) 4760.02(9) 6204.8(3) 
Z 2 2 4 
ρcalcg/cm3 1.623 1.234 1.825 
μ/mm-1 3.698 1.768 14.139 
F(000) 1728 1824 3376 
Crystal size/mm3 0.11 × 0.08 × 0.06 0.24 × 0.1 × 0.08 0.24 × 0.16 × 0.1 
Radiation CuKα (λ = 1.54184) MoKα (λ = 0.71073) CuKα (λ = 1.54184) 
2Θ range for data collection/° 9.142 to 123.278 4.244 to 54.968 6.818 to 134.34 
Index ranges 
 
-12 ≤ h ≤ 7,  
-24 ≤ k ≤ 24, 
 -14 ≤ l ≤ 16 
-18 ≤ h ≤ 18, 
 -16 ≤ k ≤ 16, 
 -33 ≤ l ≤ 33 
-16 ≤ h ≤ 15,  
-19 ≤ k ≤ 16, 
 -16 ≤ l ≤ 29 
Reflections collected 10484 128151 18682 
Independent reflections 
 
 
5214  
[Rint = 0.1091,  
Rsigma = 0.1149] 
10892 
 [Rint = 0.0484, 
 Rsigma = 0.0219] 
4863  
[Rint = 0.0927,  
Rsigma = 0.0754] 
Data/restraints/parameters 5214/0/475 10892/36/497 4863/0/437 
Goodness-of-fit on F2 1.199 1.117 1.049 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.1062,  
wR2 = 0.2791 
R1 = 0.0441, 
 wR2 = 0.1301 
R1 = 0.0513,  
wR2 = 0.1138 
Final R indexes [all data] 
 
R1 = 0.1326, 
 wR2 = 0.3351 
R1 = 0.0513,  
wR2 = 0.1351 
R1 = 0.0757, 
 wR2 = 0.1289 
Largest diff. peak/hole / e Å-3 2.50/-1.42 1.95/-0.87 0.80/-1.04 
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13.2 Crystallographic tables of ligands 
Table 13.25 Crystallographic table of ligands H2L12 and H2L22. 
Identification code H2L12 H2L22 
Empirical formula C14H11ClN2O5 C21H20BrNO4 
Formula weight 322.7 430.29 
Temperature/K 173 173 
Crystal system triclinic triclinic 
Space group P-1 P-1 
a/Å 6.9697(4) 7.5662(4) 
b/Å 12.6645(7) 8.5456(4) 
c/Å 15.0866(8) 14.8304(8) 
α/° 76.153(5) 84.747(4) 
β/° 89.966(5) 84.775(4) 
γ/° 88.423(5) 82.090(4) 
Volume/Å3 1292.45(13) 942.80(8) 
Z 4 2 
ρcalcg/cm3 1.658 1.516 
μ/mm-1 2.9 2.207 
F(000) 664 440 
Crystal size/mm3 0.12 × 0.08 × 0.01 0.28 × 0.14 × 0.04 
Radiation CuKα (λ = 1.54184) Mo Kα (λ = 0.71073) 
2Θ range for data 
collection/° 10.444 to 142.68 5.36 to 58.26 
Index ranges 
 
-5 ≤ h ≤ 8, 
 -15 ≤ k ≤ 15, 
 -18 ≤ l ≤ 18 
-10 ≤ h ≤ 10, 
 -11 ≤ k ≤ 11,  
-19 ≤ l ≤ 19 
Reflections collected 7064 21895 
Independent reflections 
 
 
4806  
[Rint = 0.0243, 
 Rsigma = 0.0398] 
4630 
 [Rint = 0.0562, 
 Rsigma = 0.0474] 
Data/restraints/parameters 4806/2/417 4630/2/253 
Goodness-of-fit on F2 1.054 1.049 
Final R indexes [I>=2σ 
(I)] 
R1 = 0.0493,  
wR2 = 0.1324 
R1 = 0.0373,  
wR2 = 0.0719 
Final R indexes [all data] 
 
R1 = 0.0593, 
 wR2 = 0.1451 
R1 = 0.0506,  
wR2 = 0.0768 
Largest diff. peak/hole / e 
Å-3 0.66/-0.33 0.40/-0.50 
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13.3 Crystallographic tables of organic products 
13.3.1 Chapter 8 
Table 13.26 Crystallographic table of organic products C8aa and C8al.  
Identification code C8aa C8al 
Empirical formula C23H18N2 C29H24N2O2 
Formula weight 322.39 432.5 
Temperature/K 100(2) 100 
Crystal system monoclinic triclinic 
Space group P21/c P-1 
a/Å 10.0681(7) 9.9468(4) 
b/Å 9.7551(7) 10.2850(5) 
c/Å 17.5082(11) 11.5735(5) 
α/° 90 75.327(4) 
β/° 94.291(6) 82.383(4) 
γ/° 90 81.347(4) 
Volume/Å3 1714.7(2) 1126.82(9) 
Z 4 2 
ρcalcg/cm3 1.249 1.275 
μ/mm-1 0.069 0.08 
F(000) 680 456 
Crystal size/mm3 0.05 × 0.05 × 0.02 0.12 × 0.04 × 0.02 
Radiation ? (λ = 0.6889) MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.636 to 53.132 4.816 to 52.736 
Index ranges 
 
-13 ≤ h ≤ 13, 
 -12 ≤ k ≤ 12, 
 -22 ≤ l ≤ 22 
-11 ≤ h ≤ 12, 
 -12 ≤ k ≤ 12,  
-14 ≤ l ≤ 14 
Reflections collected 11331 27043 
Independent reflections 
 
 
3894  
[Rint = 0.0786, 
 Rsigma = 0.0803] 
4603 
 [Rint = 0.0597,  
Rsigma = 0.0393] 
Data/restraints/parameters 3894/0/226 4603/1/304 
Goodness-of-fit on F2 1.033 1.045 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0626, 
 wR2 = 0.1375 
R1 = 0.0558, 
 wR2 = 0.1337 
Final R indexes [all data] 
 
R1 = 0.1319, 
 wR2 = 0.1681 
R1 = 0.0788,  
wR2 = 0.1463 
Largest diff. peak/hole / e Å-3 0.26/-0.21 0.39/-0.24 
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Table 13.27 Crystallographic table of organic products C8ao and C8as 
Identification code C8ao C8as 
Empirical formula C23H20N2O3 C25H22N2 
Formula weight 372.41 350.44 
Temperature/K 173 100(2) 
Crystal system monoclinic monoclinic 
Space group P21/n I2/a 
a/Å 8.8491(5) 18.3322(16) 
b/Å 10.6531(7) 10.0821(6) 
c/Å 20.9154(13) 20.0451(10) 
α/° 90 90 
β/° 96.794(6) 90.573(6) 
γ/° 90 90 
Volume/Å3 1957.8(2) 3704.7(4) 
Z 4 8 
ρcalcg/cm3 1.263 1.257 
μ/mm-1 0.085 0.074 
F(000) 784 1488 
Crystal size/mm3 0.28 × 0.18 × 0.15 0.08 × 0.05 × 0.01 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71075) 
2Θ range for data collection/° 6.872 to 52.74 4.522 to 50.056 
Index ranges 
 
-11 ≤ h ≤ 9,  
-7 ≤ k ≤ 13,  
-26 ≤ l ≤ 19 
-17 ≤ h ≤ 21, 
 -11 ≤ k ≤ 12,  
-23 ≤ l ≤ 23 
Reflections collected 6886 19320 
Independent reflections 
 
3957  
[Rint = 0.0376,  
Rsigma = 0.0635] 
3261 
 [Rint = 0.1120,  
Rsigma = 0.0883] 
Data/restraints/parameters 3957/2/262 3261/0/246 
Goodness-of-fit on F2 1.023 1.032 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0696,  
wR2 = 0.1801 
R1 = 0.0575,  
wR2 = 0.1015 
Final R indexes [all data] 
 
R1 = 0.1108,  
wR2 = 0.2212 
R1 = 0.1149,  
wR2 = 0.1202 
Largest diff. peak/hole / e Å-3 0.46/-0.41 0.21/-0.23 
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Table 13.28 Crystallographic table of organic products C8bw and C8cb. 
Identification code C8bw C8cb 
Empirical formula C17H15BrN2O2 C17H19NO2 
Formula weight 359.22 269.33 
Temperature/K 173 173 
Crystal system monoclinic monoclinic 
Space group P21/c Ia 
a/Å 13.8437(7) 13.4472(5) 
b/Å 12.9564(6) 9.3180(4) 
c/Å 8.5035(4) 11.5805(4) 
α/° 90 90 
β/° 96.989(5) 90.109(4) 
γ/° 90 90 
Volume/Å3 1513.89(12) 1451.06(10) 
Z 4 4 
ρcalcg/cm3 1.576 1.233 
μ/mm-1 3.776 0.64 
F(000) 728 576 
Crystal size/mm3 0.2 × 0.08 × 0.06 0.18 × 0.14 × 0.08 
Radiation CuKα (λ = 1.54184) CuKα (λ = 1.54184) 
2Θ range for data collection/° 9.382 to 142.13 11.554 to 142.016 
Index ranges 
 
-14 ≤ h ≤ 16, 
 -15 ≤ k ≤ 11, 
 -10 ≤ l ≤ 8 
-16 ≤ h ≤ 15, 
 -11 ≤ k ≤ 11,  
-14 ≤ l ≤ 10 
Reflections collected 4684 4020 
Independent reflections 
 
 
2826  
[Rint = 0.0454,  
Rsigma = 0.0492] 
1939  
[Rint = 0.0281, 
 Rsigma = 0.0334] 
Data/restraints/parameters 2826/0/200 1939/2/182 
Goodness-of-fit on F2 1.05 1.037 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0595, 
wR2 = 0.1530 
R1 = 0.0413,  
wR2 = 0.1052 
Final R indexes [all data] 
 
R1 = 0.0650,  
wR2 = 0.1627 
R1 = 0.0424,  
wR2 = 0.1061 
Largest diff. peak/hole / e Å-3 1.09/-0.82 0.16/-0.26 
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13.3.2 Chapter 9 
Table 13.29 Crystallographic table of organic products C9f andC9h. 
Identification code C9f C9h 
Empirical formula C15H17N3O5 C14H16N4O4 
Formula weight 319.32 304.31 
Temperature/K 373(2) 100(2) 
Crystal system monoclinic orthorhombic 
Space group P21/c Pna21 
a/Å 21.4080(6) 13.8265(3) 
b/Å 8.64361(19) 10.2290(3) 
c/Å 25.2347(5) 10.7482(3) 
α/° 90 90 
β/° 93.733(2) 90 
γ/° 90 90 
Volume/Å3 4659.59(19) 1520.13(7) 
Z 12 4 
ρcalcg/cm3 1.366 1.33 
μ/mm-1 0.875 0.1 
F(000) 2016 640 
Crystal size/mm3 ? × ? × ? 0.2 × 0.1 × 0.06 
Radiation CuKα (λ = 1.54184) MoKα (λ = 0.71073) 
2Θ range for data collection/° 10.506 to 133.198 5.894 to 52.736 
Index ranges 
 
? ≤ h ≤ ?,  
? ≤ k ≤ ?, 
 ? ≤ l ≤ ? 
-15 ≤ h ≤ 17, -12 ≤ k ≤ 12, -13 ≤ l 
≤ 13 
Reflections collected ? 15711 
Independent reflections 
 
 
8177  
[Rint = ?,  
Rsigma = 0.0615] 
3005 
 [Rint = 0.0392, 
 Rsigma = 0.0220] 
Data/restraints/parameters 8177/381/646 3005/3/209 
Goodness-of-fit on F2 1.479 1.032 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.1003, 
 wR2 = 0.3050 
R1 = 0.0624, 
 wR2 = 0.1695 
Final R indexes [all data] 
 
R1 = 0.1126,  
wR2 = 0.3310 
R1 = 0.0675,  
wR2 = 0.1758 
Largest diff. peak/hole / e Å-3 1.78/-0.74 0.95/-0.30 
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Table 13.30 Crystallographic table of organic products for C9l and C9v. 
Identification code C9l C9v 
Empirical formula C14H15FN4O4 C16H19N3O6 
Formula weight 322.3 349.34 
Temperature/K 100(2) 173 
Crystal system orthorhombic triclinic 
Space group Pna21 P-1 
a/Å 13.8506(4) 8.0625(8) 
b/Å 10.5093(3) 8.9689(9) 
c/Å 10.5961(2) 11.7791(9) 
α/° 90 80.019(8) 
β/° 90 85.910(7) 
γ/° 90 83.179(8) 
Volume/Å3 1542.38(7) 831.82(14) 
Z 4 2 
ρcalcg/cm3 1.388 1.395 
μ/mm-1 0.112 0.912 
F(000) 672 368 
Crystal size/mm3 0.12 × 0.1 × 0.07 0.14 × 0.1 × 0.08 
Radiation MoKα (λ = 0.71073) CuKα (λ = 1.54184) 
2Θ range for data collection/° 5.882 to 52.74 10.074 to 142.272 
Index ranges 
 
-11 ≤ h ≤ 17,  
-12 ≤ k ≤ 13, 
 -13 ≤ l ≤ 13 
-8 ≤ h ≤ 9, 
 -10 ≤ k ≤ 7,  
-12 ≤ l ≤ 14 
Reflections collected 10359 4562 
Independent reflections 
 
 
3077  
[Rint = 0.0175, 
 Rsigma = 0.0182] 
2946  
[Rint = 0.0310,  
Rsigma = 0.0376] 
Data/restraints/parameters 3077/1/216 2946/0/230 
Goodness-of-fit on F2 1.065 1.063 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0626,  
wR2 = 0.1832 
R1 = 0.0574, 
 wR2 = 0.1570 
Final R indexes [all data] 
 
R1 = 0.0638,  
wR2 = 0.1849 
R1 = 0.0679, 
 wR2 = 0.1672 
Largest diff. peak/hole / e Å-3 2.27/-0.27 0.51/-0.25 
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Chapter 14: Appendix 
Appendix A  
Chapter 1 
Table S1.1 Representative examples of 3d-4f PCCs (3d = NiII, CoII, CuII, ZnII) supported by Schiff 
base ligands with a nuclearity above five that display SMM properties. 
Entry Ligand Core Topology SMM 
properties 
Reference 
1 H4RL1.1 NiII2DyIII3 1,2,2M5-1 Ueff = 85 K 
τ0 = 5.9 x 10-7 s  
TB = 3 K 
56 
2 H2 RL1.2 ZnII2DyIII3 1,2,3M5-1 Ueff = 85 K 
τ0 = 3.3 x 10-7 s 
550 
3 H4RL1.3 CoIII3CoIIDy 1,1,2,3M5-1 Ueff = 13 K 
τ0 = 2.3 x 10-7 s 
74 
4 H2RL1.4 CuII4DyIII 2,4M5-1 Ueff = 12.876 K 
τ0 = 2.268 x 10-7 s 
19 
5 H4RL1.5 CuII2DyIII3 1,2,2M5-1 Ueff = 5.4 K 
τ0 = 2.6 x 10-5 s 
551 
6 H2RL1.6 NiII3DyIII3 2,4M6-1 Ueff = 10 K 
τ0 = 1 x 10-6 s 
552 
7 H2RL1.7 CoII2DyIII4 2,3,4M6-1 Ueff = 32.4 K 
τ0 = 4.2 x 10-7 s 
553 
8 H2RL1.8 NiII4LnIII2 2,3,4M6-1 (TbIII) TB= 2.9 K,  
τ0 = 2.09 x 10-9 s 
 Ueff = 30 K 
(DyIII) = TB-.2 K 
τ0 = 1.41 x 10-8 s 
Ueff = 32 K 
55 
9 H2RL1.9 CoII2DyIII4 2,3,4M6-1 Uef f = 41.9 K 
τ0 = 1.21 x 10-7 s 
516 
310 
 
 
10 H4RL1.5 CuII4DyIII2 1,2,2M6-1 Ueff = 6.5 K 
τ0 = 2.9x10-7 s 
551 
11 H3RL1.10 CuII5DyIII2 3,6M7-1 Ueff = 4 K 
τ0 = 3x10-6 s 
113 
12 HRL1.11 CoII3DyIII4 3,6M7-1 Out-of-phase signal below 4 
K 
554 
13 H2RL1.12 CuII4DyIII4 2M8-1 Ueff = 41.6 K 
τ0 = 2.1x10-5 s 
103 
14 H2RL1.13 NiII5DyIII3 2,3,5,6M8-4 Out-of-phase sign below 4 K 71 
15 H4RL1.14 NiII4DyIII4 2M8-1 Out-of-phase sign below 4K 555 
16 HRL1.15 CuII6DyIII3 3,6M9-1 Ueff = 25 K 
τ0 = 1.5x10-7 s 
526 
17 H2RL1.7 CuII6DyIII3 3,6M9-1 Ueff = 25.293 K 
τ0 = 3.939 ×10−9 s, 
19 
18 H3RL1.16 DyIII3CuII 8 2,3,4M11-1 Out-of-phase signal below 4 
K 
78 
19 H2RL1.17 DyII2CuII9 1,2,3,4,6M11-1 Ueff = 16.1 K 
τ0 = 3.6 × 10−7 s 
556 
20 H2RL1.18 NiΙΙ8DyΙΙ4 2M12-1 Frequency-dependent 
maxima below 3.5 K 
365 
21 H2RL1.19 CoII2DyIII10 (2,3,3M12-1)+2(0) Dual relaxation pathways 
Ueff = 4.3 K,  
τ0 = 1.13 ×10−4 s;  
Ueff = 25 K 
τ0 = 3.14 ×10−6 s 
525 
22 H3RL1.20 ZnII6DyIII6 2M12-1 Frequency dependent 
maxima 2-10 K 
557 
24 H2RL1.21 CuII16DyIII2 3,4,6,8M16-1 Ueff = 5.2 K 
τ0 = 6.5 × 10−6 s 
223 
23 HRL1.22 NiII8DyIII8 (2,5M8-1)+8(0) May be an SMM 558 
24 HRL1.23 ZnII12DyIII18  Frequency-dependent signal- 
below 4.5K 
28 
311 
 
 
 
Figure S1.11. Schiff base ligands used to support 3d-4f PCCs with SMM properties. 
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Chapter 2 
Table S2.1. Reported polynuclear ZnII-LnIII PCCs with a nuclearity of 4 and above. 
Entry Compound formula Ligand Nuclearity Topological nomenclature Reference 
1 [ZnII2NdIII2(RL2.2)2Cl6(MeOH)2]·MeOH 
[ZnII2DyIII2(RL2.3)2(OAc)2(CO3)2]·10CH3OH 
H2RL2.2 
H2RL2.3 
ZnII2LnIII2 1,2M4-1 72,111 
2 [ZnII2LnIII3(RL2.1)3(N3)5(OH)2]  
Ln = (Tb, Eu, Ho, Dy) 
H2RL2.1 ZnII2LnIII3 1,2,3M5-1 318 
3 [ZnII2 LnIII3(RL2.3)3Cl2(OH)3(N3)2]  
Ln = (La, Nd, Yb, Er) 
H2RL2.3 ZnII2LnIII3 1,2,3M5-1 247 
4 [ZnII2LnIII2(RL2.4)2(CO3)2(NO3)2]·solv 
Ln = Dy, Tb, Gd 
H2RL2.4 ZnII2LnIII2 1,2M4-1 330 
5 [ZnII2LnIII2(RL2.5)2(CO3)2(NO3)2]·solv 
Ln = Dy, Tb, Gd 
H2RL2.5 ZnII2LnIII2 1,2M4-1 330 
6 [ZnII2YbIII2(RL2.6)2(OH)2Cl4]·2MeCN H2RL2.6 ZnII2LnIII2  1,2M4-1 559 
313 
 
 
7 [ZnII8LnIII4(RL2.7)2(OAc)20(OH)4] 
 Ln = Nd, Yb 
H2RL2.7 ZnII8LnIII4  2(1,2,3M6-1) 234 
8 [ZnII4EuIII4(R2.L8)4(CO3)6]·EtOH H2RL2.8 ZnII4LnIII4 1,3M8-1 326 
9 [ZnII2EuIII2(PhCOO)2 (RL2.9)4] 
[ZnII2DyIII2(PhCOO)2(RL2.9)4] 
[ZnII2TbIII2(PhCOO)2 (RL2.9)4] 
H2RL2.9 ZnII2LnIII2 
 
2M4-1 560,320,561 
10 [ZnII2DyIII2(RL2.9)2(μ3-OH)2(μ4-OH)(dbm)2(MeOH)2]X 
X = NO3, ClO4 
H2RL2.9 ZnII2LnIII2 
 
3M4-1 331 
11 [ZnII2LnIII2(RL2.10)2(CO3)2(NO3)2]·4CH3OH 
Ln = Gd, Yb 
H2RL2.10 ZnII2LnIII2 1,2M4-1 325 
12 [(YbIIIRL2.11)2(H2O)Cl(OAc)]2·[ZnIICl4]2 HRL2.11 ZnII2LnIII2 3M4-1 562 
314 
 
 
13 [ZnII2LnIII2(OH)2(RL2.12)2(OAc)5(EtOH)(H2O)](ClO4)· 
2EtOH·1.5H2O 
Ln = Gd, Dy 
H2RL2.12 ZnII2LnIII2 3M4-1 239 
14 [ZnII3LaIII(RL2.16) (OAc)3] H4RL2.16 ZnII3LnIII 1,3M4-1 563 
15 [ZnII3LaIII(RL2.17) (OAc)3] H4RL2.17 ZnII3LnIII  1,3M4-1 564 
17 [ZnII4DyIII(RL2.14)4(DMF)4(NO3)3] 
Ln = Dy, Tb, Y, Er 
H2RL2.14 ZnII4LnIII 1,4M5-1 329 
18 [ZnII16LnIII(RL2.14)16(Py)8(CF3SO4)] 
Ln = Tb, Dy, Yb, Er, Nd 
H2RL2.14 ZnII16LnIII 2,3,8M17-1 250 
19 [ZnII9LnIII2(RL2.14)10(OH)(NO3)2.25Cl0.75] 
Ln = Dy, Tb, Eu 
H2RL2.14 ZnII9LnIII2 1,1,2,2,5,7M11-2 323 
20 [ZnII8LnIII(RL2.13)8(OH)3] 
 Ln = Dy, Nd 
H2RL2.13 ZnII8LnIII 
 
1,2,8M9-1 
 
323 
315 
 
 
21 [ZnII8GdIII4(OH)8(RL2.15)8(O2CHMe2)8] (ClO4)4 HRL2.15 ZnII8LnIII4 
 
3,6M12-1 225 
22 [ZnII2LnIII2(RL2.15)4(PhCO2)5(ROH)2](ClO4)·2MeOH 
Ln = Dy, Gd 
HRL2.15 ZnII2LnIII2 3M4-1 327 
23 [ZnII6LnIII(OH)(RL2.19)6(NO3)3](OH)(NO3)2·8H2O  
Ln = Er, Dy 
HRL2.19 ZnII6LnIII  2,6M7-1 565 
24 [ZnII6DyIII(RL2.20)6(OH)3(OAc)3(NO3)3] HRL2.20 ZnII6LnIII  2,6M7-1 205 
25 [ZnII6LnIII24(RL2.21)24(OAc)22(μ3OH)30(H2O)14](ClO4)7(
OAc)·2CH3OH·26H2O  
Ln = Gd, Tb, Dy 
HRL2.21 ZnII6LnIII24 3(3,3,5M10-1) 5 
26 [ZnII12DyIII18(OH)30(RL2.22)12(sal)6(OAc)6(NO3)3(H2O)6
](NO3)3·12MeOH·5H2O  
H2RL2.22 ZnII12LnIII18 3,4,6,8M30-1 28 
27 [ZnII3Ln2III(RL2.23)2(Py)2(NO3)2] 
[ZnLn(RL2.23)(Py)(NO3)3(H2O)](NO3)·solv 
Ln = Er, Gd 
H2RL2.23 ZnII3Ln2III (1,2M3-1) +(1M2-1) 238 
28 [(THF)8LnIII4Se(RL2.24)8] [ZnII8Se(L2.27)16] THF  RL2.24 ZnII8LnIII4 (3,6M8-1) +(3M4-1) 566 
316 
 
 
29 [ZnII4NdIII2(RL2.25)4(1,4-BDC)2] [ZnNd(RL2.25) 
(NO3)3(OAc)]2 
H2RL2.25 ZnII6LnIII4 2(1,2M3-1) +2(1M2-1) 31 
30 [ZnII2LnIII2(L1)4(EtOH)6](ClO4)2 H2L1 ZnII2LnIII2 2,3M4-1 This work 
31 [ZnII5LnIII(OH)(L1)6(H2O)] H2L1 ZnII5LnIII 2,3,4M6-1 This work 
32 [ZnII4DyIII2(OH)2(L2)4(OAc)2(NO3)2(DMF)3]·DMF H2L2 ZnII4DyIII2 2,3,4M6-1 This work 
33 [ZnII2LnIII2(L3)2(CO3)2(NO3)2(CH3OH)2] H3L3 ZnII2LnIII2 1,2M4-1 This work 
34 [ZnII2LnIII2(L1)4(NO3)2(DMF)2] H2L1 ZnII2LnIII2 2,3M4-1 336 
317 
 
 
Magnetic measurements 
 
Figure S2.1. ac susceptibility measures for 1 (red squares) and 10 (blue squares) for the 
frequencies 10 and 1000 Hz and under a field of 0.1 T. Both systems show a very weak response, 
showing the tails of the out-of-phase signals.  
 
Figure S2.2. ac susceptibility measurements for 7 under variable transverse field and a fixed 
frequency of 997 Hz, showing the displacement of the ac peaks as consequence of the breaking 
of the tunnelling relaxation.  
318 
 
 
Molecular Structures of 13 and 14 
 
Figure S2.3 Molecular Structure of 13. Colour code: ZnII, grey; DyIII, light blue; O, red; N, blue 
and C, white. Crystallographic data (chapter 11).  
 
Figure S2.4 Molecular Structure of 14. Colour code: ZnII, grey; DyIII, light blue; O, red; N, blue; 
Cl, green and C, white. Crystallographic data (chapter 11).  
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Chapter 3 
Magnetics measurements 
 
Figure S3.1 Field dependence of the magnetization of 18 at the indicated temperatures. 
 
Figure S3.2 Field dependence of the magnetization and reduced magnetization for 16 at the 
indicated temperatures. 
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Figure S3.3. In-phase (’ red) and out-of-phase (” blue) ac susceptibility versus frequency and 
Cole-Cole plot (green) for 17 (Co4Dy2) at indicated temperatures. The solid line is a least-squares 
fitting of the data to a generalized Debye model. 
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Appendix B - Supporting data and supplemental material. 
For supporting data, supplemental Figures, tables and schemes (SX), see attached CD. 
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Chapter 1 
1.1 1H NMR and 13C NMR of ligands (H2L1-H2L29) 
 
 
S1.1 (Top) 1H NMR of H2L1. (Bottom) 13C NMR of H2L1. 
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S1.2 (Top) 1H NMR of H2L2 (Bottom) 13C NMR of H2L2 
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S1.3 (Top) 1H NMR of H3L3 (Bottom) 13C NMR of H3L3 
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S1.4 (Top) 1H NMR of HL4 (Bottom) 13C NMR of HL4 
 
 
 
4 
 
 
S1.5. 1H NMR of H2L5 
 
S1.6. 1H NMR of H2L6 
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S1.7. (Top) 1H NMR of H2L2 (Bottom) 13C NMR of H2L7 
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S1.8. 1H NMR of H2L8. 
 
S1.9. 1H NMR of H2L9 
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S1.10. 1H NMR of H2L10 
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S1.11. (Top) 1H NMR of H2L11 (Bottom) 13C NMR of H2L11 
# 
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S1.12. (Top) 1H NMR of H2L12 (Bottom) 13C NMR of H2L12 
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S1.13. (Top) 1H NMR of H2L13 (Bottom) 13C NMR of H2L13 
 
S1.14. 1H NMR of H2L14  
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S1.15. (Top) 1H NMR of H2L15 (Bottom) 13C NMR of H2L15 
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S1.16. 1H NMR of H2L16  
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S1.17. (Top) 1H NMR of H2L18 (Bottom) 13C NMR of H2L18. 
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S1.18. (Top) 1H NMR of H2L19 (Bottom).13C NMR of H2L19. 
 
S1.19. 1H NMR of H2L20  
15 
 
 
 
S1.20. (Top) 1H NMR of H2L22 (Bottom) 13C NMR of H2L22. 
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S1.21. 1H NMR of H2L24 
 
S1.22. 1H NMR of H2L25 
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S1.23. 1H NMR of H2L27 
 
S1.24. 1H NMR of H2L28 
 
18 
 
 
S1.25. 1H NMR of H2L29 
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Chapter 2 
2.1 FT-IR of 1-12 
S2.1. FT-IR of 1 
 
S2.2. FT-IR of 2 
 
 
20 
 
 
S2.3. FT-IR of 3 
 
S2.4. FT-IR of 4 
21 
 
 
S2.5. FT-IR of 5 
 
S2.6. FT-IR of 6 
22 
 
 
S2.7. FT-IR of 7 
 
S2.8. FT-IR of 8 
23 
 
 
S2.9. FT-IR of 9 
 
S2.10. FT-IR of 10 
24 
 
 
S2.11. FT-IR of 11 
 
S2.12. FT-IR of 12 
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2.2 TGA of compounds 1-12 
Figure S2.13. TGA of Compound 1 
 
S2.14. Figure S2. Comparative TGA of isoskeletal compounds 1-3 
26 
 
 
Figure S2.15. TGA of compound 4 
 
Figure S2.16. Comparative TGA of isoskeletal compounds 4-6 
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Figure S2.17. TGA of compound 7 
 
Figure S2.18. Comparative TGA of isoskeletal compounds 7-9 
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Figure S2.19.TGA of compound 10 
Figure S2.20. Comparative TGA of isostructural compounds 10-12 
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2.3 Luminescence 
 
Figure S2.21. Normalised absorption (dashed line) and emission spectra (solid line) of compounds H2L1 (blue; 
λex = 330 nm), H2L2 (red; λex = 330 nm), and H3L3 (yellow; λex = 330 nm) recorded in DMF (1x10-5 mol dm-
3, 298 K). 
 
Figure S2.22. Normalised absorption (dashed line) and emission spectra (solid line) of compounds 5 (blue; λex 
= 440 nm), 8 (red; λex = 410 nm), and 11 (yellow; λex = 350nm) recorded in DMF (1x10-5 mol dm-3, 298 K). 
 
30 
 
 
Figure S2.23. Normalised absorption (dashed line) and emission spectra (solid line) of compounds 6 (blue; λex 
= 430 nm), 9 (red; λex = 430 nm), and 12 (yellow; λex = 350 nm) recorded in DMF (1x10-5 mol dm-3, 298 K). 
 
2.4 ESI-MS of 1-3 
 
Figure S2.24. ESI-MS of 1. [ZnII2DyIII2 (L1)4]2+ fragment 
31 
 
 
Figure S2.25. ESI-MS of 2. [ZnII2TbIII2 (L1)4]2+ fragment 
 
Figure S2.26. ESI-MS of 3. [ZnII2EuIII2 (L1)4]2+ fragment. 
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Chapter 3 
3.1 ESI-MS of 16 
 
Figure S3.1.ESI-MS of 16 [CoII4GdIII2(C14H11NO3)4(OH)2(Cl)2(CH3OH)]3+ fragment. 
 
 
Figure S3.2 ESI-MS of 16 [CoII4GdIII2(C14H11NO3)4(OH)2(Cl)2+2H]2+ fragment 
33 
 
 
Figure S3.3. ESI-MS of 16- [CoII4GdIII2(C14H11NO3)4(OH)2(Cl)2+2H+H2O]2+ fragment 
 
Figure S3.4. ESI-MS of 16 [CoII4GdIII2(C14H11NO3)4(OH)2(Cl)2+2H+(H2O)2]2+ fragment 
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3.2 TGA of 16 and 18 
 
Figure S3.5. TGA of compounds 16 and 18. 
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Chapter 4 
4.1 FT-IR of 20-24 
 
S4.1 FT-IR of 20 
 
S4.2 FT-IR of 21 
36 
 
 
S4.3 FT-IR of 22 
 
S4.4 FT-IR of 23 
37 
 
 
S4.5 FT-IR of 24 
 
S4.6 FT-IR comparison of 20-24 
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4.2 ESI-MS of 20-24 
 
S4.7 ESI-MS of 20 - (807.06m/z [CoII3GdIII4(OH)6(C19H18N3O3)6(CF3SO3)2]4+) (1125.39m/z 
[CoII3GdIII4(OH)6(C19H18N3O3)6(CF3SO3)3]3+) (1762.06m/z 
[CoII3GdIII4(OH)6(C19H18N3O3)6(CF3SO3)4]2+) 
 
S4.8 ESI-MS of 21 -(761.19 m/z [CoII3YIII4(OH)6(C19H18N3O3)6(CF3SO3)2]4+) (1038.02 m/z 
[CoII3YIII4(OH)6(C19H18N3O3)6(CF3SO3)3]3+) (1624.03 m/z [CoII3YIII4(OH)6(C19H18N3O3)6(CF3SO3)4]2+) 
39 
 
 
S4.8 ESI-MS of 22 - (774.82 m/z [NiII3DyIII4(OH)6(C19H18N3O3)6(CF3SO3)]4+) (1132.07 m/z 
[NiII3DyIII4(OH)6(C19H18N3O3)6(CF3SO3)3]3+) (1771.14 m/z 
[NiII3DyIII4(OH)6(C19H18N3O3)6(CF3SO3)4]2+) 
 
S4.9 ESI-MS of 23 - 768.09 m/z [NiII3GdIII4(OH)6(C19H18N3O3)6(CF3SO3)]4+) (1124.41 m/z 
[NiII3GdIII4(OH)6(C19H18N3O3)6(CF3SO3)3]3+) (1760.61 m/z [NiII3GdIII4 
(OH)6(C19H18N3O3)6(CF3SO3)4]2+) 
40 
 
 
S4.10 ESI-MS of 24 - (1624.09 m/z [NiII3YIII4(OH)6(C19H18N3O3)6(CF3SO3)4]2+) 
4.3 TGA of 20-24 
 
S4.11 TGA of 20 
 
41 
 
 
S4.12 TGA of 21 
 
S4.12 TGA comparison of 20 (Blue), 21 (green) and CoDy-EtOH (red) 
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S4.13 TGA of 23 
 
S4.14 TGA of 24 
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S4.15 TGA comparison of 22 (green), 23 (blue) and 24 (red) 
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Chapter 5  
 
5.1 FT-IR of Complexes 25-42 
 
S5.1 FT-IR of 25 
 
S5.2 FT-IR of 26 
 
S5.3 FT-IR of 27 
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S5.4 FT-IR of 28 
 
S5.5 FT-IR of 29 
 
S5.6 FT-IR of 30 
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S5.7 FT-IR of 31 
 
S5.8 FT-IR of 32 
 
S5.9 FT-IR of 33 
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S5.10 FT-IR of 34 
 
S5.11 FT-IR of 35 
 
S5.12 FT-IR of 36 
 
S5.13 FT-IR of 37 
55
65
75
85
95
105
6001100160021002600310036004100
70
75
80
85
90
95
100
6001100160021002600310036004100
35
45
55
65
75
85
95
105
115
5001000150020002500300035004000
75
80
85
90
95
100
105
600110016002100260031003600
48 
 
 
S5.14 FT-IR of 38
 
S5.15 FT-IR of 39 
 
S5.16 FT-IR of 40 
 
S5.17 FT-IR of 42 
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5.2 ESI-MS of Compounds 28, 31 and 37 
 
 
 
S5.18 ESI-MS of 28 
 
50 
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S5.19 ESI-MS of 31 
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S5.20 ESI-MS of 37 
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Chapter 6 
6.1 Observed Coordination modes 
 
S6.1 The coordination modes of ligands seen in 43 and 44 
6.2 TGA of 43 and 44 
 
54 
 
 
S6.2 (Top) TGA of compound 43 (Bottom) TGA of compound 44 
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6.3 Shape Analysis of 43 and 44 
S6.3 Complete results of the SHAPE analysis for the nine-coordinated LnIII ions in the complex ZnII4GdIII11 (43) and ZnII4DyIII11 (44) with the EP-9 = 
enneagon, OPY = octagonal pyramid, HBPY = heptagonal bipyramid, JTC-9 Johnson trigonal cupola, JCCU-9 = capped cube, CCU-9 spherical-relaxed 
capped cube, JCSAPR-9 = tricapped trigonal prism,TCTPR-9 = spherical tricapped trigonal prism, JTDIC-9 tridiminished icosahedron, HH-9 == hula-hoop, 
MFF-9 = muffin.  
 Gd2 Dy2 Gd3 Dy3 Gd4 Dy4 Gd5 Dy5 
EP-9 32.856 33.888 34.682 34.719 34.565 34.966 33.790 32.915 
OPY-9 19.651 19.374 23.307 22.957 23.033 23.182 19.256 19.579 
HBPY-9 17.313 18.063 18.576 17.810 17.867 18.510 18.131 17.306 
JTC-9 13.795 14.903 14.341 14.070 14.022 14.445 14.826 13.782 
JCCU-9 9.709 10.621 10.392 9.305 9.187 10.279 10.719 9.799 
CCU-9 9.037 9.625 9.787 9.063 8.946 9.694 9.747 9.126 
JCSAPR-9 2.535 2.453 1.869 1.952 2.077 1.863 2.449 2.560 
CSAPR-9 1.873 1.674 1.411 1.493 1.526 1.426 1.680 1.881 
JTCTPR-9 3.609 3.814 2.336 2.196 2.234 2.345 3.774 3.650 
TCTPR-9 2.326 1.953 2.257 2.158 2.140 2.234 1.972 2.297 
JTDIC-9 11.417 11.292 12.087 11.642 11.739 12.280 11.351 11.451 
HH-9 10.955 11.810 11.480 11.370 11.413 11.374 11.867 10.978 
MFF-9 2.070 2.023 1.345 1.694 1.688 1.326 2.055 2.077 
 
 
56 
 
S6.4 Complete results of the SHAPE analysis for the eight-coordinated LnIII ions in the complex ZnII4GdIII11 (43) and ZnII4DyIII11 (44) with OP-8 = octagon, 
HPY-8 = heptagonal pyramid, HBPY-8= hexagonal bypryramid, CU-8= cube, SAPR-8 = Johnson elongated triangular bipyramid, JBTPR-8 = biaugmented 
trigonal prism J50, BTPR-8 = biaugmented trigibal prism, JSD-8 = snub diphenoid, TT-8 triakis tetrahedron, ETBPY-8 = elongated trigonal bipyramid. 
 Gd6 Dy6 Gd1 Dy1 
OP-8  31.768  31.704  31.016  31.225  
HPY-8  23.124  23.055  23.510  23.441  
HBPY-8  11.900  11.897  16.622  16.472  
CU-8  11.657  11.699  9.222  9.053  
SAPR-8  5.979  5.957  0.335  0.372  
TDD-8  4.248  4.198  2.444  2.420  
JGBF-8  8.139  8.196  16.869  16.824  
JETBPY-8  22.734  22.756  29.112  29.098  
JBTPR-8  4.258  4.195  3.158  3.196  
BTPR-8  3.861  3.831  2.502  2.547  
JSD-8  4.145  4.106  5.594  5.615  
TT-8  12.447  12.495  10.087  9.920  
ETBPY-8  19.543  19.599  24.829  24.821  
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6.4 Magellan program 
 
Table S6.5 Input file for Magellan program for complex Zn4Dy11 (44) leading to Figure!sites 11 1 2 
18 20 36 37 38 39 40 41 42  
Dy 9.36027 22.08810 7.25876 3  
Dy 9.94045 22.08810 3.78454 3  
O 11.03397 24.14126 3.91088 -0.33  
N 11.24306 24.18858 5.20250 0  
O 8.26675 24.14126 7.13243 -0.33  
N 8.05766 24.18858 5.84080 0  
O 9.63739 23.37475 1.79962 0  
O 9.65036 20.65005 5.52165 -1  
O 11.98787 21.23221 3.48814 -0.5  
O 8.33567 23.11293 5.17843 -0.33  
O 10.96505 23.11293 5.86488 -0.33  
O 7.66207 21.46178 2.85447 0  
O 9.85848 20.25645 2.41340 -0.5  
O 9.66334 23.37475 9.24369 0  
O 7.31285 21.23221 7.55517 -0.5  
O 11.63865 21.46178 8.18883 0  
O 9.44224 20.25645 8.62990 -0.5  
Dy 11.74418 26.37177 3.46539 3  
O 11.66689 25.25792 5.70298 -0.33  
Dy 7.55654 26.37177 7.57791 3  
O 7.63383 25.25792 5.34032 -0.33  
O 10.99017 28.61349 2.61881 -2  
O 9.54633 26.86350 4.06084 -1  
O 11.90841 28.00049 5.09185 -1  
O 10.39682 26.03004 1.59289 -1  
O 13.54765 27.77127 2.83592 -1  
O 13.24838 25.13174 1.74330 0  
O 13.88692 25.15733 3.87487 0  
O 8.31055 28.61349 8.42449 -2  
O 9.75439 26.86350 6.98246 -1  
O 7.39232 28.00049 5.95146 -1  
O 8.90390 26.03004 9.45042 -1  
O 5.75307 27.77127 8.20738 -1  
O 6.05234 25.13174 9.30001 0  
O 5.41380 25.15733 7.16843 0  
Dy 10.48151 27.65946 9.03364 3  
Dy 9.65036 28.72355 5.52165 3  
Dy 12.96595 29.74066 3.94180 3  
Dy 9.93471 31.07006 2.55917 3  
Dy 6.33477 29.74066 7.10151 3  
Dy 9.36601 31.07006 8.48413 3  
Dy 8.81921 27.65946 2.00966 3  
O 8.40357 30.55695 6.44575 -1  
O 10.89715 30.55695 4.59755 -1  
O 10.75462 29.42908 7.54147 -1  
O 8.54610 29.42908 3.50183 -1  
O 6.68450 27.27112 3.22244 -0.33  
O 7.40024 25.62137 2.02291 -0.33  
O 9.23000 29.66881 0.83554 -1  
O 8.50383 27.16528 -0.49938 0  
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O 6.84262 28.17678 0.57138 0  
N 6.47923 26.10505 2.75420 0  
O 12.24025 31.05149 2.11347 -0.66  
O 13.66344 31.87198 4.30026 -0.5  
O 14.88928 29.01305 5.30763 -0.33  
O 15.11480 29.87525 2.50904 0  
O 13.40112 30.04313 6.50583 -0.33  
O 10.73303 33.15757 2.96844 -0.5  
O 8.38651 32.24210 4.25609 -0.33  
O 7.06047 31.05149 8.92984 -0.66  
O 8.56769 33.15757 8.07486 -0.5  
O 10.91422 32.24210 6.78721 -0.33  
O 11.55665 32.15762 8.88323 -0.33  
O 9.37909 32.10926 10.83127 0  
O 10.07073 29.66881 10.20777 -1 
N 11.78768 32.54982 7.68614 0  
O 7.74407 32.15762 2.16007 -0.33  
O 9.92163 32.10926 0.21203 0  
N 7.51304 32.54982 3.35716 0  
O 12.61622 27.27112 7.82087 -0.33  
O 11.90048 25.62137 9.02039 -0.33  
O 10.79690 27.16528 11.54268 0  
O 12.45810 28.17678 10.47192 0  
N 12.82149 26.10505 8.28910 0  
O 5.63728 31.87198 6.74304 -0.5  
O 4.41144 29.01305 5.73567 -0.33  
O 5.89960 30.04313 4.53747 -0.33  
O 4.18593 29.87525 8.53426 0 
Chapter 7 
7.1 ESI-MS of LMLn 
 
S7.1 ESI-MS of 1CoDy- ClO4 
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Figure S7.2. Experimental and theoretical ESI-MS patterns of 1CoDy-ClO4 corresponding to 
[CoII2DyIII2(L1)4(ClO4)-H]+ (upper) and [CoII2DyIII2(L1)4(MeOH)2-H]2+(lower) fragments. 
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Figure S7.3. ESI-MS of 1NiDy-ClO4 
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Figure S7.4. Experimental and theoretical ESI-MS patterns of 1NiDy-ClO4 corresponding to 
{[NiII2DyIII2(L1)4(MeOH)2(EtOH)]+2H}+ (upper) and {[NiII2DyIII2(L1)4]-H}2+ (lower) fragments 
 
Figure S7.5. ESI-MS of of 1NiDy-Cl 
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Figure S7.6. Experimental and theoretical ESI-MS patterns of 1NiDy-Cl corresponding to 
{[NiII2DyIII2(L1)4Cl2(CH3CN)(CH3OH)]+4H}+ (upper) and {[NiII2DyIII2(L1)4]-H}2+ (lower) fragments 
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S7.7. ESI-MS of 1NiY-Cl (Top) [NiII2YII2(C14H11NO3)4(CH3N)]1+ Fragment (bottom right) {[NiII2YII2 
(C14H11NO3)4]-1H}2+ (bottom left) 
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S7.8. ESI-MS of 1NiSm-Cl (Top) [NiII2SmIII2(C14H11NO3)4(CH3N)]1+ Fragment (bottom left) {[ 
NiII2SmIII2(C14H11NO3)4]-1H}2+ (bottom right) 
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S7.9. ESI-MS of 1-NiEu-Cl (Top) {[NiII2EuIII2(C14H11NO3)4]-1H}2+ fragment (bottom left) {[ 
NiII2EuIII2(C14H11NO3)4(CH3CN)]+1H}1+ fragment (bottom right) 
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S7.10. ESI-MS of 1NiTb-Cl (Top) [NiII2TbIII2 (C14H11NO3)4]2+ fragment (left) [NiII2TbIII2 
(C14H11NO3)4(CH3CN)]1+ fragment (right) 
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S7.11. ESI-MS of 1NiGd-Cl (Top) {[NiII2GdIII2(C14H11NO3)4]-1H}2+ fragment (Left) 
{[NiII2GdIII2(C14H11NO3)4)(CH3CN)]+2H}1+ fragment (Right) 
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S7.12. ESI-MS of 16NiY-Cl (Upper) [NiII2YII2(C21H17NO3)4(CH3CN)]1+ (Lower) 
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S7.13. ESI-MS of 2NiY-Cl (Upper) [NiII2YIII2(C18H13NO3)Cl(CH3OH)]1+ fragment. (Lower) 
[NiII2YIII2(C18H13NO3)Cl(CH3OH)]2+ fragment. 
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S7.14. ESI-MS of compound 6NiY-Cl [Y2Ni2(C17H15NO3)]2+Fragment (Left) 
[NiII2YIII2(C17H15NO3)4(CH3CN)]1+Fragment (Right) 
 
 
 
 
 
 
 
 
71 
 
7.2 FT-IR of LNiLn-Cl 
 
S7.15 FT-IR of 1NiY-Cl 
 
S7.16 FT-IR of 1NiSm-Cl 
 
S7.17 FT-IR of 1NiEu-Cl 
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S7.18 FT-IR of 1NiTb-Cl 
 
S7.19 FT-IR of 1NiGd-Cl 
 
S7.20 FT-IR of 1NiDy-Cl 
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S7.21 FT-IR of 2NiY-Cl 
 
S7.22 FT-IR of 6NiY-Cl 
 
S7.23 FT-IR of 16NiY-Cl 
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7.3 TGA for LNiLn-Cl 
S7.24. TGA for 1NiY-Cl 
 
S7.25. TGA for 1NiTb-Cl 
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S7.26.  TGA for 1NiGd-Cl 
 
S7.27.  TGA for 1NiDy-Cl 
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S7.28. TGA for 1NiSm-Cl 
 
S7.29. TGA for 1NiEu-Cl 
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S7.30. TGA for 2NiY-Cl 
 
S7.31. TGA for 6NiY-Cl 
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S7.32. TGA for 16NiY-Cl 
7.4 Side Product Structures 
 
S7.33 Molecular Structure of [NiII2SmIII2(L1)4(O-Van)2(H2O)2]·4CH3CN (1NiSm-Cl -B). Colour code: 
NiII, green; DyIII, light blue; O, red; N, blue; C, white. Hydrogen atoms are omitted for clarity. 
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S7.34 Molecular Structure of [NiII5SmIII2(CO3) (L1)7(L1′) (H2O)3] (1NiSm-Cl -A) Colour code: NiII, 
green; DyIII, light blue; O, red; N, blue; C, white. Hydrogen atoms are omitted for clarity. 
 
S7.35 [SmIII4(OH)2(L1)4(HL1)2] 2CH3CN (1NiSm-Cl -C). Colour code: DyIII, light blue; O, red; N, 
blue; C, white. Hydrogen atoms are omitted for clarity. 
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7.5 NMR Data of Stenhouse salts 
 
S7.36. Calculated NMR chemical shifts for model compounds C7f and C7f’ 
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7,6 1H NMR of Products (C7a-C7k) 
 
S7.37. 1H NMR of C7a 
 
S7.38. 1H NMR of C7b  
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S7.39. 1H NMR of C7e 
 
S7.40. 1H NMR of C7c 
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S7.41. 1H NMR of C7d 
 
S7.42. 1H NMR of C7j 
84 
 
 
S7.43. 1H NMR of C7k 
 
S7.44. 1H NMR of C7f 
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S7.45 
 
S7.46. 1H NMR of C7g 
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S7.47. 1H NMR of C7h 
 
S7.48. 1H NMR of C7i 
87 
 
7.7 13CNMR of (C7f-C7i) 
 
S7.49. 13C NMR of C7f 
 
S7.50. 13C NMR of C7g 
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S7.51. 13C NMR of C7h 
 
S7.52. 13C NMR of C7i 
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7.8 ESI-MS of C7f, C7g and C7i 
 
S7.53. ESI-MS of C7f 
 
S7.54. ESI-MS of C7g 
 
S7.55. ESI-MS of C7i 
 
 
 
 
 
90 
 
7.9 FT-IR of C7f and C7g 
 
S7.56. FT-IR of C7f 
 
S7.57. FT-IR of C7g 
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Chapter 8  
8.1 FT-IR of 1ZnLn-NO3 
 
S8.1. FT-IR of 1ZnDy-NO3 
 
S8.2. FT-IR of 1ZnY-NO3 
 
S8.3. FT-IR of 1ZnGd-NO3 
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S8.4. FT-IR of 1ZnEu-NO3 
 
S8.5. FT-IR of 1ZnTb-NO3 
 
S8.6. FT-IR of 1ZnYb-NO3 
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S8.7. FT-IR of 1ZnSm-NO3  
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8.2 ESI-MS of 1ZnLn-NO3 
 
S8.8. ESI-MS of 1ZnY-NO3. [ZnII2YIII2(C14H11NO3)4]2+ fragment – 635.9867 m/z, [ZnII2YIII2 
(C14H11NO3)4(MeOH)]2+ fragment – 652.9971 m/z and [ZnII2YIII2(C14H11NO3)4(NO3)]2+ fragment – 
667.0126 m/z. 
 
S8.9. ESI-MS of 1ZnY-NO3.  [ZnII2YIII2(C14H11NO3)4(NO3)]1+ fragment -1335.9672 m/z. 
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S8.10. ESI-MS of 1ZnGd-NO3. [ZnII2GdIII2(C14H11NO3)4]2+ fragment – 705.0127 m/z, [ZnII2GdIII2 
(C14H11NO3)4(MeOH)]2+ fragment – 722.0254 m/z and [ZnII2GdII2 (C14H11NO3)4(NO3)]2+ fragment – 
738.0366 m/z. 
 
S8.11. ESI-MS of 1ZnGd-NO3. [ZnII2GdIII2(C14H11NO3)4(NO3)]1+ fragment -1471.9936 m/z. 
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S8.12. ESI-MS of 1ZnDy-NO3. [ZnII2DyIII2(C14H11NO3)4]2+ fragment – 710.0163 m/z, 
[ZnII2DyIII2(C14H11NO3)4(MeOH)]2+ fragment – 726.0345 m/z and [ZnII2DyII2(C14H11NO3)4(NO3)]2+ 
fragment – 742.0491 m/z. 
 
S8.13. ESI-MS of 1ZnDy-NO3. [ZnII2DyIII2(C14H11NO3)4(NO3)]1+ fragment -1482.0975 m/z. 
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S8.14. ESI-MS of 1NiDy-NO3. [NiII2DyIII2(C14H11NO3)4]2+ fragment – 703.5153 m/z, 
[NiII2DyIII2(C14H11NO3)4(MeOH)]2+ fragment – 719.5384 m/z and [NiII2DyIII2(C14H11NO3)4(NO3)]2+ 
Fragment – 736.0445 m/z. 
 
S8.15. ESI-MS of 1NiDy-NO3. [NiII2DyIII2(C14H11NO3)4(NO3)]1+ fragment -1469.0383 m/z. 
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S8.16. ESI-MS of 1CoDy-NO3. [CoII2DyIII2 (C14H11NO3)4]2+ fragment – 704.0153 m/z, 
[CoII2DyIII2(C14H11NO3)4(MeOH)]2+ fragment – 720.0350 m/z and [CoII2DyIII2 (C14H11NO3)4(NO3)]2+ 
fragment – 736.0379 m/z. 
 
S8.17. ESI-MS of 1CoDy-NO3. [CoII2DyIII2(C14H11NO3)4(NO3)]1+ fragment -1470.0136 m/z.  
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S8.18. ESI-MS of 1ZnYb-NO3. [ZnII2YbIII2(C14H11NO3)4(NO3)]1+ fragment. 
 
S8.19. ESI-MS of 1ZnYb-NO3. [ZnII2YbIII2(C14H11NO3)4(NO3)]2+ fragment. 
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S8.20. ESI-MS of 1ZnTb-NO3. [ZnII2TbIII2(C14H11NO3)4(NO3)]1+ fragment. 
 
 
S8.21. ESI-MS of 1ZnTb-NO3. [ZnII2TbIII2(C14H11NO3)4(NO3)]2+ fragment 
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S8.22. ESI-MS of 1ZnEu-NO3. [ZnII2EuIII2(C14H11NO3)4(NO3)]2+ fragment. 
 
S8.23. ESI-MS of 1ZnEu-NO3. [ZnII2EuIII2(C14H11NO3)4(NO3)]1+ fragment. 
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S8.24. ESI-MS of 1ZnSm-NO3. [ZnII2SmIII2 (C14H11NO3)4(NO3)]1+ fragment. 
 
 
S8.25. ESI-MS of 1ZnSm-NO3. [ZnII2SmIII2 (C14H11NO3)4(NO3)]2+ fragment. 
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8.3 TGA of 1ZnLn-NO3 
S8.26 TGA of 1ZnY-NO3 
 
S8.27 TGA of 1ZnDy-NO3 
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S8.28 TGA of 1ZnGd-NO3 
 
S8.29 TGA of 1ZnTb-NO3 
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S8.30 TGA of 1ZnYb-NO3 
 
S8.31 TGA of 1ZnEu-NO3 
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S8.32 TGA of 1ZnSm-NO3 
 
8.4 EPR of 1GdZn-NO3 
 
S8.33 . EPR Simulation of solution phase (80% DMF, 20% Et2O) 1Y at 34.0865 GHz and 7 K. 
Hamiltonian: ?̂? = 𝐵2
0 (3?̂?𝑧
2
− ?̂?2) +
𝐵2
2
2
(?̂?+
2
+ ?̂?−
2
) + 𝐵4
0 (35?̂?𝑧
4
− 30?̂?2?̂?𝑧
2
+ 25?̂?𝑧
2
+ 3?̂?2
2
−
6?̂?2) +
𝐵4
4
2
(?̂?+
4
+ ?̂?−
4
) + 𝜇𝐵𝑔?̂? ⋅ 𝐵. Parameters: 𝑔 = 1.961(2), 𝐵2
0 = -0.0259(7) cm-1, 𝐵2
2 = 0.0212(6) 
cm-1, 𝐵4
0 = 0.000018(6) cm-1, 𝐵4
4 = -0.00011(3) cm-1, Lorentzian frequency-space linewidth = 1.13(8) 
GHz. Given the complexity of the ZFS for the S = 7/2 state, this is likely not the only parameter set 
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which can approach agreement with the data. We provide this simulation to show a plausible parameter 
set for the data. 
 
8.5 UV-binding Studies 
 
 
S8.34 UV-Vis binding study of Zn(OTf)2 with 2-napthaldehyde 
 
S8.35 UV-Vis binding study of Dy(OTf)3 with 2-napthaldehyde 
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S8.36 UV-Vis binding study of 1ZnDy-NO3 with 2-napthaldehyde 
 
S8.37 UV-Vis binding study of Dy(OTf)3 with trans-β-nitrostyrene 
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S8.38 UV-Vis binding study of Zn(OTf)2 with trans-β-nitrostyrene 
 
S8.38 UV-Vis binding study of 1ZnDy-NO3 with trans-β-nitrostyrene 
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S8.39 UV-Vis binding study of Dy(OTf)3 with indole 
 
S8.40 UV-Vis binding study of Zn(OTf)2 with indole 
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S8.41 UV-Vis binding study of 1ZnDy-NO3 with indole 
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8.6 1H NMR of C8aa-C8au 
 
S8.42 1H NMR of C8aa 
 
S8.43 1H NMR of C8ab 
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S8.44 1H NMR of C8ad 
 
S8.45 1H NMR of C8ak 
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S8.46 1H NMR of C8am 
 
S8.47 1H NMR of C8aj 
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S8.48 1H NMR of C8ae 
 
S8.49 1H NMR of C8ac 
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S8.50 1H NMR of C8af 
S8.51 1H NMR of C8ag 
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S8.52 1H NMR of C8ah 
S8.53 1H NMR of C8an 
118 
 
 
S8.54 1H NMR of C8ai 
 
S8.55 1H NMR of C8af 
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S8.56 1H NMR of C8ap 
 
S8.57 1H NMR of C8aq 
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S8.58 1H NMR of C8ar 
 
S8.59 1H NMR of C8at 
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S8.60 1H NMR of C8as 
 
S8.61 1H NMR of C8af 
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S8.62 1H NMR of C8au 
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8.7 13CNMR C8aa-C8au 
 
S8.63 13C NMR of C8au 
 
S8.64. 13C NMR of C8ae 
124 
 
 
S8.65. 13C NMR of C8an 
 
S8.66. 13C NMR of C8af 
 
125 
 
 
S8.67. 13C NMR of C8ab 
 
S8.68. 13C NMR of C8ak 
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S8.69. 13C NMR of C8aj 
 
S8.70. 13C NMR of C8ac 
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S8.71. 13C NMR of C8ai 
 
S8.72. 13C NMR of C8ap 
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S8.73. 13C NMR of C8ar 
 
S8.74. 13C NMR of C8aq 
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S8.75. 13CNMR of C8ar 
8.8 ESI-MS C8aa-C8au 
 
 
S8.76. ESI-MS of C8ak 
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S8.77. ESI-MS of C8ab 
 
S8.78. ESI-MS of C8ae 
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S8.79. ESI-MS of C8an 
 
S8.80. ESI-MS of C8al 
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S8.81. ESI-MS of C8am 
 
S8.82. ESI-MS of C8aj 
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S8.83. ESI-MS of C8ao 
 
S8.84. ESI-MS of C8as 
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S8.85. ESI-MS of C8ag 
 
S8.86. ESI-MS of C8ah 
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8.9 1HNMR of C8ba-C8au 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.87 1H NMR of C8ba 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.88 1H NMR of C8bb 
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S8.88 1H NMR of C8bc 
S8.89 1H NMR of C8bd 
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S8.90 1H NMR of C8be 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.91 1H NMR of C8bf 
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S8.92 1H NMR of C8bg 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.93 1H NMR of C8bh 
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S8.94. 1H NMR of C8bi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.95. 1H NMR of C8bj 
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S8.96. 1H NMR of C8bk 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.97. 1H NMR of C8bi 
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S8.98. 1H NMR of C8bm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.99. 1H NMR of C8bn 
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S8.100. 1H NMR of C8bo 
S8.101. 1H NMR of C8bp 
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S8.102. 1H NMR of C8bq 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.103. 1H NMR of C8br 
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S8.104. 1H NMR of C8bs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.105. 1H NMR of C8bt 
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S8.106. 1H NMR of C8bu 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.107. 1H NMR of C8bv 
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S8.108. 1H NMR of C8bw 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.109. 1H NMR of C8bx 
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S8.110. 1H NMR of C8by 
8.10 13CNMR of C8ba-C8au 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.111. 13C NMR of C8ba 
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S8.112. 13C NMR of C8bb 
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S8.113. 13C NMR of C8bc 
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S8.114. 13C NMR of C8bd 
S8.115. 13C NMR of C8be 
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S8.116. 13C NMR of C8bf 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.117. 13C NMR of C8bg 
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S8.118. 13C NMR of C8bh 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.119. 13C NMR of C8bi 
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S8.120. 13C NMR of C8bj 
S8.121. 13C NMR of C8bk 
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S8.122. 13C NMR of C8bl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.123. 13C NMR of C8bm 
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S8.124. 13C NMR of C8bn 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.125. 13C NMR of C8bo 
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S8.126. 13C NMR of C8bq 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.126. 13C NMR of C8br 
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S8.127. 13C NMR of C8bs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.128. 13C NMR of C8bt 
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S8.129. 13C NMR of C8bu 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.130. 13C NMR of C8bv 
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S8.131. 13C NMR of C8bw 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.132. 13C NMR of C8bx 
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S8.133. 13C NMR of C8by 
 
160 
 
8.11 1H NMR of C8ca-C8cq 
S8.134. 1H NMR of C8ca 
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S8.135. 1H NMR of C8cb 
 
S8.136. 1H NMR of C8cc 
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S8.137. 1H NMR of C8cd 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.138. 1H NMR of C8ce 
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S8.139. 1H NMR of C8cf 
S8.140. 1H NMR of C8cg 
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S8.141. 1H NMR of C8ch 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.142. 1H NMR of C8ci 
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S8.143. 1H NMR of C8cj 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.144. 1H NMR of C8ck 
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 S8.145. 1H NMR of C8cl 
 
S8.146. 1H NMR of C8cm 
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S8.147. 1H NMR of C8cn 
 
S8.148. 1H NMR of C8co 
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S8.149. 1H NMR of C8cp 
 
S8.150. 1H NMR of C8cq 
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8.12 13C NMR of C8ca-C8aq 
S8.151. 13C NMR of C8ca 
S8.152. 13C NMR of C8cb 
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S8.153. 13C NMR of C8cc 
S8.154. 13C NMR of C8cd 
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S8.155. 13C NMR of C8ce 
S8.156. 13C NMR of C8cf 
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S8.157. 13C NMR of C8cg 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.158. 13C NMR of C8ch 
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S8.159. 13C NMR of C8ci 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.160. 13C NMR of C8cj 
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S8.161. 13C NMR of C8ck 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S8.162. 13C NMR of C8cl 
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S8.163. 13C NMR of C8cm 
 
S8.164. 13C NMR of C8cn 
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S8.165. 13C NMR of C8co 
 
S8.166. 13C NMR of C8cp 
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S8.167. 13C NMR of C8cq 
 
 
 
 
 
 
 
 
 
 
 
 
 
178 
 
Chapter 9 
9.1 UV-studies  
  
 
 
  
Figure S9.1. trans--nitrostyrene -1x10-5 mmol, dimethylbarbituric acid – 1x10-5 mmol, 1ZnY-NO3 – 
0.0000125 mmol, concentration of substrates 4x10-5 mmol L-1 for study. Usual concentration for a 
reaction 10 mmol L-1, Solution – 250 mL -1 of EtOH/H2O (1:9). 
 
 
Figure S9.2. trans-beta-nitrostyrene -1x10-5 mmol, dimethylbarbituric acid – 1x10-5 mmol, no catalyst, 
solution – 250 mL -1 of EtOH/H2O (1:9). 
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Figure S9.3. trans-beta-nitrostyrene -1x10-5 mmol, dimethylbarbituric acid – 1x10-5 mmol, and at 60 
min catalyst 1ZnY-NO3 – 0.0000125 mmol, was added.  
9.2 EPR Studies 
 
 
 
 
 
 
 
1ZnGd with BA (1:1) 1ZnGd with NS (1:1) 
1ZnGd with BA and NS (1:1) 
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1ZnGd with BA (1:20) 1ZnGd with NS (1:20) 1ZnGd with BA and NS (1:20) 
 
 
 
 
 
 
 
1ZnGd with BA (1:40) 1ZnGd with NS (1:40) 1ZnGd with BA and NS(1:40) 
Figure S9.4. The EPR Data 
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9.3 Theoretical Studies 
 
Figure S9.5. Natural atomic charges and the relevant FMOs of the triketo and diketo-enol forms of 
1,3-dimethyl barbituric acid, the aminodiketo, aminoketo-enol and diketo-ammonium forms of 6-
amino 1,3-dimethyl barbituric acid and the (Z)-(2-nitrovinyl)benzene, (Z)-(2-nitroprop-1-
enyl)benzene and (Z)-1-methoxy-4-(2-nitroprop-1-enyl)benzene calculated at the PBE0/6-
311++G(d,p) level of theory in aqueous solutions. 
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Figure S9.6. 3D plots of FMOs of the representative catalyst 7ZnY calculated at the PBE0/Def2-
TZVP(Zn,Y) 6-31G(d,p)(E) (E = main group element) level of theory in aqueous solutions. 
Figure S9.7. The equillibrium geometries of the 7ZnY-barbiturate and 7ZnY-trans-nitro-styrene 
adducts optimized at the PBE0/Def2-TZVP(Zn,Y) 6-31G(d,p)(E) (E = main group element) level 
of theory in aqueous solutions 
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Figure S9.8. 3D plot of the RDG (Reduced Density Gradient, isosurface = 0.800 au) of the catalyst-
substrate complex 2Im. 
 
9.4 ESI-MS substrate binding studies 
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Figure S9.9. ESI-MS Spectra of 1ZnGd-NO3 with trans-β-nitrostyrene (catalytic ratio). Fragment 
[ZnIIGdIII(L1)2(S1)(NO3)(CH3OH)5] -1075.1676 
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Figure S9.10. ESI-MS spectra of 1ZnGd-NO3 with dimethylbarbituric acid. Fragment 
[ZnIIGdIII(L1)2(S2)(NO3)(H2O)] - 946.0998 
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Figure S9.11. ESI-MS spectra of 1ZnGd-NO3 with trans-β-methyl-β nitrostyrene acid (catalytic 
ratio). Fragment [ZnIIGdIII(L1)2(S3)(NO3)(CH3OH)2(H2O)] – 1009.0995 
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Figure S9.12. ESI-MS spectra of 1ZnGd-NO3 with trans-β-methyl-β Nitrostyrene acid and 
DMBA(Catalytic Ratio). Fragment [ZnIIGdIII(L1)2(S2)(S3)2(NO3)(CH3OH)3] – 1345.2556 
 
9.5 Theoretical Data 
Table S9.13. Cartesian Coordinates and energies of 1 calculated at the /6-31G(d,p)/PCM level of 
theory in aqueous solution. 
Triketo form of 1,3-Me2-barbituric acid 
N,0,-6.2246702034,1.2061475337,0.0282966307 
 C,0,-5.5245258923,0.0056207973,0.0489237536 
 O,0,-4.3242411739,-0.0066010337,0.2117219715 
 N,0,-6.2287262003,-1.1806062054,-0.120979318 
 C,0,-7.5915394353,-1.260486692,-0.3118657355 
 O,0,-8.1622633661,-2.3212491806,-0.4561691526 
 C,0,-8.3445111697,0.034314701,-0.3332906493 
 C,0,-7.5872696814,1.3137537374,-0.1501114235 
 O,0,-8.1545046479,2.3860930435,-0.1600038024 
 C,0,-5.4250966293,2.4138972756,0.2125282444 
 C,0,-5.433268778,-2.4045922981,-0.0889380103 
 H,0,-9.115699291,-0.0130953737,0.4412741323 
 H,0,-8.8807670146,0.0950223385,-1.2849563449 
 H,0,-6.101266481,3.2632142721,0.1715166227 
 H,0,-4.679425817,2.4907798849,-0.578819715 
 H,0,-4.9214273495,2.3831104046,1.178757387 
 H,0,-6.1127070278,-3.2400736615,-0.2323315182 
 H,0,-4.9273567354,-2.4945330731,0.8723838526 
 H,0,-4.6896331061,-2.3862164706,-0.8857369251 
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Sum of electronic and zero-point Energies=           -568.081435 
 Sum of electronic and thermal Energies=              -568.070797 
 Sum of electronic and thermal Enthalpies=            -568.069853 
 Sum of electronic and thermal Free Energies=         -568.118876 
 
Diketo-enol form of 1,3-Me2-barbituric acid 
N,0,-1.1793133356,0.352995236,-0.000660351 
 C,0,-0.0054205302,1.0684681466,-0.0001813724 
 O,0,0.014313101,2.2873146442,0.0006522064 
 N,0,1.1761346905,0.3404300363,-0.0005746777 
 C,0,1.1607119091,-1.0249035277,-0.0002142247 
 O,0,2.3715274102,-1.5739243459,0.0000716104 
 C,0,-0.0027180419,-1.7275341012,-0.0000990666 
 C,0,-1.2589565395,-1.0517208217,-0.000279931 
 O,0,-2.3524393294,-1.6089680943,0.0003224193 
 C,0,-2.4062603179,1.1370538019,-0.0004517374 
 C,0,2.4138538436,1.1165303865,-0.000152084 
 H,0,0.0011747326,-2.8087729256,0.0003576147 
 H,0,-3.2386629893,0.4385768983,-0.0057124605 
 H,0,-2.445284283,1.7737255362,-0.8854895445 
 H,0,-2.4505005172,1.7659704486,0.8899624399 
 H,0,3.2576605349,0.4344779594,-0.0042050411 
 H,0,2.4510135628,1.7451818522,0.8898332684 
 H,0,2.4473066935,1.7511848702,-0.8859454508 
 H,0,2.294959406,-2.5345860001,0.0001663827 
 
Sum of electronic and zero-point Energies=           -568.067503 
 Sum of electronic and thermal Energies=              -568.056906 
 Sum of electronic and thermal Enthalpies=            -568.055962 
 Sum of electronic and thermal Free Energies=         -568.104437 
 
 
1,3-Me2-barbituric carbanion 
N,0,1.1729008772,0.4131873397,-0.0405865222 
 C,0,0.0000004469,1.1251033642,0.0061107638 
 O,0,0.0000001758,2.3533223226,0.0872170641 
 N,0,-1.1729011923,0.4132107609,-0.0409182424 
 C,0,-1.2363443615,-1.0017324455,-0.1356374537 
 O,0,-2.3563241622,-1.5428697846,-0.1718316048 
 C,0,-0.0000012508,-1.6628977743,-0.1798622586 
 C,0,1.236342853,-1.0017460795,-0.1354661663 
 O,0,2.3563224688,-1.5428872358,-0.1715997188 
 C,0,2.4017512098,1.1843923101,0.0111749435 
 C,0,-2.401750029,1.1844379485,0.0105524499 
 H,0,-0.00000286,-2.7423736646,-0.2518453319 
 H,0,3.227120783,0.4778826859,-0.0296037215 
 H,0,2.4531541298,1.7646348173,0.9349973123 
 H,0,2.4600249212,1.8736335284,-0.8341565863 
 H,0,-3.2271258485,0.4780617881,-0.0323595559 
189 
 
 H,0,-2.4587943904,1.8750286928,-0.8337356654 
 H,0,-2.4543737708,1.7632114259,0.9352502943 
 
Sum of electronic and zero-point Energies=           -567.631214 
 Sum of electronic and thermal Energies=              -567.621088 
 Sum of electronic and thermal Enthalpies=            -567.620144 
 Sum of electronic and thermal Free Energies=         -567.666954 
 
Diketo-6-amino 1,3-dimethyl barbituric acid 
 
H,0,0.6349625761,0.4094326281,-0.3599488656 
 N,0,-0.2742474727,-1.3571170964,-2.122187326 
 O,0,-0.6076282567,1.2752912062,1.8029664604 
 O,0,-4.0782807925,-1.354248656,0.4728795771 
 N,0,-2.1989851515,-1.3443744067,-0.8190158582 
 N,0,-2.3498708559,-0.0498416547,1.140192544 
 C,0,-0.359363711,0.0278801425,-0.1760455046 
 C,0,-0.9303367287,-0.8661278218,-1.0454993641 
 C,0,-2.8001738973,-2.3133708403,-1.7258177879 
 H,0,-3.7544498986,-2.6118711612,-1.3024445517 
 H,0,-2.1581176371,-3.1913426826,-1.8200892163 
 H,0,-2.9771876848,-1.869400003,-2.7090701134 
 C,0,-2.946640739,-0.9371017871,0.2812606054 
 C,0,-3.1437975433,0.3614592088,2.2887480642 
 H,0,-3.4101718896,-0.5065039993,2.8938702817 
 H,0,-4.0591516395,0.855453216,1.9587634279 
 H,0,-2.5375675636,1.0504332969,2.8707554906 
 C,0,-1.0503436466,0.4783522445,0.975008177 
 H,0,-0.787198487,-1.7555113624,-2.8910700131 
 H,0,0.5904510194,-0.9063904717,-2.3741560274 
 
Sum of electronic and zero-point Energies=           -548.201704 
 Sum of electronic and thermal Energies=              -548.190991 
 Sum of electronic and thermal Enthalpies=            -548.190047 
 Sum of electronic and thermal Free Energies=         -548.237744 
Diketo-6-amino 1,3-dimethyl barbituric carbanion 
 
N,0,2.494035381,-1.3787877682,-0.0396080546 
 O,0,-2.2506086972,-1.718747789,-0.2507722461 
 O,0,-0.2333247701,2.3366905638,0.0794815129 
 N,0,1.0978824675,0.4848656959,-0.0351899748 
 N,0,-1.2206666168,0.2892915854,0.0084252922 
 C,0,0.1192556237,-1.7652300753,-0.0815639279 
 C,0,1.1814546113,-0.9128952676,-0.0288588161 
 C,0,2.2833148387,1.3269833139,-0.0797310054 
 H,0,1.9705772829,2.3424675494,-0.3089400945 
 H,0,2.9625641504,0.9677738289,-0.8540346868 
 H,0,2.8049805543,1.3356389866,0.8832595875 
 C,0,-0.1261666347,1.1089744198,0.0234259776 
 C,0,-2.5104808345,0.9561715565,0.0775488464 
190 
 
 H,0,-2.7045168373,1.5330675097,-0.831222958 
 H,0,-2.5367515871,1.63795624,0.9293551731 
 H,0,-3.2684893062,0.1845284173,0.1835717698 
 C,0,-1.1550951146,-1.1381252209,-0.1272036966 
 H,0,3.1618143236,-0.8819422019,0.5349390697 
 H,0,2.5079211654,-2.3724813445,0.1413182318 
 
Sum of electronic and zero-point Energies=           -547.672265 
 Sum of electronic and thermal Energies=              -547.661810 
 Sum of electronic and thermal Enthalpies=            -547.660866 
 Sum of electronic and thermal Free Energies=         -547.708262 
 
Diketo-6-ammonium 1,3-dimethyl barbituric acid 
 
H,0,2.877458019,-1.0516487222,-1.135829195 
 N,0,2.4213505305,-1.3804799813,-0.2808298032 
 O,0,-2.3030799529,-1.6886646117,0.2291553673 
 O,0,-0.3287700256,2.3794201463,0.1010469802 
 N,0,1.0204211134,0.5415029431,0.0209390744 
 N,0,-1.3048107865,0.324285665,-0.0511554673 
 C,0,0.0505255593,-1.7204241094,-0.1016251693 
 C,0,1.0509343475,-0.843060322,-0.0901307075 
 C,0,2.2086768604,1.3607421903,0.2201847772 
 H,0,1.8851144845,2.3967177199,0.2784513741 
 H,0,2.9022504446,1.2644962976,-0.6180917437 
 H,0,2.7121427647,1.0980833918,1.1543565739 
 C,0,-0.2112553981,1.1621719836,0.0265711141 
 C,0,-2.609508126,0.9705236572,-0.0653928276 
 H,0,-3.325745951,0.2734840075,-0.4939093972 
 H,0,-2.5526541872,1.8791638719,-0.6615141599 
 H,0,-2.9320617014,1.2300896204,0.9469719234 
 C,0,-1.2452882208,-1.0872318565,0.0492691206 
 H,0,3.057166716,-1.2081198696,0.5017884004 
 H,0,2.2791335095,-2.3914520218,-0.3603562348 
 
Sum of electronic and zero-point Energies=           -548.100426 
 Sum of electronic and thermal Energies=              -548.089600 
 Sum of electronic and thermal Enthalpies=            -548.088656 
 Sum of electronic and thermal Free Energies=         -548.137095 
 
(Z)-(2-nitrovinyl)benzene 
 
C,0,-8.5143493794,-0.7502181258,0.0029095475 
 C,0,-8.4339476887,-2.1429207128,-0.0012202436 
 C,0,-7.1918758836,-2.768198721,-0.0053818588 
 C,0,-6.0335653279,-2.0033663401,-0.005408619 
 C,0,-6.0999809253,-0.602776519,-0.0012742899 
 C,0,-7.3607140709,0.0153832139,0.0028893239 
 C,0,-4.8522217208,0.1387805171,-0.0015249579 
 C,0,-4.7167315967,1.4705559249,0.0021182244 
191 
 
 N,0,-3.4095914051,2.0654305786,0.0012936547 
 O,0,-3.3718003828,3.2892068056,0.0036601611 
 O,0,-2.4138284678,1.358434371,-0.0020759309 
 H,0,-9.4835577683,-0.2632629636,0.0061447359 
 H,0,-9.3416375705,-2.7372609789,-0.0011860851 
 H,0,-7.12523174,-3.8507188041,-0.0086046159 
 H,0,-5.0626703284,-2.48895122,-0.0086524818 
 H,0,-7.4422218602,1.0968165184,0.0061133959 
 H,0,-3.9362990515,-0.4467019494,-0.0049901305 
 H,0,-5.5011748322,2.212468405,0.0056901702 
 
Sum of electronic and zero-point Energies=           -513.577359 
 Sum of electronic and thermal Energies=              -513.568291 
 Sum of electronic and thermal Enthalpies=            -513.567346 
 Sum of electronic and thermal Free Energies=         -513.612982 
 
Protonated (Z)-(2-nitrovinyl)benzene 
 
O,0,-3.6379726488,-0.4835845761,-0.7609654422 
 N,0,-2.7889846356,0.2057287805,-0.2487428148 
 C,0,0.9934012985,0.2330433241,-0.024183534 
 C,0,-0.3513085399,0.5163382908,0.0535446628 
 H,0,-0.6528288977,1.5464969743,0.2361522387 
 H,0,-1.5426474077,-1.012397327,0.8852352984 
 C,0,2.8563608636,-1.2864092725,-0.293442821 
 H,0,3.2591920802,-2.2780018082,-0.4580280759 
 C,0,3.2589800215,1.1031211466,0.0800598531 
 H,0,3.9576300332,1.9216711718,0.1996938034 
 C,0,3.7282947279,-0.1966575823,-0.1345123748 
 H,0,4.798399136,-0.3704191851,-0.1812094564 
 C,0,1.905252667,1.3236767796,0.1366681554 
 H,0,1.5082610518,2.3188367006,0.3037784619 
 C,0,1.5027214948,-1.0850474327,-0.2432730769 
 H,0,0.8243058208,-1.92119677,-0.3659245982 
 C,0,-1.4471632621,-0.4538225665,-0.0571198329 
 H,0,-1.3349012935,-1.1793173379,-0.8634585447 
 O,0,-2.9331925099,1.3404406901,0.1417280981 
 
Sum of electronic and zero-point Energies=           -513.948681 
 Sum of electronic and thermal Energies=              -513.939205 
 Sum of electronic and thermal Enthalpies=            -513.938261 
 Sum of electronic and thermal Free Energies=         -513.985141 
 
(Z)-(2-nitrovinyl)-p-F-benzene 
 
C,0,-8.5206100106,-0.7426353696,0.0029189805 
 C,0,-8.4092856245,-2.1258370501,-0.0013319896 
 C,0,-7.1888153944,-2.7766544924,-0.0055430042 
 C,0,-6.0371504855,-2.0052210637,-0.005476139 
 C,0,-6.1017838256,-0.6042460811,-0.0012598535 
192 
 
 C,0,-7.3631205204,0.0135797532,0.0029308095 
 C,0,-4.8552908368,0.1372541596,-0.0014194146 
 C,0,-4.7201173802,1.4692153179,0.0022621445 
 N,0,-3.4127065604,2.0626761766,0.0012613019 
 O,0,-3.3736235093,3.2864223032,0.003240623 
 O,0,-2.4181004199,1.3541585267,-0.001862983 
 H,0,-9.5003738672,-0.2796202063,0.006126397 
 F,0,-9.5329055562,-2.8589778689,-0.0013066142 
 H,0,-7.1485488657,-3.8594345221,-0.0087756938 
 H,0,-5.0689924955,-2.4951545269,-0.0087403333 
 H,0,-7.4481178978,1.0943888704,0.0062272165 
 H,0,-3.9395648013,-0.4484498446,-0.004868462 
 H,0,-5.5040919487,2.2117359181,0.0058170144 
 
Sum of electronic and zero-point Energies=           -612.765504 
 Sum of electronic and thermal Energies=              -612.755622 
 Sum of electronic and thermal Enthalpies=            -612.754678 
 Sum of electronic and thermal Free Energies=         -612.802303 
 
Protonated (Z)-(2-nitrovinyl)-p-F-benzene 
 
O,0,-3.6410356101,-0.4965156018,-0.7352361394 
 N,0,-2.7859030509,0.2033372797,-0.2479056252 
 C,0,0.9939608936,0.2356874163,-0.0280652717 
 C,0,-0.3476073961,0.5167194032,0.0536378882 
 H,0,-0.6497830716,1.5461092769,0.2372003278 
 H,0,-1.5410838101,-1.0114317364,0.8900857528 
 C,0,2.8524604736,-1.2955934833,-0.3020376477 
 H,0,3.2786726788,-2.2768684313,-0.4683306644 
 C,0,3.2602383682,1.1138116503,0.0833921737 
 H,0,3.979336951,1.9140583657,0.203575291 
 C,0,3.7030078548,-0.1929830731,-0.1340554415 
 F,0,4.9949208786,-0.4059814486,-0.1869146274 
 C,0,1.9106198968,1.3244750784,0.1362410405 
 H,0,1.5183966426,2.3208181875,0.3059777059 
 C,0,1.5058210488,-1.0832391066,-0.2514392856 
 H,0,0.8293463758,-1.9201072982,-0.3777592035 
 C,0,-1.4438947623,-0.4552056424,-0.0530704046 
 H,0,-1.3336585603,-1.182004831,-0.8584620776 
 O,0,-2.9252158013,1.3476139947,0.1155662087 
 
Sum of electronic and zero-point Energies=           -613.138308 
 Sum of electronic and thermal Energies=              -613.128027 
 Sum of electronic and thermal Enthalpies=            -613.127083 
 Sum of electronic and thermal Free Energies=         -613.176190 
 
 
 
(Z)-(2-nitrovinyl)-p-Br-benzene 
 
193 
 
C,0,-8.5120064533,-0.739010561,0.0028509962 
 C,0,-8.4167901353,-2.1288616673,-0.0013890889 
 C,0,-7.1852314364,-2.7702197537,-0.0055922304 
 C,0,-6.0315163258,-2.0004193132,-0.0055190198 
 C,0,-6.0929650131,-0.6006763876,-0.0013186709 
 C,0,-7.3531960764,0.0164510714,0.0028624938 
 C,0,-4.8454828386,0.1404780316,-0.0015061402 
 C,0,-4.7135151708,1.4720154395,0.0020944998 
 N,0,-3.4066501014,2.0697384213,0.0014470781 
 O,0,-3.3717510832,3.2930718815,0.0037216703 
 O,0,-2.4107166816,1.3636994212,-0.0017571 
 H,0,-9.4811061459,-0.2550871362,0.0060966226 
 Br,0,-10.0023494371,-3.162122313,-0.001400869 
 H,0,-7.1245930771,-3.8516754028,-0.0088652348 
 H,0,-5.0650657126,-2.4940623154,-0.0087834724 
 H,0,-7.4396556439,1.0972172995,0.0061715838 
 H,0,-3.9291745607,-0.4439341874,-0.004861067 
 H,0,-5.4993341068,2.2124974716,0.0055479488 
 
Sum of electronic and zero-point Energies=          -3086.809128 
 Sum of electronic and thermal Energies=             -3086.798590 
 Sum of electronic and thermal Enthalpies=           -3086.797645 
 Sum of electronic and thermal Free Energies=        -3086.847969 
 
Protonated (Z)-(2-nitrovinyl)-p-Br-benzene 
 
O,0,-3.6281642347,-0.5160925978,-0.7532939404 
 N,0,-2.7831336581,0.1962727135,-0.2662998578 
 C,0,0.9922807046,0.2402507632,-0.0199724608 
 C,0,-0.350112701,0.5210341334,0.0695489976 
 H,0,-0.6531161999,1.5491043045,0.2579301439 
 H,0,-1.555087226,-0.9877112359,0.9202103786 
 C,0,2.8498764001,-1.2888990856,-0.318027222 
 H,0,3.2489324655,-2.2789922777,-0.4964978914 
 C,0,3.263024653,1.1080899786,0.0820401053 
 H,0,3.9655147545,1.921900863,0.2067510359 
 C,0,3.7242205113,-0.1966992574,-0.1509939605 
 Br,0,5.551606401,-0.4992112117,-0.2476419917 
 C,0,1.9129545601,1.3228579034,0.1461909672 
 H,0,1.5275647018,2.3203209128,0.3268707002 
 C,0,1.5025262798,-1.0749972954,-0.2556721823 
 H,0,0.8260230937,-1.9116523735,-0.3845975927 
 C,0,-1.4431048399,-0.4544035281,-0.0347429672 
 H,0,-1.3194088656,-1.2006042262,-0.8198306094 
 O,0,-2.9315968003,1.3475315167,0.0703283474 
 
Sum of electronic and zero-point Energies=          -3087.180339 
 Sum of electronic and thermal Energies=             -3087.169449 
 Sum of electronic and thermal Enthalpies=           -3087.168505 
 Sum of electronic and thermal Free Energies=        -3087.220415 
194 
 
 
(Z)-(2-nitrovinyl)-p-Me-benzene 
 
C,0,-8.4921231374,-0.739859813,-0.0006355948 
 C,0,-8.4350052512,-2.1416244424,-0.008176655 
 C,0,-7.1793810435,-2.7495391515,-0.0137037243 
 C,0,-6.0195434124,-1.9882990437,-0.0119111283 
 C,0,-6.0774600487,-0.5885208406,-0.0044179643 
 C,0,-7.342272588,0.0248882529,0.0012369682 
 C,0,-4.8333672303,0.1512444624,-0.0028353213 
 C,0,-4.6964794121,1.484844303,0.004715123 
 N,0,-3.3926994559,2.0788328178,0.0054307127 
 O,0,-3.3532896809,3.3038003597,0.01254662 
 O,0,-2.3949434555,1.3726040083,-0.0007831857 
 H,0,-9.4600006197,-0.247456142,0.0038374395 
 C,0,-9.6945464609,-2.9521377975,-0.0105893915 
 H,0,-7.108765959,-3.8327668077,-0.0194809265 
 H,0,-5.0518468488,-2.4806909699,-0.0163185431 
 H,0,-7.4280790443,1.1062647371,0.0071237634 
 H,0,-3.9168882817,-0.4336132172,-0.0082442077 
 H,0,-5.4821527153,2.2253133174,0.0108171166 
 H,0,-10.302910774,-2.722606737,-0.8910770324 
 H,0,-10.3056385606,-2.7241102493,0.8683331937 
 H,0,-9.4816060199,-4.0224670471,-0.011367262 
 
Sum of electronic and zero-point Energies=           -552.830103 
 Sum of electronic and thermal Energies=              -552.819095 
 Sum of electronic and thermal Enthalpies=            -552.818151 
 Sum of electronic and thermal Free Energies=         -552.869679 
 
Protonated (Z)-(2-nitrovinyl)-p-Me-benzene 
 
O,0,-4.237000438,-0.9032243942,-0.3978049408 
 N,0,-3.4377132813,-0.0596729036,-0.0676992471 
 C,0,0.3246635507,0.2300825126,0.0815866627 
 C,0,-1.0254476356,0.4575356729,0.1566370213 
 H,0,-1.3799636915,1.4861685969,0.136201099 
 H,0,-1.9061200227,-1.475006574,-0.2857726244 
 H,0,-2.1549480906,-0.8619409221,1.355011738 
 C,0,2.2630030252,-1.2189280585,0.0425165829 
 H,0,2.7093679062,-2.2068182734,0.0590601296 
 C,0,2.5447591878,1.2061941324,-0.080208592 
 H,0,3.1955938548,2.0693319308,-0.155202626 
 C,0,3.1077739701,-0.0848770834,-0.0544391944 
 C,0,4.5758774163,-0.2724839707,-0.1175559157 
 C,0,1.188496693,1.3684908,-0.0140610268 
 H,0,0.7477675007,2.359349258,-0.0328002205 
 C,0,0.9086874155,-1.0778815994,0.1066296698 
 H,0,0.2777876834,-1.9563386346,0.1758499125 
 C,0,-2.0676335968,-0.5699758124,0.2987884858 
195 
 
 O,0,-3.6537617277,1.1264175295,0.0210000935 
 H,0,4.8338117188,-1.0382752442,-0.8551361309 
 H,0,4.9306019203,-0.6484767505,0.850711528 
 H,0,5.1026849915,0.6531084979,-0.3457177344 
 
Sum of electronic and zero-point Energies=           -553.208220 
 Sum of electronic and thermal Energies=              -553.197606 
 Sum of electronic and thermal Enthalpies=            -553.196662 
 Sum of electronic and thermal Free Energies=         -553.247067 
 
(Z)-(2-nitrovinyl)-p-MeO-benzene 
 
C,0,-8.5413971588,-0.7170671185,0.0007939973 
 C,0,-8.4740069767,-2.11701861,-0.003190375 
 C,0,-7.2254100742,-2.7519730834,-0.0062972147 
 C,0,-6.0709980943,-1.999482867,-0.0055029121 
 C,0,-6.115340519,-0.5927722779,-0.0016053002 
 C,0,-7.3748972485,0.0253064854,0.0015262267 
 C,0,-4.8705336813,0.1365984872,-0.000989331 
 C,0,-4.717892215,1.4712079113,0.0022024558 
 N,0,-3.4108348816,2.047566241,0.0021601556 
 O,0,-3.3544002113,3.2732541546,0.0038228801 
 O,0,-2.4196963636,1.329580025,0.0000551579 
 H,0,-9.4956821493,-0.2059856413,0.0033486707 
 O,0,-9.5465680136,-2.923480758,-0.0041189525 
 H,0,-7.1893745442,-3.8356677415,-0.0093068177 
 H,0,-5.1080558099,-2.5009321868,-0.0079436311 
 H,0,-7.4541610675,1.1070906364,0.0046348014 
 H,0,-3.959263689,-0.4565325863,-0.003390948 
 H,0,-5.4954684764,2.2204565128,0.0046906199 
 C,0,-10.8419903854,-2.3370873674,-0.0012517171 
 H,0,-11.5438529988,-3.1688448434,-0.0030363539 
 H,0,-10.9975913296,-1.7257179968,-0.8949067808 
 H,0,-10.995984112,-1.7308973754,0.8962053688 
 
Sum of electronic and zero-point Energies=           -627.980349 
 Sum of electronic and thermal Energies=              -627.968668 
 Sum of electronic and thermal Enthalpies=            -627.967724 
 Sum of electronic and thermal Free Energies=         -628.019463 
 
Protonated (Z)-(2-nitrovinyl)-p-MeO-benzene 
 
O,0,-3.5318279841,-0.301112817,-0.787079238 
 N,0,-2.6538727605,0.3624573146,-0.2871667735 
 C,0,1.0883849324,0.1184223776,-0.0441557272 
 C,0,-0.2112445607,0.5055284255,0.1064264744 
 H,0,-0.4221045065,1.552329621,0.3118084182 
 H,0,-1.5799289279,-0.7988087445,1.054220954 
 C,0,2.8072179304,-1.548626402,-0.4230925123 
 H,0,3.1418935457,-2.5590725399,-0.6234126054 
196 
 
 C,0,3.4291270065,0.8141552268,-0.0275248501 
 H,0,4.1825274627,1.5829800337,0.0765948499 
 C,0,3.7965365243,-0.5317132988,-0.2828700435 
 O,0,5.0259080389,-0.9370485459,-0.4101675219 
 C,0,2.1095150477,1.1216342318,0.0873490129 
 H,0,1.8075446484,2.1441740667,0.2859082743 
 C,0,1.4947574679,-1.2360764083,-0.3109044877 
 H,0,0.7508711852,-2.0158453364,-0.4226205904 
 C,0,-1.3878805924,-0.3807468509,0.0564723505 
 H,0,-1.3184859706,-1.2071097384,-0.6483141409 
 O,0,-2.7241083041,1.5390946283,-0.0170108494 
 C,0,6.1239166402,-0.0153684798,-0.2949193317 
 H,0,6.139190446,0.4253616064,0.7028084722 
 H,0,6.0479624486,0.7552737831,-1.0629733417 
 H,0,7.014400282,-0.6168821535,-0.4531767927 
 
Sum of electronic and zero-point Energies=           -628.367534 
 Sum of electronic and thermal Energies=              -628.355464 
 Sum of electronic and thermal Enthalpies=            -628.354520 
 Sum of electronic and thermal Free Energies=         -628.407718 
 
 
(Z)-(2-nitroprop-1-enyl)benzene 
 
C,0,-8.5468918436,-0.900601663,0.3013320554 
 C,0,-8.4269673977,-2.2318385458,-0.0875542852 
 C,0,-7.1689421441,-2.7633879095,-0.3575449163 
 C,0,-6.0406006231,-1.9648254007,-0.2443297365 
 C,0,-6.1499183719,-0.6106717189,0.1087951285 
 C,0,-7.4215880202,-0.0935845084,0.397051881 
 C,0,-4.9197577411,0.1649010628,0.1980267161 
 C,0,-4.7477314126,1.4824590687,0.002129942 
 N,0,-3.3844889019,1.9832520617,0.2229999768 
 O,0,-3.219117021,3.1888804469,0.1236100333 
 O,0,-2.4843765763,1.2063962237,0.4994963012 
 H,0,-9.5223983103,-0.4899054452,0.539343686 
 H,0,-9.310167501,-2.8572356856,-0.1648525068 
 H,0,-7.0667330635,-3.8040516169,-0.646245437 
 H,0,-5.0587116103,-2.3843829573,-0.4409048326 
 H,0,-7.5308653345,0.9296278188,0.73553561 
 H,0,-4.0219603564,-0.4015451728,0.4279228788 
 C,0,-5.7236456373,2.5137647457,-0.4367939329 
 H,0,-6.0658131122,3.1347567376,0.3968219218 
 H,0,-6.5896343849,2.0323218764,-0.8902512038 
 H,0,-5.2674906359,3.1778705819,-1.17238928 
 
Sum of electronic and zero-point Energies=           -552.826234 
 Sum of electronic and thermal Energies=              -552.815763 
 Sum of electronic and thermal Enthalpies=            -552.814818 
 Sum of electronic and thermal Free Energies=         -552.863699 
197 
 
 
Protonated (Z)-(2-nitroprop-1-enyl)benzene 
 
O,0,0.9453835641,7.1231082077,13.8057478086 
 N,0,1.7816933576,7.2354885066,14.6692697937 
 C,0,5.4977776961,7.1552959248,14.4390358937 
 C,0,4.2135380492,7.2116331358,14.9330566255 
 H,0,4.0179703425,7.8616076932,15.7849410473 
 C,0,2.9214224041,5.1417662546,15.2993851412 
 H,0,2.8719871832,5.36937548,16.3648024298 
 H,0,3.7811400662,4.5004021752,15.1055077352 
 H,0,2.0139936528,4.6211611781,14.9882886871 
 C,0,7.1758169364,6.3344300366,12.9002069846 
 H,0,7.4747578483,5.727351816,12.0547351644 
 C,0,7.791083401,7.9283053678,14.6576025732 
 H,0,8.5491985447,8.5266214797,15.1473077413 
 C,0,8.1286315901,7.1228897875,13.5648978291 
 H,0,9.1564730923,7.1087828396,13.2171828914 
 C,0,6.4907670484,7.9493153507,15.0961698012 
 H,0,6.1971572648,8.562529619,15.9409703707 
 C,0,5.8723404675,6.3458967566,13.3209818828 
 H,0,5.1322589889,5.7478637166,12.8032757842 
 C,0,3.0574272481,6.429199105,14.4658611372 
 H,0,3.0755908584,6.2014746259,13.4013438861 
 O,0,1.6763903954,7.8879009432,15.6820287916 
 
Sum of electronic and zero-point Energies=           -553.198541 
 Sum of electronic and thermal Energies=              -553.187625 
 Sum of electronic and thermal Enthalpies=            -553.186681 
 Sum of electronic and thermal Free Energies=         -553.236397 
 
(Z)-1-methoxy-4-(2-nitroprop-1-enyl)benzene 
 
C,0,1.1339672325,3.1448623368,0.7929989561 
 C,0,2.5321719472,3.1533371324,0.8868664735 
 C,0,3.2058653324,1.9833555589,1.2472247616 
 C,0,2.4773645071,0.8359593445,1.5171658091 
 C,0,1.0754549075,0.8166984007,1.4719938237 
 C,0,0.4206396474,2.0014028685,1.08284137 
 C,0,0.4117143281,-0.4311744386,1.7866283285 
 C,0,-0.8537799326,-0.6465782233,2.1978879353 
 N,0,-1.2346034633,-2.046905844,2.3581869166 
 O,0,-2.3970231036,-2.2745058125,2.6653056917 
 O,0,-0.4113928084,-2.9343323744,2.1789785243 
 H,0,0.6276895725,4.0508816234,0.4786069297 
 O,0,3.1358136547,4.3192583236,0.5969126629 
 H,0,4.2862151368,1.9552930342,1.3091695678 
 H,0,3.0099817403,-0.0716932871,1.7842373803 
 H,0,-0.6553478308,2.0200656897,0.9644300048 
 H,0,1.0293519943,-1.3201335685,1.6962121974 
198 
 
 C,0,-1.916116771,0.3351346085,2.5440955091 
 H,0,-2.6287618653,0.4792046983,1.7255066936 
 H,0,-1.4653425918,1.2977931396,2.7849977763 
 H,0,-2.4813235941,-0.009021673,3.4109479845 
 C,0,4.5532026861,4.3821902277,0.6631881924 
 H,0,5.0118890046,3.6922723052,-0.0515016256 
 H,0,4.9104451685,4.1606094398,1.6733443269 
 H,0,4.8182251011,5.4047264896,0.4009738097 
 
Sum of electronic and zero-point Energies=           -667.228283 
 Sum of electronic and thermal Energies=              -667.215250 
 Sum of electronic and thermal Enthalpies=            -667.214306 
 Sum of electronic and thermal Free Energies=         -667.268970 
 
Protonated (Z)-1-methoxy-4-(2-nitroprop-1-enyl)benzene 
 
O,0,-2.7018291273,2.7954596053,0.092694847 
 N,0,-1.6498587651,2.7219164459,0.6836962658 
 C,0,0.8304063468,-0.0273738532,0.6428686391 
 C,0,0.2064331823,1.1482898214,0.9447399982 
 H,0,0.8168243737,2.0377317143,1.0872106592 
 C,0,-1.5847830499,1.2583995269,2.6614522636 
 H,0,-0.9855415463,1.967075508,3.2348905782 
 H,0,-1.3806191246,0.247673155,3.0162906042 
 H,0,-2.6457697704,1.4730827152,2.8017543514 
 C,0,0.8314922858,-2.4073873018,0.1784577597 
 H,0,0.3370581785,-3.3584763437,0.023124817 
 C,0,2.9650794548,-1.1574095642,0.2766880755 
 H,0,4.0440382167,-1.1315808884,0.2062644773 
 C,0,2.2542345009,-2.372061898,0.0984800632 
 O,0,2.8209510251,-3.5166047219,-0.1476406219 
 C,0,2.2649098927,-0.0225127701,0.5425180135 
 H,0,2.7904247515,0.9151692924,0.68723592 
 C,0,0.1393934895,-1.2734712052,0.4393068595 
 H,0,-0.9417229675,-1.3130942769,0.4932141429 
 C,0,-1.2444066716,1.3376066449,1.1675313402 
 H,0,-1.8675107003,0.656854417,0.590251934 
 O,0,-0.9246283634,3.6524586434,0.9537393667 
 C,0,4.250981637,-3.6279599262,-0.2516320737 
 H,0,4.7183138887,-3.3385701193,0.6906741104 
 H,0,4.6152953764,-3.0141544226,-1.07630213 
 H,0,4.437333486,-4.6784601982,-0.4556102612 
 
Sum of electronic and zero-point Energies=           -667.617605 
 Sum of electronic and thermal Energies=              -667.604043 
 Sum of electronic and thermal Enthalpies=            -667.603099 
 Sum of electronic and thermal Free Energies=         -667.659286 
 
Product I 
 
199 
 
O,0,3.3897828458,2.9747288604,0.2173794992 
 O,0,2.7990835356,4.2374425921,1.851009913 
 N,0,2.520671241,3.1963739006,5.8646884825 
 O,0,4.1050921818,0.3347780359,2.4229838849 
 O,0,6.8143309238,1.5943070082,5.8370519242 
 N,0,2.7830154688,3.1840665938,1.2478140662 
 N,0,4.6796598132,2.3861882332,5.8192975206 
 N,0,5.4642964532,1.0157557567,4.0966087498 
 C,0,0.8053214272,1.0539966807,3.7306056484 
 C,0,1.1012300377,-0.3003439462,3.8908977613 
 H,0,2.1144647291,-0.6509292991,3.7246398202 
 C,0,0.1069809336,-1.2011223631,4.2571711684 
 H,0,0.351897784,-2.2515858775,4.3781625335 
 C,0,-1.1962541927,-0.7607920328,4.4693117885 
 H,0,-1.9698693372,-1.464287531,4.7594821793 
 C,0,-1.5000930801,0.5869895935,4.310885578 
 H,0,-2.5118631171,0.9420229495,4.4785961326 
 C,0,-0.5047484794,1.4864198598,3.9413476331 
 H,0,-0.7513058228,2.53828323,3.8193801432 
 C,0,1.8715662342,2.0552886966,3.3057625004 
 H,0,1.5014554265,3.0516413593,3.5690481386 
 C,0,1.9261562859,2.0711742797,1.7785396315 
 H,0,0.932414535,2.2774935662,1.3725958533 
 H,0,2.3276728303,1.1571435803,1.3537855034 
 C,0,3.2130306894,1.8730894947,3.9828384443 
 C,0,3.4577564628,2.4950160528,5.1942692426 
 C,0,4.906985351,3.0298440487,7.1076796024 
 H,0,5.9022334872,2.7525331878,7.4407409033 
 H,0,4.1739989006,2.6833468235,7.8390172602 
 H,0,4.8616967334,4.1179691529,7.0126888339 
 C,0,5.7308687583,1.658126488,5.2779256602 
 C,0,6.5211153195,0.2080656762,3.5015981784 
 H,0,6.3066644727,-0.8553362141,3.6283666837 
 H,0,7.4560919384,0.4539767175,3.996609724 
 H,0,6.5840820042,0.4280362849,2.4369131918 
 C,0,4.2259872289,1.032971999,3.4325561953 
 H,0,2.7773524514,3.8352505706,6.5975653533 
 H,0,1.6261775449,3.3600759906,5.4371846724 
 
Sum of electronic and zero-point Energies=          -1061.800149 
 Sum of electronic and thermal Energies=             -1061.779398 
 Sum of electronic and thermal Enthalpies=           -1061.778454 
 Sum of electronic and thermal Free Energies=        -1061.852595 
 
Product VI 
 
O,0,12.4433428414,9.9153671296,9.9085592819 
 O,0,12.9769568712,9.5838866787,11.9614951298 
 O,0,10.815839274,8.9825246622,7.1990978488 
 O,0,9.0802544602,12.8080853038,8.869098834 
200 
 
 O,0,9.4532319737,9.2957970189,11.6885323999 
 N,0,12.4595220028,9.2408725731,10.9214331075 
 N,0,9.1754537526,11.0306513501,10.2668207396 
 N,0,9.8835974172,10.8806396615,7.9988706495 
 C,0,9.8872001959,8.8445592007,9.3910449113 
 C,0,10.8793396309,7.6850728972,9.6992960196 
 C,0,10.1629712909,6.3530773614,9.8425434194 
 C,0,9.3584605806,11.6405378064,9.032182544 
 C,0,10.2692320906,9.5625695624,8.1116299347 
 C,0,10.4238641771,5.3266749017,8.9347031918 
 C,0,8.6731693319,11.887919165,11.3384519371 
 C,0,9.7765030252,4.0996204498,9.0434598418 
 C,0,8.8591556797,3.8838307698,10.0657909963 
 C,0,12.9668651294,6.8611785499,10.8905717622 
 C,0,11.8229060438,7.8671425352,10.8957294685 
 C,0,9.5150004829,9.7286046639,10.5551717227 
 C,0,9.2381782656,6.128665446,10.8655610155 
 C,0,8.591793317,4.9024307489,10.9757594995 
 C,0,10.1051303073,11.5839479464,6.7374010004 
 H,0,8.9267819107,8.3733176934,9.1278254812 
 H,0,11.5025640501,7.6153398815,8.8048510181 
 H,0,11.1390246951,5.4889293829,8.1334729411 
 H,0,7.8025458486,12.434779406,10.9814442466 
 H,0,9.4417398974,12.5972472051,11.6502186943 
 H,0,8.4033569763,11.2498585664,12.1751122452 
 H,0,9.9901587932,3.3130314295,8.3269519865 
 H,0,8.3529307601,2.9278999266,10.1523639348 
 H,0,13.5546147401,6.9400215283,9.9724260881 
 H,0,12.552199911,5.854070548,10.9512985885 
 H,0,13.6164858322,7.0198466856,11.7521776957 
 H,0,11.2834714785,7.822789999,11.8409475989 
 H,0,9.0198437002,6.9214111885,11.574707561 
 H,0,7.8754812497,4.7429470276,11.77540813 
 H,0,9.1890133016,12.0924520635,6.4411192332 
 H,0,10.3852633371,10.8450941977,5.9922455142 
 H,0,10.9045973763,12.3181988877,6.8483987866 
 
Sum of electronic and zero-point Energies=          -1120.923057 
 Sum of electronic and thermal Energies=             -1120.901378 
 Sum of electronic and thermal Enthalpies=           -1120.900434 
 Sum of electronic and thermal Free Energies=        -1120.976341 
 
Product XXII 
 
O,0,1.677621887,1.9978135381,-1.7613314021 
 O,0,2.6377249734,0.089518375,-1.5319224115 
 O,0,-0.7362325866,3.7950194876,0.9025398275 
 O,0,1.1680585991,-0.445621406,1.5774854653 
 O,0,-1.3642368296,1.5287866254,4.7683972058 
 O,0,3.8808392051,4.4567399954,5.8975525629 
201 
 
 N,0,2.3482046106,1.1988970743,-1.137974026 
 N,0,-1.0255440495,2.6891417299,2.8606222758 
 N,0,-0.0467196578,0.5423351054,3.1996148113 
 C,0,4.1963492439,2.3865585346,-0.0995060797 
 H,0,4.8746350396,1.7704604734,-0.6929512512 
 H,0,4.6912695243,2.6346548872,0.8400919127 
 H,0,3.9840114902,3.3131163962,-0.638418733 
 C,0,2.9107188214,1.6275081468,0.2011378967 
 H,0,3.1208861426,0.6842040884,0.7025367191 
 C,0,1.8901363575,2.4758266833,0.9657041022 
 H,0,1.6805384221,3.3531269899,0.3478744373 
 C,0,2.4537139216,2.9572908555,2.2864495174 
 C,0,2.3950919563,4.316982345,2.6096085072 
 H,0,1.9667655773,5.0184270037,1.8996759664 
 C,0,2.8754959689,4.7907966475,3.8178913539 
 H,0,2.8273240656,5.8468991105,4.0606401439 
 C,0,3.4368853577,3.908335802,4.7443737733 
 C,0,3.5121677318,2.549709869,4.4375690983 
 H,0,3.9494927142,1.8423845206,5.1309545219 
 C,0,3.0216752579,2.09048086,3.2188025571 
 H,0,3.1045246697,1.0286796664,3.0060593274 
 C,0,4.4583645581,3.5980092929,6.8668676326 
 H,0,5.3513458787,3.1007555792,6.4746424093 
 H,0,3.7398051371,2.8462594029,7.2090090154 
 H,0,4.7388633221,4.2359813174,7.7033534745 
 C,0,0.4965192166,1.7875471895,1.1426913483 
 H,0,0.1434119038,1.4810886846,0.1528063951 
 C,0,-0.4783956591,2.8415010218,1.6067237037 
 C,0,-0.8366084244,1.5830186257,3.6805700602 
 C,0,0.5684335738,0.5357368377,1.9717751792 
 C,0,0.0790737302,-0.6596520919,4.0205967534 
 H,0,-0.2635092791,-0.4249377505,5.0236601831 
 H,0,1.122814943,-0.9695022102,4.0388553606 
 H,0,-0.5258566433,-1.4658413028,3.601438486 
 C,0,-1.9130042853,3.7254721545,3.3837150355 
 H,0,-1.9027127538,4.5524275813,2.6794827664 
 H,0,-1.5550514128,4.0545954002,4.3583363182 
 H,0,-2.9268922197,3.3364668623,3.4849977985 
 
Sum of electronic and zero-point Energies=          -1235.326912 
 Sum of electronic and thermal Energies=             -1235.302444 
 Sum of electronic and thermal Enthalpies=           -1235.301500 
 Sum of electronic and thermal Free Energies=        -1235.384957 
 
17ZnY catalyst 
 
Y,0,-1.8556052082,-0.3403403094,1.08187914 
 Zn,0,1.57271329,-0.276694545,0.5096605221 
 Cl,0,7.7888926741,-2.7013371571,-1.0882091854 
 Cl,0,-0.7971624273,6.724134444,0.1542132752 
202 
 
 O,0,-0.0931897231,0.8906142799,0.2601317592 
 O,0,0.0076976849,-1.6538827669,0.6533856532 
 O,0,3.1068843634,0.7551745759,-0.2234731885 
 O,0,1.8178033512,0.0471104392,2.5443297577 
 O,0,-3.9826014499,-0.4963939137,0.7248157385 
 O,0,-2.1965834534,-2.8476064103,1.2187960242 
 O,0,-1.4372896414,1.0784537187,2.9762284361 
 O,0,-2.2270972005,-0.8753424934,3.3933159467 
 O,0,-6.297133195,-1.7282912593,0.7853396957 
 O,0,1.9375343504,6.2841619181,-0.667879996 
 N,0,2.8244741114,-1.9045636805,0.0640860081 
 N,0,-2.5477212612,1.8788408474,0.2352486328 
 O,0,8.4523444036,-0.1337572017,-2.2659070927 
 N,0,1.9846920121,5.2119191956,-0.0854134083 
 O,0,-1.8465683523,0.5019169378,5.0314889927 
 O,0,3.0073520805,4.7314355212,0.3851752159 
 N,0,1.3677835058,-0.4043935745,4.7264933661 
 O,0,7.873753889,1.57894114,-1.0839795329 
 N,0,-1.8374869882,0.2467787233,3.8487200911 
 N,0,7.6965665772,0.4416390232,-1.4988189356 
 C,0,4.1452379151,0.003078131,-0.4420866194 
 C,0,0.0783420093,-2.9687248419,0.7200542885 
 C,0,-4.9276923763,1.4889592365,-0.2181537864 
 C,0,-1.6185871134,4.1800696721,0.1680382163 
 H,0,-2.5976480585,4.6367945447,0.2603294161 
 C,0,6.4876157181,-0.2476720806,-1.0698371601 
 C,0,4.0827789218,-1.4216201398,-0.3097148863 
 C,0,-6.2936023367,-0.4714880651,0.2775659002 
 C,0,-7.4042269943,0.1865648356,-0.2201041322 
 H,0,-8.3712034296,-0.3047961362,-0.2251920817 
 C,0,5.2173488594,-2.2043499177,-0.52741485 
 H,0,5.187504395,-3.2783764618,-0.3797084787 
 C,0,0.7622516812,4.433493212,0.036103548 
 C,0,-1.4818581555,2.7911929942,0.1778667229 
 C,0,-0.5108832093,5.0159272101,0.0820808911 
 C,0,5.3816155182,0.5529368188,-0.8245857895 
 H,0,5.4693715266,1.6264623837,-0.9412003795 
 C,0,1.5004167035,-0.7488165924,3.4545648097 
 H,0,1.3051940913,-1.8081433841,3.2479112481 
 C,0,-1.1424499375,-5.0464911955,1.1409636687 
 H,0,-2.0602063255,-5.5622708418,1.3982921587 
 C,0,2.5310595799,-3.1635784883,0.1268097479 
 H,0,3.2940008791,-3.9096659017,-0.1125230329 
 C,0,1.2539940594,-3.7255946059,0.4860651771 
 C,0,-3.7107352156,2.2408545042,-0.2287203878 
 H,0,-3.8016451742,3.2278725091,-0.692831461 
 C,0,-7.2992783664,1.4953527125,-0.7300261696 
 H,0,-8.184439663,1.9889262016,-1.1173187355 
 C,0,-1.1117489963,-3.6689043769,1.035376089 
 C,0,-6.0836222402,2.1333166008,-0.7296838556 
203 
 
 H,0,-5.9907934945,3.1458819728,-1.1134943 
 C,0,0.9205737509,3.0510985065,0.1036488244 
 H,0,1.9190022393,2.6268666515,0.0652685895 
 C,0,6.4237010328,-1.6423594729,-0.9203053167 
 C,0,-0.1881589508,2.2130716179,0.1875423962 
 C,0,-5.0115270441,0.1611732439,0.2812217238 
 C,0,0.0276376924,-5.7864585986,0.9102338737 
 H,0,0.0002689043,-6.8676624984,0.9901504617 
 C,0,-3.4507594317,-3.4701518958,1.518559515 
 H,0,-4.1885888621,-2.66983052,1.5234737664 
 H,0,-3.3988951129,-3.9680403408,2.4911443368 
 H,0,-3.7030347546,-4.1946172915,0.7388216125 
 C,0,1.1957529579,-5.1365977614,0.5821714825 
 H,0,2.1027895515,-5.7053241608,0.3968088056 
 C,0,-7.5305575702,-2.4186726232,0.8111177126 
 H,0,-7.935475069,-2.5549739579,-0.1989695788 
 H,0,-8.2712050323,-1.8950978474,1.4277026245 
 H,0,-7.3226352602,-3.3948193288,1.2499651953 
 C,0,1.5661186285,0.9649629433,5.1655945699 
 H,0,1.8971440416,1.5652018549,4.3200141966 
 H,0,2.3213953443,0.9913867661,5.9558432023 
 H,0,0.6240211218,1.3626002563,5.5539898529 
 C,0,0.981585639,-1.3737408145,5.7350724845 
 H,0,0.8747001075,-2.3601389196,5.2812012829 
 H,0,0.0270866076,-1.0802945182,6.1816687457 
 H,0,1.7437953042,-1.4225892531,6.5178069482 
 
Sum of electronic and zero-point Energies=          -5312.291492 
 Sum of electronic and thermal Energies=             -5312.238283 
 Sum of electronic and thermal Enthalpies=           -5312.237339 
 Sum of electronic and thermal Free Energies=        -5312.383479 
 
17ZnY catalyst-DMF 
 
Y,0,2.0922299764,-0.1223759285,-0.9073037974 
 Zn,0,-1.3533113226,-0.0620537947,-0.3912632984 
 Cl,0,-7.8538876101,-2.2036571178,-0.424638239 
 Cl,0,1.151513157,6.5968392721,1.6779973689 
 O,0,0.2915050991,1.0745485399,-0.1315192174 
 O,0,0.1368684907,-1.3904111857,-0.8730469469 
 O,0,-2.9574767528,1.0467838352,-0.1411448975 
 O,0,4.2240670521,-0.3028139205,-0.6426081969 
 O,0,2.3575579331,-2.6188746079,-1.2427972094 
 O,0,2.2896458955,1.5914836955,-2.555360218 
 O,0,2.388714524,-0.4402416413,-3.250018493 
 O,0,6.5384006518,-1.5058317613,-0.9113250433 
 O,0,-1.6726522376,6.114149081,2.0611418091 
 N,0,-2.7401054251,-1.5776408961,-0.6653617074 
 N,0,2.7577102701,1.8635609049,0.4238251448 
 O,0,-8.6143303341,0.2949705725,0.828995855 
204 
 
 N,0,-1.683686775,5.2511854379,1.1974651418 
 O,0,2.5872426946,1.1926530882,-4.6707617618 
 O,0,-2.6577972584,4.9831284385,0.5067830707 
 O,0,-7.7651548639,2.0655019549,-0.0709530431 
 N,0,2.4271426618,0.7994079063,-3.5415893415 
 N,0,-7.7118316854,0.8893312562,0.2612582527 
 C,0,-4.0529035687,0.3396045969,-0.1926207914 
 C,0,0.0269448222,-2.6749959932,-1.1475473423 
 C,0,5.0972785235,1.2927266008,0.9111072994 
 C,0,1.8933314398,4.1131595392,1.0278644153 
 H,0,2.8881806491,4.5220280481,1.1632659877 
 C,0,-6.4749340241,0.1714350135,-0.0144727006 
 C,0,-4.0250284186,-1.0646291631,-0.4641846293 
 C,0,6.4974994674,-0.4582606613,-0.0519487732 
 C,0,7.5689053529,-0.0015168896,0.6953894612 
 H,0,8.533485928,-0.4917646879,0.6198694513 
 C,0,-5.2087005527,-1.8014862293,-0.5089750018 
 H,0,-5.1951974463,-2.8637318646,-0.7268077974 
 C,0,-0.479136735,4.4635016632,0.9885237177 
 C,0,1.7194678354,2.7883671988,0.6218927397 
 C,0,0.808209323,4.9571781525,1.2345460744 
 C,0,-5.311067478,0.9265031445,0.0150006665 
 H,0,-5.3735596358,1.9887655119,0.2183869398 
 C,0,1.2261359178,-4.734502835,-1.6893267151 
 H,0,2.1552482639,-5.2640470048,-1.8643845 
 C,0,-2.4955964014,-2.8016672835,-1.0137369801 
 H,0,-3.3274655949,-3.4944665842,-1.1654422167 
 C,0,-1.198484893,-3.3820902991,-1.2340198719 
 C,0,3.8909373811,2.0512199082,1.0412109588 
 H,0,3.9677701015,2.8823483963,1.7486847464 
 C,0,7.4265104437,1.0986471495,1.562884847 
 H,0,8.2810578522,1.4368226543,2.1394465124 
 C,0,1.2280677349,-3.389510424,-1.373194742 
 C,0,6.2138754507,1.7341430671,1.6670979603 
 H,0,6.0942938513,2.5911860768,2.3245937185 
 C,0,-0.6690637622,3.1653080821,0.5203143002 
 H,0,-1.6761974457,2.8103723049,0.3242667637 
 C,0,-6.4412464343,-1.2073623139,-0.2769661195 
 C,0,0.4171142294,2.3193211372,0.3234751868 
 C,0,5.2183494867,0.1703875808,0.0481202286 
 C,0,0.0069931054,-5.4240208497,-1.7869030312 
 H,0,0.0094269437,-6.4788651495,-2.0384893415 
 C,0,3.6179917223,-3.263068201,-1.4665246154 
 H,0,4.3783590669,-2.5030537275,-1.2931317455 
 H,0,3.6712541907,-3.6343813616,-2.4941460959 
 H,0,3.7436505064,-4.0899469787,-0.7616401932 
 C,0,-1.1765072625,-4.7595714088,-1.5622287724 
 H,0,-2.1221483646,-5.2898018275,-1.6327202273 
 C,0,7.7699419555,-2.1858137697,-1.0542649969 
 H,0,8.0978408755,-2.6266799652,-0.1050635085 
205 
 
 H,0,8.5546490529,-1.5190270481,-1.4314105961 
 H,0,7.5947024029,-2.9810064353,-1.7791659023 
 
Sum of electronic and zero-point Energies=          -5064.137461 
 Sum of electronic and thermal Energies=             -5064.091760 
 Sum of electronic and thermal Enthalpies=           -5064.090816 
 Sum of electronic and thermal Free Energies=        -5064.221568 
 
17ZnY catalyst-DMF + barbiturate substrate 
 
Y,0,2.055879763,-0.2440343673,-0.8053964281 
 Zn,0,-1.3502043819,-0.3075273097,0.0993851173 
 Cl,0,-7.891703618,-1.9049396894,-1.2039875492 
 Cl,0,1.2617791229,6.4524985675,1.776824891 
 O,0,0.3100139562,0.8765919236,0.1853096168 
 O,0,0.1188198323,-1.5345849292,-0.7005016821 
 O,0,-2.9065323054,0.9237528717,0.1268885932 
 O,0,4.1926088686,-0.4622130022,-0.6121808527 
 O,0,2.3168196594,-2.7380945614,-1.2704576488 
 O,0,2.0627712732,1.5427794907,-2.3873163375 
 O,0,2.1098999579,-0.4586931511,-3.1688930001 
 O,0,6.4801418979,-1.6905967811,-0.9932970891 
 O,0,-1.5356868807,5.9801684479,2.3334985631 
 N,0,-2.7656859933,-1.6275674049,-0.6975949237 
 N,0,2.7999638968,1.6924099043,0.5439666783 
 O,0,-8.6791528804,0.498573813,0.2118750077 
 N,0,-1.5928044561,5.0950444047,1.4943742768 
 O,0,2.1142177969,1.2302523495,-4.5375124737 
 O,0,-2.6018927744,4.8116261065,0.8627227969 
 O,0,-7.6040765203,2.2860634237,-0.3482657165 
 N,0,2.0952032101,0.7923006352,-3.4143595664 
 N,0,-7.6692118525,1.0802587512,-0.1515540224 
 C,0,-4.0195776431,0.3120746801,-0.1580764528 
 C,0,-0.014636837,-2.7672910136,-1.153895572 
 C,0,5.1562035009,1.1120505996,0.9099072867 
 C,0,1.9704995324,3.9517787888,1.1547043848 
 H,0,2.9717675384,4.3629628991,1.2175034405 
 C,0,-6.4498327029,0.3052379721,-0.3354404992 
 C,0,-4.0354600528,-1.0521814221,-0.592661013 
 C,0,6.490061698,-0.6469618963,-0.1282505971 
 C,0,7.6003581697,-0.2055301927,0.5700461731 
 H,0,8.5548010871,-0.7057630688,0.446554625 
 C,0,-5.2417981217,-1.689259572,-0.8849471925 
 H,0,-5.2578430934,-2.7178141142,-1.2284918616 
 C,0,-0.4012155299,4.2992751821,1.2433424659 
 C,0,1.7736646661,2.6176428363,0.7944237463 
 C,0,0.8971071519,4.8003459272,1.4016855522 
 C,0,-5.2606379268,0.9640520032,-0.0587560289 
 H,0,-5.2901160231,2.0000889357,0.2567246923 
 C,0,1.1457049427,-4.7710654451,-1.9403871593 
206 
 
 H,0,2.0653223893,-5.2958837761,-2.1711428998 
 C,0,-2.5447769521,-2.8110355627,-1.1716298199 
 H,0,-3.3853356694,-3.4335373253,-1.4908075663 
 C,0,-1.2542546433,-3.4222985071,-1.3623439976 
 C,0,3.9623839222,1.8760468495,1.1047196042 
 H,0,4.0748183077,2.70393837,1.8115023029 
 C,0,7.5113092929,0.8914185758,1.4484150248 
 H,0,8.3959940203,1.2176050222,1.9850378784 
 C,0,1.1722029268,-3.4705829176,-1.4725738424 
 C,0,6.3115819607,1.5384449165,1.6140077704 
 H,0,6.23174303,2.3925735171,2.2813092369 
 C,0,-0.617247043,2.9880168271,0.8251197591 
 H,0,-1.6326831249,2.6297512081,0.684977995 
 C,0,-6.4590669156,-1.0363258932,-0.7504244233 
 C,0,0.457386921,2.1357949528,0.5924295238 
 C,0,5.2241768136,-0.00491833,0.034322825 
 C,0,-0.0858311833,-5.4178861714,-2.1252553024 
 H,0,-0.103538909,-6.4372571453,-2.494969873 
 C,0,3.5640852249,-3.3834524313,-1.5515281198 
 H,0,4.3383298054,-2.6551237687,-1.3155060316 
 H,0,3.6121543488,-3.6639208616,-2.6079731031 
 H,0,3.6730184863,-4.2719331652,-0.9227840644 
 C,0,-1.2578686302,-4.7509457047,-1.8499085544 
 H,0,-2.2146569944,-5.2408049668,-2.008443016 
 C,0,7.6947249698,-2.387156769,-1.1916335853 
 H,0,8.0582681498,-2.8339088915,-0.258334041 
 H,0,8.470863804,-1.7305196131,-1.6026334834 
 H,0,7.4763588043,-3.1786620917,-1.9088213761 
 N,0,0.9433204338,-2.0886748418,5.1328191834 
 C,0,-0.4316287994,-2.1468928065,5.2929007601 
 O,0,-0.933104294,-2.5156514609,6.3324066227 
 N,0,-1.2488530356,-1.7607847923,4.2162697954 
 C,0,-0.7753323865,-1.3354583047,3.0186117693 
 O,0,-1.5475104096,-0.9910234625,2.1171703883 
 C,0,0.7026184759,-1.3062862067,2.8240246171 
 C,0,1.5827776227,-1.6772459174,3.9799704549 
 O,0,2.7937775913,-1.6247334083,3.8900668723 
 C,0,1.7370529799,-2.4887286141,6.2912386702 
 C,0,-2.688692975,-1.8295574667,4.4629516869 
 H,0,0.9781391,-0.3019658239,2.4878264064 
 H,0,0.9404915824,-1.9799143993,1.9932227933 
 H,0,2.7839901149,-2.3974714848,6.0123966436 
 H,0,1.5052925221,-3.5202321683,6.5597765322 
 H,0,1.5137696084,-1.8377961134,7.1377313542 
 H,0,-3.1982704924,-1.5514415849,3.5445110753 
 H,0,-2.956750605,-1.1416102249,5.265722652 
 H,0,-2.9580680754,-2.844979858,4.7535386608 
 
17ZnY catalyst-DMF + barbiturate + trans-nitrostyrene substrates 
 
207 
 
Y,0,1.7427978435,-0.3451948842,-0.6507860989 
 Zn,0,-1.7401908836,-0.1260579456,-0.284896142 
 Cl,0,-7.8797576018,-2.2888029959,-2.5115367596 
 Cl,0,0.7840055839,6.7992854411,-1.1340785282 
 O,0,-0.0665602586,1.0441034598,-0.2937200969 
 O,0,-0.219192161,-1.5326147468,-0.4414916026 
 O,0,-3.2849195707,0.982771679,-0.8357394618 
 O,0,3.9116573458,-0.3829590166,-0.5067322457 
 O,0,1.9965624675,-2.7755583771,-0.0418323718 
 O,0,1.7239094552,0.6421282376,-2.8379267659 
 O,0,2.0438674218,-1.482051349,-2.7422342223 
 O,0,6.2174987773,-1.5993752165,-0.2566055631 
 O,0,-2.0355699488,6.5323561038,-0.5566239992 
 N,0,-3.0371830589,-1.6925171159,-0.8443124127 
 N,0,2.40730554,1.9972283682,-0.2321282339 
 O,0,-8.9253197751,0.364317329,-1.994466361 
 N,0,-2.0479393531,5.3763460452,-0.9495267551 
 O,0,2.0596907041,-0.4781824567,-4.6692637409 
 O,0,-3.0249047235,4.8296727608,-1.4439977717 
 O,0,-7.7043537372,1.9844784064,-2.7356499461 
 N,0,1.946255302,-0.441053287,-3.466972989 
 N,0,-7.8437117064,0.8706127446,-2.2487737804 
 C,0,-4.3180302403,0.2726116327,-1.190029392 
 C,0,-0.3248290729,-2.8365009333,-0.2954220948 
 C,0,4.7562474445,1.668455096,0.3962858861 
 C,0,1.5333311237,4.2827856821,-0.6369942367 
 C,0,-6.6360927817,0.1241887222,-1.9258019555 
 C,0,-4.2738915228,-1.1582311403,-1.2099185809 
 C,0,6.1700181805,-0.3074406187,0.1499375918 
 C,0,7.2344159932,0.3955764002,0.6845992053 
 C,0,-5.3874425666,-1.8961341741,-1.6134901172 
 C,0,-0.8412243278,4.578745221,-0.796622493 
 C,0,1.3627957862,2.9149387658,-0.4188475099 
 C,0,0.4448879508,5.1318864314,-0.80626076 
 C,0,-5.5278257341,0.8789143073,-1.5673605899 
 C,0,0.8619908561,-4.93244315,0.1182532993 
 C,0,-2.8161097689,-2.9576149102,-0.6805441402 
 C,0,-1.5428676755,-3.5566758748,-0.3727431612 
 C,0,3.547213481,2.4193166782,0.2354748528 
 C,0,7.0851434496,1.7396340161,1.0816586886 
 C,0,0.8681837574,-3.5631951348,-0.0642775957 
 C,0,5.8691856686,2.3623988094,0.9397360875 
 C,0,-1.0292043438,3.2064253032,-0.6399192719 
 C,0,-6.581636248,-1.2784008586,-1.9575456899 
 C,0,0.0589799481,2.3594657044,-0.4538284529 
 C,0,4.8881145393,0.3098704456,-0.0086003858 
 C,0,-0.3524439544,-5.6354203817,0.0584847638 
 C,0,3.2553650987,-3.438909041,0.1245499594 
 C,0,-1.5258936342,-4.959833332,-0.1895794996 
 C,0,7.447793216,-2.2827942124,-0.1181474184 
208 
 
 N,0,-0.9449976321,1.3610030097,5.2625795174 
 C,0,-1.8520439825,0.3146493785,5.2730267682 
 O,0,-2.3003753674,-0.1255605138,6.3095609159 
 N,0,-2.2379056271,-0.2480435953,4.0447528324 
 C,0,-1.7966303884,0.18700191,2.836871823 
 O,0,-2.155985488,-0.3718304075,1.7952314877 
 C,0,-0.8851937756,1.3672244445,2.8127228221 
 C,0,-0.3888712474,1.9075739623,4.1209726487 
 O,0,0.443966026,2.7910954886,4.1631511832 
 C,0,-0.5471817284,1.8735414259,6.5702613093 
 C,0,-3.1595559579,-1.3796362631,4.1341978315 
 C,0,5.9548875954,-1.2492263337,6.8136457045 
 C,0,7.0805162843,-0.456426212,6.5712222286 
 C,0,7.1604733762,0.3148530922,5.4133857962 
 C,0,6.1170928444,0.2954595489,4.4975390177 
 C,0,4.9794544526,-0.4998843382,4.7279026852 
 C,0,4.9116700655,-1.2742292455,5.9028286203 
 C,0,3.9332579393,-0.4803348675,3.7326744928 
 C,0,2.7977343814,-1.210643152,3.7512288209 
 N,0,1.8588799587,-1.1022665588,2.7032524013 
 O,0,0.867233445,-1.8099732011,2.7446183278 
 O,0,2.065663975,-0.2799673272,1.7808702483 
 H,0,2.528227875,4.7072280626,-0.711463876 
 H,0,8.1996387869,-0.084574212,0.8035811399 
 H,0,-5.3392835838,-2.9773607259,-1.6840420243 
 H,0,-5.6022340452,1.9597344017,-1.5634267279 
 H,0,1.783368702,-5.4715891611,0.3056525401 
 H,0,-3.6380621575,-3.672343775,-0.7842429833 
 H,0,3.6272455209,3.463937406,0.5523909123 
 H,0,7.9364939485,2.2720408112,1.4926784226 
 H,0,5.7435696543,3.4009153378,1.2344764723 
 H,0,-2.0348470578,2.7981245628,-0.6747762884 
 H,0,-0.3533991277,-6.7106238583,0.2003905556 
 H,0,4.0162399538,-2.6629349983,0.049742695 
 H,0,3.3960594185,-4.1799785995,-0.6676732523 
 H,0,3.2955222373,-3.9243920551,1.1041188763 
 H,0,-2.4654476849,-5.5020293004,-0.2526822623 
 H,0,7.7628853328,-2.333568102,0.9311403102 
 H,0,8.2394681847,-1.8068479056,-0.7091239114 
 H,0,7.2773040013,-3.2924428313,-0.4923695597 
 H,0,-1.407894604,2.18078705,2.294316661 
 H,0,-0.0257443332,1.1226170752,2.1809810953 
 H,0,0.146267504,2.6931736622,6.3981957307 
 H,0,-0.0622501396,1.0856014181,7.1487077016 
 H,0,-1.4258213456,2.2272848093,7.1109555301 
 H,0,-3.3881275549,-1.7044830627,3.1229203562 
 H,0,-4.0695312608,-1.0671537032,4.6468161288 
 H,0,-2.6912539722,-2.190145862,4.6938089088 
 H,0,5.8963444801,-1.8467143,7.7178425851 
 H,0,7.8947842701,-0.4418960053,7.2895384911 
209 
 
 H,0,8.0347416961,0.9300183269,5.2255991034 
 H,0,6.1758678454,0.8927719454,3.591094001 
 H,0,4.0424995807,-1.8919241949,6.1055862699 
 H,0,4.0788907451,0.1832494776,2.8826616353 
 H,0,2.4893936958,-1.9259995765,4.4998161395 
 
Sum of electronic and zero-point Energies=          -6145.538507 
 Sum of electronic and thermal Energies=             -6145.469432 
 Sum of electronic and thermal Enthalpies=           -6145.468487 
 Sum of electronic and thermal Free Energies=        -6145.655539 
 
17ZnY catalyst + trans-nitrostyrene-I 
 
Y,0,-1.3917322277,0.4915678619,1.0659704334 
 Zn,0,1.9498678951,-0.1243361462,0.3605433307 
 Cl,0,7.7070683658,-3.7493703035,-0.4598669184 
 Cl,0,0.301510783,6.3982990826,-2.7969967945 
 O,0,0.4333249347,1.164575557,-0.1315365305 
 O,0,0.2584749915,-1.1383972298,1.0357996552 
 O,0,3.5195223032,0.3729553457,-0.7538522295 
 O,0,2.4314157963,0.7422608693,2.187191625 
 O,0,-3.5178397274,0.8428777589,1.3139673072 
 O,0,-2.073806897,-1.7962274648,1.9010312487 
 O,0,-0.90440931,2.4139629779,2.4645050943 
 O,0,-1.1820914915,0.5339092356,3.4697153762 
 O,0,-5.918184503,0.2461577072,2.1845986756 
 O,0,2.8339558595,5.2302527412,-3.5588669735 
 N,0,2.9395709671,-1.9817494718,0.4006606726 
 N,0,-1.9083144619,2.3959138748,-0.4219845888 
 O,0,8.5951100159,-1.8411257927,-2.4576693086 
 N,0,2.855110451,4.5232300857,-2.5631297484 
 O,0,-0.8028416547,2.3305958208,4.6329649584 
 O,0,3.8812830971,4.142902618,-2.0145551205 
 N,0,2.2111795979,0.9119958669,4.4438529663 
 O,0,8.2926186229,0.2295079413,-1.9229209891 
 N,0,-0.9565839778,1.7826799151,3.5629967251 
 N,0,7.9585493055,-0.9475782182,-1.9217068839 
 C,0,4.449129906,-0.5369989819,-0.7251445773 
 C,0,0.1222878889,-2.3996462416,1.3858472634 
 C,0,-4.3630513576,2.3137482467,-0.3741715491 
 C,0,-0.7601639825,4.2694569248,-1.5769683351 
 H,0,-1.6623140374,4.8690025542,-1.6189521569 
 C,0,6.7040757792,-1.2882134707,-1.2657104966 
 C,0,4.2242071523,-1.8177893413,-0.1258292518 
 C,0,-5.8502676896,1.1063726887,1.1381116698 
 C,0,-6.9425659219,1.6670356068,0.5005659515 
 H,0,-7.9477578104,1.4262332444,0.8294499917 
 C,0,5.2448127574,-2.7673902169,-0.0741141933 
 H,0,5.0966995758,-3.7114436202,0.4390772378 
 C,0,1.5907626709,4.0735725065,-2.0041942543 
210 
 
 C,0,-0.769825733,3.0162313487,-0.960992681 
 C,0,0.4020802703,4.8052599955,-2.119441474 
 C,0,5.7170452633,-0.3127776012,-1.288797758 
 H,0,5.9251071105,0.6389466883,-1.7628173689 
 C,0,2.1199177541,0.2566133708,3.2970596866 
 H,0,1.7383193911,-0.767101785,3.3859730411 
 C,0,-1.3882283761,-4.1074449902,2.2721459206 
 H,0,-2.3612872288,-4.397978311,2.6507526397 
 C,0,2.4658532663,-3.1270852271,0.7745069793 
 H,0,3.0892278986,-4.0220493159,0.6884045386 
 C,0,1.1461728454,-3.3764397711,1.2946140898 
 C,0,-3.0859103726,2.7511071573,-0.8520319476 
 H,0,-3.1473727783,3.468718831,-1.6760614453 
 C,0,-6.7700863052,2.552739755,-0.5809142857 
 H,0,-7.6422147636,2.9793436396,-1.0651884522 
 C,0,-1.1453662829,-2.8073164253,1.8723765668 
 C,0,-5.5042552175,2.8706010608,-1.0073334772 
 H,0,-5.3576755229,3.5610888525,-1.8338510685 
 C,0,1.6149142905,2.8520669498,-1.3351370038 
 H,0,2.5498847318,2.3068282016,-1.2520652967 
 C,0,6.4854502443,-2.5307435226,-0.6499053081 
 C,0,0.4506332133,2.3136095581,-0.7929647653 
 C,0,-4.5191107215,1.4052779428,0.7091108188 
 C,0,-0.3650240029,-5.0651848506,2.1848078435 
 H,0,-0.5604224321,-6.085082229,2.4976078924 
 C,0,-3.383909002,-2.1208039334,2.3761897089 
 H,0,-3.9691435829,-1.2060181793,2.2926325923 
 H,0,-3.3337851531,-2.4529519172,3.4174497643 
 H,0,-3.8248546421,-2.9060821306,1.7544381587 
 C,0,0.8709746316,-4.7049442439,1.6990322552 
 H,0,1.6633557666,-5.4442925112,1.6206100288 
 C,0,-7.2031659599,-0.1097199635,2.6542567432 
 H,0,-7.7918394954,-0.609161561,1.8750803452 
 H,0,-7.7554106502,0.7662303491,3.0155054924 
 H,0,-7.0430329273,-0.800289488,3.4825937515 
 C,0,2.6760483707,2.2858843078,4.4975459552 
 H,0,2.9968604713,2.5922848195,3.5033603109 
 H,0,3.5138968731,2.3626410544,5.1959507876 
 H,0,1.8640809964,2.9346252192,4.839203051 
 C,0,1.7850755937,0.3075287194,5.692117372 
 H,0,1.4961486663,-0.7307588441,5.5226000799 
 H,0,0.9273955289,0.855928812,6.0922195003 
 H,0,2.602659064,0.3353085233,6.4176925709 
 C,0,-5.2634258789,-4.3784849999,-5.2325446491 
 C,0,-6.0594025728,-5.2649893536,-4.5018990582 
 C,0,-6.0561349482,-5.2260909908,-3.1089745361 
 C,0,-5.2580367164,-4.3025580048,-2.4469873982 
 C,0,-4.4516813248,-3.4050163183,-3.1692590974 
 C,0,-4.4654719962,-3.4552670351,-4.5762905335 
 C,0,-3.6443529877,-2.4688817586,-2.4189924414 
211 
 
 C,0,-2.8123588545,-1.5397595252,-2.929856269 
 N,0,-2.0792980506,-0.6822351072,-2.0738088901 
 O,0,-1.3376387058,0.1370899874,-2.5850746956 
 O,0,-2.2199743322,-0.7996974963,-0.8379324958 
 H,0,-5.2691600176,-4.4117595164,-6.3174040846 
 H,0,-6.6823731269,-5.9860186989,-5.0226345318 
 H,0,-6.6743884025,-5.9141104536,-2.541255512 
 H,0,-5.2512710758,-4.2672158827,-1.3610013202 
 H,0,-3.8529637449,-2.7724224195,-5.1564822108 
 H,0,-3.7156457979,-2.521143121,-1.3350730837 
 H,0,-2.6081122253,-1.3414261932,-3.9720636291 
 
Sum of electronic and zero-point Energies=          -5825.751729 
 Sum of electronic and thermal Energies=             -5825.688221 
 Sum of electronic and thermal Enthalpies=           -5825.687276 
 Sum of electronic and thermal Free Energies=        -5825.858981 
 
17ZnY catalyst + trans-nitrostyrene-II 
 
Y,0,1.8118985949,-0.7949250889,-1.3920033865 
 Zn,0,-1.524175326,-0.5444746464,-0.47208726 
 Cl,0,-8.0048777106,-2.5004748169,0.4684562197 
 Cl,0,1.6554510674,5.8605619081,1.5219913353 
 O,0,0.2628616886,0.4289964714,-0.2321234202 
 O,0,-0.1525710774,-1.9799647068,-1.1139435849 
 O,0,-2.9132592537,0.447936605,0.5458487693 
 O,0,-1.8771997274,0.1999090459,-2.3987726167 
 O,0,3.9419684855,-0.9638906585,-1.7173789404 
 O,0,1.987675127,-3.2932407893,-1.6807481642 
 O,0,1.6726972609,0.9240590929,-3.0561053441 
 O,0,1.4283837146,-1.0998858116,-3.7332205603 
 O,0,6.1013105519,-2.1818229034,-2.5695153221 
 O,0,-1.0313005648,5.4228226602,2.4914082699 
 N,0,-2.9316666252,-2.0873807892,-0.3476575888 
 N,0,2.8150516679,1.1527941391,-0.221690425 
 O,0,-8.4201334999,-0.2311759886,2.2244574016 
 N,0,-1.2536191927,4.5925438262,1.6240638202 
 O,0,1.3951895248,0.5273574894,-5.1747748841 
 O,0,-2.3615358697,4.3711980731,1.1535069596 
 N,0,-1.8374254741,-0.0264654833,-4.6613174438 
 O,0,-7.5828157937,1.6298509341,1.5175396029 
 N,0,1.494704011,0.1350482309,-4.0349213364 
 N,0,-7.5627962922,0.4124872666,1.6399341072 
 C,0,-4.0423807995,-0.198082332,0.5666859662 
 C,0,-0.298706297,-3.2849628168,-1.1944691094 
 C,0,5.1873866416,0.5229155852,-0.3146839267 
 C,0,2.1674108865,3.3898538218,0.6407370241 
 H,0,3.1788551463,3.7734372179,0.5686171183 
 C,0,-6.4238975763,-0.2999290111,1.0783508873 
 C,0,-4.1394063508,-1.5518191033,0.108387272 
212 
 
 C,0,6.2848685896,-1.18691714,-1.6664080172 
 C,0,7.5093862042,-0.7942575447,-1.1552113087 
 H,0,8.417617942,-1.2946963192,-1.4731662596 
 C,0,-5.3661279237,-2.2155989683,0.10437522 
 H,0,-5.4515969784,-3.2145459425,-0.3097323116 
 C,0,-0.1459231471,3.7883203411,1.1329418065 
 C,0,1.8723116596,2.0864432406,0.2357315618 
 C,0,1.1772942698,4.2466513336,1.108573368 
 C,0,-5.2220830729,0.3940082512,1.0496340214 
 H,0,-5.1912018084,1.4125973453,1.417380249 
 C,0,-1.8127533464,-0.5077213536,-3.4269554283 
 H,0,-1.7246263929,-1.5987105919,-3.3636066617 
 C,0,0.7951829733,-5.4223463186,-1.6621401696 
 H,0,1.6814927267,-5.988360929,-1.9239139297 
 C,0,-2.7422564662,-3.3527938633,-0.540588788 
 H,0,-3.5582027826,-4.0550116166,-0.3447876498 
 C,0,-1.5155043056,-3.9766513764,-0.9660782434 
 C,0,4.0644076248,1.2948580792,0.1238406236 
 H,0,4.3242214042,2.0914047114,0.827621013 
 C,0,7.5971473947,0.2523305371,-0.2170419231 
 H,0,8.5685423157,0.5399846558,0.1711783905 
 C,0,0.8482851952,-4.0489414718,-1.5234003534 
 C,0,6.4576473941,0.8995415648,0.1931133961 
 H,0,6.5122702926,1.7132047639,0.9114927192 
 C,0,-0.4694978295,2.5124105622,0.6761411108 
 H,0,-1.5038071826,2.182941387,0.6972694415 
 C,0,-6.5168437068,-1.6156774782,0.597704289 
 C,0,0.5228444778,1.6518001347,0.2148446087 
 C,0,5.0788179965,-0.5467005076,-1.2447491934 
 C,0,-0.4198951642,-6.0953110355,-1.4567597045 
 H,0,-0.4583517294,-7.1734996191,-1.5670358993 
 C,0,3.184962033,-3.988409415,-2.0494539242 
 H,0,3.9596361174,-3.228214344,-2.1366842479 
 H,0,3.0406909886,-4.4977275898,-3.0067194132 
 H,0,3.449544349,-4.7140587178,-1.2748730996 
 C,0,-1.5454108047,-5.3847322423,-1.1078794218 
 H,0,-2.4845211988,-5.9022336034,-0.9317996354 
 C,0,7.2476722988,-2.8817470487,-3.0118700863 
 H,0,7.7592709101,-3.3808967349,-2.1799569217 
 H,0,7.9539626926,-2.2143620069,-3.520091917 
 H,0,6.8908933525,-3.6321914558,-3.717620928 
 C,0,-1.9359206797,1.3986857513,-4.9172989735 
 H,0,-2.0768280806,1.9208146567,-3.9724290452 
 H,0,-2.7850615538,1.5948551728,-5.5778132574 
 H,0,-1.0188634186,1.7506520806,-5.3991031001 
 C,0,-1.7007277445,-0.8977191565,-5.8130997376 
 H,0,-1.6709467977,-1.9396382403,-5.4907065714 
 H,0,-0.7739535581,-0.6627342289,-6.3447526603 
 H,0,-2.5490368399,-0.758561443,-6.4889444541 
 C,0,3.853340603,2.6291722787,4.4436500578 
213 
 
 C,0,5.2032859488,2.3044533993,4.5989164159 
 C,0,5.6622776379,1.0373103075,4.245232649 
 C,0,4.7739504251,0.0974134641,3.7368379672 
 C,0,3.4132507643,0.4094915233,3.5776832444 
 C,0,2.9634447277,1.6930051757,3.9386216009 
 C,0,2.5412805493,-0.608764866,3.02247102 
 C,0,1.2186252005,-0.5051543914,2.8126745769 
 N,0,0.5033145911,-1.5843746394,2.2065569896 
 O,0,-0.7090041575,-1.418768522,2.0574704017 
 O,0,1.0952204952,-2.6007177074,1.8622099322 
 H,0,3.4974496516,3.6177685996,4.7166793562 
 H,0,5.8951957765,3.0418670874,4.9947284599 
 H,0,6.7107356617,0.7825466294,4.3641004195 
 H,0,5.128792149,-0.890751074,3.4567986536 
 H,0,1.918626206,1.9619135343,3.8188868326 
 H,0,3.0070613473,-1.5488444762,2.734560909 
 H,0,0.5781467947,0.3341199896,3.0423804901 
 
Sum of electronic and zero-point Energies=          -5825.745649 
 Sum of electronic and thermal Energies=             -5825.681056 
 Sum of electronic and thermal Enthalpies=           -5825.680112 
 Sum of electronic and thermal Free Energies=        -5825.856039 
 
 
-N(O)OH Michael addition product 
 
 O,0,-1.286231384,-1.6895695387,1.091401106 
 O,0,-0.2536400296,-3.5912509089,0.7260784877 
 O,0,-0.7716177911,1.4044669942,2.1863328382 
 O,0,-4.2718273931,1.0013166981,-0.6617762484 
 O,0,-0.3028461081,-0.7470952919,-1.9599259812 
 N,0,-0.1957747142,-2.2035255635,0.7756613468 
 N,0,-2.2607098787,0.230700829,-1.3793513195 
 N,0,-2.5109013661,1.2806158509,0.7390809298 
 C,0,-0.2529688262,0.6540937482,-0.0237514232 
 C,0,0.980816516,-0.0964590252,0.5629603596 
 C,0,2.3013208837,0.4055351003,0.0074857893 
 C,0,-3.0833231554,0.8508568638,-0.4497812818 
 C,0,-1.1852427176,1.1111955334,1.080168046 
 C,0,3.1498855037,1.1537977837,0.8265437984 
 C,0,-2.9156148719,-0.2911204345,-2.5739528014 
 C,0,4.3643829747,1.6344647915,0.3420310545 
 C,0,4.7462021418,1.3673919895,-0.9699632758 
 H,0,1.7542463283,-2.1819069188,0.1656945776 
 C,0,0.9021691097,-1.58805496,0.4673029607 
 C,0,-0.9220775039,-0.0442516035,-1.181458164 
 C,0,2.6907743234,0.1432129847,-1.3101632449 
 C,0,3.9058577658,0.6206533089,-1.7936713516 
 C,0,-3.4293236143,1.8560517584,1.7162225895 
 H,0,0.1294717267,1.5927714061,-0.4544595822 
214 
 
 H,0,0.9579535581,0.1696546016,1.6283059432 
 H,0,2.8574849461,1.3627166222,1.852682739 
 H,0,-3.6049855478,0.4593526631,-2.957227265 
 H,0,-3.4708243363,-1.2034052702,-2.3419042437 
 H,0,-2.1429997154,-0.5128873012,-3.3062467933 
 H,0,5.0123838414,2.214866671,0.9924119738 
 H,0,5.6935608909,1.7391655631,-1.3494090979 
 H,0,0.6579650956,-3.9119176,0.643336065 
 H,0,2.0269035046,-0.4265993303,-1.9536826639 
 H,0,4.1965847374,0.4097818235,-2.8189355201 
 H,0,-4.0027419739,2.6562015813,1.2485362491 
 H,0,-2.8322748189,2.244150878,2.5375430619 
 H,0,-4.1176381016,1.0933277021,2.0864803416 
 
Sum of electronic and zero-point Energies=          -1081.384739 
 Sum of electronic and thermal Energies=             -1081.364105 
 Sum of electronic and thermal Enthalpies=           -1081.363161 
 Sum of electronic and thermal Free Energies=        -1081.436745 
 
 
 
 
 
 
-NO2 Michael addition product 
 
O,0,-1.2346208963,-1.7053022181,1.0904645873 
 O,0,0.075859554,-3.3201299198,1.6633049276 
 O,0,-0.7773142792,1.4575373542,2.0899890782 
 O,0,-4.2923482074,0.8987542313,-0.7109167629 
 O,0,-0.2883779996,-0.7411390564,-2.0473224091 
 N,0,-0.138891769,-2.2505924958,1.1264423359 
 N,0,-2.2761725369,0.1361005858,-1.4174527965 
 N,0,-2.5255818347,1.2617262096,0.6636599637 
 C,0,-0.2598423332,0.6456929648,-0.0994989707 
 C,0,0.9799664936,-0.0610312302,0.5126725805 
 C,0,2.3052338971,0.448215724,-0.0305482602 
 C,0,-3.1009655772,0.7788495901,-0.5021930239 
 C,0,-1.1944576814,1.126555525,0.9962681725 
 C,0,3.305810721,0.8282932079,0.8686583155 
 C,0,-2.9427391771,-0.4209885385,-2.5909671398 
 C,0,4.5403069503,1.2813721939,0.4109589298 
 C,0,4.7908541027,1.3595745724,-0.9567149228 
 H,0,1.8997175971,-1.9846160287,0.9024554512 
 C,0,1.0020859791,-1.5873581693,0.4307273314 
 C,0,-0.9248777622,-0.0720372833,-1.2495475457 
 C,0,2.5675407841,0.5235670273,-1.4023442933 
 C,0,3.8012005086,0.9795943405,-1.8603881064 
 C,0,-3.4446373108,1.8598335586,1.6272247349 
 H,0,0.1037446643,1.5821499149,-0.5536058698 
215 
 
 H,0,0.9512989349,0.2102676175,1.5725583993 
 H,0,3.1145018342,0.7742875152,1.9376972832 
 H,0,-3.5481098116,0.3521952207,-3.0631473012 
 H,0,-3.5875267145,-1.2531965774,-2.3010877899 
 H,0,-2.1715140311,-0.7713849984,-3.2719750498 
 H,0,5.3037123822,1.5779105025,1.1243682219 
 H,0,5.7517404801,1.7157768581,-1.31642127 
 H,0,0.9473925726,-1.9383633094,-0.6028270963 
 H,0,1.8013592941,0.2191112965,-2.1096052608 
 H,0,3.9892610649,1.0362339044,-2.9287672498 
 H,0,-4.0326951766,2.633941268,1.1346173665 
 H,0,-2.8468689487,2.2864397223,2.428576397 
 H,0,-4.1184457674,1.1011589199,2.0305870424 
 
Sum of electronic and zero-point Energies=          -1081.410627 
 Sum of electronic and thermal Energies=             -1081.390523 
 Sum of electronic and thermal Enthalpies=           -1081.389579 
 Sum of electronic and thermal Free Energies=        -1081.462764 
 
1Im 
Y,0,-2.0960341887,-1.599042146,0.6994400105 
 Zn,0,1.3376966806,-1.0685472828,0.3642025698 
 Cl,0,7.7982603627,-3.1137658866,-0.5448246748 
 Cl,0,-0.9098467363,3.2853211792,5.8859232221 
 O,0,-0.2698850972,-0.2820468142,1.2610538396 
 O,0,-0.1614584707,-2.2579705366,-0.385560509 
 O,0,2.9623592362,-0.0876279694,0.8997910395 
 O,0,-4.2354941021,-1.409178255,0.4974185725 
 O,0,-2.4078389278,-3.0798610599,-1.3114831598 
 O,0,-1.4474308631,-2.4694457527,2.8486226845 
 O,0,-2.4982311074,-3.8051814283,1.5328698861 
 O,0,-6.5691908842,-2.0927815691,-0.4869674958 
 O,0,1.8479045072,3.5983150577,5.0781387482 
 N,0,2.7050488374,-2.3275761177,-0.5622106927 
 N,0,-2.7123595264,0.4019526297,2.017739006 
 O,0,8.7094832068,-0.4892793323,0.2851187824 
 N,0,1.8646717995,2.4936882178,4.558198458 
 O,0,-1.9064536743,-4.4880127839,3.5092315328 
 O,0,2.8656719716,1.7963313826,4.4598769779 
 O,0,7.727954135,0.2937701039,2.0427165469 
 N,0,-1.9495817833,-3.6239050711,2.6669772538 
 N,0,7.7309091103,-0.3479377108,1.0011685429 
 C,0,4.0478904401,-0.7312057474,0.5664874628 
 C,0,-0.0764593342,-3.149450635,-1.3540185202 
 C,0,-5.0810817126,0.6301744111,1.4124608151 
 C,0,-1.7555616857,1.7886446728,3.8395828206 
 C,0,6.4729022043,-0.9498281046,0.5809927041 
 C,0,3.997868431,-1.9293556535,-0.2136572445 
 C,0,-6.5131647218,-0.9102680745,0.1732068069 
216 
 
 C,0,-7.5796779062,-0.0472319012,0.3499168386 
 C,0,5.1665229096,-2.6197178692,-0.5342223559 
 C,0,0.6308058173,1.9758489445,3.9882702277 
 C,0,-1.6337936394,0.9556161298,2.726534426 
 C,0,-0.6373124851,2.3209892547,4.4721146135 
 C,0,5.318317253,-0.2723834926,0.9487242946 
 C,0,-1.3159844653,-4.5820202027,-2.8963614363 
 C,0,2.4464954909,-3.2153587602,-1.4699420998 
 C,0,1.1386151341,-3.6447159096,-1.8886893446 
 C,0,-3.8505848274,1.0391669078,2.0154422745 
 C,0,-7.4199828881,1.1640141764,1.0519018658 
 C,0,-1.2931161631,-3.6370853617,-1.8882593629 
 C,0,-6.1940337765,1.4960426162,1.572547944 
 C,0,0.77287409,1.0976563482,2.9157075624 
 C,0,6.4145803277,-2.1396799137,-0.161534835 
 C,0,-0.3461970692,0.569782092,2.2805289698 
 C,0,-5.2216694347,-0.5896508675,0.696042986 
 C,0,-0.1074306184,-5.0738133064,-3.4150296206 
 C,0,-3.6846036206,-3.5273728714,-1.783312064 
 C,0,1.0913253734,-4.6110804905,-2.9221844329 
 C,0,-7.8127700273,-2.4724708224,-1.0422363233 
 H,0,-2.7325182747,2.0115361598,4.2538044706 
 H,0,-8.5543875581,-0.2961139099,-0.0557327507 
 H,0,5.1228151329,-3.5641867823,-1.0658608849 
 H,0,5.4013511655,0.6354738692,1.5341555035 
 H,0,-2.256322801,-4.9478577161,-3.2919859854 
 H,0,3.272955009,-3.689400199,-2.0071146978 
 H,0,-3.902738256,2.0100954043,2.5178488223 
 H,0,-8.2722003871,1.8239215739,1.1757368518 
 H,0,-6.0596669334,2.424480924,2.1213768101 
 H,0,1.7675682103,0.8367286759,2.566791816 
 H,0,-0.1295711834,-5.8161535163,-4.2053074672 
 H,0,-4.4262087946,-2.9681604312,-1.2151347406 
 H,0,-3.791952868,-4.6013107861,-1.6049023018 
 H,0,-3.7837222404,-3.3094667123,-2.8501287621 
 H,0,2.0283070143,-4.9856332575,-3.3248244878 
 H,0,-8.1572076234,-1.7473746733,-1.7895999194 
 H,0,-8.5810125878,-2.5828187749,-0.2674426315 
 H,0,-7.6478056833,-3.4360344161,-1.5248590894 
 O,0,-1.9860820076,0.1241654024,-1.0723694225 
 O,0,-3.5154697888,-0.2647234988,-2.5470403163 
 O,0,-1.5034090058,3.8051602323,-0.8593098145 
 O,0,2.8659088943,5.0154951073,-0.7567040902 
 O,0,1.8986992999,0.9057424913,-2.4184849675 
 N,0,-2.6202495497,0.4041231759,-2.0978924761 
 N,0,2.4000887787,2.948748454,-1.5650393646 
 N,0,0.6763823224,4.4303336654,-0.8324384485 
 C,0,0.0498074036,2.1997978647,-1.6753194897 
 C,0,-0.7360714119,1.8365061616,-2.969234695 
 C,0,-0.4598925044,2.8244815277,-4.0892808748 
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 C,0,2.0300653628,4.1808114244,-1.036956651 
 C,0,-0.3351336845,3.5381890589,-1.1003018355 
 C,0,0.4696978089,2.4906974552,-5.0796600761 
 C,0,3.8339221643,2.738712419,-1.744029073 
 C,0,0.7632321535,3.3825406576,-6.1078848369 
 C,0,0.1258190091,4.6196421197,-6.1629008022 
 H,0,-2.7586472587,1.6312742939,-3.7458192436 
 C,0,-2.2487393553,1.6711138616,-2.7849267607 
 C,0,1.5201329282,1.9561064573,-1.9270705219 
 C,0,-1.0963330624,4.0701188873,-4.1526181536 
 C,0,-0.8048401064,4.9596278181,-5.1838334969 
 C,0,0.3521669482,5.7339758732,-0.2598289074 
 H,0,-0.2299718263,1.467206502,-0.9068984846 
 H,0,-0.3291380422,0.8683808176,-3.2770928442 
 H,0,0.9686881769,1.5262421845,-5.0397282942 
 H,0,4.3371360862,2.7668569931,-0.7761023208 
 H,0,4.2442570407,3.5195305065,-2.385251875 
 H,0,3.9648310688,1.7633675287,-2.2057195705 
 H,0,1.4876263927,3.106733293,-6.8686266512 
 H,0,0.3507308615,5.3146474959,-6.9665252528 
 H,0,-2.6698315609,2.4641355129,-2.1603242716 
 H,0,-1.8219669413,4.3554056595,-3.3962222089 
 H,0,-1.3091080535,5.9207830182,-5.221030006 
 H,0,0.8324983344,5.8418726758,0.7137028112 
 H,0,-0.7285671481,5.7833718389,-0.153932166 
 H,0,0.7039383497,6.5255672077,-0.9227152165 
 
Sum of electronic and zero-point Energies=          -6145.547670 
 Sum of electronic and thermal Energies=             -6145.479678 
 Sum of electronic and thermal Enthalpies=           -6145.478734 
 Sum of electronic and thermal Free Energies=        -6145.664358 
 
2Im 
Y,0,-1.0947329209,0.1148115111,1.5472588127 
 Zn,0,2.2378752717,0.1767668308,0.5978656357 
 Cl,0,8.7483197385,-1.8977677453,0.3986105465 
 Cl,0,0.4495625794,7.041508129,2.4565528977 
 O,0,0.6078752332,1.464197786,0.5767390466 
 O,0,0.783442,-1.1535090824,1.05081978 
 O,0,3.7780299179,1.2270419325,-0.0082419638 
 O,0,-3.2464041861,0.1371445187,1.740322269 
 O,0,-1.4458056419,-2.3789564298,1.4572260935 
 O,0,0.1874590404,0.9713479975,3.3934268916 
 O,0,-0.9818421729,-0.7909210892,3.7742605106 
 O,0,-5.612365539,-0.9643928519,1.9295914897 
 O,0,2.9526252037,6.7982733117,1.0369633494 
 N,0,3.6279868839,-1.3655066469,0.6749092771 
 N,0,-1.7030548657,2.4832622019,1.4343034843 
 O,0,9.4188481327,0.5000952056,-1.0884271611 
218 
 
 N,0,2.9962872153,5.5941304966,1.2313243503 
 O,0,0.2342269553,0.0562561039,5.3632900748 
 O,0,4.0318226547,4.9480313048,1.3180567357 
 O,0,8.5648240303,2.3169183213,-0.2905480884 
 N,0,-0.1710556422,0.0777877354,4.2254506586 
 N,0,8.5232430692,1.1197440639,-0.5374222254 
 C,0,4.8892313904,0.5425480897,0.0569204083 
 C,0,0.8748926777,-2.4664800384,1.1704051382 
 C,0,-4.1516811281,2.3248031916,1.3891606754 
 C,0,-0.5896200209,4.6552220295,1.862319608 
 C,0,7.3070660274,0.4031210804,-0.1764721483 
 C,0,4.8957712484,-0.8434930488,0.4091201704 
 C,0,-5.5855272862,0.3718007304,1.7047858354 
 C,0,-6.7000441051,1.1776811866,1.5610982123 
 C,0,6.0949684915,-1.5508051534,0.4950932255 
 C,0,1.7435200307,4.8625755105,1.3384192677 
 C,0,-0.5866555009,3.3320547369,1.4162679577 
 C,0,0.5586787655,5.4378800872,1.8141906293 
 C,0,6.1294307584,1.1352665674,-0.2263081617 
 C,0,-0.3440731685,-4.5537160566,1.548142632 
 C,0,3.3742121415,-2.6273217553,0.8119066936 
 C,0,2.0795623619,-3.2058750984,1.0668908047 
 C,0,-2.8952889654,3.0023094463,1.3207863405 
 C,0,-6.5660776504,2.561273024,1.3274594848 
 C,0,-0.3280651426,-3.1777569438,1.4072448591 
 C,0,-5.3170689098,3.1230227713,1.2434088809 
 C,0,1.7768331453,3.5284442659,0.9362270668 
 C,0,7.309251961,-0.9518747394,0.1913053304 
 C,0,0.6262546168,2.7561659094,0.9749755523 
 C,0,-4.269407581,0.9244323485,1.6157304325 
 C,0,0.8540408283,-5.2768285732,1.4448601515 
 C,0,-2.689134089,-2.9942747086,1.8270179817 
 C,0,2.0371376711,-4.6135498047,1.2058008062 
 C,0,-6.8795995948,-1.5832147312,2.0316401486 
 H,0,-1.487471268,5.0859889326,2.2912106694 
 H,0,-7.6942209422,0.7486995074,1.6254420845 
 H,0,6.1060491554,-2.5852528792,0.8208517658 
 H,0,6.1677898361,2.1823723479,-0.5015225916 
 H,0,-1.2735318314,-5.0793360362,1.7350310647 
 H,0,4.1850571311,-3.3552236871,0.7192347763 
 H,0,-2.9763466003,4.0790365736,1.1424130675 
 H,0,-7.4566486255,3.1711571463,1.2181523348 
 H,0,-5.2011746071,4.1895644401,1.0695601365 
 H,0,2.7098986824,3.0969805234,0.5853041345 
 H,0,0.8379537831,-6.3554175658,1.5551656517 
 H,0,-3.4187503596,-2.1857816834,1.8683670944 
 H,0,-2.5909849561,-3.4724572312,2.8055052995 
 H,0,-2.9848699593,-3.7265395115,1.0713451022 
 H,0,2.9671035481,-5.1695117538,1.1263986033 
 H,0,-7.4555755827,-1.4741799246,1.1047399511 
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 H,0,-7.460329452,-1.1726475443,2.8664674336 
 H,0,-6.6868344737,-2.6407772437,2.2130709317 
 O,0,-1.5466934046,-0.1378718354,-0.7549080513 
 O,0,-0.2840481278,1.3663718181,-1.8641570415 
 O,0,1.1113347437,-2.3808598602,-2.7106654866 
 O,0,0.0827581066,-6.7696638803,-2.1829592102 
 O,0,-3.2817835031,-3.7707069497,-1.6444258289 
 N,0,-0.9419431198,0.1807208115,-1.8432668825 
 N,0,-1.6111179296,-5.2847557911,-1.923489362 
 N,0,0.6090554622,-4.5805306255,-2.4544324231 
 C,0,-1.1218642142,-2.8756588641,-2.0673319314 
 C,0,-1.735167524,-1.7863209438,-2.9964469014 
 C,0,-1.9357419202,-2.263840172,-4.4205678772 
 C,0,-0.2848370248,-5.6128407485,-2.1834405289 
 C,0,0.2873987653,-3.2442158663,-2.4523766993 
 C,0,-3.2120293177,-2.6612693146,-4.8304667825 
 C,0,-2.5059187611,-6.4101904329,-1.6686814011 
 C,0,-3.4281413253,-3.1288340075,-6.1241839467 
 C,0,-2.3698664841,-3.2011678057,-7.0266377668 
 H,0,-0.387141012,-0.1120450422,-3.7502793786 
 C,0,-0.9505923107,-0.5200182875,-2.9233586655 
 C,0,-2.1074409388,-4.0023549936,-1.8750880176 
 C,0,-0.8773287338,-2.3402794031,-5.3331600448 
 C,0,-1.0951938158,-2.805215476,-6.6276459021 
 C,0,1.9819892902,-4.9889319895,-2.738043211 
 H,0,-1.0412049224,-2.4072488373,-1.0751571304 
 H,0,-2.7171808752,-1.5870550338,-2.5501901496 
 H,0,-4.0391910824,-2.606642095,-4.1281096983 
 H,0,-2.1891034885,-6.9401922403,-0.7687733899 
 H,0,-2.4851320737,-7.0967097483,-2.5156161887 
 H,0,-3.5061650287,-6.0062368227,-1.5339563564 
 H,0,-4.4262009611,-3.4316648946,-6.4270444426 
 H,0,-2.5377015615,-3.5616269981,-8.0372751736 
 H,0,0.1004861878,1.4474159929,-0.9368517576 
 H,0,0.1236720039,-2.0410603907,-5.0352230183 
 H,0,-0.2649180639,-2.8563279865,-7.3258968708 
 H,0,2.4090017062,-5.4813861584,-1.8627669745 
 H,0,2.5461104557,-4.090737638,-2.9763634807 
 H,0,1.9943513942,-5.6794958288,-3.5818299862 
 
Sum of electronic and zero-point Energies=          -6145.544478 
 Sum of electronic and thermal Energies=             -6145.477122 
 Sum of electronic and thermal Enthalpies=           -6145.476178 
 Sum of electronic and thermal Free Energies=        -6145.656179 
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9.6 ESI-MS of LMLn-NO3 
 
Figure S9.14. ESI-MS of 6ZnY-NO3  
 
Figure S9.15. ESI-MS of 8ZnY-NO3. 789.85 m/z peak corresponds to- [ZnII2YIII2(L8)4(NO3)2]2+  
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Figure S9.16. ESI-MS of 9ZnY-NO3 789.85 m/z peak corresponds to a [ZnII2YIII2(L9)4(NO3)2]2+ 
fragment.  
 
Figure S9.17. ESI-MS of 2ZnY-NO3. 1534.08 m/z m/z peak corresponds to a - 
[ZnII2YIII2(L2)4(CH3OH)2]1+ fragment. 
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Figure S9.18. ESI-MS of 16ZnY-NO3  849.1129 m/z peak corresponds to a [ZnII2YIII2(L16)4(NO3)]2+ 
fragment and the  1697.15 m/z peak corresponds to a [ZnII2YIII2(L11)4(NO3)]1+ fragment. 
 
Figure S9.19. ESI-MS of 19ZnY-NO3 821.04 m/z peak corresponds to a [ZnII2YIII2(L19)4(NO3)]2+ 
fragment; 1641.09 m/z peak corresponds to a [ZnII2YIII2(L19)4(NO3)]1+ fragment. 
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Figure S9.20. ESI-MS of 20ZnY-NO3. 901.11 m/z peak corresponds to a [ZnII2YIII2(L20)4(NO3)]2+ 
fragment; 1801.21 m/z peak corresponds to a ZnII2YIII2(L20)4(NO3)]1+fragment. 
 
Figure S9.21. ESI-MS of 27ZnY-NO3. 781.11 m/z peak corresponds to a [ZnII2YIII2(L27)4(NO3)]2+ 
fragment; 1561.21 m/z peak corresponds to a [ZnII2YIII2(L27)4(NO3)]+ fragment. 
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ZnY17 
 
Figure S9.22. ESI-MS of 28ZnY-NO3. 861.11 m/z peak corresponds to a [ZnII2YIII2(L28)4(NO3)]2+ 
fragment; 1720.21 m/z peak corresponds to a [ZnII2YIII2(L28)4(NO3)] +. 
 
Figure S9.23. ESI-MS of 24ZnY-NO3. 710.97 m/z peak corresponds to a 
[ZnII2YIII2(L24)4(NO3)2(H2O)] fragment ;1336.94 m/z peak corresponds to a [ZnII2YIII2(L24)4(NO3)]+ 
fragment. 
225 
 
 
Figure S9.24. ESI-MS of 25ZnY-NO3  
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9.7 TGA of LMLn-NO3 
 
Figure S9.25. TGA of 6ZnY-NO3 
 
Figure S9.26. TGA of 5ZnY-NO3 
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Figure S9.27. TGA of 8ZnY-NO3 
 
Figure S9.28. TGA of 9ZnY-NO3 
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Figure S9.29. TGA of 11ZnY-NO3 
 
Figure S9.30. TGA of 12ZnY-NO3 
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Figure S9.31. TGA of 13ZnY-NO3 
 
Figure S9.32. TGA of 15ZnY-NO3 
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Figure S9.33. TGA of 2ZnY-NO3 
 
Figure S9.34. TGA of 16ZnY-NO3 
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Figure S9.35. TGA of 18ZnY-NO3 
 
Figure S9.36. TGA of 19ZnY-NO3 
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Figure S9.37. TGA of 20ZnY-NO3 
 
Figure S9.38. TGA of 22ZnY-NO3 
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Figure S9.39. TGA of 27ZnY-NO3 
 
Figure S9.40. TGA of 28ZnY-NO3 
234 
 
 
Figure S9.41. TGA of 29ZnY-NO3 
 
Figure S9.42. TGA of 24ZnY-NO3 
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Figure S9.43. TGA of 25ZnY-NO3 
 
Figure S9.44. TGA of 26ZnY-NO3 
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9.8 FT-IR of LMLn-NO3 
 
Figure S9.45. FT-IR of 6ZnY-NO3 
 
Figure S9.46. FT-IR of 5ZnY-NO3 
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Figure S9.47. FT-IR of 8ZnY-NO3 
 
Figure S9.48. FT-IR of 9ZnY-NO3 
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Figure S9.49. FT-IR of 11ZnY-NO3 
 
 
Figure S9.50. FT-IR of 12ZnY-NO3 
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Figure S9.51. FT-IR of 13ZnY-NO3 
 
 
Figure S9.52 FT-IR of 15ZnY-NO3 
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Figure S9.53. FT-IR of 2ZnY-NO3 
 
 
Figure S9.54. FT-IR of 16ZnY-NO3 
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Figure S9.55. FT-IR of 18ZnY-NO3 
 
 
Figure S9.56. FT-IR of 19ZnY-NO3 
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Figure S9.57. FT-IR of 20ZnY-NO3 
 
 
Figure S9.58. FT-IR of 22ZnY-NO3 
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Figure S9.59. FT-IR of 27ZnY-NO3 
 
 
Figure S9.60. FT-IR of 28ZnY-NO3 
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Figure S9.61. FT-IR of 29ZnY-NO3 
 
 
Figure S9.62. FT-IR of 24ZnY-NO3 
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Figure S9.63. FT-IR of 25ZnY-NO3 
 
 
 
Figure S9.64. FT-IR of 26ZnY-NO3 
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9.9 1HNMR and 13CNMR of C9a-C9v 
 
 
Figure S9.65. (Top) 1H NMR of C9a (Bottom) 13C NMR of C9a 
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Figure S9.66. (Top) 1H NMR of C9c (Bottom) 13C NMR of C9c 
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Figure S9.67. (Top) 1H NMR of C9e (Bottom) 13C NMR of C9e 
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. Figure S9.68. (Top) 1H NMR of C9b (Bottom) 13C NMR of C9b 
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Figure S9.69. (Top) 1H NMR of C9f (Bottom) 13C NMR of C9f 
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Figure S9.70. (Top) 1H NMR of C9v (Bottom) 13C NMR of C9v 
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Figure S9.71. (Top) 1H NMR of C9g (Bottom) 13C NMR of C9g 
253 
 
 
Figure S9.72. (Top) 1H NMR of C9d (Bottom) 13C NMR of C9d 
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Figure S9.73. (Top) 1H NMR of C9h (Bottom) 13C NMR of C9h 
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Figure S9.74. (Top) 1H NMR of C9g (Bottom) 13C NMR of C9g 
256 
 
 
 
 
Figure S9.75. (Top) 1H NMR of C9k (Bottom) 13C NMR of C9k 
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Figure S9.76. (Top) 1H NMR of C9l (Bottom) 13C NMR of C9l 
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Figure S9.77. (Top) 1H NMR of C9m (Bottom) 13C NMR of C9m 
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Figure S9.78. (Top) 1H NMR of C9n(Bottom) 13C NMR of C9n 
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Figure S9.79. (Top) 1H NMR of C9o (Bottom) 13C NMR of C9o 
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Figure S9.80. (Top) 1H NMR of C9p (Bottom) 13C NMR of C9p 
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Figure S9.81. (Top) 1H NMR of C9s (Bottom) 13C NMR of C9s 
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Figure S9.82. (Top) 1H NMR of C9t (Bottom) 13C NMR of C9t 
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Figure S9.83. (Top) 1H NMR of C9r (Bottom) 13C NMR of C9r 
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Figure S9.84. (Top) 1H NMR of C9q (Bottom) 13C NMR of C9q 
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Figure S9.85. (Top) 1H NMR of C9u (Bottom) 13C NMR of C9u 
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Figure S9.86.1H NMR of C9g  
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9.10 Crude 1HNMR Stereo selectivity  
 
Figure S9.87. Trans 1-Ln Crude 1H NMR 
  
 
Figure S9.88. Cis 1-Ln Crude 1H NMR 
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9.11 ESI-MS C9a-C9v 
 
 
Figure S9.89. ESI-MS of C9j 
 
 
Figure S9.90. ESI-MS of C9i 
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Figure S9.91. ESI-MS of C9j 
 
Figure S9.92. ESI-MS of C9h 
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Figure S9.93. ESI-MS of C9a 
 
Figure S9.94. ESI-MS of C9e 
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Figure S9.89. ESI-MS of C9m 
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Chapter 10 
 
10.1 Reported PCCs in this thesis 
 
Table S10.1 List of PCCs synthesised  
Entry Formula Ligand Topology Chapter Ref 
1 [ZnII2LnIII2(L1)4(EtOH)6](ClO4)2 
Ln = Dy (1), Tb (2), Eu (3) 
H2L1 2,3M4-1 2 1 
2 [ZnII5Ln(OH)(L1)6(H2O)] 
Ln= Dy (4), Tb (5), Eu (6) 
H2L1 2,3,4M6-1 2 1 
3 [(ZnII4LnIII2(OH)2(L2)4(OAc)2(NO3)2(DMF)3] 
Ln = Dy (7), Tb (8), Eu (9) 
H2L2 2,3,4M6-1 2 1 
4 [ZnII2LnIII2(L3)2(NO3)2(CO3)2(CH3OH)2] 
Ln = Dy (10), Tb (11), Eu (12) 
H3L3 1,2,4M-1 2 1 
5 [ZnII4DyIII7(OH)4(O2)2(L1)8Cl4(H2O)4]Cl5 (13) H2L1 2,4,4,4M11-1 2 1 
6 [ZnII6DyIII4(OH)2(L1)10(MeOH)2(H2O)4]Cl2 (14) H2L1 2,2,3,3M10-1 2 1 
274 
 
7 [CoII4LnIII2(µ3-OH)2(L1)4Cl2(NO3)2(MeOH)4] 3(Et2O) 
Ln = Y (15), Gd (16), Dy(17), Tb (18) 
H2L1 2,3,4M6-1 3 2 
8 [CoII4DyIII2(µ3-OH)2(L5)4Cl2(NO3)2(MeOH)4] (19) H2L5 2,3,4M6-1 3 2 
10 [CoII3LnIII4(µ3-OH)6(L4)6(CF3SO3)](CF3SO3)5] 
Ln = Gd (20), Y (21) 
HL4 3,6M7-1 4 3 
11 [NiII3LnIII4(µ3-OH)6(L4)6(CF3SO3)](CF3SO3)5] 
Ln = Dy (22) Gd (23), Y (24) 
HL4 3,6M7-1 4 3 
12 (Et3NH)[CoIII(L8)2]·3MeOH (25) H2L8 (0) 5 4 
13 (Et3NH)[CoIII(L18)2]·2MeOH (26) H2L18 (0) 5 4 
14 [NiII2DyIII2(L20)4(allyl-o-vanillin)2(EtOH)2]·3CH2Cl2 (27) H2L20 2,3M4-1 5 4 
15 [NiII2DyIII2(L20)4(DMF)6](ClO4)2.4DMF (28) H2L20 2,3M4-1 5 4 
16 [NiII2DyIII2(L22)4(bromo-o-vanillin)2(EtOH)2].6EtOH (29) H2L22 2,3M4-1 5 4 
17 [NiII2DyIII2(L16)4(allyl-o-vanillin)2(EtOH)2] 2THF 2EtOH (30) H2L16 2,3M4-1 5 4 
18 [NiII2DyIII2(L16)4(DMF)2](ClO4)2 (31) H2L16 2,3M4-1 5 4 
19 [NiII2DyIII2(L1)4(EtOH)4(H2O)2](ClO4)2 (32) H2L1 2,3M4-1 5 4 
20 [NiII2DyIII2(L1)4(DMF)6](OTf3)2·2DMF (33) H2L1 2,3M4-1 5 4 
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21 [NiII2DyIII2(L18)4(DMF)6] [NiII2DyIII2(L18)4(DMF)4(H2O)2] (ClO4)4 5DMF 
(34) 
H2L18 (2,3M4-1)+ (2,3M4-1) 5 4 
22 [NiII4(L2)4(MeOH)4] (35) H2L2 3M4-1 5 4 
23 [NiII2DyIII2(L2)4(EtOH)6](ClO4)2 4EtOH (36) H2L2 2,3M4-1 5 4 
24 [NiII2DyIII2(L19)4(DMF)6](ClO4)2·2Et2O (37) H2L19 2,3M4-1 5 4 
25 [NiII2DyIII2(L1)4(OAc)2(MeOH)2] ·2MeOH (38) H2L1 2,3M4-1 5 4 
26 [CoII2DyIII2(L9)4(M1)2(DMF)2] (39) H2L9 2,3M4-1 5 4 
27 [CoII2DyIII2(L9)4(M2)2(DMF)2] · 2DMF (40) H2L9 2,3M4-1 5 4 
28 [DyIII(M1)3(DMF)2] (41) M1 (0) 5 4 
29 [NiII2DyIII2(OH)(L2)3(M1)3(DMF)2] (42) H2L2 2,3M4-1 5 4 
30 [ZnII4LnIII11(µ4-OH)2(µ3-OH)8(µ2-OH2)2(µ3-NO3)2(NO3)6Cl4(HL)2(L’)4(µ2-
MeO)7(µ3-MeO)2(MeOH)2(H2O)2] 
Ln = Dy (43), Gd (44)  
H2L 1,2,3,4,5,5,5,8M15--1 6 This 
work 
31 [NiII2DyIII2(L1)4(EtOH)6](ClO4)2·2(EtOH) (1NiDy-ClO4) H2L1 2,3M4-1 7 5 
32 [CoII2DyIII2(L1)4(EtOH)6](ClO4)2·2(EtOH) (1CoDy-ClO4) H2L1 2,3M4-1 7 5 
33 [NiII2LnIII2(L1)4Cl2(CH3CN)2]·2(CH3CN) 2 H2L1 2,3M4-1 7 5,6 
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Ln = Dy (1NiDy-Cl), Sm (1NiSm-Cl), Eu (1NiEu -Cl), Gd (1NiGd-Cl), Tb 
(1NiTb-Cl), Y (1NiY-Cl) 
34 [CoII2LnIII2(L1)4Cl2(CH3CN)2]·2(CH3CN) 2 (1CoDy-Cl) H2L1 2,3M4-1 7  
35 [NiII2LnIII2(L6)4Cl2(DMF)2] (6NiY-Cl) H2L6 2,3M4-1 7 6 
36 [NiII2LnIII2(L2)4Cl2(DMF)2] (2NiY-Cl) H2L2 2,3M4-1 7 6 
37 [NiII2LnIII2(L16)4Cl2(DMF)2] (16NiY- Cl) H2L16 2,3M4-1 7 6 
38 [NiII5SmIII2(CO3)(L1)7(L’)(H2O)3] (1NiSm-Cl-A) H2L1  7 6 
39 [NiII2SmIII2(L1)4(O-Van)2(H2O)2] (1NiSm-Cl-B) H2L1 2,3M4-1 7 6 
40 [SmIII4(OH)2(L1)4(HL1)2] (1NiSm-Cl-C) H2L1  7 6 
41 [NiΙΙ8EuΙΙΙ4(L1)8(CO3)4Cl4(H2O)14] (1NiEu-Cl-A) H2L1  7 6 
42 [ZnII2LnIII2(L1)4(NO3)2(DMF)2] 
Ln = Y(1ZnY-NO3), Sm (1ZnSm-NO3), Eu (1ZnEu-NO3), Gd(1ZnGd-
NO3), Dy (1ZnDy-NO3), Tb (1ZnTb-NO3), Yb (1ZnYb-NO3) 
H2L1 2,3M4-1 8 7 
44 [ZnII2YIII2(L5)4(NO3)2(DMF)2] (5ZnY-NO3) H2L5 2,3M4-1 9 8 
45 [ZnII2YIII2(L6)4(NO3)2(DMF)2] (6ZnY-NO3) H2L6 2,3M4-1 9 8 
46 [ZnII2YIII2(L8)4(NO3)2(DMF)2] (8ZnY-NO3) H2L8 2,3M4-1 9 8 
47 [ZnII2YIII2(L9)4(NO3)2(DMF)2] (9ZnY-NO3) H2L9 2,3M4-1 9 8 
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48 [ZnII2YIII2(L11)4(NO3)2(DMF)2] (11ZnY-NO3) H2L11 2,3M4-1 9 8 
49 [ZnII2YIII2(L12)4(NO3)2(DMF)2] (12ZnY-NO3) H2L12 2,3M4-1 9 8 
50 [ZnII2YIII2(L13)4(NO3)2(DMF)2] (13ZnY-NO3) H2L13 2,3M4-1 9 8 
51 [ZnII2YIII2(L15)4(NO3)2(DMF)2] (15ZnY-NO3) H2L15 2,3M4-1 9 8 
 ZnII2YIII2(L2)4(NO3)2(DMF)2] (2ZnY-NO3) H2L2 2,3M4-1 9 8 
52 [ZnII2YIII2(L16)4(NO3)2(DMF)2] (16ZnY-NO3) H2L16 2,3M4-1 9 8 
53 [ZnII2YIII2(L18)4(NO3)2(DMF)2] (18ZnY-NO3) H2L18 2,3M4-1 9 8 
54 [ZnII2YIII2(L19)4(NO3)2(DMF)2] (19ZnY-NO3) H2L19 2,3M4-1 9 8 
55 [ZnII2YIII2(L20)4(NO3)2(DMF)2] (20ZnY-NO3) H2L20 2,3M4-1 9 8 
56 [ZnII2YIII2(L22)4(NO3)2(DMF)2] (22ZnY-NO3) H2L22 2,3M4-1 9 8 
57 [ZnII2YIII2(L24)4(NO3)2(DMF)2] (24ZnY-NO3) H2L24 2,3M4-1 9 8 
58 [ZnII2YIII2(L25)4(NO3)2(DMF)2] (25ZnY-NO3) H2L25 2,3M4-1 9 8 
59 [ZnII2YIII2(L26)4(NO3)2(DMF)2] (26ZnY-NO3) H2L26 2,3M4-1 9 8 
60 [ZnII2YIII2(L27)4(NO3)2(DMF)2] (27ZnY-NO3) H2L27 2,3M4-1 9 8 
61 [ZnII2YIII2(L28)4(NO3)2(DMF)2] (28ZnY-NO3) H2L28 2,3M4-1 9 8 
62 [ZnII2YIII2(L29)4(NO3)2(DMF)2] (29ZnY-NO3) H2L29 2,3M4-1 9 8 
278 
 
63 [CuII2DyII2(L1)4(NO3)2].4MeCN (1CuDy-NO3) H2L1 2,3M4-1 9 8 
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